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Abstract 
Metabolic syndrome (MetS) is defined as the clustering of medical conditions (that is impaired fasting 
glucose (IFG) or type 2 diabetes mellitus (T2DM), hypertension (HTN), obesity and dyslipidaemia) that 
increase an individual's risk of developing diabetes or cardiovascular diseases (CVD). In the United 
Arab Emirates (UAE), the prevalence of MetS and its features are among the highest in the world. 
However, research that explores the health needs of patients with MetS within the socio-cultural 
context of the UAE is lacking. This study aimed to explore patient and professional perceptions of 
MetS and its management in the UAE. 
A qualitative approach that drew on the broad principles of grounded theory was undertaken to meet 
the aims of the study. Following ethical approval, semi-structured interviews were conducted with 29 
patients with MetS and 27 health care professionals (HCP) involved in the management of patients 
with MetS (10 physicians, 11 pharmacists, 4 dieticians and 2 health educators). This was followed by 
one focus group discussion with nine pharmacists for further exploration of identified themes. 
Interviews were audio-recoded and transcribed verbatim. NVivo aided the organisation of data. 
Thematic analysis based on the principles of grounded theory was conducted. 
This study was able to identify a number of factors that influenced patients' perceptions of their 
health and attitude towards their treatment plan. All patients interviewed were unfamiliar with the 
MetS concept and claimed to have never been informed by their physicians about their MetS 
diagnosis. Patients' awareness of the high prevalence of MetS features in the UAE, the asymptomatic 
nature of the cardiometabolic risk factors (CRFs) and the availability of treatment resulted in 
downplaying of MetS risk. Not all HCPs were familiar with the MetS concept or definition. Factors 
such as the complexity of the MetS name and the absence of the MetS diagnosis from the list of 
reimbursed medical conditions discouraged physicians from informing patients of their MetS 
diagnosis and limited the clinical utility of the MetS concept respectively. The study found that a 
number of socio-cultural factors hindered successful implementation of lifestyle interventions. Such 
factors included family restrictions of outdoor exercising by women, lack of culturally sensitive health 
clubs, food-centric activities and eating habits. Patients' beliefs about medicine and medicine brands 
affected their medicine-taking habits and altered their adherence. 
HCPs believed that a population-focused health approach would result in behavioural change. They 
also emphasised the key role of the public health policy to prevent MetS and promote a healthy 
lifestyle. Patients acknowledged the importance of adhering to lifestyle interventions to control their 
clustering risk factors. However, they believed that their lack of motivation, willpower, and limited 
physical mobility, due to coexisting health condition, were detrimental to adherence to lifestyle 
interventions. 
This study provides important new information for understanding the dynamics of patients' health 
behaviour and attitude towards MetS treatment in the UAE. It also demonstrates how aspects of the 
health policy and professionals' clinical practice limit the clinical utilisation of the MetS concept. 
Efforts to promote healthy behaviour and enhance the prevention and management of MetS in the 
UAE need to be stepped up and be tailored to patients' personal, social and cultural needs. 
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Chapter 1 
Chapter 1 
Introduction 
1.1 Introduction 
Introduction 
This thesis contributes to a better understanding of factors influencing the management of patients 
with metabolic syndrome (MetS) within the socio-cultural context of the United Arab Emirates (UAE). 
Using a qualitative methodology, this thesis describes and characterises various aspects of patients' 
health behaviour, knowledge of their health condition, perception of MetS risk and their attitude 
towards their prescribed treatment plans. This thesis also describes contextual factors that influence 
the implementation of pharmaceutical and lifestyle interventions. This chapter deals with the 
preliminary considerations; it begins with a description of background information and the problem 
statement of the study, which is followed by the aims and objectives of the study and an outline of 
the ensuing chapters of the thesis. 
1.2 The problem statement 
MetS is defined as a constellation of a number of cardiometabolic risk factors (CRF) that include Type 
2 diabetes mellitus (T2DM) or impaired fasting glucose (IFG), hypertension, obesity and dyslipidaemia 
(Alberti, Zimmet et al. 2006). This clustering of CRFs increases the risk of developing (T2DM) and 
cardiovascular diseases (CVDs) (Alberti 2005). MetS is also known as prediabetes syndrome and is 
believed to be the new driving force for a CVD epidemic. Patients with MetS are twice as likely to die 
from, and three times as likely to develop, CVDs compared with individuals without MetS. Patients 
with MetS are also at a fivefold higher risk of developing T2DM (Alberti 2005). The exact 
pathophysiology of MetS is still unclear; however, central obesity and insulin resistance are believed 
to be the main underlying causes (Byrne and Wild 2005). Other factors such as genetics, physical 
inactivity, ageing, a proinflammatory state and hormonal changes may also have a causal effect, but 
the role of these factors varies depending on the patient's ethnicity (Alberti 2005). 
12 
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The associated cardiovascular risk of MetS attracted a number of expert groups to develop uniform 
MetS definitions to facilitate the identification of this group of patients within the clinical setting. The 
World Health Organization (WHO) introduced the first definition and diagnostic criteria for the 
syndrome in 1998 (World Health Organization 1999). This was closely followed by many other 
definitions, specifically those of the European Group on Insulin Resistance (EGIR) (Balkau and Charles 
1999); the National Cholesterol Education Programme Expert Panel (NCEP) (Adult Treatment Panel 
III) (Cleeman, Grundy et al. 2001); the American Association of Clinical Endocrinologists (AACE) 
(Einhorn, Reaven et al. 2003); American Heart Association/National Heart, Lung, and Blood Institute 
(AHA/NHLBI) (Grundy, Cleeman et al. 2005) and the International Diabetes Federation (IDF) (Alberti, 
Zimmet et al. 2006). Although all groups agreed on the CRFs that constitute MetS, the existence of 
multiple definitions for MetS resulted in confusion and hindered direct comparisons of data between 
studies where different definitions were used to identify patients with MetS (Byrne and Wild 2005). 
Despite the controversy, MetS is believed to be important as a pre-morbid condition and its concept 
is useful in identifying patients whose clustering CRFs do not meet the conventional mandatory 
treatment levels but who will thus benefit from an early lifestyle intervention (Byrne and Wild 2005). 
According to the IDF consensus worldwide definition of MetS (Alberti, Zimmet et al. 2006), it is 
estimated that around 20-25% of the world's adult population have MetS. In the UAE, the 
prevalence of MetS in adults of different ethnic backgrounds was found to be 40.5% and 39.6%, 
according to the IDF and NCEP definitions of MetS, respectively (Malik and Razig 2008). Similarly, the 
UAE has a high prevalence of the CRFs that constitute MetS. For example, in 2005, the WHO 
announced that the UAE had the second highest prevalence of T2DM (20.5%) in the world, and in 
2009 the IDF reported that T2DM prevalence in the UAE was 18.7% (Hajat and Harrison 2010). 
According to the International Obesity Taskforce/International Association for the Study of Obesity, 
the prevalence of obesity in adult women living in the UAE was 31% compared with 17% of adult 
men, which makes the UAE 22"d in the prevalence of obesity worldwide (Global Prevalence of Adult 
Obesity 2010). According to the WHO, the UAE continues to show an increase in CVD risk amongst its 
adult population when compared with other neighbouring countries (Hajat and Harrison 2010). It is 
still unclear whether the high prevalence MetS in the UAE is due to a genetic predisposition, an 
unhealthy and sedentary lifestyle or a combination of both. Thus, early screening, lifestyle and 
pharmaceutical interventions are key factors in the prevention and management of MetS. Different 
strategies have been implemented to help arrest the prevalence of MetS in the UAE. The Ministry of 
13 
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Health (MOH) in the UAE has already taken initiative to address the rising prevalence of T2DM by 
establishing an independent body of local specialists and scientists to formulate a local clinical 
guideline (CG) for the management of T2DM (Mathew, Ahmed et al. 2010). Abu Dhabi's health 
authority (HAAD) stated that preventing and managing MetS was the primary target in Abu Dhabi's 
public health challenges of 2007, which was followed by cancer and road deaths (HAAD 2007). HAAD 
is also working alongside the Abu Dhabi Tourism Authority and the Imperial College London Diabetes 
Centre (ICLDC) in sponsoring public health awareness campaigns that promote health education and 
encourage early screening for CRFs and MetS (ICLDC 2009). 
The multifaceted nature of MetS suggests the need for both pharmaceutical and lifestyle 
interventions to ensure successful management. However, this indicates the presence of a strong 
behavioural element, which can render MetS management quite challenging (Kappagoda and 
Amsterdam 2007). A limited number of studies have been dedicated to exploring personal and 
contextual factors that may influence the prevention and management of MetS (Frisman and Bertero 
2008; Lopes, Zanini et al. 2008; Vieira and Turato 2010). For example, psychosocial stressors from 
everyday life and heart disease were found to be important contributing factors in the development 
of MetS (Chandola, Brunner et al. 2006). Lack of time and motivation, social isolation and leading a 
stressful lifestyle discouraged patients from initiating or maintaining a lifestyle change and resulted 
in the recurrence of unhealthy behaviour despite patients' awareness of their MetS health risk 
(Frisman and Bertero 2008). Despite the high prevalence of MetS in the UAE and its constituting 
CRFs, literature that addressed personal and contextual factors that may influence MetS holistic 
management within the UAE was not available at the time of this study. For example, Ypinazar and 
Margolis (2006) focused their exploration on the impact of religion perception of health and illness of 
a small group of elderly Emiratis. Other available local qualitative health studies used focus group 
discussions rather than in-depth interviews, which might have prevented some participants from 
engaging and disclosing some of their personal concerns. They also focused exclusively on females' 
perception of their health issues and the health care system (Winslow and Honein 2007; Berger and 
Peerson 2009; Ali, Baynouna et al. 2010; Trainer 2010). 
This study aimed to elucidate personal and contextual factors that influence MetS management in 
the UAE through the exploration of patient and professional perceptions of MetS and its 
management. Patients and health care professionals (HCPs) are in direct contact with MetS and the 
14 
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health care system within the UAE and are thus capable of describing their health issues and other 
contextual factors that affect MetS management. This research is also important because it identifies 
barriers and facilitators to MetS management within the UAE that can be utilised to help build a 
more robust health care system capable of catering for different MetS patients' needs. Reporting 
these findings will also enable HCPs and health policy makers to become more cognizant of patients' 
cultural needs and personal beliefs in order to deliver a more culturally sensitive health care system 
and thus enhance MetS successful management. 
1.3 Aims and objectives of the study 
This study aimed to explore factors that affect the implementation and success of MetS management 
in the UAE with a focus on the influence of the socio-cultural context of the UAE on MetS treatment. 
The study objectives were: 
1. To explore patient perceptions and beliefs about their health condition, their awareness of 
MetS diagnosis and associated risks 
2. To examine patient attitudes towards their prescribed treatment plans and factors affecting 
their adherence to prescribed medicines 
3. To examine HCP perceptions of MetS as a condition in its own right and factors that impact 
its management in the UAE 
4. To elicit facilitators that can improve the management of MetS within the UAE 
This research provides an in-depth understanding of patient and professional perceptions of MetS 
and its management in the UAE. It also explores contextual factors that influence the successful 
implementation of lifestyle and pharmaceutical interventions needed for MetS management. Such 
information can aid public health promotion programmes and help HCPs and policy makers to deliver 
a more culturally competent health care service. 
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1.4 The organisation of the thesis 
Introduction 
This study is divided into eight chapters. The current chapter (Chapter 1) describes the background of 
the study and presents the aims and objectives of the study. Chapter 2 reviews the literature of MetS 
including definitions and prevalence. It also presents information about the health care system in the 
UAE and its efforts in tackling MetS. This is followed by literature that reports factors that influence 
people's health behaviour and perceptions of health and illness. 
Chapter 3 describes the methodological approach used in the research and the tools used to collect 
data. The data collection process and methods of analysis are given in detail. Data analysis and 
translation, study limitations, reliability and validity of data are discussed in detail. 
Chapter 4 presents patient perceptions of their health conditions and factors affecting their attitude 
towards the risk of their presenting CRFs and coping strategies. It also illustrates factors influencing 
the clinical utility of MetS diagnostic criteria as perceived by HCPs, which impacts patients' 
perception of their health condition. 
Chapter 5 illustrates personal as well as contextual factors influencing patients' attitudes towards 
lifestyle intervention as reported by both patients and HCPs. 
Chanter 6 presents identified factors influencing patients' attitudes towards prescribed medicines 
and medicine-taking behaviour. 
Chanter 7 presents themes describing facilitators to MetS management in the UAE. It will also link 
these facilitators to existing strategies and future plans of UAE health authorities in tackling the MetS 
problem in the country. 
Chanter 8 discusses and concludes the study and takes a reflexive look at the study process. The 
strengths and limitations of the study are described and recommendations for future work are also 
included. 
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Chapter 2 
Literature review 
2.1 Introduction 
Literature review 
This chapter starts by describing the literature search strategy, tools and inclusion criteria used to 
build the study's background and identify gaps in the literature. The following sections describe: (i) 
the UAE health care system strategies and health promotion campaigns implemented to tackle MetS; 
(ii) the impact of Emirati socio-cultural context on the health behaviour of patients living in the UAE; 
(iii) lay perceptions of MetS; and (iv) the controversy associated with MetS. A summary of key areas 
for further research are subsequently addressed. 
2.2 Literature search strategy 
The study literature review started in November 2007, and was repeated at regular intervals (most 
recently October 2011) to identify literature concerned with patients' perceptions of MetS and 
factors affecting its management. The search strategy involved using key words specific to the 
research topics. These key words increased as the study progressed and themes emerged during data 
analysis. Table 2.1 illustrates an example of the key words used combined into four groups. 
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Table 2.1 Example of key words used in the literature search 
Condition Informer Perception Research environment 
Metabolic Syndrome Patient Perception United Arab Emirates 
Syndrome X Physician Perspective Arab 
Insulin resistance Pharmacist Lay Culture 
Prediabetes Professional Attitude Social norm 
Diabetes Health belief Tradition 
Obesity Health issues Religion 
Hypertension Qualitative research Spirituality 
Dyslipidaemia Islam 
Literature that described the health care system in the UAE, public health, health promotion, 
prevention strategies and UAE culture were also searched. At the beginning of the literature review 
process, searches were restricted to the English language. However, because of the extremely limited 
literature concerning lay perception of MetS, non-English literature concerning qualitative studies on 
MetS was included. During the literature search, Google translation service was used to translate the 
content of three main studies (Lupatini, da Silva et al. 2008; Vieira and Turato 2010; Vieira, Cordeiro 
et al. 2011). Google Translate uses statistical matching to translate rather than a dictionary/grammar 
rules approach, therefore it does not always deliver accurate translations and translated text can 
often include grammatical errors (Gomes 2010; Shen 2010). As such, Google Translate service was 
used to help understand the general content of the selected non-English literature when needed. 
The database and search engines used for searching included MEDLINE, EMBASE, Scopus, 
International Pharmaceutical Abstracts, PsychINFO, Web of Knowledge, Global Health and PubMed. 
The search, throughout the study, included research reports, review articles of research studies, and 
articles that commented on research studies. 
The initial literature search identified few studies and articles that described the UAE health care 
system, the impact of the UAE culture on patients' health behaviour and qualitative studies on MetS. 
This was overcome by modifying the search strategy to include more papers and studies of relevant 
importance. The following three sections describe these search modifications. 
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2.2.1 Literature on the UAE health care system 
The initial electronic search found few papers that described the health care system in the UAE or its 
efforts in tackling MetS health issues. Thus, a more comprehensive literature search was conducted 
comprising an electronic as well as a manual approach. This was done to encompass all information 
relevant to the UAE health care system, public health and health promotion strategies used to 
manage MetS in the UAE. The following web sites were also used in the search: 
  
Health Authority 
- 
Abu Dhabi (HAAD) available at www. haad. ae 
  
Abu Dhabi Health Services (SEHA) available at www. seha. ae 
  
United Arab Emirates Ministry of Health (MOH) available at www. moh. gov. ae 
  
Imperial College London Diabetes Centre (ICLDC) available at www. icldc. ae 
  
Diabetes UAE available at www. diabetesuae. ae 
Visits to and phone calls with officials working in the MOH and HAAD were arranged to enquire 
about their activities in combating MetS in the UAE. 
2.2.2 Literature on UAE cultural impact 
Literature that addressed the impact of the Emirati socio-cultural context on the health care system 
and patients' attitudes was scarce. Although some obstacles and barriers might be similar in all 
patients with MetS, regardless of their race or cultural background, it is likely that other barriers 
might emerge specifically in this particular area given its unique cultural and religious characteristics. 
Thus, the literature search was expanded to include papers that described MetS and CRFs 
management-related issues in other Middle Eastern countries (e. g., Qatar, Bahrain, Kuwaiti, Saudi 
Arabia, Oman and Jordan) as their socio-cultural context resembles that of the UAE. A hand-search 
was also carried out for the major clinical journals of the Middle East which were found online (using 
Google), at the UAE University library in Al-Ain and at the University of Nottingham library. Issues of 
journals were hand-searched for up to the past 20 years, depending on their availability. The 
following journals were included in the search: 
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Journal of the Gulf and Arabian Peninsula Studies 2000 - 2011 (April) 
  
Middle East Journal of Family Medicine 2003 
- 
2011 (October) 
  
Middle East Health 1997 
- 
2011 (May) 
  
Middle East Pharmacy 1998 
- 
2006 
  
Eastern Mediterranean Health Journal 1995 
- 
2011 (October) 
  
Medical Principles and Practice 1998 
- 
2011 (October) 
  
Annals of Saudi Medicine 2000 
- 
2011 (September) 
  
Saudi Medical Journal 2000 
- 
2011 
  
Kuwait Medical Journal 2001-2011 (September) 
2.2.3 Qualitative literature on MetS 
Literature review 
The literature search identified few qualitative studies that were exclusively concerned with patients 
diagnosed with MetS. In addition, qualitative studies that explored perceptions of MetS in Middle 
Eastern or Muslim countries were unavailable at the time of this study. Thus, qualitative studies 
concerning patients diagnosed with T2DM, hypertension and obesity were included in the search 
process. Therapy requirements of individual CRFs can be similar to that of MetS (i. e., pharmaceutical 
and lifestyle interventions). In addition, some of these qualitative studies were concerned with 
patients of Asian ethnicities or similar religious and cultural backgrounds. Therefore, themes 
identified in such studies might be similar to those experienced by Middle Eastern patients with 
MetS. The literature search included literature that addressed the research questions and elucidated 
study findings as the research progressed. 
The following section describes the literature found in four main areas: (i) the extent of the MetS 
problem in the UAE and the health care system's efforts in tackling it; (ii) the impact of the socio- 
cultural context of the UAE on patients' health attitudes; (iii) perceptions on MetS risk and 
management; and (iv) the controversy surrounding the MetS concept. 
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2.3 The extent of the MetS problem in the UAE 
Literature review 
The UAE is a federation situated in the southeast of the Arabian Peninsula in Southwest Asia on the 
Persian Gulf (Figure 2.1). It borders Oman and Saudi Arabia and shares sea borders with Iraq, Kuwait, 
Bahrain, Qatar and Iran. The UAE is a relatively young country that was established between 1971 
and 1972 through the alliance of seven Kingdoms (i. e., Abu Dhabi, Dubai, Sharja, Ajman, Fujairah, Ras 
al-Khaimah and Umm al-Quwain). 
Before the discovery of oil, people in the UAE led very simple lives; they lived in mud houses and 
worked in fishing, pearling (i. e., fishing for pearls) and simple trades. Due to revenues from oil in the 
past four decades, the UAE witnessed rapid economic development resulting in tremendous 
urbanisation and modernisation of the UAE societies. This historic depth and rapid pace of 
development brought remarkable benefits to the UAE population. However, early data indicates a 
substantial increase in CVDs and cardiovascular risk amongst its adult population when compared to 
neighbouring Arab countries (Mathew, Ahmed et al. 2010). It is believed that this is due to the rapid 
transformation of the UAE that changed the population's lifestyle and dietary habits from a highly 
physical active lifestyle with less food and caloric intake to a sedentary lifestyle with more food 
availability and higher caloric intake. As a result, the UAE today has some of the highest proportions 
of obese/overweight people in the world, with respectively high rates of chronic disease (Reid 2010). 
In 2008, data from the Emirates National Diabetes study and screening for risks factors for Coronary 
Artery Disease in the year 2000 (ENDCAD) was used to determine the prevalence of MetS in the 
United Arab Emirates. Using the IDF definition, the prevalence of MetS was found to be 40.5%. The 
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survey also showed that women had a higher prevalence of MetS (45.9%) compared to men (32.9%) 
and that MetS was significantly associated with increasing age, female gender, family history of 
diabetes and, less intuitively, rural location (Malik and Razig 2008). 
The prevalence of MetS features (e. g., T2DM and obesity) is also significantly high in the UAE. For 
example, according to the IDF Diabetes Atlas report (IDF 2010) the prevalence of T2DM in the adult 
population of the UAE (18.7%) is the second highest worldwide after Nauru (30.9%) and is expected 
to increase to 21.4% by the year 2030. It was also estimated that one in five people living in the UAE 
between the age of 20 to 79 have T2DM (ICLDC 2007). According to the WHO global database on 
body mass index, the prevalence of obesity amongst UAE adult nationals was 33.6% (WHO 2000). 
However, the International Obesity Taskforce/International Association for the Study of Obesity 
reported the prevalence of obesity in adult women living in the UAE to be 31% compared to 17% in 
adult men, which makes the UAE the 22nd in the world for obesity prevalence (Global Prevalence of 
Adult Obesity 2010). Unfortunately, obesity, T2DM and MetS are not restricted to the adult 
population of the UAE. In the year 2000, a survey conducted in 4,000 school children in the UAE 
between 6-16 years of age found that 25% were either overweight or obese (Al-Haddad, AI-Nuaimi et 
al. 2000). In a small study, 44% of young obese children (n=260) living in the UAE were found to have 
MetS and there was a significant association with a positive family history of obesity, T2DM or 
hypertension (Eapen, Mabrouk et al. 2010). Although my study did not intend to explore the MetS 
problem in children living in the UAE, such figures highlight the severity and extent of MetS health 
problems in the UAE. 
In January 2010, the UAE government indicated that the population of the UAE has reached eight 
million; the vast majority of the population are foreign nationals, and the minority Emirati population 
was estimated to be one million (UAE Interact 2010). A more detailed examination of the prevalence 
of the MetS and its features in the UAE revealed such figures to be higher in the local Emirati 
population of the country, which is commonly attributed to very sedentary patterns of living, along 
with the widespread consumption of high-fat, high-calorie foods (Musaiger and Radwan 1995; 
Musaiger 2003; Malik, Bakir et al. 2005). The MetS and other CRFs were, therefore, health issues 
with a paramount concern to health authorities in the region. 
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2.4 Strategies of the UAE health care system 
Literature review 
Over the last two decades the quality and scope of health care services in the UAE has developed 
significantly. In 2000, the UAE health care system was ranked 27th worldwide in the first analysis of 
the world's health care systems report (WHO 2000). The health care services of Abu Dhabi, the 
capital of the UAE and where this research took place, were regulated, operated and financed by the 
UAE government through the UAE ministry of health (MOH). However, in 2006, health reform began 
in Abu Dhabi to improve the health services outcomes within the city. This resulted in the breakdown 
of the MOH responsibilities and the formation of three independent bodies responsible for 
regulating, operating and financing the health care services of Abu Dhabi alone. Since then, Abu 
Dhabi Health Authority (HAAD) and Abu Dhabi health Service Company (SEHA1) became Abu Dhabi's 
independent health service regulator and operator, respectively. Through the introduction of a 
mandatory requirement for health insurance, the National Health Insurance Company (DAMANI) was 
established as a third independent body responsible for the financing of the health services of Abu 
Dhabi. Abu Dhabi health authorities work towards achieving three main goals: quality, accessibility 
and affordability of health services to all residents of the capital city. Currently, 12 hospitals, 2,644 
licensed beds, and more than 40 Ambulatory and Primary Health Care Clinics operate under the 
health authorities of Abu Dhabi (HAAD 2009). 
The following two sections: prevention strategies for MetS and public health awareness campaigns 
are two examples that describe the efforts made by the health care system to tackle the high 
prevalence of MetS and its features in the UAE. 
2.4.1 Prevention strategies for MetS 
Interest in health promotion and disease prevention has increased in the past two decades 
worldwide. This is due to many factors including the gradual shift from infectious to chronic diseases 
as the leading cause of deaths (WHO 2009). Evidence from intervention trials indicated the 
effectiveness of health promotion and intervention programmes in changing health behaviour 
leading to a reduction in morbidity and mortality (Tengland 2009). In addition, there is compelling 
SEHA is Arabic for health 
2 DAMAN is Arabic for insurance 
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evidence from randomised controlled trials that T2DM can be substantially reduced in people with 
MetS by increasing physical activity, diet control and appropriate pharmacological intervention 
(Norris, Zhang et al. 2005). Health authorities in the UAE are highly aware of the MetS risk in the UAE 
and preventative measures, as well as public awareness campaigns, have been implemented 
throughout the country. However, because of the study location, this literature review will describe 
the prevention strategies and public awareness campaigns organised by the health authorities of Abu 
Dhabi. 
In 2007, MetS was ranked a top health priority in HAAD's list of health priorities for Abu Dhabi's 
public health strategy (HAAD 2007). In the following year, HAAD launched Abu Dhabi cardiovascular 
prevention programme WEQAYA3 which included a public screening service for cardiovascular risk 
using Framingham Risk Score4 (Hajat and Harrison 2010; WEQAYA 2010). This prevention programme 
was inspired by the recent WHO global health risk report which stated that eight easily modifiable 
risk factors (i. e., alcohol, smoking, elevated blood pressure, obesity, dyslipidaemia, elevated blood 
glucose, poor diet, and sedentary lifestyle) are responsible for 61% of all global cardiovascular deaths 
(WHO 2009). 
The innovators of WEQAYA were also motivated by the remarkable reduction in cardiovascular risk 
achieved in Finland using prevention programmes built on Framingham Risk Score (Hajat and 
Harrison 2010; Vartiainen, Laatikainen et al. 2010). This 35-year long follow-up revealed that an 80% 
reduction in coronary mortality was due to three main factors: long comprehensive cardiovascular 
prevention, engagement of the community in the prevention programme and active health 
promotion campaigns. Thus, organisers of WEQAYA set a plan to identify Abu Dhabi's residents who 
had a 10% risk of developing CVD and then provided them with the recommended preventative 
measures. WEQAYA is set to achieve its target through three synchronized stages that include: 
1. Determining the CVD burden in Abu Dhabi through screening all the city's residents for risks 
of developing CVDs (e. g., family history of CVD and MetS features) 
3 WEQAYA is Arabic for prevention 
Framingham score is a scoring system of risk factors to predict absolute 10% for coronary heart diseases (CHD) events in people who do not have 
evidence of vascular diseases. 
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2. Implementing different intervention strategies to reduce and prevent cardiovascular risk. 
Both health and non-health sectors, government and private authorities are involved. 
Strategies to empower patients and increase compliance are included. 
3. Continuous review of the effectiveness and cost-effectiveness of the programme 
To enable screening for cardiovascular risk factors, a population-level epidemiological database that 
included notification of deaths, births and diagnosed diseases was created. In addition, the database 
of the medical insurance e-claims was also integrated. A specialised website linked to WEQAYA was 
launched to invite more individuals to the screening programme. Visitors to the website can easily 
access information about WEQAYA and register in the screening programme using their health 
insurance number. In addition, a mobile text messaging and email service to allow participants easier 
and faster access to their screening results was launched on October 2010 (WEQAYA 2010). 
WEQAYA calls for the collaboration of government, as well as private non-health sectors such as 
schools, food regulation, urban planning, environment, media, telecom and universities, to engage in 
facilitating and delivering holistic prevention strategies. Other efforts were also made by HAAD to 
equip the Abu Dhabi health sector with tools that will facilitate WEQAYA. For example, clinical 
guidelines for regular screening and prevention of cardiovascular risk were recently developed and 
made available online for health practitioners and public access (HAAD 2009). HAAD also mandated a 
continuous medical education (CME) programme for all health staff working in Abu Dhabi. HAAD 
acknowledges the importance of engaging the public in WEQAYA to create more responsible and 
empowered patients. Thus, HAAD and other collaborative entities in Abu Dhabi have been 
sponsoring health promotion campaigns delivered through media, outreach and social networks 
since 2008 (Hajat and Harrison 2010). 
WEQAYA started in April 2008 using the Framingham Risk Score. However, because the Framingham 
Risk Score lacks family history and central obesity, those two factors were added to the prevention 
programme. Up to the end of April 2010, a total number of 173,501 adult Emiratis, with a mean age 
of 35.2 (SD 13.8) years, have been screened for CVDs in Abu Dhabi through WEQAYA. Early data 
showed high prevalence of central obesity (57%) and around 44% of the people screened were either 
diabetic or pre-diabetic. This prevention programme plans to continue running for the coming years 
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and to include non-national residents of Abu Dhabi. Data that reflect clinical outcomes or assess 
WEQAYA's effectiveness has not been published yet. 
2.4.2 Public health awareness campaigns 
Despite awareness of MetS being a prediabetes syndrome and a new driving force for a CVD 
epidemic, health promotion campaigns in the UAE still target individual components of the MetS 
rather than the whole of the syndrome with the great focus on T2DM and obesity. This section 
describes in detail two of the public awareness campaigns that are held annually to enhance public 
awareness of the risks of diabetes, obesity and MetS. It will then present a table that summarises 
some of the health campaigns that were or will be organised in different locations of the UAE. 
2.4.2.1 'Diabetes-Knowledge-Action' campaign 
The Imperial College London Diabetes Centre (ICLDC) is a health centre that was established in Abu 
Dhabi in 2005. It specialises in diabetes treatment, research, training and public health. The 
establishment of ICLDC came as a response to the high prevalence of diabetes in the UAE. Thus, 
ICLDC aims to identify factors responsible for the high prevalence of diabetes in the UAE, to provide 
world-leading diabetes treatment and to prevent the development of diabetes in the first place. The 
ICLDC together with HAAD, SEHA, MOH, Abu Dhabi tourism authority and the Emirates foundation 
collaborated in organising and conducting the 'Diabetes-Knowledge-Action' public awareness 
campaign. 
The aim of the 'Diabetes-Knowledge-Action' campaign is to increase awareness of the risk of 
diabetes, encourage a healthy lifestyle and early screening for T2DM and MetS (ICLDC 2005; Diabetes 
UAE 2007). The 'Diabetes-Knowledge-action' campaign is composed of five health-advocating 
activities each of which delivers a health awareness goal and is held annually in Abu Dhabi. Table 2.2 
is a photographic illustration of the 'Diabetes-Knowledge-Action' health awareness activities. 
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Table 2.2 Photographic illustration of the 'Diabetes-Knowl 
'I WONDER' 
These are diabetes information messages that are podcasted online 
and on television as health adverts or promoted in public outreach v' 
campaigns. It provides information about diabetes, diabetes risk, 
' complications, management and the importance of early screening. 
'I COOK HEALTHILY' 
Is a cookery illustration designed to provide families with information 
on how to cook healthy. It is usually run inside malls and shopping 
centres every night during the month of Ramadan. 
'I EAT RIGHT' 
Are educational programmes that target children and school kids. 
Through the collaboration with School Health and the Abu Dhabi 
Education Counsel (ADEC), nutrition education is provided to school 
students. Targeting school children will help create more informed 
and health conscious generations in the UAE. 
'I PLAY SPORTS' 
I,, a Ramadan football tournament that is annually held and run over 
five nights. Around 16 local and affiliated football teams compete in 
this sports event. It advocates for group sports and the importance of 
an active daily life. 
'WALK UAE' 
Is a walkathon that is held annually in the month of November in 
unison with the world diabetes day. It aims at drawing public 
attention to the importance of incorporating exercise into their daily 
lives. Family games, activities and musical concerts are included to 
create a carnival like atmosphere and to attract more public 
attendance. 
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2.4.2.2 'Your Health Matters' campaign 
'Your Health Matters' campaign is a Gulf Cooperation Council (GCC)5 wide public health awareness 
campaign against diabetes, abdominal obesity and MetS. It was launched in the UAE through the 
MOH on May 2007. The campaign is organised and sponsored by Sanofi-aventis pharmaceutical 
company, the WHO, the Gulf Heart Association, Emirates Cardiac Society and the MOH. It aims at 
enhancing both professional and public awareness of the risks of the MetS (Ministry of Health 2007). 
Outreach campaigns and free medical screening for MetS features are provided during certain 
notified weekdays and weekends in malls and shopping centres throughout the UAE (Ministry of 
Health 2007). The 'Your Health Matters' campaign includes a Continuous Medical Education (CME) 
programme on the risk of MetS for physicians across the GCC region and is provided via a live 
transmission from Harvard University. 
Table 2.3 presents a summary of all public awareness campaigns organised and sponsored by MOH 
and HAAD and launched at different locations in the UAE since 2000 (Ministry of Health 2011). 
Although these campaigns specifically target diabetes or obesity, they also screen for and educate 
about other MetS features. 
5The Gulf Cooperation Council (GCC) is a political and economic union created in 1981 involving the six Arab states of the Persian Gulf: Saudi Arabia, 
Bahrain, Oman, Qatar, Kuwait and the UAE. 
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Table 2.3 Summary of the public awareness campaigns in the UAE for MetS 
The Right Beginning MetS in Free screening for MetS features Dubai MOH 2008 
children and Health education to children and 
young adults parents 
The Fat Truth Obese children School children and parents UAE MOH 2009 
and Health education Unicef 
adolescents Screening for MetS features 
No to Obesity Teenage Teenagers weighing > 90kg UAE MOH 2010 
obesity Health education 
Weight reduction programmes 
World Diabetes Bus Diabetes Free screening UAE MOH 2010 
Health education 
Your Health Matters MetS CME programmes to physicians Dubai MOH Quarterly 
Health awareness programmes about 
the risk of MetS 
Family health festival MetS Free screening Dubai MOH Annually 
Health education 
Beat Diabetes Diabetes Health education Dubai MOH Annually 
Walkathon Walkathon 
The Diabetes Diabetes Free screening for diabetes Dubai MOH Annually 
Campaign Free condition assessment 
Health education 
Diabetes-Knowledge- Diabetes Free screening for diabetes Abu Dhabi ICLDC Annually 
Action Health education, cooking lessons HAAD 
Exercise and sports activities SEHA 
School education about health diet MOH 
2.4.3 Assessing needs for prevention management 
To our knowledge, data that describes the impact of health awareness campaigns on the prevalence 
of diabetes, obesity or the MetS in the UAE have not been published yet. It was anticipated that 
clinical outcomes of WEQAYA would be available by December 2010. However, such data was not 
available at the time of preparing this thesis. Strategies used in prevention and public awareness 
campaigns in the UAE are based on interventions designed to cater for western communities such as 
Finland and the United States of America (see section 2.4.1). However, such programmes might not 
be directly transferable to countries of different cultural and religious backgrounds such as the UAE. 
Therefore, data that reflect the impact of such programmes on clinical outcomes will help assess 
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effectiveness or identify gaps and areas of improvement if similar programmes are to be launched in 
the future. Literature that describes public perceptions of health campaigns in the UAE were not 
available. Lay perception of how MetS can be prevented has important implications for the design, 
delivery and uptake of prevention and public awareness programmes (Petrie, Weinman et at. 1996; 
Narayan, Imperatore et at. 2002). It will also illustrate whether the health care system of the UAE is 
culturally situated and able to cater for the different needs of all residents in the region. 
The WAKEUP toolkit was a toolkit of informational material for patients with prediabetes, which 
health care providers developed to improve the practice system for the management of MetS (Evans, 
Greaves et al. 2007). The information toolkit was designed through assessing both patient and health 
care professionals' needs for the management of prediabetes. An action research approach was best 
suited for the development of the educational toolkit, as it enabled the development process to be 
tailored to the views and needs of both health professionals and patients with prediabetes. In the 
needs assessment phase both patients and health professionals admitted they lacked knowledge 
about prediabetes syndrome, nature, causes, risk and management needs. Health professionals were 
highly concerned with the best means of communicating information to patients and triggering 
behaviour change. Although health professionals praised the idea of group sessions that included 
family members, patients were not as enthusiastic. Interestingly, patients felt that stronger words 
should be used to convey and emphasise the seriousness of the condition. They also felt that detailed 
information and follow-up appointments give patients an impression that health professionals 
consider MetS to be a serious condition. The final toolkit incorporated all feedback from patients and 
health professionals. Details about the availability of psychological support for patients were also 
included. 
One of the limitations of the study was lack of involvement of patients of different ethnicities in the 
needs assessment phase. This might have elicited more information about educational needs specific 
to that group of patients. The impact of the WAKEUP toolkit on patients' health behaviour, 
prevention of diabetes or CVDs is yet to be assessed and identified. However, the main lesson 
learned from the WAKEUP toolkit, is the importance of involving users of health education services. 
The process through which the WAKEUP toolkit was developed enabled: (i) the identification of 
health professionals and patients attitudes towards prediabetes care, (ii) changing the practice 
system to optimally manage the condition, (iii) develop education material that addressed patient 
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and health professionals' information needs (Evans, Greaves et al. 2007). Similarly, to inform the 
development of effective health promotion strategies that encompass public awareness campaigns 
and educational interventions for MetS in the UAE, health authorities need to ascertain individual 
experiences with the current health care system, their appraisal of their health condition and the 
experience of the health professionals in the region. 
The following section presents studies that explored the health needs of patients living in the UAE 
and the impact of the UAE contextual setting on patients' health attitudes. 
2.5 The impact of the UAE culture on patients' health behaviour 
To patients, illness is not merely a pathological feature. Illness is expressed through patients' social 
and cultural location and in the way they live and experience life. Thus, there are alternative ways in 
which patients understand and respond to their health condition (Heiman 2007). Many social 
researchers in health have examined the health behaviour of patients from different cultural 
backgrounds. This is mainly due to the realisation of the impact of culture on patients' lay health 
beliefs (Heiman 2007). Culture is defined as the day-to-day activities and practices of given 
community members as they develop their interpretation of different issues in their lives including 
health and illness (Dutta 2008). Culture, in that sense, influences how people think and understand 
their health. The UAE has a very rich culture that is composed of its history, traditions, religious 
beliefs, language and many other elements that are vital to the human condition. It is also composed 
of the cultures of expatriates that live and work in the UAE interacting and influencing one another. 
Therefore, culture provides the local context within which health meanings are constituted and 
negotiated in the UAE. In this study, it was important to explore how the UAE culture influences 
people's perceptions and interpretations of their health condition and how it influences the choices 
they make when it comes to living with or managing MetS. 
Five qualitative studies that investigated the impact of the UAE context on patients' health behaviour 
were found during the literature search (Ypinazar and Margolis 2006; Winslow and Honein 2007; Ali, 
Bernsen et al. 2009; Berger and Peerson 2009; Ali, Baynouna et al. 2010). These studies identified 
two main paradigms influencing patients' perceptions of health and illness: the role of religion and 
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the role of social norms. The following sections describe the influence of these two paradigms on 
patients' health behaviour. 
2.5.1 The role of religion 
Religion seems to exert a powerful influence on patients' perceptions of health and illness and is 
therefore considered one of the main influencing factors in individuals' health beliefs (McAuley, 
Pecchioni et al. 2000). Religious beliefs were found to be common amongst patients seeking health 
care, even among those who identified themselves as spiritual, but not religious (Koenig, George et 
al. 2004). Religion was also found to influence health care and medical decision-making, such as 
blood transfusion and organ donation (McDonald and Wren 1967; Rady and Verheijde 2009). 
The UAE is a developed Muslim country with Islam as its official religion. Although the UAE is 
perceived as one of the most liberal countries of the region, the influence of Islam is reflected in 
every sphere of the seven emirates of the UAE and dominates all aspects of life. In the year 2007, the 
number of mosques in the whole of the UAE reached 4,818 with 926 mosques in Abu Dhabi alone. 
Abu Dhabi also has the Grand Zayed Mosque, which is the fourth largest mosque in the world (Awqaf 
2010). The call for the Muslim prayer is heard five times a day from all mosques' minarets all over the 
city. Shopping centres, banks, hospitals, schools, beaches and other public places have specially 
designed washing and praying areas open to the public for worship whenever prayer time 
commences. It is very common to see men arrange themselves into multiple rows of straight lines in 
public gardens when prayer time is announced moving simultaneously with the loudly recited prayer 
instructions. The dress code of employees and students is often designed to preserve modesty and to 
respect the Islamic identity of the country. All governmental establishments segregate men from 
women and ensure a female employee is always available to attend to female customers. In general, 
the Islamic identity of the UAE is strongly evident in all aspects of people's lives. Therefore, it stands 
to reason that Islamic teachings in the UAE influence patients' health behaviour and many of the 
choices they make when managing their health. 
Muslims believe that God is the creator of the universe and all creatures. They believe that their 
bodies are gifts from God that they should protect and care for. Muslims show gratitude to God for 
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their good health through worship and protecting the self from harm. The Muslims' prophet 
Mohammed supported health promotion and disease prevention and stressed the importance of 
seeking health care when ill. In his sermons and lectures, he clearly stated to his followers that God 
instructs them to take care of their health. Thus, Muslims consider prevention measures and seeking 
medication when ill as a religious obligation that all Muslims should follow (Rahman 1998). In 
available literature, religion was sometimes reported as a barrier to changing health behaviour when 
describing patients' beliefs in the predetermined fate and fatalism (McAuley, Pecchioni et al. 2000; 
Ypinazar and Margolis 2006; Grace, Begum et al. 2008; Shuval, Weissblueth et al. 2008). Other 
studies described the positive role of religion in enhancing compliance, patients empowerment and 
acceptance of illness (Koenig 2004; Winslow and Honein 2007; Abdoli, Ashktorab et al. 2008). The 
following two sections present these two viewpoints. 
2.5.1.1 Fatalism 
Fatalism is defined as an individual's belief that events are predetermined and that negative 
outcomes might occur to one or others despite efforts for personal control and behavioural change 
(Keeley, Wright et al. 2009). The exact relation between fatalism and health behaviour is unclear and 
encompasses three main dimensions: (i) patients' lack of internal control over external events that 
might impact their health, (ii) belief in destiny, luck and predetermined fate (i. e., role of God in 
health and illness) and (iii) feelings of powerlessness, despair and meaninglessness (Keeley, Wright et 
al. 2009). Fatalism has generated great interest in health research because patients' fatalistic 
attitudes usually correlate with poor adherence to a treatment plan (Powe and Finnie 2003). Thus, 
there has been increasing interest in health promotions and intervention programmes to rectify 
patients' fatalistic attitudes towards their health (Davison, Frankel et al. 1992). 
Ypinazar and Margolis (2006) examined health beliefs of 10 elderly Emirati patients aged between 65 
to 76 years. They focused on the impact of Islam on the way elderly Emiratis viewed their health. 
Their aim was to elicit health needs of elderly Muslim Arabian Gulf Arabs and provide an insight on 
how such patients think and interpret their condition and react towards their treatment. Results 
showed that the role of Islam on patients' health beliefs was an overarching theme that shaped 
patients' perceptions of health and illness. Patients strongly believed that health and illness was in 
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God's hands. However, they also perceived seeking treatment and protecting self from harm as a 
religious obligation instructed in the Qur'an6. They also agreed that a physician's role was to provide 
treatment while God's role was to grant cure. When asked about the causes of illness participants' 
answers varied but most attributed illnesses to pathogens and an unhealthy lifestyle. The study 
authors admitted that participants found difficulty in understanding questions about causes of 
illness, which could explain their varied answers. However, study authors concluded that participant 
narratives illustrated a strong belief in God's control over illness and health (Ypinazar and Margolis 
2006). The study reflected on the views of elderly Emiratis who were mostly illiterate. Thus, younger 
and more educated Emiratis might not share the perceptions identified in Ypinazar and Margolis' 
study. However, such views are yet to be explored in future qualitative studies that investigate the 
impact of religion on Emiratis' health behaviour. 
Studies conducted in other countries but with participants of a similar religious background, also 
reported evidence of fatalism in participants' health attitudes. Through focus group interviews, one 
study aimed at exploring the role of culture, environment and religion on the promotion of physical 
activities in 45 young Arab Israelis. Participants perceived religion as a facilitator because Muslim 
scripts encouraged engaging in physical activity and sports. However, some religious participants 
expressed a fatalistic attitude towards health. In their perception, their inability to control death 
abolished the value of engaging in physical activity and a healthy lifestyle (Shuval, Weissblueth et al. 
2008). 
The impact of religion was also explored in participants of other faiths. For example, McAuley et al 
(2000) examined the role of religion in the perception of elderly white and black Christian Americans 
of health and illness. Participants gave God many attributes that defined his role in health and illness. 
Four of these attributes were: (i) the arbiter who punishes sinners with illness, (ii) the guardian who 
protects believers from illness, (iii) the healer and miracle maker who works with doctors to promote 
cure and (iv) the evaluator who tests individuals' faith or guides them back to faith through illness 
(McAuley, Pecchioni et al. 2000). 
Much of the available literature has hypothesised that fatalism is a cultural belief that hinders 
behavioural change. This has sparked the interest of some researchers to examine the impact of 
6 Qur'an is the holy book for all Muslims 
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fatalism on patients' health attitudes. For example, the impact of fatalism on screening for breast 
cancer was explored with 25 Dominican women through in-depth interviews. The aim of the study 
was to investigate whether fatalism among Latinas was deterrent to breast cancer screening. Results 
showed overarching positive attitudes towards screening for breast cancer as a preventative 
measure. Participants perceived multiple factors to be in control of breast cancer that ranged from 
internal factors (e. g., personal health behaviour) to external factors (e. g., the will of God). Despite 
participants' belief in predetermined fate, they actively participated in screening for breast cancer 
and believed that early diagnosis increases the chance of successful treatment (Floret, Aguirre et al. 
2009). 
Some aspects of fatalistic belief engendered a sense of responsibility towards one's health. One 
study explored, through focus groups, the perceptions of 51 Arab Israeli women of breast and 
cervical cancer (Azaiza and Cohen 2008). The results showed that participants viewed cancer in one 
of three ways: (i) a predetermined fate from God, (i) a punishment from God for committing sins and 
(iii) a test from God to those he loves for patience. However, perceiving cancer as a test was 
associated with taking responsibility for managing their illnesses and taking care of their health 
(Azaiza and Cohen 2008). 
The attitude of health professionals towards religious patients were also affected by the notion of 
fatalism. In their perception, patients who believed in fatalism and the predetermined fate were less 
willing to change their health behaviour. Grace et al (2008) explored the perceptions of British 
Bangladeshis on the prevention of diabetes. Seventeen focus groups were conducted with 80 British 
Bangladeshis at risk of developing diabetes, 20 health professionals and 29 Muslim religious leaders. 
The non-health professional participants perceived implementing a healthy lifestyle and seeking 
knowledge about diabetes as a religious obligation with which they should comply. On the other 
hand, physicians perceived religious patients to be fatalistic and thus neglectful towards their health 
and treatment plan. The preconceived notion about the impact of fatalism on patients' health 
attitudes discouraged physicians from discussing lifestyle interventions with British Bangladeshi 
patients. According to the study authors, physicians' poor cultural and religious competence was 
partially responsible for their misinterpretation of Bangladeshi's belief in the predetermined fate 
particularly 'the will of God'(Grace, Begum et al. 2008). 
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Keeley et al (2009) argued that fatalism is a socially situated phenomenon where lay individuals use 
fatalistic talk to serve a specific function and does not always clash with the efficacy of health 
behaviour. In their study, they examined how 96 participants from various social backgrounds, used 
fatalistic talk in discussing health and illness during in-depth interviews. They found that participants' 
statements endorsing positive health behaviour always accompanied their fatalistic talk. Upon 
analysis, they found that fatalistic talk was not merely a declaration of participants' inability to 
control their health, rather there were four reasons why fatalistic expressions were used: 
1. Face saving: where fatalistic talk was used to avoid self-blame and to rebut responsibility for 
acquiring an illness through unhealthy behaviour. 
2. Stress relief: where accepting illness liberated participants from overstressing and worrying 
about their illness and future outcomes. This group's strategy included praying and 
submitting to God's will in taking care of their health and illness. However, they still 
acknowledged their limited role in controlling their health through behavioural change. 
3. Uncertainty management: Participants expressed uncertainty and inability in finding 
explanations or causes to illness despite changing behaviour or leading a healthy lifestyle. 
Fatalistic talk was a means of expressing realistic understanding that there are issues outside 
an individual's control that can result in illness, such as lung cancer in people who never 
smoked cigarettes. 
4. Sense making: this was observed in participants whose previous health behaviour 
contributed to their current health state, such as ex-smokers. In their perception, their 
previous unhealthy attitude caused irreversible damage that could not have been prevented 
by rectified behaviour. 
These findings suggest that fatalistic talk serves to negotiate power-differences, balance priorities, 
express the limited power to control one's health and highlight the complexity of illness prevention. 
The findings also stress the fact that fatalistic talk is highly context-specific, which suggests that 
changing health behaviour may require rectifying contexts that triggered fatalistic talk in the first 
place rather than focusing entirely on counteracting patients' fatalistic beliefs (Keeley, Wright et at. 
2009). 
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Fatalistic talk was mostly used as an indication of patients fatalism in studies that explored the 
impact of religion on health behaviour (McAuley, Pecchioni et al. 2000; Ypinazar and Margolis 2006; 
Azaiza and Cohen 2008; Shuval, Weissblueth et al. 2008). However, factors that triggered 
participants' fatalistic talk were not traced or identified. In addition, participants were able to list 
biomedical, pathological and behavioural factors as causes of illnesses (Ypinazar and Margolis 2006; 
Azaiza and Cohen 2008). Thus, quotes illustrating participants' belief in the predetermined fate or the 
role of God in health and illness may have been used to attain stress relief, sense making or 
uncertainty management (Keeley, Wright et al. 2009). 
These studies did not explore the impact of fatalism on patients' compliance and adherence to their 
treatment plans. In addition, study authors did not report evidence of patients having a neglectful 
attitude towards their health because of their religious beliefs or fatalism. Such investigations will 
enable identification of the actual impact of fatalism on patients' health behaviour. Florez et at 
(2009) demonstrated in their study that participants' fatalism and belief in destiny did not deter 
screening for breast cancer. Similarly, Azaiza and Cohen (2008) found that participants' belief that 
illness is a test from God triggered a sense of responsibility towards their health. This suggests that 
fatalistic beliefs might not always antagonise behavioural change. Keeley et al argues that if fatalism 
is a patient's only way to reach acceptance of illness and stress then discouraging fatalism might 
further complicate disease management. 
2.5.1.2 The positive role of religion 
The relationship between religion, spirituality and both mental and physical health is supported by 
growing scientific evidence. Around 1,200 studies examined the relationship between some aspects 
of religious belief and some indicators of health. Most of these studies found a positive association 
between religion and physical and mental health (Koenig, McCullough et al. 2001). Religious beliefs 
were also found to be useful in boosting social support, abstaining from self-harming behaviour (e. g., 
substance abuse and alcoholism) and enhancing patients' ability to cope with their illnesses (Koenig 
2004). 
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In the UAE, the positive role of religion in health was elicited in a qualitative study that explored 
women's health needs. Winslow and Honein (2007) conducted six focus groups with 60 women 
between the ages of 16 and 54 years. The study did not report a fatalistic attitude towards health 
influenced by the participants' religious beliefs. Rather, Islam was perceived as a bridge through 
which participants gained psychological and physical comfort. Religion, according to the study 
participants, facilitated health and treatment through three routes: (i) abiding to Islamic teachings 
prevents Muslims from engaging in harmful practices such as drinking alcohol; (ii) reading the Qur'an 
and praying when distressed leads to psychological comfort; and (iii) Qur'an has healing abilities 
(some women talked about seeking religious healers to recite Qur'an scripts for them) 
Despite reporting the positive role of Islam in health, participants did not substitute religious 
practices for conventional medicine. Women in the study described gaps in their health facilities and 
reported needs to improve health services such as the need for more health education and 
community centres. In conjunction with the health care system, religion and religious practices 
helped achieve three main needs: physiological relief, physical healing and prevention of future 
illness (Winslow and Honein 2007). 
British Bangladeshis and religious leaders that participated in Grace et al's study (2008) viewed 
religion as a facilitator and promoter of health. In their perception Islamic teachings promoted health 
through: (i) instructing individuals to protect the body from harm and illness through leading a 
healthy lifestyle, (ii) encouraging healthy diet and physical activity, and (iii) encouraging knowledge 
seeking, which participants felt they could apply to health education and diabetes awareness (Grace, 
Begum et al. 2008). 
A qualitative study conducted in Iran explored the process of empowerment in 16 diabetic Iranian 
patients aged between 21 and 73 years. Results showed that the empowerment process was 
enhanced by accepting diabetes as God's will. The study followed the process through which diabetic 
patients achieved empowerment and took responsibility for their own health. Data analysis revealed 
that participants' belief that illness is in God's hands enabled them to accept the condition and 
endure it. Participants also perceived their bodies as a divine gift from God, which generated a sense 
of responsibility towards their bodies and an obligation to protect it from harm and illness through 
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complying with the treatment plan. The study authors concluded that religion motivated patients to 
take control and to be in charge of their own health (Abdoli, Ashktorab et al. 2008). 
Around 60 studies have examined the role of religion in helping patients cope with a number of 
chronic illnesses such as asthma, HIV/AIDS, kidney diseases, heart disease and diabetes. Participants 
in these studies reported that religion provided them with meaning, a sense of relief and optimism 
when dealing with their illnesses; thus, religion enables patients to cope with and accept their health 
conditions (Koenig, McCullough et al. 2001). Such perceptions were mainly popular in patients who 
consider themselves religious, women, elderly patients and patients of ethnic minorities (Koenig 
2004). 
Religion was also found to be linked to improved health behaviour (Harrigan 2009). Data from the 
International Health Interview Survey was analysed to determine the health habits of people who 
pray for their health. The results of the survey showed that participants who prayed for their health 
had higher rates of clinic visits, flu shots, participation in physical activity, support groups, relaxing 
techniques and meditation than those who did not pray for their health. Such results suggested a link 
between praying and health promotion behaviour (Harrigan 2009). However, whether there is a 
cause and effect relationship between prayer and health promotion behaviour is yet to be identified. 
There is also growing evidence of the role of religion in the physical improvement of health. A review 
of 35 studies that examined the relationship between religious beliefs and health-related 
physiological processes found that both Judeo-Christian and Eastern religious practices were 
associated with reduced blood pressure and improved immune function (Seeman, Dubin et al. 2003). 
Religious beliefs were also associated with lower rates of cancer, better cardiac health and 
outcomes, improved blood pressure, lower cholesterol levels, better health behaviour (Koenig 2004), 
fewer risk factors to breast cancer (Gillum and Williams 2009) and even lower rates of death (Gillum, 
King et al. 2008). 
The role of religion on blood pressure was explored in hypertensive Thai patients living in Southern 
California. In-depth interviews were conducted with 15 participants between the age of 46 and 93 
years who belonged to two religious faiths: Christianity and Buddhism. Factors affecting blood 
pressure control, including the role of religion, were also examined to compare the views of patients 
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who were able to manage their blood pressure with those who did not. Participants with better 
blood pressure control claimed that religion facilitated stress management and a healthy lifestyle. 
According to participants, their religious beliefs helped to generate a sense of peace that enabled 
them to think clearly and deal with issues efficiently. Religion trained participants to attain calmness 
and tranquillity. Christian participants' dedication to healthy lifestyles was engendered by their belief 
that the body is a temple of God. On the other hand, Buddhist participants were driven by their belief 
in the Buddhist middle path and the importance of making virtues (Naewbood, Sorajjakool et al. 
2010). 
The studies presented in this section illustrate how religion is perceived as a facilitator to health care. 
Religious teachings motivated individuals to engage in health promotion activities, comply with the 
treatment plans and maintain healthy lifestyles. Participants also attained calmness, tranquillity, and 
acceptance of their illness through religion and spirituality that might have indirectly affected their 
clinical outcomes. The biological impact of religion and spirituality on health is yet to be examined in 
research. Meanwhile, health care professionals may use people's religion and spirituality in 
advocating healthy lifestyles and to encourage patients to comply with their treatment plan. They 
can also help patients identify stress factors in their lives and support their engagement in religious 
practices to reduce stress levels. 
2.5.2 The role of social norms 
Social norms are customary rules or cues of behaviour within a society that coordinate the 
interactions of that social group with others. Social norms are theoretically hypothesised to influence 
health-related attitudes such as physical activity and diet and are believed to be the most powerful 
forms of social control over human behaviour (Berkman and Glass 2000). The idea that social norms 
are important determinants of healthy behaviours is widely accepted and has been incorporated into 
a number of theories of health behaviour, such as the Theory of Planned Behaviour and Social 
Cognitive Theory (Conner and Norman 2008). Social norms can sometimes raise challenges to health 
care and behavioural change. Prevention strategies, lifestyle and to some extent pharmaceutical 
interventions might fail to achieve therapy goals if social norms are not considered or the 
appropriate adaptations are not made. Arabic traditions and social norms in countries of the Middle 
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East are derivatives of Islamic teachings. However, they are sometimes interchangeable and people 
find them hard to differentiate. Social norms might sometimes divert from what Islamic teachings 
instruct, however they are sometimes more popular and practiced in a community than the original 
Islamic teachings. Social norms might differ in nature and intensity of practice from one 
Muslim/Arabic country to the other depending on the country's cultural context (Helman 2007; 
Dutta 2008). Despite the modernisation of the Emirati society and the cultural exchange with 
neighbouring non-Muslim countries, Arabic traditions and social norms are highly manifested and 
influential in people's everyday life. Most of the UAE social norms revolve around reserving modesty 
both in the way people dress and interact with one another. For example, men wear the dishdasha 
or kandura, which is a white full-length shirt-dress together with a head cloth. Women, on the other 
hand, wear the black abaya, which is a long black robe that covers their normal clothes with a black 
headscarf in public (Table 2.4). 
Pw 
a   The traditional Emirati dress for both men and women. 
  
Women wear black robes 'Abayo'to cover their casual clothes worn underneath. 
The head is also covered with a black scarf 'Shelo. ' 
  
Men dress in a white ankle-length shirt called dishdasho or kandora. The head is 
covered with a white and sometimes red cloth and tied with a black headband. 
Many residents in the UAE including Emiratis and other Arab nationalities prefer to 
dress traditionally. 
  
Some women prefer to wear black veils 'niqab' to cover their faces. 
  
The veil is not a traditional way of dressing, but in recent years it has became popular 
amongst Emirati women. 
  The veil is not enforced on women by the Emirati law, but some women wear it for 
religious reasons or as a way of obscuring identity when in public. 
People in the UAE, like many other Middle Eastern countries, take great pride in displays of 
hospitality. When visited by guests they will serve lavish choice of expensive delicacies in abundance 
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and to refuse such hospitality when offered can sometimes cause offense to the host. Family and 
family values are paramount in the UAE cultural system. Extended families living within the same 
neighbourhood and sometimes within one large house are very common in the UAE. Hence, 
protecting family honour and name is a high priority. Family members strive to protect family names 
and reputation by living up to society's expectations and abiding by the rules of the Emirati 
community (Abu Dhabi Tourism Authority 2010). 
Recently published studies have shown that some of the UAE's social norms were found to hinder 
behavioural change, especially when attempting to implement lifestyle interventions, mainly exercise 
(Al-Kaabi, Al-Maskari et al. 2009; Berger and Peerson 2009; Ali, Baynouna et al. 2010). For example 
Ali et al (2010) examined barriers and facilitators to weight management in Emirati women. Focus 
groups were conducted with 75 Emirati women between 20 and 60 years of age. All participants 
were at risk of developing T2DM. Data analysis revealed that a number of social, personal and 
environmental factors hindered physical activity and weight management. Women reported socio- 
cultural norms that restrict outdoor exercising like walking in public gardens. Some of the 
participants' husbands or fathers discouraged outdoor exercise and found it socially unacceptable. 
Participants' suggestions on means of enhancing engagement in exercise included the establishment 
of culturally sensitive exercise facilities. These facilities should be: (i) women only, (ii) allow the use of 
traditional attires during exercise, (iii) restrict the use of mobile phones that contain cameras, and 
(iv) free of security cameras. Some suggested creating women-only walking tracks to facilitate 
outdoor exercising while abiding by societal rule. Participants found maintaining a diet regimen 
challenging because of family and social gatherings that mandate joining others during meals. 
Findings from this research support the importance of designing interventions that encompass 
interpersonal, organisational, community and public policy dimensions. Thus creating a culturally 
sensitive environment that facilitates the implementation of lifestyle interventions (Ali, Baynouna et 
al. 2010). 
Berger and Peerson (2009) investigated the relationship between physical activity and the social 
setting of young Muslim Emirati women in the UAE. This was a participatory action research that 
included in-depth interviews and focus groups with 15 female students in one of the UAE colleges 
between 18 and 27 years old. Participants' attitudes toward health promotion initiatives and 
swimming classes were documented and followed by interviews to further explore observations. 
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None of the participants ever joined an exercise facility or exercised regularly before the study. 
Participants were reluctant to join in swimming classes or any other exercise programme that was 
advocated. Participants stated that they preferred to swim fully clothed. The study authors 
concluded that compared with men, women in the UAE are faced with many religious and cultural 
barriers to engaging in exercise and physical activity (Berger and Peerson 2009). 
A cross-sectional, self-reported survey was designed to assess physical activity practice in a group of 
T2DM patients living in the UAE (Al-Kaabi, Al-Maskari et al. 2009). The results showed that only 3% of 
the study sample (n=390) reported physical activity levels that meet the recommended guidelines. 
Cultural reasons were reported to be the third most limiting factor to physical activity (29.2%) after 
lack of time (29.7%) and coexisting diseases (32.1%). The study authors suggested that cultural 
factors specific to women rendered recommended physical activity difficult to achieve and maintain. 
Factors such as the limited number of women-only health clubs, traditional clothes that obscured 
weight and hindered movement were among the culturally related factors that influenced physical 
activity in the study sample (AI-Kaabi, AI-Maskari et al. 2009). 
Acknowledging social norms, in the form of Islamic and/or old Arabic traditions, were perceived to be 
vital in the success of lifestyle intervention by Muslim patients living in western societies. Participants 
in Grace et al's study (2008) found walking more acceptable than other exercises because it retained 
modesty. Another study that explored the attitude of British Asian overweight women towards 
exercise, found that walking slowly was an appealing form of workout compared to running or 
vigorous activity. Participants believed that it was not acceptable for women to walk fast in public 
(Khanam and Costarelli 2008). In the study by Shuval et al (2008) study participants felt men were 
more active than women because of conservative social norms. Women participants could not 
exercise or power-walk outdoors without being accompanied by a male family member. Women 
were sometimes subject to verbal abuse from the community when attempting to exercise outdoors. 
In such cases, women were inclined to power-walk next to Jewish towns away from the their Arab 
communities (Shuval, Weissblueth et al. 2008). 
Despite the limited number of studies that examined the impact of the socio-cultural context in the 
UAE, other studies conducted on participants of similar religious backgrounds confirmed the strong 
role social norms play in altering physical interventions and behavioural change. One would assume 
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that Muslims or Arabs living in western or non-Muslim countries would have a less socially imposed 
restriction to lifestyle interventions; however data presented in this section suggest otherwise 
(Khanam and Costarelli 2008; Ludwig, Cox et al. 2011). Data that describe the impact of the socio- 
cultural context of communities is useful when designing health promotion and prevention 
campaigns or lifestyle interventions. Most of the data available illustrated the influence of social 
norms on behavioural change of women with great focus on barriers to exercise and physical activity. 
Exploring the impact of social norms on men, as well as health professionals, and with a broader 
focus that includes other aspects of management is equally important. The literature identified 
portrayed negative impacts of social norms. Thus, it would be interesting to see if social norms that 
enhance management and behavioural change exist and whether such norms can be utilised to help 
improve patients' health behaviour and clinical outcomes. 
2.6 Health beliefs and behaviour 
Health beliefs are individuals' ways of understanding their bodies and making sense of what is going 
on within them. People's health beliefs affect the way in which they act towards their health, 
treatment plan, health services and even health education messages. Health behaviour is defined as 
an action that people take or do not take in order to prevent or identify diseases or improve their 
health condition (Conner and Norman 2008). Health behaviours have been widely studied and have 
been shown to vary among individuals according to a number of factors such as level of education, 
socioeconomic background, age, gender and ethnicity. A number of models were developed to 
analyse patients' beliefs, attitudes, and behaviours with regard to health and thus be able to predict 
the likelihood of change in any of these health behaviours (Conner and Norman 2008). This study 
was not built on any of the existing health behaviour models and did not use any of these existing 
theories to build a data analysis framework. However, it was important to be aware of these theories 
during the preparation process of this study. Therefore, this section describes in brief some these 
health behaviour models or theories. 
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2.6.1 The health belief model (HBM) 
Literature review 
The HBM is a health specific social cognition model and was originally developed to explain why 
people fail to participate in disease prevention programmes or screening tests (Rosenstock 1974). 
The original model proposed that the likelihood of individuals engaging in a particular behaviour 
(e. g., taking medications) was a function of their beliefs about the perceived threat of the disease and 
an evaluation of the risk/benefit of the recommended course of action. In turn, perceived threats 
included two distinct dimensions: perceived seriousness or severity of the threat and the individual's 
perceived susceptibility to it. Becker and Maiman (1975) further modified the model by incorporating 
cues to action, which they argued was a necessary component to trigger the behaviour such as 
symptoms, social influence and health education campaigns. Furthermore, an individual's health 
motivation was incorporated in later versions of the model (Becker, Maiman et al. 1977; Horne and 
Weinman 1998). 
Although several studies have demonstrated the value of the HBM in predicting adherence to 
medication, there have been several criticisms of the model (Horne and Weinman 1998; Abraham 
and Sheeran 2005). The HBM assumes that good health is always praised by individuals and is, 
therefore, the aim of a behavioural change. Conversely, some individuals perceive illness as way of 
escaping social responsibility and gaining sympathy from family, friends and society. In addition, HBM 
also assumes a variety of triggers to behaviour change; however, behaviour change might not 
respond to triggers or might be initiated without an existing or apparent factor. The HBM simplifies 
health-related cognitions into broad constructs such as 'barriers' and 'benefits' without specifying 
the beliefs underlying these constructs and implying that behaviour is a direct result of cognitions. 
The model also does not incorporate social factors and fails to include an intention stage, which has 
been found by many researchers to mediate between cognitions and behaviour. The HBM assumes 
that people are rational actors and driven by their conscious perceptions of the world. This may 
falsely suggest that health behaviours can always be understood as being under an individual's 
control, rather than being determined by a combination of incidental reality and an individual's 
habits, emotions, unconscious and irrational reactions to the external world. In addition, the 
definitions of the main constructs of the model were left open to debate, which led to large 
inconsistencies in the conceptualisation and operationalisation of the model across different studies. 
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2.6.2 Theory of reasoned action/Theory of planned behaviour (TRA/TPB) 
The theory of reasoned action was first developed by Fishbein and Ajzen in 1975. According to this 
theory, behaviour is mainly dependent on the individual's intention to engage in that behaviour. 
Intention, in turn, is determined by attitudes towards the behaviour and subjective norms concerning 
the behaviour (Fishbein and Ajzen 1975). Attitude towards the behaviour is a function of the 
individual's beliefs about the likely outcome (e. g., 'taking my medication will control my blood 
pressure') and the perceived value of the outcome (e. g., 'keeping my blood pressure under control is 
important to me'). Subjective norms are a function of an individual's perceptions of others beliefs 
about the behaviour (e. g., 'my family want me to take my medications') and the motivation to 
comply with these beliefs (e. g., 'I wish to please my family by taking my medications'). The theory 
was later modified and re-named the theory of planned behaviour (TPB) after incorporating another 
predictor of behaviour, which is the perceived behavioural control (PBC) (Ajzen 1991). This refers to 
the extent to which one believes he/she has control over performing the behaviour, or the ease or 
difficulty of performing the behaviour. In the TPB, attitudes, subjective norms and perceived 
behavioural control all indirectly influence behaviour through their effect on intentions. However, 
PBC can also influence behaviour directly. 
In summary, the theory of planned behaviour assumes that the more positive people's attitudes and 
subjective norms regarding the behaviour, and the greater their perceived behavioural control, the 
stronger their intentions to perform the behaviour. In addition, the stronger people's intentions are, 
and the greater their perceived behavioural control is, the more likely it is that they will perform that 
behaviour. Many studies have used the theory of reasoned action/planned behaviour to predict 
adherence to medication. Studies have proven that components of the theory were useful in 
predicting adherence to medication prescribed for urinary tract infections (Ried and Christensen 
1988), malaria (Abraham, Clift et al. 1999), bipolar affective disorders (Cochran and Gitlin 1988) and 
hypertension (Miller, Wikoff et al. 1992). Although TRA/TPB has the advantage of incorporating an 
intention stage between behaviour and cognitions and accounting for societal influence in predicting 
behaviour, it has been faced with many criticisms. One of the major criticisms is that the theory can 
account only for rational behaviours and fails to explain non-cognitive irrational behaviours (Conner 
and Sparks 2005). In addition, the theory does not incorporate the influence of past behaviour on 
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future behaviour, a predictor that has been shown to largely impact the performance of behaviour 
(Conner and Armitage 1998). 
2.6.3 Self-efficacy (SE) 
In 1977, Albert Bandura introduced the concept of perceived 'self-efficacy' in his social cognitive 
theory denoting an individual's belief that he/she is able to perform a particular behaviour that will 
lead to a desired outcome (Bandura 1977). In this way, LC refers to one's beliefs about the degree of 
control one has over behaviour, whereas SE refers to one's confidence in the ability to perform that 
behaviour (Horne and Weinman 1998). Another principal component of the social cognitive theory of 
Bandura is 'outcome efficacy', which refers to one's belief that his/her action will lead to a particular 
consequence. Bandura's theory suggests that both self-efficacy and outcome-efficacy beliefs are 
important in modifying health behaviours, such that people with high self-efficacy and high outcome- 
efficacy are more likely to perform health-related behaviours. For example, patients are more likely 
to take their medications if they believe that they are capable of doing that and that this will lead to 
the desired outcome (e. g., good health). 
Many studies have utilised the concepts of self-efficacy and/or outcome-efficacy to understand and 
predict patients' adherence to medication regimens. Studies found that greater self-efficacy 
predicted better adherence to medication in diabetes (Skelly, Marshall et at. 1995; Aljasem, Peyrot et 
al. 2001; Nelson, McFarland et at. 2007), hypertension (Roh 2005), asthma (van Es, Kaptein et at. 
2002) and HIV (Molassiotis, Nahas-Lopez et at. 2002; Murphy, Greenwell et at. 2002), although some 
studies found no association between self-efficacy and adherence to medication (Chlebowy and 
Garvin 2006). Although self-efficacy was originally developed within Bandura's social cognitive 
theory, it became highly appealing to health psychologists and was incorporated into most theories 
of health behaviour like the health belief model, theory of reasoned action and protection 
motivation theory (Schwarzer and Fuchs 2005). 
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2.6.4 Locus of control (LC) 
Literature review 
The LC theory was developed by Rotter (1966) to denote the extent to which the person feels that 
they have control over a situation or that the situation is being controlled by external factors such as 
fate, luck or chance. In this respect, Rotter suggested that people could have either an internal or an 
external locus of control. The theory assumes that internals will be more likely to engage in 
reinforcing behaviours because they believe that reinforcement is dependent on their own behaviour 
(Horne and Weinman 1998). For example, if patients believe that taking medications is within their 
control, they are more likely to adhere to their medications. 
The concept of locus of control was later applied to health by Wallston et al (1976) adapting the 
health locus of control (HLC), which was unidimensional (i. e., external vs. internal), as the original LC 
(Wallston, Wallston et al. 1976). Later, it was further extended to adapt the multidimentional health 
locus of control scale (MHLC) (Wallston and Wallston 1978), which divided control beliefs into three 
separate scales: an internal scale and two external scales, i. e., chance and powerful others (Levenson 
1973a; Levenson 1973b). As the general HLC was found to be a weak predictor of health behaviour, 
Wallston et al (1994) developed a condition-specific version of MHLC which further divides powerful 
others into two independent scales: doctors and powerful others. Similar to the LC, both the general 
and condition-specific HLC assume that internals are more likely to engage in health-promoting 
activities. Many studies have utilized the HLC theory to explain individual differences in the likelihood 
of engaging in treatment adherence behaviour. Some studies found that 49 individuals high in 
internal locus of control were more likely to adhere to HIV (Molassiotis, Nahas-Lopez et al. 2002), 
hypertension (Kirscht and Rosenstock 1977) and diabetes medication regimens (O'Hea, Grothe et al. 
2005). Overall, it has been found that the HLC is relatively weak in predicting health behaviour 
(including adherence to medication), accounting for only small amounts of the variance in patients 
behaviours (Conner and Norman 2005). Therefore, there is currently little research interest in the 
HLC as a predictor of patients' adherence to their treatment plan. 
2.6.5 Protection motivation theory (PMT) 
Protection motivation theory was originally developed by Rogers in 1975 as a framework to 
understand the impact of fear appeals (messages that use fear to persuade) on behaviour (Rogers 
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1975). The theory can be seen as a hybrid theory in which three components originate from the 
health belief model (i. e., vulnerability, severity and response efficacy), while other components 
originate from the social learning theory (i. e., self-efficacy, outcome-efficacy). Further, as in the TPB, 
PMT also incorporates and stipulates that intentions, which are labelled "protection motivation", are 
the main and most immediate predictor of behaviour. However, these intentions are influenced by 
constructs other than those proposed by the TPB. These are threat and coping appraisal (as in the 
HBM). 
Threat appraisal involves the evaluation of a fear appeal to determine the perceived vulnerability, 
severity and fear of the threat. Therefore, one is more likely to have intentions to perform the 
behaviour if one believes one is vulnerable to the threat, the threat is severe and one is fearful of the 
threat (Bosworth and Voils 2006). Coping appraisal comprises three constructs: self-efficacy, 
response-efficacy and response costs. The first two constructs have been explained previously, and 
the latter refers to one's beliefs about how costly the recommended response will be. According to 
the theory, one is more likely to perform the behaviour if one believes one is capable of performing 
the behaviour, the behaviour will effectively reduce the threat and the recommended response is 
not costly (Bosworth and Voils 2006). In summary, PMT postulates that threat and coping appraisal 
both influence intentions to perform the behaviour. However, they may also lead to maladaptive 
coping responses (e. g., avoidance, denial, fatalism, wishful thinking and hopelessness) which may 
influence behavioural intentions. These responses occur when following the recommended 
behaviour does not reduce fear, or when the individual receives a fear-arousing message but no 
recommended behaviour is suggested to reduce this fear (Norman, Boer et al. 2005). The PMT has 
been applied to a number of health-related behaviours, including exercise, condom use, breast self- 
exam, smoking, substance use and dietary fat consumption (Bosworth and Voils 2006). Applications 
of the theory to adherence to medications are limited; nevertheless, it has been utilized to predict 
adherence to medication in diabetes (Palardy, Greening et al. 1998) and asthma (Bennett, Rowe et 
al. 1998). 
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2.6.6 Social learning (cognition) models (SCMs) 
Social cognitive models commonly assume that attitudes and beliefs are major determinants of 
adherence. According to these models, behaviour is a function of an individual's beliefs or the 
expectancy that the behaviour will lead to a particular reinforcement and the extent to which that 
reinforcement is valued (Rotter 1982). Therefore, patients are more likely to adhere to their 
medications if they believe that this will lead to a particular outcome (e. g., improved health, saving 
their life), and if that outcome was important to them (Horne and Weinman 1998). Social cognitive 
models were originally derived from the Social Learning Theory (Rotter 1954), which was later 
termed the Social Cognitive Theory (Bosworth and Voils 2006). The theory suggests that before 
people can engage in a particular behaviour, they must undergo processes of reasoning, decision- 
making and problem-solving. There are a number of social cognitive models that are based on the 
social learning theory. Some models were specifically designed to explain health-related behaviours 
such as the Health Belief Model (Rosenstock 1974), while others were designed to explain general 
behaviours such as the Theory of Planned Behaviour (Ajzen 1991). In addition, two competing views 
emerging from Social Learning Theory are Locus of Control and Self-Efficacy. These will be discussed 
in the following sections. 
2.6.7 Transtheoretical model of change (TMC) 
This model is one of the stage models of health behaviour, which assumes that the initiation and 
maintenance of health behaviours may involve different stages, and is not the result of a one-off 
decision (Conner and Norman 2005). Following that assumption, different cognitions may be more 
salient at different stages in promoting health behaviours. The transtheoretical model of change 
(TMC) was developed by Prochaska and DiClemente in 1984 and was widely used to understand the 
processes of change in alcoholism and smoking cessation. The most widely used version of the model 
identifies five distinct stages through which individuals are thought to progress in order to initiate 
and maintain a new behaviour (Conner and Sparks 2005). These stages are: 
1. Pre-contemplation: where an individual is unaware that his/her current behaviour (e. g., 
smoking) constitutes a problem and has no intention to change it. 
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2. Contemplation: the individual is thinking about changing the risky behaviour but is not 
committed yet. 
3. Preparation: the individual has an intention to change the behaviour and is starting to make 
plans about how to change it. 
4. Action: the individual is actually attempting to change the behaviour. 
S. Maintenance: the individual is six months abstinent from the risky behaviour and is 
attempting to prevent relapse. 
Individuals are thought to move through these stages in order, although they may cycle through the 
stages several times before achieving long-term behaviour change (Conner and Sparks 2005). The 
model's strengths lie in its capacity to integrate a wide range of information and serve as an 
instrument for the design and management of both individual and community or population level 
health behaviour change intervention programmes. In some areas, such as dietary change, its 
application might have advantages over alternative approaches. Yet the TTM's critics believe that the 
use of stage change-based targets as substitutes for health gain can be counter-productive. 
As mentioned earlier, this study was not built on any of these health behaviour theories and results 
and identified themes that describe factors influencing the behaviour of patients with MetS from this 
study will not be compared to these theories as this is beyond the scope of the current study. The 
following section represents identified studies that explored health issues in patients diagnosed with 
MetS. 
2.7 Patient perceptions of MetS 
The complex nature of MetS calls for the implementation of both pharmacological and lifestyle 
interventions to help control existing CRFs and prevent others from developing. This suggests a 
strong behavioural element that might influence patients' interpretation of their condition, the risk 
of developing CVDs and the importance of complying with the treatment plan (Byrne and Wild 2005). 
Understanding patients' perception of their health condition (i. e., MetS or multiple CRFs) and their 
attitude towards the treatment plan can help health professionals identify factors that deter 
behavioural change (Frisman and Bertero 2008). Thus, it was important to search for literature that 
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explored patients' perceptions and health concerns with regards to MetS. However, the study 
literature search identified only eight papers that explored perceptions and health issues of patients 
with MetS using qualitative approaches (Evans, Greaves et al. 2007; Machado, de Freitas et al. 2007; 
Oh, Bang et al. 2007; Frisman and Bertero 2008; Lupatini, da Silva et al. 2008; Troughton, Jarvis et al. 
2008; Kirkendoll, Clark et al. 2010; Vieira and Turato 2010). Google translation was not available for 
two of these papers (Machado, de Freitas et al. 2007; Oh, Bang et al. 2007). However, English 
translated abstracts for these two papers were available. It is important to mention that none of the 
identified studies explored the perceptions of patients from the UAE or countries of similar cultural 
context. The identified studies explored three main aspects of living with MetS: 
  
Patients' perceptions of MetS as a prediabetes condition (Oh, Bang et al. 2007; Troughton, 
Jarvis et at. 2008) 
  
Patients' attitudes towards lifestyle adjustments (Frisman and Bertero 2008; Lupatini, da 
Silva et al. 2008; Kirkendoll, Clark et al. 2010; Vieira and Turato 2010; Vieira, Cordeiro et al. 
2011) 
  
Educational needs of patients with MetS (Evans, Greaves et al. 2007) 
The literature review did not identify studies that explored risk perceptions, coping strategies and 
factors influencing adherence to medicines in this group of patients. However, literature that 
explored such aspects of diseases within other chronic illnesses such as diabetes, hypertension, 
dyslipidaemia and astma were included. The following three sections present different aspects of 
living with MetS as identified in the literature review. 
2.7.1 Patient attitudes towards MetS 
Understanding patients' attitudes towards the name and diagnosis of their illness attracted a lot of 
research attention because of its impact on subsequent course of treatment. Patients' perceptions of 
their diagnosis can be more than simply detection and naming of the disease. Patients' perceptions 
of the diagnosis of their diseases can facilitate their adaptation to the condition (Parry, Peel et al. 
2004). A recently published survey showed that, upon diagnosis of diabetes, patients reported 
feeling anxious, frightened, angry or that the disease was unfair (Mosnier-Pudar, Hochberg et al. 
52 
Chapter 2 Literature review 
2009). A group of diabetic patients reported feeling shocked and overwhelmed by their diagnosis. 
Patients also felt that having diabetes was unfair and unjustified because they believed they led a 
healthy lifestyle (Gazmararian, Ziemer et al. 2009). Many factors affect patients' attitude towards 
their diagnosis such as beliefs, socio-cultural factors, previous knowledge about the condition, and 
patient-physician communication. 
During the development of the WAKEUP education toolkit for patients with prediabetes, participants 
admitted feeling frustration, confusion and shock towards the diagnosis because of the limited 
information they received about it. Other participants reported that they did not have previous 
knowledge about prediabetes and that being informed of the diagnosis was their first encounter with 
the condition (Evans, Greaves et al. 2007). This can explain why participants in that study stressed 
having detailed information about prediabetes in their feedback during the development of the 
WAKEUP toolkit. Another group of diabetic patients felt that attending educational sessions after 
they were diagnosed with T2DM facilitated their acceptance of the condition (Parry, Peel et al. 2004). 
On the other hand, another group of patients with MetS expected to be diagnosed with the 
condition due to their previous knowledge about their uncontrolled CRFs. Lupatini et al (2008) 
explored the perceptions of living with MetS of 18 Brazilian patients between the ages of 45 and 69 
years through in-depth interviews. Their main struggle was adjusting to the chronic nature of MetS 
and the need for a lifelong treatment. In their perception, more time and education was needed to 
fully comprehend the condition management needs of MetS. 
Study participants in Parry et al (2002) reported refusal to accept their diagnosis of diabetes because 
they felt that the general practitioners that were delivering the news were not competent enough to 
confirm their diagnosis. Participants' accepted the diagnosis only when it was delivered by a 
consultant (Parry, Peel et al. 2004). This reflects the impact of patients' perception of their health 
professionals and the role that doctor-patient communication plays in patients' attitude towards 
their diagnosis (Parry, Peel et al. 2004; Wensing, van den Hombergh et al. 2006). 
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2.7.2 Patient perceptions of CVD risk in MetS 
Literature review 
Lay perception of risk is subjective and relates to the probability of an adverse event and refers to 
the degree to which a situation poses a threat to an individual (Lawton 2003). Many physiological 
models of health-related behaviour, such as the Health Belief model, Theory of Reasoned and Action, 
and Protection Motivation Theory, have identified factors influencing people's perceptions of 
individual risk and their likelihood of adopting behaviour change. Such factors include perceived 
susceptibility to illness; perceived seriousness of the condition; the benefits and barriers to 
behavioural change; and cues that facilitate behavioural change. However, some of these 
psychological models did not take into account other factors, such as environmental, structural and 
economic factors, that may influence health behaviours. Others did not incorporate the influence of 
social norms, cultural and peer influences on people's decisions regarding their health behaviours 
(Conner and Norman 2008). As was illustrated in section 2.5, different aspects of the UAE socio- 
cultural context were found to substantially influence patients' perception of their health and illness. 
A meta-analysis showed consistent relationships between risk perception and health behaviour, 
implying that perceived risk is instrumental in motivating behaviour change (Brewer, Chapman et al. 
2007). However, empirical studies showed that this prediction might not always be the case 
(Adriaanse, Twisk et al. 2008). Health professionals tend to assume that patients perceive risk as they 
do, resulting in a false prediction of patients' health behaviour. Moreover, patients are sometimes 
inclined to underestimate their personal risk of developing diseases. Therefore, it is very important 
for health professionals to understand how patients interpret, think, and live with their illnesses 
(Conner and Norman 2008). 
Lay perception of risk was explored with patients diagnosed with other features of the MetS such as 
diabetes and hypertension. Weaver et at (2006) explored how hypertensive patients perceived and 
coped with the risk of hypertension. In-depth interviews were conducted with 11 newly diagnosed 
hypertensive patients between the ages of 41 and 82 years. Data analysis showed that a group of 
participants were in denial towards the risk of developing CVDs. Denial was prompted by either 
perceiving risk as an out of reach event, thus unexpected, or because they have taken preventative 
measure against risk (e. g., lifestyle interventions). Another group of participants expressed feelings of 
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acceptance towards the risk of developing CVDs. This group of patients believed that risk was an 
inevitable event and an everyday phenomenon (Weaver, Murtagh et al. 2006). 
Patients' denial of the risk of developing CVDs is referred to as 'optimistic bias' and it is proved to 
hinder behavioural change (Conner and Norman 2008). In the Weaver et al (2006) study, 
participants' denial reflected their poor health awareness or their confusion because of their inability 
to differentiate between the meaning of being hypertensive and being free of risk. Other participants 
who denied being subject to risk because of adapting a healthy lifestyle showed a higher level of 
health awareness. Acceptance, on the other hand, was mostly prevalent with older participants, 
which could suggest a link between the level of experience with the condition and the use of an 
acceptance narrative towards risk of developing CVDs. 
Conversely, denial was found to be a key factor that prevented a group of diabetic patients from 
adhering to lifestyle intervention (Gazmararian, Ziemer et al. 2009). In this study, three focus groups 
were conducted with 35 mostly African American diabetic patients. The aim of the study was to 
investigate the educational and system barriers to achieving optimal diabetes self-management. 
Patients perceived implementing lifestyle changes as the most challenging in diabetes management. 
Optimistic bias and failure to expect the consequences of unhealthy behaviour demotivated study 
participants from complying with lifestyle interventions (Gazmararian, Ziemer et al. 2009). 
2.7.3 Patient attitudes towards MetS treatment 
Patients with MetS need to abide by MetS treatment requirements, which include both 
pharmacological and lifestyle interventions. However, patients' attempts to comply with the 
treatment plan can be beset by many challenges that may affect the outcomes of treatment. 
Addressing such barriers while designing a treatment plan can enhance the management of MetS. 
Frisman and Bertero (2008) explored how patients with MetS interpret and live with their condition. 
They also investigated how patients' awareness of the risk of MetS affects health behaviour. in-depth 
interviews were conducted with 13 Swedish adults aged between 33 and 82 years that were 
recruited from an outpatient lipid clinic. All study participants fall into the National Cholesterol 
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Education Programme (NCEP) diagnostic criteria of MetS. However, none of the participants were 
diabetic or had a history of CVDs. Data analysis revealed that despite patients' knowledge of the risk 
of MetS, patients struggled to implement lifestyle changes and fell back to their everyday behaviour 
(also known as recurrence of behaviour). Participants' cognisance of the risk associated with having 
MetS subsided with time. Patients lacked the motivation to proceed with or maintain healthy 
lifestyle interventions. Maintaining a healthy lifestyle required patients to make certain modifications 
to their lives, which they were not always ready or motivated to make. Patients also perceived 
unhealthy behaviour, such as over eating and not exercising, as normal behaviours and thus strived 
to maintain it by resisting change. In their perception, being content with life meant accepting life's 
circumstances regardless of having MetS or being at risk of developing CVDs. In some other cases, 
patients' awareness of the genetic predisposing factor to acquiring MetS endorsed their fatalistic and 
neglectful attitude towards their condition thus triggering recurrence behaviour. 
The study results highlighted the complexity of implementing and maintaining a healthy lifestyle. It 
also emphasised the importance of addressing contextual and personal factors to achieve successful 
MetS management. Although the study authors stress the role of health education in rectifying 
patients' health attitudes, study findings raise the question of whether health education solely can 
reduce recurrence of behaviour. Participants in the study were aware of the risk of MetS and the 
importance of lifestyle interventions. However, downplaying MetS risk was prompted by personal 
and contextual factors, such as life's competing demands, fatalism and striving to feel satisfied with 
life's circumstances (Frisman and Bertero 2008). One of the study limitations was the inability to 
recruit participants from different cultural and social backgrounds, which might have enabled the 
discovery of different experiences and perceptions of the MetS. In addition, the study did not 
describe patients' attitudes towards pharmaceutical interventions. This would have verified if 
patients' neglectful attitude was limited to lifestyle interventions or included different elements of 
the management of the MetS. In comparison to this study, participants in the Lupatini et al study 
admitted that their recurrence behaviour was mainly due to the asymptomatic nature of MetS and 
its invisible features (i. e., hypertension, diabetes and dyslipidaemia). In their case, more information 
and education about the seriousness of all CRFs of MetS would improve compliance to lifestyle 
interventions. 
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Kappagoda and Amsterdam (2007) argue that patients with MetS need motivational interviewing, 
which is a counselling approach based on the principle that all human behaviour is motivated. This 
approach recognises that all patients with MetS become indecisive about their behaviour towards 
their treatment plan periodically. Thus, the aim of motivational interviews is to encourage change 
without emphasising the change itself. During these interviews, health professionals are advised to 
emphasise the importance of dietary control and physical activity in a peaceful and non- 
condemnatory way. The approach was used in trials related to smoking cessation, weight loss, 
diabetes and hypertension. Although this approach was not used in patients with MetS, the 
counselling technique can be transferred into a MetS setting (Kappagoda and Amsterdam 2007). On 
the other hand, recurrence of behaviour due to lack of motivation, despite awareness of risk, was 
identified in a group of diabetic patients with and without a history of CVDs (Carroll, Naylor et at. 
2003). In-depth interviews were conducted with 20 diabetic patients between 52 and 77 years of 
age. The results of the study showed that ongoing motivation to comply with lifestyle interventions 
relied on an intricate interplay of factors such as patients' belief, level of awareness, 
and attitude towards illness. Contrary to Kappagoda and Amsterdam's (2007) claim of the role of 
motivational interviews in reviving behaviour change, participants in this study admitted that 
knowledge and warning messages of the consequences of non-compliance were not strong 
motivating factors and did not always result in behaviour change (Carroll, Naylor et al. 2003). 
The psychological impact of living with the MetS was explored in nine Portuguese patents between 
the age of 37 and 63 through in-depth interviews (Vieira and Turato 2010). Participants' narratives 
revealed profound dominance of feelings towards obesity compared to other features of the MetS. 
Obesity was perceived as a burden and a clear indication of an unhealthy body. Societal and cultural 
disapproval of obesity intensified participants' feelings of social rejection and stigma. Participants felt 
embarrassed and devitalised because of their obesity but did not transfer this feeling to other 
features of MetS (i. e., hypertension, diabetes and dyslipidaemia) because of their invisibility. They 
were, therefore, disposed to undergo surgical operation to remove excess fat, which they perceived 
as a quick solution to their agony and discomfort. Participants claimed their weight gain was not due 
to their eating habits. Despite their compliance with dietary recommendations, they continued their 
struggle to lose weight. This fuelled patients' sense of despair and anguish as people around them 
were not convinced that they were complying with recommendations. 
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There are a wide range of factors that impact patients' perceptions of their MetS diagnosis, its risk 
and the risk of developing CVDs and their attitude towards its treatment plan. These factors affect 
the success of MetS management and are thus important to be identified and modified when 
applicable. 
The literature search failed to identify any literature that describes health professionals' perceptions 
of MetS or the factors that impact its management. However, many concerned and specialised 
authors have written about the concept of MetS and the controversy that surrounds it. The following 
section presents the history of the MetS concept followed by arguments surrounding the MetS 
concept drawn out of articles that investigate the clinical implications of MetS. 
2.8 Controversy surrounding the MetS concept 
The risk associated with the clustering of cardiometabolic anomalies is not a new concept but was 
first reported in the early 1920's (Alberti 2005). It was not until 1988 when this phenomenon started 
to receive increased attention as Reaven (1988) coined the term Syndrome X to describe a disorder 
consisting of insulin resistance, glucose intolerance, increased triglyceride, decreased high-density 
lipoprotein cholesterol levels and hypertension. Reaven proposed that the cluster of these 
atherogenic risk factors occurred in the presence of insulin resistance and that this clustering 
increased patients' risk of developing CVD and T2DM. He also noted that the more obese and 
sedentary an individual, the greater the degree of insulin resistance (Reaven 1988). The term 
'metabolic syndrome' was first used by the WHO as a separate condition in 1998 when it introduced 
the first definition and diagnostic criteria for the syndrome (WHO 1999). This was closely followed by 
many other definitions, specifically those of the European Group on Insulin Resistance (EGIR) (Balkau 
and Charles 1999), the NCEP (Adult Treatment Panel III) (Cleeman, Grundy et al. 2001), the American 
Association of Clinical Endocrinologists (AACE) (Einhorn, Reaven et al. 2003), American Heart 
Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) (Grundy, Cleeman et al. 2005) 
and the International Diabetes Federation (IDF) (Alberti, Zimmet et al. 2006). Table 2.5 illustrates the 
diagnostic criteria of each MetS definition. The aim of each speciality group's attempt in producing 
new diagnostic criteria for the MetS was to facilitate and enhance patient identification within 
clinical sittings. 
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Chapter 2 Literature review 
Despite slight variations amongst these six definitions, they all agreed on the underlying 
aetiology of MetS and the increased risk of developing T2DM or CVDs associated with the 
clustering of CRFs. Although the AHA/NHLBI and the IDF definitions were in common use and 
produced a significant amount of epidemiological data, the use of either of these two definitions 
by different groups rendered the comparison between some studies impossible due to 
differences in cut-off points of the syndrome's metabolic features used to identify study 
participants. Thus, in 2009, attempts were made to harmonise the AHA/NHLBI and the IDF 
definitions in order to unify the diagnostic criteria used to identify patients with MetS (Alberti, 
Eckel et al. 2009). As a result of this meeting, the IDF agreed with the AHA/NHLBI definition that 
a predetermined increased waist circumference is not a prerequisite for the diagnosis of MetS 
and that the existence of any three of the five cardiometabolic risk factors is enough to confirm 
MetS diagnosis'. At the same time, the IDF insisted on the importance of using ethnic and 
country specific criteria for the measurement of waist circumference. Despite the fact that it has 
been 13 years since the first MetS definition was introduced by the WHO, controversy continues 
over the validity of naming and treating the syndrome as a separate condition. This 
disagreement started when the American Diabetes Association (ADA) and the European 
Association for the Study of Diabetes (EASD) issued a statement questioning the clinical value of 
MetS (Kahn, Buse et al. 2005). 
The authors of the ADA/EASD joint statement argued that MetS diagnostic criteria are 
ambiguous and the rationale for thresholds was ill defined. They did not see the value of 
including T2DM in the definition of MetS and questioned the validity of using insulin resistance 
as the unifying aetiology. In addition, the benefit of excluding other non-cardiometabolic factors, 
such as smoking and family history, from MetS diagnostic criteria as risk factors and predictors 
for the development of CVD and T2DM was unconvincing. The authors also opposed the claim 
that the CVD risk associated with MetS was greater than the sum of its parts. Since the 
treatment guidelines of MetS did not vary from that of its individual components, the ADA/EASD 
statement authors did not see the additional benefit of labelling patients with MetS as a 
separate diagnosis (Kahn, Buse et al. 2005). ADA/EASD censure of MetS was followed by others 
(Brietzke 2007; Kahn 2007; Kahn 2008); however, most of these challenging statements were 
7 The report regarding the harmonisation of the IDF and the AHAMHLBI definitions of the MetS syndrome was published on the T" of Oct 2009 after 
the whole current study was completed; therefore, the current study's inclusion criteria relied on the IDF definition of the MetS that was published in 2006. All study participants had BMI > 30kg/m2 plus two other cardiometabolic r sk factors. 
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repeatedly defended by supporters of MetS (Grundy 2006; Grundy 2007; Alberti, Eckel et al. 
2009; Sadikot and Hermans 2010). 
A number of cardiologists and endocrinologists who agreed to incorporate MetS diagnostic 
criteria into their clinical practice still stand firm against some of the reported benefits of the 
MetS concept (Hughes 2010). Such doubtful benefits include the superiority of the MetS 
definition over other cardiovascular risk determining tools in estimating absolute cardiovascular 
risk of individuals such as Framingham Risk Score and the Joint British Societies Risk Chart. 
Grundy (2006) who is a key supporter of the MetS concept stresses that MetS should not be 
used as a predictor of CVD risk, but rather as a means of identifying patients' who will benefit 
from an early lifestyle and pharmaceutical intervention to prevent cardiovascular risk. He states 
that acknowledging the MetS will generate a greater sense of the potential long-term risk of 
developing CVD or T2DM in such patient groups and will draw health care professionals' 
attention towards the importance of a holistic management of the clustering cardiometabolic 
features of MetS (Grundy 2006). 
Sadikot and Hermans (2010) stated that while MetS fails to provide an absolute risk prediction, it 
is a simple and cost-effective tool that can be utilised by family medicine and primary care 
physicians to identify individuals at high, long-term risk for both CVD and T2DM. Moreover, using 
the MetS diagnostic criteria in clinical practice will encourage HCPs to look for other 
cardiometabolic anomalies once one or more risk factors have been identified. The elevated 
prevalence of CVDs and T2DM worldwide calls for joint efforts to take immediate and effective 
steps in halting this global health hazard, and one way of tackling this epidemic is through using 
the MetS concept within the primary and family medicine setting. Sadikot and Hermans also 
argue that the MetS concept might be perceived by some endocrinologists as an attempt by 
cardiologists to take over the diabetes field, hence the ADA/ESAD persistent criticism of the 
MetS (Sadikot and Hermans 2010). 
In the UAE, the MetS was recognised as a paramount risk factor that contributed to the high 
prevalence of T2DM and CVDs in the country (HARD 2007). Thus, MetS prevention was 
prioritised in Abu Dhabi's public health strategy (HAAD 2007). In addition, the Abu Dhabi CVD 
prevention campaign WEQAYA incorporates both MetS diagnostic criteria and Framingham Risk 
Score to identify individuals at risk of developing CVDs (WEQAYA 2010). This suggests a 
consensus among health authorities and professionals working in the UAE on the importance of 
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acknowledging the MetS concept in clinical practice. However, to our knowledge, HCPs' 
perception of the MetS concept, diagnostic criteria or management in the UAE was not explored. 
Given the fact that HCPs' perception of the syndrome might be swayed by existing and ongoing 
controversy surrounding the MetS clinical implications (Hughes 2010), it was important for this 
study to explore the perceptions of HCPs working in the UAE of the MetS concept. Identifying 
this group's perception of the MetS concept will help elucidate their attitude towards utilising 
the MetS diagnostic criteria in clinical settings and will aid in eliciting professional-related factors 
that might influence MetS management in the UAE. 
2.9 Gaps in the literature 
There has been a huge interest in exploring lay perceptions of a wide range of chronic diseases in 
recent years, which reflects the growing interest in the use of qualitative techniques in health 
service research more generally. However, the literature review has identified three main gaps 
in the literature concerning MetS: (i) health concerns of patients with MetS in the UAE; (ii) 
professional perceptions of MetS; and (iii) the role of the UAE health care system in the 
prevention and management of MetS 
2.9.1 Health concerns of patients with MetS in the UAE 
Little has been reported about perspectives of living with MetS. Although studies that explore 
health issues of this group of patients have emerged in the past ten years, the vast majority of 
these studies were conducted in European or North American countries. The UAE, with its 
unique Islamic and Arabic cultural identity and traditions, has different perspectives of disease, 
medicine and behavioural approaches to chronic disorders. Thus, there is a need to address 
MetS management issues within the UAE context. Although many health issues are similar 
amongst patients with MetS of different cultural and religious backgrounds, other identified 
health matters might reflect the impact of the unique context of the UAE. 
The limited number of qualitative studies that explored health beliefs in the UAE have illustrated 
a strong religious and socio-cultural influence on lay perception of health and illness. 
Unfortunately, these studies explored health beliefs of elderly Emiratis (Ypinazar and Margolis 
2006), as well as health issues and barriers to weight management in women living in the UAE 
(Winslow and Honein 2007; Berger and Peerson 2009; All, Baynouna et al. 2010). Themes 
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elicited from these studies are important and provide an understanding of the impact of the 
Emirati context on perceptions of health and illness. However, exploring lay perceptions of MetS 
and health concerns of individuals belonging to a variable range of demographics will provide a 
wider and clearer picture of barriers and facilitators to MetS management in the UAE. 
2.9.2 Professional perspectives of MetS 
During the time of this study, there was limited information on health care professionals' 
perceptions of the MetS. Literature concerning the clinical value as well as the controversy of the 
MetS definition reflects the views of elite scientists, endocrinologists and cardiologists in the 
medical field (Grundy 2006; Johnson and Weinstock 2006; Ferrannini 2007; Hughes 2010). 
Current understanding of the perceptions of MetS and barriers to its management comes 
primarily from studies on patients' views. However, health care professionals' perceptions of 
MetS as a condition in its own right and factors influencing its management have been 
inadequately reported. In additions, previous studies showed that patients and physicians' 
understanding of diseases and risk varies, which resulted in physicians making unrealistic 
assumptions about patients' attitudes towards their treatment plan (Heijmans, Foets et al. 2001; 
Saberi and Heisler 2008). Thus, one of the main aims of this study is to explore the perceptions 
of health care professionals of different specialities (i. e., physicians, pharmacists, dieticians, and 
health educators) of MetS and its management. Addressing factors that impact MetS clinical 
utility may help improve MetS management. 
2.9.3 The role of the UAE health care system in MetS 
The UAE has the second highest prevalence of T2DM and an equally alarming prevalence of 
MetS and obesity. The UAE reformed health care system is trying to provide substantial solution 
and prevention measures to tackle this epidemic. However, the efficacy of these strategies to 
reduce the prevalence of MetS or prevent CVDs is yet to be assessed and reported. Exploring the 
impact of such services on health behaviour will be highly important if future preventative 
strategies are to be launched. The UAE is home to almost 8 million residents; the majority of 
which come from different ethnicities and cultural backgrounds. It is, therefore, important to 
explore the health concerns of MetS patients of different nationalities. This may provide answers 
to whether the current health care system is able to cater for the health needs of all residents of 
the UAE. It may also help find out whether the needs of any community or society were 
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marginalised when the UAE health care system was structured. Although the scope of this study 
does not encompass the role of the UAE health care policy in the management of MetS, findings 
from this study may highlight areas that need improvement in order to improve the 
management and prevention of MetS. 
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Chapter 3 
Methodology 
3.1 Introduction 
Methodology 
This chapter describes the methodological approach used in the research and the sources of 
data used to investigate the aims of the study. This qualitative research explored health care 
issues in patients with MetS through face-to-face in-depth interviews with patients and HCPs 
which were then followed by a focus group with pharmacists to further explore some of the 
themes indentified in the semi-structured interviews. This qualitative approach allowed people 
to voice their concerns about living with MetS in the UAE. The study was structured using the 
following steps: 
  
The research paradigm 
  
Choosing the research methods and rational 
  
Developing the study instruments 
  
Ethical issues 
  
Selecting the study site and setting 
  
Selection of the study participants (sampling and recruitment) 
  
Data collection and management 
  
Data analysis 
  
Reliability and validity of data and methods 
3.2 The research paradigm 
To ensure rigour in qualitative research, it is important that the researcher explicitly describes 
the decision-making trail within the report to enable audibility by readers (Creswell 2007). A 
paradigm refers to the basic belief systems or a worldview that guides the choices of methods as 
they relate to the underlying ontology (nature of reality) and epistemology (what can be known) 
of that view (Denzin and Lincoln 1994). There are multiple social research paradigms available to 
qualitative researchers, which can be tailored to fit a study according to the set of beliefs that 
researchers apply to their research (Creswell 2007). A clear consideration of the philosophical 
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basis of the research is essential to ensure conformity of the study design in terms of the 
ontological, epistemological and methodological premises of the research. The enquiry 
paradigms of positivism, post-positivism and constructivism were explored in relation to the 
ontological, epistemological and methodological stance of this thesis. 
Positivism dominated the physical and social sciences for over four hundred years and is still 
considered by many scientists to be the gold standard within health research, particularly with 
the influence of medical research (Bryman 2008). It encompasses any research approaches that 
apply scientific methods to understanding human behaviour and affairs. A positivist stance in 
research assumes that there is an absolute approachable reality which researchers can identify 
(Guba and Lincoln 1994). Positivism is also reductionist and determinist in nature as it aims to 
identify cause and effect relationships and to make predictions (Cohen and Manion 1994). In the 
positivist paradigm the relationship between the researcher and participants must be objective 
as the researcher adopts a distant, non-interactive relationship with aims to exclude bias and 
personal values. Research methodology appropriate to the positivist paradigm is experimental 
and manipulative in nature. It involves the formulation of questions and/or hypotheses that are 
subjected to empirical testing, whilst exerting maximum control of variables. 
The post-positivist paradigm has been developed in the past few decades in response to the 
criticism of positivism and is believed to be adopted by researchers with prior quantitative 
research training who are new to qualitative research (Denzin and Lincoln 1994; Phillips and 
Burbules 2000; Creswell 2007). However, post-positivism remains within the same set of 
essential beliefs about the nature of reality. It involves research in natural settings, incorporating 
situational information and accepting discovery as an element of enquiry. Post-positivism has an 
ontological basis where reality is assumed to exist but is imperfectly understood because of the 
complexity of human nature. The epistemology basis of the post-positivism paradigm assumes 
that the relationship between the researcher and the subject is that of a modified 
dualist/objectivist with objectivity as an ideal aim. Researchers who belong to this paradigm 
view enquiry as a series of logically related steps and believe in multiple perspectives from 
participants rather than a single reality. They also support rigorous methods of qualitative data 
collection and analysis and will use multiple levels of data analysis to establish validity and 
rigour. Computer programmes will often be employed to organise data and help in data analysis. 
Researchers adopting a post-positivist paradigm will tend to write in the form of scientific 
reports similar in structure to quantitative approaches (Creswell 2007). 
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Constructivism is an alternative paradigm with a major difference in assumption to positivism 
and post-positivism. Constructivism implies that social phenomena are produced through social 
interactions and are also in a constant state of revision. Researchers belonging to this paradigm 
believe that there are multiple realities and views of the world that are each constructed by 
individuals. Therefore, reality is relative and is derived from the mental constructs of individuals, 
which is then restructured through communication and interpretation (Strauss and Corbin 1994). 
The social context in which the individual lives and operates plays an influential role in what is 
important; therefore, knowledge is created as individuals interact with their environment. As 
such, the realities of a particular phenomenon or experience are not identical copies of each 
other as individuals are influenced and guided by a number of different factors including culture, 
prior learning, knowledge and experience (Crotty 1998). Researchers belonging to this paradigm 
also acknowledge their contribution in the construction of the social world. As such, they try to 
understand the world that they live and work in and try to make sense or interpret the meanings 
others have of the world. They acknowledge their stance and recognise how their own personal, 
cultural and historical experiences influence their interpretations of the findings and inform the 
research. They validate their data through trustworthiness and authenticity. 
Neither the epistemological nor the ontological foundations of positivism or post-positivism are 
consistent with the focus of this thesis because of their focus on objectivity and on prediction 
and control. The study aims and objectives cannot be addressed through the experimental and 
manipulative approaches of the positivist paradigm. In addition, the post-positivist paradigm is 
not consistent with the requirements of the study. The constructivist paradigm, on the other 
hand, is directly relevant to the study enquiry which aims to explore the meanings and 
experiences in the respondent's own terms. It is consistent with both the findings of the 
literature reviewed in chapter 2 and the researcher's own belief that the context of this enquiry 
is subjectively perceived and socially constructed. This research is based on the constructivist 
epistemological perspective, whereby reality is created when an individual interacts with their 
environment. It must be noted here that the realities of particular phenomenon or experience 
are not carbon copies of each other as individuals are influenced and guided by a number of 
different factors including culture, prior learning, creative abilities, knowledge and experience 
(Crotty 1998). The constructivist paradigm recognises the subjective nature of the phenomenon 
under investigation and the relationship between the researcher and the participants. Thus, this 
perspective is consistent with the study aims and objectives and, therefore, underpins the study 
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approach. The participants in this study have their own constructed views of the world and the 
phenomenon explored and as a researcher, I carry the responsibility of allowing their worldviews 
to be presented and seek to minimise my re-interpretation of their views. I also acknowledge 
that I do not enter the research with a blank mind. Being a pharmacist and having worked with 
other HCPs and patients with MetS in the UAE exposed me to some of the health concerns and 
factors that impact the management of this group of patients. This means that I have my own 
experiences and have constructed a view of the world that might be different from that of the 
study participants. Therefore, the method chosen to conduct this study should facilitate 
accessing an individual's experiences and address the impact of the social context in which the 
study participants live and interact. As such, this research was approached from a constructivist 
viewpoint. 
3.3 Choosing the research methods and rational 
This section describes how the chosen methodologies were selected and why they were suitable 
to achieve the research aims. This section starts with the methodological perspective followed 
by a detailed explanation of the methodology used. 
3.3.1 Methodological perspective 
My project has been significantly inspired and shaped by my professional background, work 
experience and the feasibility study conducted during the first year of my PhD journey. My 
interest in factors influencing the therapeutic outcomes of patients with diabetes and other 
MetS features started in the early years of my work as a community pharmacist in the UAE. The 
nature of my job as a pharmacist responsible for dispensing medicines allowed for a great deal 
of interaction with this group of patients in particular. It was during the dispensing of 
prescriptions that patients usually talked to me about different aspects of their lives and 
circumstances that they believed were key influencing factors in the control of their CRFs. On 
many occasions patients expressed concerns about their treatment plan and often suggested 
alternatives that they believed were facilitators to their disease management. Working alongside 
other HCPs (i. e., other pharmacists, physicians and nurses) and attending multiple workshops on 
diabetes and other MetS features gave me an additional professional insight into the health 
needs of patients with MetS living in the UAE. This sparked my interest in exploring factors 
influencing this group of patients. 
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During the preparation for my PhD study, I started reading around the MetS topic in the 
available literature. I came across a study by Arcucci and colleagues (2007) that looked at the 
relationship between the degree of blood pressure (BP) control and the number of CRFs in 
patients with MetS. They found that among 4,551 hypertensive patients the probability of 
uncontrolled BP was 43% higher in patients with MetS than in those without (Arcucci, de Simone 
et al. 2007). This study and others that explored factors influencing BP control in patients with 
MetS inspired the preliminary design of the PhD project. In the feasibility study, I wanted to look 
at hypertensive patients with other CRFs as a subgroup of patients with MetS and to investigate 
factors that might result in suboptimal BP control. in addition to exploring the impact of the 
clustering of CRFs on BP control, I also wanted to examine the impact of other established 
factors in the literature such as physicians' adherence to clinical guidelines of the management 
of hypertension (Frijling, Spies et al. 2001; Burnier 2002; Oliveria, Lapuerta et al. 2002) and 
patients' related factors (Dean, Kerry et al. 2007). Therefore, the preliminary study design lent 
itself to a mixed method approach where the quantitative arm aimed to: (i) assess physicians' 
level of adherence to clinical guidelines of the prevention of CVDs in patients with MetS; (ii) 
identify whether or not physicians were intensifying hypertension therapy as needed by 
patients; and (iii) the impact of coexisting CRFs on BP control. The qualitative arm of the study 
aimed to explore factors that impacted the holistic management of patients with MetS and thus 
enable a better understanding of patient, professional and contextual factors that might be 
influential in MetS holistic management including BP control. 
For the quantitative part of the study, I decided to use a medication assessment tool for the 
assessment of physicians' level of adherence to the clinical guidelines of the prevention of CVDs 
(MATCVD) in patients with MetS (Dreischulte, McAnaw et al. 2007; Kanis, Dreischulte et al. 2007). 
In addition, the intensification of hypertension therapy would be assessed by observing 
treatment options/decisions for elevated BP within three months before and three months after 
the high BP reading was first documented. Hypertension therapy intensification was indicated by 
documented changes made to the patient's hypertension management that were in the form of 
adding new drugs, increasing the dose of at least one of the ongoing drugs or the switching from 
one drug type to another. 
The preliminary study design was piloted to test the accessibility and workability of the methods 
and study procedure within the study environment and to ensure data obtained could meet the 
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study objectives. The study quantitative tools were then tested on 100 patients with MetS that 
were identified as hypertensive. In addition, semi-structured interviews were conducted with 
three participants (i. e., one pharmacist and two patients). Unfortunately, the data collection 
phase during the quantitative part of the study had a number of limitations. These barriers were 
believed to affect the completeness, reliability and validity of data. For example, a robust 
electronic database system, through which study subjects can be identified and from which 
patients' data can be extracted, was lacking in the research setting. The reliance on alternative 
tools for identifying hypertensive patients with MetS (i. e., limiting sampling locations, using the 
clinic visits registration system, indicator drugs and manual access of patients' medical files) 
contributed towards manipulation of the overall sampling process and resulted in losing both 
potential subjects and valuable research time. Missing data and poor documentation of therapy 
justifications in patient medical files may have led to a flawed assessment of clinicians' 
compliance with clinical guidelines' recommendations. 
Unlike the quantitative part of the pilot study, the data generated from the three semi- 
structured interviews revealed a number of factors that were not documented in patients' 
medical files but were believed by the study participants to be significant contributors to MetS 
holistic management. Such factors included patients' adherence to the treatment plan, the 
impact of the socio-cultural context and health policy of the UAE. The pilot study outcome 
indicated that, given the significant limitations within the study health care setting, the 
quantitative tools would fail to deliver most of the study aims and objectives. It also 
demonstrated that some clinical outcomes could be better explained by exploring patient and 
professional perceptions of the holistic management of the MetS. Therefore, a decision was 
made to omit the quantitative arm of the study and to expand the qualitative part. 
Qualitative methods have become increasingly used in health care research, especially when a 
complex detailed explanation of a phenomenon is needed and can only be obtained through 
hearing people's voices. People are believed to be an important source of information about 
themselves and the issues that affect their lives and they can, therefore, articulate their 
concerns openly and freely (Creswell 2007). Qualitative research is effective in identifying subtle 
factors, such as social norms, gender roles, ethnicity and religion, whose role in the researched 
issues may not be apparent. It also enables HCPs and policy makers to understand patients' 
health needs and their perspectives and interpretations of the health care services. Published 
qualitative research on health care issues can be used to influence health policy at a local and 
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national level (Bowling 2009). Qualitative methods are also useful to follow-up, explain or 
validate findings from quantitative research (Silverman 2004; Creswell 2007). 
In this study, qualitative methods were chosen on the basis of being better suited to exploring 
the range, depth and complexity of patients' perspectives than a quantitative approach. This 
involved the use of in-depth interviews as a research technique followed by focus group 
discussions to further explore identified themes. Patients with MetS are in direct contact with 
MetS health issues and with the health care services that cater for their needs. Therefore, these 
patients are in a better position to describe issues they encounter when managing their illnesses. 
By including HCPs in this exploration we can gain a professional insight into the MetS concept 
and its utility in the UAE. It will also enable the identification of obstacles and facilitators to MetS 
management from individuals involved in the treatment decision-making process and, therefore, 
identify issues within the clinical practice. 
The following section presents description of four qualitative approaches that were considered 
when choosing the study's methodology. 
3.3.2 Considered qualitative approaches 
There was a range of distinct research approaches associated with qualitative research that were 
considered before a decision was finally made on the appropriate methodology to explore 
factors influencing MetS management in the UAE. Narrative research, ethnography, case studies 
and grounded theory are examples of qualitative research approaches that were considered 
when choosing the qualitative approach for this research. This section presents a brief 
description of each of these approaches and then concludes with the rationale behind selecting 
Grounded Theory as the methodological approach for this study. 
Narrative research methods encompass a wide range of different research methodologies and 
methods that include autobiography, auto-ethnography, personal history, life history and 
narratives (Creswell 2007). Narrative can both be a method of enquiry which focuses on the 
stories told by the study subjects or the phenomenon investigated (Creswell 2007). As a method, 
narrative research is employed to clarify and investigate the intersection of biography, history 
and society. The narrative of personal experiences are elicited to inform us of the complexity of 
social, cultural and historical processes and to provide us with insights into the ways in which 
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social structures shape people's lives (Riessman 2001; Creswell 2007). Narrative studies are 
conducted through studying a small number of individuals, gathering their accounts of events 
and individual experiences and then arranging them into a story using a plot line. 
Contextualisation is paramount in narrative research as it provides meaning to the narrative 
account and better explains the subjects' experiences. 
Reviewers have noted the power of narrative to enlighten the world of illness especially as 
experiences of illness influence a person's sense of self. The power of stories lies in their ability 
to expose how bodily suffering or stigma can shape a life. Through the language of disease and 
dysfunction, patients' narratives illuminate meanings associated with illness or disability, which 
are experienced when the body is medically treated. Thus, an interest in patients' stories has 
grown remarkably over the past ten years amongst health and social researchers, which has 
resulted in a 'narrative turn' in the social sciences (Burner 1990). Stories can also highlight the 
experiences of HCPs and their practical reasoning where narrative is examined as a way of 
thinking and decision-making (Burner 1990). However, a common critique of narrative research 
methods is that they emphasise the individual rather than the social context in which life is lived 
(Connelly and Clandinin 1990). It is also perceived as a very challenging approach in qualitative 
research as investigators need to collect detailed information about the study participants and 
have a clear understanding about the context in which these participants live their lives. 
Researchers also need to discuss participants' stories and reflect on their own stance and how it 
impacts the story line (Creswell 2007). The focus of narrative research is to explore the lives of a 
small number of individuals. Therefore, applying the narrative approach in this study would have 
demanded a reduction in the number of participants. This in turn would have compromised the 
main scope of the study which is to gain a deeper understanding of factors influencing MetS 
management from the perspective of a range of patients and HCPs of varying educational and 
social backgrounds. Therefore, the narrative approach was not suitable for the research problem 
and questions. 
As explained earlier in section 3.3.1, this study started as a mixed method research with a 
defined set of research questions in its qualitative part. As the pilot study informed the need for 
the elimination of the quantitative part of the study, the qualitative arm retained its original 
scope, which was to explore factors influencing MetS management through exploring patient 
and professional perceptions. As such, a narrative approach would not have delivered the study 
aims and objectives. However, on reflection, using narrative research could be applied in the 
72 
Chapter 3 Methodology 
future, as it would provide a deeper understanding of the lives of patients with chronic illnesses 
such as MetS 
Another qualitative approach that was considered when designing this study was Ethnography, 
which emphasises the relationship between the participants and their natural environment. 
Ethnography focuses on an entire cultural group and enables researchers to examine individuals 
in the same place while interacting and developing a shared pattern of behaviour, beliefs and 
language (Creswell 2007). In an ethnographic study, the researcher is required to spend time 
immersed in the participants' world observing them as they interact with and within their 
environment. The researcher, therefore, becomes an instrument of the research enabling 
him/her to identify the beliefs and values of the participants and to contextualise the social 
action. Observation, in conjunction with in-depth interviews, leads to the development of frames 
of understanding which can be applied to a wide range of situations in order to develop complex 
systems of meaning based on the participants' world (Creswell 2007). Ethnography would have 
enabled me to immerse myself in the lived experience of both patients and HCPs and to observe 
their interaction. However, the priority of the current research was to explore patients' 
viewpoint of living with and managing MetS as well as that of HCPs when managing this group of 
patients. In addition, implementing an ethnographical approach to the current enquiry would 
have resulted in multiple observation sights, such as patients' homes and different patient-HCP 
encounters, which would have complicated the enquiry. The presence of the researcher in such 
locations would have impacted the nature of the relationship between patients and their HCPs in 
the clinical environment. Therefore, ethnography was not adopted as the research approach for 
this study. 
Case study is another qualitative approach that is slightly similar to ethnography but differs in 
the fact that it focuses on examining an issue within a bounded system or through observing an 
entire cultural-group. A researcher can explore one cultural group or a number of cultural groups 
over a period of time using explicit in-depth data collection tools and numerous sources of 
information (Creswell 2007). Case studies are an appropriate approach for a qualitative 
investigation when the researcher is able to determine cases with clear boundaries to provide a 
deeper understanding of this bounded group or compare it to other cases. A case study could 
consist of one individual, a number of individuals, a programme, an incident or an activity where 
purposeful sampling is employed to show different perspectives of the investigated issue. Data 
collection should employ an extensive exploration and the gathering of information from 
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multiple resources such as observations, interviews and documents. In the early stages of this 
study design, a clear bounded system within the MetS and the Emirati context was difficult to 
identify. The lack of previous studies that explored health issues concerning patients with MetS 
within the UAE context added to the challenge of determining the boundaries of a case to 
explore how it might be constrained in terms of time, events and processes. There was also the 
difficulty of employing observation as an additional source of information and to gain a deeper 
understanding of the explored case. Therefore, case study was not selected as an approach for 
this study. 
Grounded Theory (GT) is another qualitative approach that is described as an inductive 
approach to qualitative research. It was developed to study social phenomena from the 
perspective of symbolic interactionism. GT is concerned with human behaviour and how people 
manage problematic situations in their daily lives. It was first described by Barney Glaser and 
Anseim Strauss in 1967 in their book The Discovery of Grounded Theory (Glaser and Strauss 
1967; Glaser 2002). Glaser and Strauss challenged the common belief of their time, that 
qualitative methods in research lacked rigour and failed to generate theories, by introducing a 
thorough and systematic analysis of data (Charmaz 2006). GT, therefore, encourages researchers 
to move beyond description into the generation and development of theories that are derived 
directly from the research data (Glaser and Strauss 1967; Cutcliffe 2005; Charmaz 2006). The 
components of GT include: 
  
Concurrent involvement in data collection where the data collection, coding and analysis 
occur simultaneously. This allows the researchers to move back and forth within the 
data and to focus and pursue new leads as they unravel during the ongoing data 
analysis. 
  
Generation of analytical codes and categories from data in order to identify emerging 
substantive theory. 
  
Using constant comparative analysis among and between groups of people or 
participants in the area of interest during each stage of the research. 
  
Writing memos, exploring relationships between categories and identifying gaps. 
  
Theoretical sampling where participants, situations or literature are included if they add 
to identified categories and advance the construction of the theory. 
  
Conducting a literature review after the completion of the data analysis phase. 
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Observational field notes and interviews are the main source of data collection. Other methods 
such as quantitative surveys, journals, books, videos, photographs and informal meetings with 
participants have also been integrated (Glaser and Strauss 1967; Glaser 1978; Schreiber and 
Stern 2001). The generation of theory in GT is an evolutionary process that occurs as the 
research is being conducted. The primary approach in GT is inductive and the researcher is 
continually guided by the data and its subsequent patterns, codes and categories. This approach 
aids the researcher to identify the emerging theory from the data; hence the name 'grounded 
theory' as the theory is grounded in the data. Therefore, novice grounded theorists are strongly 
advised to delay literature review to avoid forming preconceived ideas and seeing the world 
through the paradigms of existing theories (Charmaz 2006). Deduction is also allowed in GT but 
usually at advanced stages of the research in order to verify and elaborate on the codes and 
categories as they emerge during each incremental step of theory development. However, this is 
not to be confused with verification of an existing theory which is another methodological 
approach and is not linked to GT (Glaser 1978; Schreiber and Stern 2001). GT is also a flexible 
and adaptable methodology as it can be used to develop both substantive and formal theory. 
Substantive theory is developed from research conducted in one specific area or contextual 
situation. Formal theories, on the other hand, are more conceptual (Glaser and Strauss 1967). 
Most theories developed through GT are substantive theories because they address defined 
problems in a specific area (Bryman 2008). For example, the current study explores factors 
influencing therapeutic management within the MetS and the UAE contexts. However, the logic 
of GT reaches across multiple substantive areas by generating abstract concepts and identifying 
relationships between them in order to address specific problems within these multiple 
substantive areas. Each exploration within a new substantive area can be used as a basis upon 
which formal theory can be built (Charmaz 2006). 
GT is particularly suited to research in areas which have had limited or no investigation. Stern 
(1980, p. 20) states that 'the strongest case for the use of GT is in investigations of relatively 
uncharted waters, or to gain a fresh perspective in a familiar situation'. She also believes that GT 
is helpful in studying complex areas of human behaviour where salient variables have not been 
identified (Stern 1980). As explained earlier in the literature review chapter, there is limited 
qualitative research regarding patients with MetS and their treatment needs within the UAE 
context. There is also limited data on factors influencing the clinical utilisation of the MetS 
concept and is, therefore, a relatively new area of enquiry. In addition, the use of GT allows the 
investigator to reveal covert reality and meanings underlying individuals' unique behaviours 
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when they deal with and resolve the basic social psychological problems. It also enables the 
researcher to identify individuals' shared reality, meanings, and behaviours, and to discover their 
shared social psychological process. Trajectory exists while individuals create and modify their 
reality, meanings and behaviours through their own actions and interactions with others and 
objects. Strategies or influencing factors during this process or trajectory are identified as 
categories and concepts during data analysis. The investigator, as such, attempts to discover and 
conceptualise the essence of complex process of social interactions (Crotty 1998; Schreiber and 
Stern 2001; Charmaz 2006). GT was, therefore, chosen for this study to understand covert reality 
and meanings toward factors affecting the management of patients with MetS in the UAE 
underlying their unique behaviours to deal with and resolve the basic social problems related to 
having CRFs. 
This study was undertaken to discover the shared social process related to having MetS. An 
assumption of this study was that this shared social process also explained factors contributing 
to patient and professional perceptions of MetS and its management in the UAE. Accordingly, it 
was appropriate to choose GT for this study as the research method to achieve the purpose of 
this study and appropriately respond to the research questions. 
The following section describes the development of GT and follows the modification it has 
undergone since it was first discovered. This will be followed by the critiques and criticisms of 
GT. At the end of the section an illustration of the GT principles used in this study will be 
provided in section 3.3.6. 
3.3.3 The development of grounded theory 
Before the development of GT and particularly before the 1960's, novice qualitative researchers 
were trained through mentoring and lengthy immersion in the research field. Early guidelines for 
conducting qualitative studies dealt primarily with data collection methods and the researcher's 
role in the field with less attention given to strategies of data analysis. Fortunately, Glaser and 
Strauss provided detailed written guidelines for conducting qualitative research and thus made 
data analysis guidelines accessible to novice qualitative researchers (Charmaz 2006). 
Glaser worked at the University of Columbia and was a well-known researcher who engaged in 
quantitative methods of enquiry. Strauss, on the other hand, was from the School or Pragmatism 
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at the University of Chicago and specialised in qualitative methods of research. Both researchers 
were dissatisfied with the direction of their disciplines and the methodologies used in their 
respective areas of research. This dissatisfaction was engendered by the gap between theory 
and research at that time and the strong emphasis placed on theory verification rather than 
theory generation (Glaser and Strauss 1967). 
During his doctoral programme at the University of Chicago, Anselm Strauss was influenced by 
the philosophies of symbolic interactionism and pragmatism. Symbolic interactionism is a social- 
psychological theory that attempts to explain human behaviour (Blumer 1969; de Laine 1997; 
Patton 2002). It states that human beings have concepts of self that enable them to be social 
beings that make sense of the world through social interactions. It also states that social 
interaction and life are experienced by symbols and the meanings that are attached to them. 
Therefore, self is defined by the social roles one is involved in and it is these roles that enable 
individuals to experience and understand their world (Blumer 1969; Bogdan and Biklen 2003). 
Symbolic interactionism perceives meaning as arising in the process of interaction between 
people. The meaning an individual attributes to any thing is derived from the way in which other 
individuals act towards him/her with regard to the situation or thing. Similarly, social life is 
formed, maintained and changed by the basic meaning attached to it by people who interact 
within the social system. Thus, symbolic interactionism sees meaning as a social product and as 
creations that are formed in and through the defined activities of people and their interactions. 
Strauss was also influenced by many scholars who contributed to the symbolic interactionism 
philosophy, such as Robert E. Parks, John Dewey and Herbert Bulmer (Charmaz 2006). The 
influence of these scholars and the academic education Strauss received was later evident in his 
contribution to GT, of which the philosophical underpinnings come from symbolic interactionism 
(Schreiber and Stern 2001). 
In contrast, Glaser used the analytical skills that he acquired from his work in quantitative 
research and codified qualitative analysis. Although Glaser had previously participated in 
research using qualitative data, he believed that qualitative data analysis needed a more explicit 
and systematic way of coding and generating theoretical hypothesis in research. Glaser, 
therefore, constructed specific guidelines for qualitative data coding (Strauss and Corbin 1990; 
Charmaz 2006). As such, Glaser's educational background influenced his contribution to GT, 
whereby he integrated quantitative methods and established a detailed and systematic 
mechanism for coding and hypothesis generation. 
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Glaser and Strauss later met in the 1960's at the University of California 
- 
San Francisco in the 
School of Nursing. Glaser was among other sociologists that Strauss recruited to help study and 
build his own programme in medical sociology using symbolic interactions and pragmatism. It 
was during that time that both Strauss and Glaser received funding for their study into dying 
patients. Their joint work 'Awareness of Dying' in 1965 showed that there was considerable 
deception operating in hospitals with regard to the dying process. The study findings, at that 
time, had a significant impact on how death was dealt with by nursing and medical staff in the 
hospital setting. It was during this study that Glaser and Strauss realised that their methodology 
was original. As GT was developed, Strauss contributed the philosophy of symbolic 
interactionism component, while Glaser contributed the systematic approach to qualitative data 
analysis (Schreiber and Stern 2001). Therefore, GT represents a marriage between two divergent 
and competing traditions in sociology: Colombia university positivism represented in Barney 
Glaser and Chicago school pragmatism and field research as represented in Anselm Strauss 
(Charmaz 2006). 
3.3.3.1 The modification of grounded theory 
The successful scholarly relationship between Glaser and Strauss led to the publication of their 
influential work on GT The Discovery of Grounded theory: Strategies for Qualitative Research in 
1967. They also went on to conduct many collaborative research projects including Time for 
Dying (1967), Anguish: Case Study of a Dying Patient (1970), Status Passage (1971) and Chronic 
Illness and the Quality of Life (1975). However, since that time both have taken GT in slightly 
deviating directions. While Glaser remained loyal to his earlier ideas of the method, Strauss 
moved the method towards verification (Charmaz 2006). In the early 1990, the relationship 
between Strauss and Glaser became strained when Anselm Strauss and Juliet M. Corbin 
published their book, Basics of Qualitative Research: Grounded Theory Procedures and 
Techniques, where they emphasised the comparative methods in GT. Since then, the work of 
Glaser has been described as the traditional GT and that of Strauss and Corbin as the evolved GT 
(Mills, Bonner et al. 2006). Strauss and Corbin's modification of GT included: 
  
Allowing investigators to engage with literature before and during the study to help in the 
development of categories and properties. They, however, warn investigators that 
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literature might repress and constrain the discovery and sensitivity to the emerging 
concepts (MacDonald 2001). 
  
Quantitative data is used for verification. This is in direct contrast to the traditional GT 
approach, which does not differentiate between different types of data as each has its place 
in theory generation and development. 
  
Defining the research questions before engaging in the research helps in setting the 
boundaries around what needs to be explored and investigated. Therefore, investigators 
are allowed to focus on the research questions and more purposefully examine the 
specified phenomenon of interest. This differs from the traditional GT approach where the 
researched problems are discovered or emerge as coding begins; therefore, research 
questions do not define the explored phenomenon. 
  
Verifying provisional hypotheses through alternating data collection and data analysis. 
Therefore, investigators are encouraged to examine preliminary theories through 
comparing concepts as they emerge during data analysis. This modification contrasts with 
Glaser's approach to GT, as he insists that verification of hypotheses are properties of 
different methodologies and that GT developed out of the need to move away from the 
verification model. 
Despite Glaser's attempts to persuade Strauss and Corbin to remove their text from publication 
and correct the numerous discrepancies he believed were evident in their book, Strauss and 
Corbin's version of GT became very popular and instructed many novice grounded theorists 
throughout the world. Although Glaser and Strauss fought the supremacy of positivism in 
qualitative research through the discovery of GT in the 1960's, by the 1990's GT was famous not 
only for its rigour and usefulness, but also for its positivist assumptions. in addition, GT became a 
popular method amongst quantitative researchers who adopted it when conducting mixed 
method research. 
Strauss and Corbin's modifications of GT were followed by a number of scholars that have 
worked in moving GT away from the positivism in both Glaser's and Strauss and Corbin's version 
of the methodology. One of these scholars was Kathy Charmaz who advocated for her take on 
GT in a number of her publications and her book: Constructing Grounded Theory published in 
2006. Charmaz took a more constructivist view of GT and saw it as a set of principles and 
practices rather than a philosophy or a prescription. Although symbolic interactionism is the 
philosophy that underpins the GT presented by Glaser and Strauss in 1967, Charmaz accused 
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their version as well as that of Strauss and Corbin's of being far too realist. She states that both 
approaches to GT assumes an objective external reality that exists and can be identified and, 
therefore, take a positivist and objectivist stance. Therefore, Charmaz advocates a constructive 
approach that assumes multiple social realities. 
Charmaz does not support the view that theories are discovered but believes that the studied 
world needs to be portrayed in an interpretive way (Charmaz 2000). She states that 'data do not 
provide a window on reality. Rather, the 'discovered' reality arises from the interactive process 
and its temporal, cultural, and structural context' (Charmaz, 2000, p. 524). Researchers are not 
separate from their theories but construct them through their interactions with people, places 
and research perspectives. For example, when study participants answer interview questions, 
their responses are 'a construction-reconstruction-of reality' (Charmaz, 2006, p. 27). Therefore, 
the act of theorising means constructing an abstract understanding of the world. Charmaz 
stresses the importance of researchers' acknowledgment of their role as well as the 
respondents' role in constructing the research data and theory. This is mainly because of her 
belief that theory neither emerges nor is discovered but is rather constructed (Charmaz 2006). 
As such, Charmaz recognises the importance of reflexivity in the research process. According to 
Mills and Authors (2006), constructivist GT brings to the fore the notion of the researcher as an 
author by reshaping the interaction between the researcher and participants during the research 
process. Charmaz developed a style of writing that is a delicate balancing act between the 
researcher and study participants. She calls for an analytical writing manner where the 
researchers' voices need to re-visualise their experience and at the same time enable the 
participants' accounts to maintain a level of visibility in the text. This enables the reader to make 
a connection between the analytical findings and the data from which these findings were 
extracted (Mills, Bonner et al. 2006). This, again, emphasises Charmaz's attempt to reveal the 
researcher as the author of a co-construction of experience and meaning, and not as a sole 
identifier of a theory that was imbedded in the data, as traditional GT proposes (Mills, Bonner et 
al. 2006). 
GT has evolved since its inception in the 1960's in the USA. Although many scholars continue to 
work and add to GT, the writing of Glaser and Strauss (1967), Strauss and Corbin (1990) and 
Charmaz (2006) are seen as influential in the development of GT. 
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3.3.4 Grounded theory methods 
Methodology 
GT offers researchers a methodology with philosophical direction for substantive and formal 
theory development. It also provides methods that facilitate all aspects of data collection, 
analysis and the writing of theory (Glaser 2002). The following sections describe the techniques 
of GT which were discussed by Glaser and Strauss in The Discovery of Grounded Theory: 
Strategies for Qualitative Research (1967) and further developed in Glaser's second book 
Advances of the Methodology of Grounded Theory: Theoretical Sensitivity (1978). 
3.3.4.1 Constant comparative analysis 
Constant comparative analysis is a fundamental technique in GT where data collection, coding 
and analysis occur simultaneously (Glaser and Strauss 1967). This allows the researchers to move 
back and forth within the data, change focus and pursue new leads as they emerge in the 
ongoing data analysis (Glaser and Strauss 1967). Glaser and Strauss (1967, p. 105) put forward 
the four stages of constant comparative method which are: (i) comparing incidents applicable to 
each category; (ii) integrating categories and their properties; (iii) defining the theory; and (iv) 
writing the theory. Each stage of this process is continually revisited in any sequence throughout 
the course of the research. Constant thematic analysis begins with the coding of incidents that in 
turn lead to the emergence of categories and their properties and finishes with the theoretical 
codes that connect the categories with each other. This allows the data to be compared and 
analysed throughout the course of the study, which resultes in the emergence of a theory that is 
a true reflection of both the data that has been collected and the study participants (Glaser 
1978). 
3.3.4.2 Substantive coding 
Substantive coding consists of two distinct stages: open coding and selective coding. Open 
coding is the first stage of constant comparative analysis and begins with the raw data obtained 
from the fieldwork, observation or interviews that have been transcribed verbatim. Each 
segment of the data is coded, examined closely and then compared to each other for similarities 
and differences (Glaser and Strauss 1967). This enables the researcher to identify patterns that 
allow for the grouping of similar codes in order to form categories and subcategories. During this 
process a core category might be identified, which will be the main category that explains the 
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variations in the data and, therefore, the behaviour or action of the study participants. This core 
category then becomes the guide to ongoing data collection and theoretical sampling. 
Selective coding is the second phase of analysis in GT and is similar in procedure to open coding. 
However, selective coding is more analytical and abstract than open coding, which leads to the 
generation of the conceptual names of the categories. This is because as codes and categories 
emerge and are compared, the researcher starts to look for the core category that explains the 
main concern or problem of the study participants. This results in more integration and refining 
of the abstract concepts covering the variations in behaviour patterns. Thus, during selective 
coding the researcher focuses on a limited number of categories that best represent the major 
aspects of the data. The criteria for core category selection as defined by Glaser (1978, p. 95-96) 
states that it should be central to as many other categories as possible and is, therefore, 
frequently seen in the data. The core category, as such, takes more time to be saturated or 
expanded than other categories identified. In addition, the core category should have 
meaningful links to other categories that are quickly and easily identified and should be able to 
explain participants' behaviour throughout the period of the data analysis (Glaser 1978). 
3.3.4.3 Theoretical coding 
During this coding phase, properties, connections and links between categories and core 
categories emerge from the data. It is also the stage during which the descriptive links between 
categories are changed into theoretical links (Glaser and Strauss 1967; Glaser 1978). Theoretical 
codes are viewed as the conceptual connectors that link categories to each other and to the core 
category enabling and guiding the process of theory generation, development and integration 
(Glaser 1978). Theoretical codes can be identified through diagrams or models that present the 
relationships between the categories and the core category. 
3.3.4.4 Theoretical sampling 
Theoretical sampling involves the inclusion of individuals, situations or literature that can add to 
the categories, properties or links identified during the data analysis process. After the process 
of open coding and the development of preliminary conceptual codes and categories, some 
questions may still remain unanswered. Such questions guide further data collection to facilitate 
theory development. Sampling and data collection continues up to the point of saturation. It is 
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at this stage of the research that the process of ongoing data collection is controlled by the 
emerging theory. Therefore, only relevant data that will add density to the emergent theory is 
collected. This process is referred to as theoretical sampling (Glaser 1978). 
3.3.4.5 Category saturation 
There are two situations that indicate the saturation of categories in GT: (i) when theoretical 
sampling does not add any new information to the categories in the study; and (ii) when there is 
no new information available to the researcher to assist his/her understanding of the properties, 
connections or links between the categories and the core category (Glaser and Strauss 1967). 
However, some researchers may choose to confirm findings with another group of participants. 
This can lead to the discovery of a new perspective or information that was not found in the 
original area of the study. This may put the researcher in a dilemma where he/she needs to 
choose between either pursuing the new lead or dismissing it as a negative case that is 
insignificant to change the theory (Glaser and Strauss 1967). Therefore, saturation of categories 
is important to mark the end of data collection in GT. 
3.3.4.6 Memoing 
Memos are the building blocks that are used to develop theoretical ideas that are grounded in 
the research data and, therefore, facilitate theory generation. Memos enable the researchers to 
document their ideas, thoughts, hunches, questions, emerging hypotheses and analytical 
schemes. This in turn enables the researchers to keep track of the emerging theory. Memoing is 
a mechanism for theorising ideas about codes, categories and the core category and their 
relationships, which are generated by the researcher during the period of the study. Memos can 
be as simple as a sentence or as complex as a diagram. Therefore, there should be no constraints 
placed on the researchers when documenting memos freely as they emerge. To accurately 
employ GT, researchers must be careful not to abandon or neglect memoing during theory 
development (Glaser 1978). 
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3.3.4.7 Theoretical sorting 
Methodology 
Theoretical sorting begins towards the end of coding and when categories are close to 
saturation. As memos are developed they may consist of all the notes, pictures, diagrams, 
comments, hunches and hypotheses that were written down from the beginning of the data 
collection and coding until the completion of the final write-up of the thesis; thus, the purpose 
of theoretical sorting is to sort the memos that were documented by the researcher throughout 
the course of the research in order to identify the emerging theory. This process is crucial in GT 
as it enables the highlighting of the connections between the categories, core category and their 
properties and facilitates the outlining of a generalised, integrated and complex theory. The 
major focus of theoretical sorting is to put back together the fractured data collected during the 
research in an effort to provide a whole picture of the substantive area under investigation 
(Glaser 2002). 
3.3.5 Problems and critiques of grounded theory 
Like any other methodology, GT has limitations. Becker (1993) highlights a number of pitfalls and 
states that many researchers claim to have produced GT research but have in fact only delivered 
elaborate descriptive studies (Becker 1993). She identifies the common problems associated 
with descriptive studies that claim to be grounded in the theory. These include: 
  
Failure to identify the problematic situations in the research area 
  
Failure to use theoretical sampling to make sure the theory produced is adequate. In 
most studies, sampling is usually decided before the start of the empirical work. 
  
Failure to use correct theoretical lens for the proposed research questions 
  
Failure to concurrently engage in both data collection and analysis 
  
Failure to identify the correct core variable due to reliance on computer programmes, 
which manage data with the identification of the core variable based solely on the 
frequency of its occurrence in the programme. 
Bryman (2008) lists a number of critiques to GT in his book Social Research Methods that include 
the following: 
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[1] The impracticality of a theory neutral observation. Bulmer (1979) questioned the difficulty 
of setting aside theory at the start of the research and argued that theory neutral observation is 
impossible. The traditional GT approach, as presented by Glaser and Strauss, stresses the 
importance of inducting the theory from the data and setting the theory construction apart from 
existing theories. However, social researchers are always aware of theories that are relevant to 
their discipline. It is, therefore, unlikely that this awareness can be suspended until advanced 
stages of data analysis. In addition, awareness of existing theories enable researchers to focus 
on defined research questions and build their explorations on previous work (Bulmer 1979; 
Bryman 2008). 
[2] The need to specify theories for research bids. Many researchers need to specify theory 
when applying for research bids or when embarking on research within an academic setting. For 
example, researchers seeking sponsorships or bids for postgraduate studies need to submit 
study proposals that mandate a substantial degree of literature review and the identification of 
gaps within literature. They also need to illustrate how their prospective research will build upon 
existing literature and how it would contribute to knowledge. This extensive exposure to 
literature and existing theories is irrevocable and conflicts with the traditional GT approach that 
discourages researchers from engaging with available literature before the actual fieldwork. 
[3] GT is lengthy and time consuming. Transcribing recorded data followed by analysis in the 
form of coding can be quite challenging especially when faced with tight deadlines. Genuine and 
thorough GT data analysis, which is concurrent with data collection and conceptualisation, may 
be problematic due to the time commitment involved (Bartlett and Payne 1997). As presented 
earlier in the pitfalls of GT, implementing theoretical sampling lengthens the data collection 
process. Thus, theoretical sampling is often the key component of GT that is usually left aside 
because of time constraints. Hence, many researchers decide on the study sample before the 
empirical work starts. 
[4] Difficulty or failure to produce a theory. One of the main criticisms of GT is that it does not 
result in the production or generation of a formal theory but only provide a rigorous approach to 
the generation of concepts. Most GT theories are substantive in character because they cannot 
be transferable to other contexts apart from the social phenomenon that was explored. 
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[5] Coding breaks up narrative flow of data. Researchers in GT are encouraged to fragment data 
through the process of coding which results in data that is dissected into separate and distinct 
segments. Some writers believe that this coding process can alter narrative flow and result in a 
loos of the sense of context in data (Coffey and Atkinson 1996). 
[6] Realist vs constructivist GT. One of the main criticisms of GT is the positivist and realist 
nature of the methodology, especially Glaser and Strauss's or Strauss and Corbin's GT 
approaches. As illustrated earlier in section 3.2.2.2, many modifications of the traditional GT 
approach aimed at moving GT away from positivism and realism, such as Charmaz's constructive 
approach in GT. For example, the original work of Glaser and Strauss from 1967 suggests that 
the researcher should start collecting data with a 'blank mind' and avoid reviewing the existing 
literature in order to carry out a truly inductive study. Therefore, theory emerges from the 
collected data where it was already embedded. Glaser and Strauss's approach assumes that 
every individual will see and understand the data from the same point of view and make the 
same observations and will, therefore, come to similar conclusions. In that situation, the 
researcher takes a passive stance and allows the data to emerge. This, in Charmaz's perspective, 
is a characteristic of an objectivist or positivist paradigm (Charmaz 2000; Bryant 2003). 
[7] Variations amongst different GT approaches can confuse novice researchers. As presented 
earlier in section 3.2.2.2, scholars' attempts in modifying GT has resulted in competing accounts 
of the components of GT. Which makes it difficult to determine the correct method of 
implementing the theory (Bryman 2008). For example while Glaser (1992) believed that 
researchers should allow theory to emerge as they observe codes and analyse data, Strauss and 
Corbin (1990), on the other hand, believed that researchers should do more than wait for theory 
to emerge. Therefore, they developed a more structured approach to GT that included 
procedures and techniques to help theory generation. Glaser opposed Strauss and Corbin's 
approach because he believed that such procedures produced a preconceived theory that needs 
verification (also see section 3.3.2.2). Another example of variation, which is relevant to point [6] 
from the list of GT critiques mentioned above, is whether GT is positivist or constructivist. 
[81 Variations in terminologies amongst different GT approaches. There is also still some 
confusion and uncertainty on some of the terms used in different approaches to GT. For 
example, while Strauss and Corbin (1998) emphasise 'concepts' when talking about the 
importance of undergoing theoretical sampling based on emerging concepts, Charmaz (2000), 
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on the other hand, uses the word 'categories'. Another terminology difference is evident in the 
use of 'axial coding' that Strauss and Corbin introduced in their version of GT. Glaser viewed this 
as another way for describing 'theoretical coding', which was proposed in the traditional GT 
approach (Glaser 1992). Strauss and Corbin (1990) also introduce new concepts in their GT 
approach, such as 'traditional system'; 'conditional matrix'; 'conditional path'; 'code notes' 
(another type of memo-writing); 'dimensions and dimensionalising'; and referring to the location 
of properties of categories along a continuum. Glaser, on the other hand, believed that such 
concepts and terms are unnecessary because they are complex, redundant and force theory 
rather than allow it to emerge from the data (Glaser 1992). This inconsistency in terms between 
different GT approaches might confuse novice researchers. 
Despite all these critiques and limitations, GT remains the most influential strategy for the 
analysis of qualitative data (Charmaz 2006; Bryman 2008). GT is also popular amongst 
quantitative researchers when conducting mixed method research (Charmaz 2006). GT also 
significantly influenced the development of computer-assessed qualitative data analysis 
software (Lonkila 1995). Interestingly, such computer software also contributed to the wide use 
of the GT approach in qualitative data analysis (Bryman 2008). 
3.3.6 Grounded theory and this study 
This study draws on GT methods for guidance and principles rather than strict rules, as described 
by Charmaz (2006). In order to follow all of the requirements underpinning Glaser and Strauss's 
original method requires a separation between the researcher and the research environment, 
including both the research participants and the data collected. Charmaz (2006) argues that it is 
not possible to fully remove oneself from previous experiences in order to conduct purely 
objective analysis of the data and, further, that the researcher is an active participant in the 
environment they research whether by interview, observation or other method of enquiry. She 
also adds that prior experience can help in interpretation of the data and relation of findings to 
the research context. Knowledge of the research environment provided through literature or 
personal experience can also help to focus initial aims and objectives of the research. It is often 
the case that personal experience can spark interest in researching a particular topic and so has 
already influenced the data to be collected before the study begins. My thoughts on the place of 
prior knowledge align with those presented by Charmaz. I am a pharmacist by profession and my 
work with patients with MetS features in the UAE has exposed me to health and social issues 
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that impact patients' therapeutic outcomes. During the early stages of the PhD, I have also come 
across a substantial amount of literature concerning MetS and patients' lay health beliefs as a 
requirement for the study's proposal and first year reports. I, therefore, acknowledge that it is 
not possible to detach myself from past experiences or newly acquired knowledge about the 
research topic in order to analyse data with a blank page perspective. In addition, Charmaz's 
approach to GT acknowledges the role of the researcher in constructing meaning with the study 
participants. As such, I need to acknowledge my role in the construction of meaning as I listen to 
informants' accounts and analyse them. Before I define myself as a researcher, I am an individual 
with a set of opinions and worldviews. Thus, I do not step into the research as an empty vessel 
but rather with preconceived opinions that might affect the way I will interpret data and 
construct meaning and understanding of informants' accounts. In this study, I have to 
acknowledge my role as an author of this research and have, therefore, maintained an ongoing 
reflecting approach as recommended by Charmaz (2006). This study is conducted on the basis of 
the adapted constructivist GT principles as described by Charmaz (2006), which means that the 
techniques of constant comparison and deviant case analysis were used in order to ground the 
findings in the data 
3.3.7 Interviews 
Interviews are social interactions that take place between two or more individuals during which 
information is negotiated and exchanged. Interviews are considered the backbone of qualitative 
research and are the most commonly used qualitative approach in social health research. One of 
the main reasons for the popularity of interviews is their flexibility and ability to access people's 
experiences, their attitudes, perceptions, feelings and realities. They also help elicit participants' 
interpretations of their experiences with the explored phenomenon and give the researcher the 
opportunity of capturing rich data (Britten 1996; Creswell 2007). Interviews are believed to be a 
rewarding experience for the researcher and the study participants alike. They provide study 
participants the freedom to talk about their experience with the research phenomenon and 
express their feelings and viewpoints in their own words. Participants may see interviews as an 
opportunity to have someone listening attentively to their accounts. Through engaging with 
participants in in-depth interviews, researchers are able to collect rich descriptive data that 
explain and give meaning to people's lives. They also have the privilege of having strangers 
entrust them with their personal lives and intimate issues. 
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The success of interviews in qualitative research rests on the skills of the interviewer. For 
example, during interviews, the interviewee is considered the expert and the interviewer is 
considered the student. Researchers or interviewers are motivated by the desire to learn 
everything the participant decides to disclose about the research topic. Interviewers need to 
avoid leading questions that might imply ideas or influence participants' views. They should also 
be able to pick up cues that uncover new areas and ideas in the research and to give participants 
enough time to express their views and perceptions. At the same time, interviewers need to 
maintain their control of the interview process (Britten 1996). It is recommended that 
interviewers develop an initial interview guide that defines the areas to be explored, but is 
flexible enough to allow for the addition of questions as new relevant themes emerge from each 
interview. Open-ended, non-judgmental questions are best suited for qualitative research 
investigation as they invite and encourage participants to give a detailed description of the topic 
explored allowing unforeseen declarations and stories to emerge (Britten 1996; Smith 2005). The 
flexibility of qualitative interviews helps to correct the researcher's tendency to follow any 
preconceived notions about the phenomenon by encouraging openness to new ideas that 
emerge during interviews and continuous visits to the data collection field to collect more 
focused data (Charmaz 2006; Creswell 2007). Qualitative interviews were best suited for this 
study as they allowed participants to express their views and perceptions about MetS and gave 
the researcher the flexibility to amend and change the interview guide to allow further 
exploration of emerging themes. 
Semi-structured Interviews were chosen as a data collection tool for this study because they 
permit participants to express their views about MetS and its management in their own words 
while interviewers listen and observe with care and sensitivity. The following sections discuss 
different types of interviews in qualitative research and limitations to this data collection tool. 
3.3.7.1 Types of interviews 
All qualitative interviews contain the same basic elements of discussion, detail and description. 
However, they vary according to the degree of control the interviewer imposes on the responses 
of the informants. Therefore, based on the degree of structuring, interviews can be divided into 
three categories: structured interviews, semi-structured interviews and unstructured interviews 
(Fontana and Fray 2008). Structured interviews are composed of a set of predefined questions 
that are carefully and fully worded. These questions get to be asked to each informant in the 
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same way, order and with the same probes. This standardisation is intended to minimize the 
effects of the instrument and the interviewer on the research results. Thus, structured 
interviews allow a cross-comparison of responses over time. They are also suitable for studying 
the views of a large sample of participants on well known or previously explored topics through 
open questions interviews. However, the weakness of this approach lies in its standardisation 
which prevents the interviewer from pursuing topics that might suddenly emerge during the 
interview. They also limit the extent to which contextual factors as well as informants 
circumstances can be considered and explored. Most of the interviews in qualitative research 
tend to be less structured and controlled; therefore, structured interviews are the approach of 
choice in some quantitative studies in order to maximise reliability and validity of the 
measurement of variables. 
Semi-structured interviews, on the other hand, are less controlled than structured interviews 
and thus more flexible. An interview guide, usually including both closed and open questions, is 
prepared. However, in the course of the interview, the interviewer has a certain amount of room 
to adjust the sequence of the questions to be asked and to add questions based on the context 
of the participants' responses. The interviewer prepares a list of topics that need to be covered 
during the interview, which is referred to as the interview guide. However, the interview guide 
should not constrain interviewers and they should not feel the need to abide to the order of the 
topics or the phrasing of the questions. Rather, interviewers have the flexibility to enquire about 
the topics of interest as they see appropriate and to add new questions as they pick up on things 
said by the informants. The interviewer needs to skilfully move between the proscribed and 
unstructured questions in order to clarify answers or ask for elaborations (Barbour 2008). 
Unstructured interviews are useful for the exploration of new topics or areas that are not well 
known or understood. Because of their high degree of flexibility, study informants have the 
ability to express their views freely with minimum control from the interviewer. Although the 
interviewer needs to be aware of the areas to be covered during the interview and may be 
equipped with a checklist, he or she is advised to initiate the interview with a single question and 
then allow the informant to respond freely and in the way they decide. Interviewers should only 
probe or respond to points raised in order to encourage and stimulate the informants to talk and 
express their views. One type of unstructured interview is known as narrative interviewing, 
which is an approach that encourages study participants to tell a story about significant events in 
their lives (Flick 1998; Barbour 2008). Although narrative interviewing or storytelling has been 
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mainly employed in biographical studies and oral history, it has recently been embraced in other 
disciplines including social health and health service research (Barbour 2008). This technique in 
qualitative interviewing came as a response to the critique to question-response-scheme of most 
interviews and the structure imposed by defining the theme of the topics, ordering and wording 
of questions (Bruner 1990). 
The underlying concept of narrative interviews is that informants' perspectives are best revealed 
in stories using their own spontaneous language in the narration process. However, it would be 
unrealistic to assume that storytelling is an unstructured act as it follows a self-generated rule 
and even the narrator abides by the basic rules of storytelling (Flick 1998). Another critique of 
narrative interviews is that the interviewer should pose as someone who knows nothing or very 
little and is, therefore, looking forward to learning all about what the informants have to say. 
This pretence is difficult to maintain as the researcher's knowledge about the topic increases 
with every interview and will eventually affect the informants' responses. Every informant will 
unintentionally develop a hypothesis about what the interviewer is seeking in an interview. 
Knowing that they are not the first to be interviewed, informants will tend to speculate about 
the amount of knowledge the interviewer has developed about the research topic from previous 
interviews. This results in strategic storytelling where purposeful accounts are communicated 
during interviews in order to please the interviewer or make a particular point (Flick 1998; 
Barbour 2008). 
Another weakness of narrative interviews lies in the fact that an interview may go through a 
series of narration and subsequent questioning, which may blur the boundaries between 
narrative interviews (or unstructured interviews) and semi-structured interviews. This 
occurrence results in narrative interviews that resemble narrative-saturated, semi-structured 
interviews rather than a new form of unstructured interview (Flick 1998). Hence, there is a 
growing tendency to refer to both semi-structured and unstructured interviews as in-depth 
interviews (IDIs) or as qualitative interviewing. Despite the variation between the two interview 
approaches, most interviews conducted in qualitative research are close to one or the other. 
However, if the researcher is embarking on a research topic with a clear focus then the ideal 
interview approach would be semi-structured interviewing. 
In this study, the literature review highlighted areas worthy of exploration in patients with MetS 
and within the UAE socio-cultural context. It also started as a mixed method research with 
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defined areas of exploration in the qualitative part of the study. Thus, upon the elimination of 
the quantitative arm of the study, the qualitative part retained its original scope and aims, which 
was to explore the health concerns of patients with MetS living in the UAE. These health 
concerns mainly revolve around the management of MetS and factors influencing the 
implementation of a MetS treatment plan. As such, a narrative interview approach would not 
have been ideal for the scope of the study and thus a semi-structured interview approach was 
used. Semi-structured interviews allow informants to respond with as much detail as they want 
to share their viewpoints regarding their experiences of living with and managing MetS. Whilst 
using the semi-structured approach, it was ensured that the interview covered all the study's 
questions, while allowing for the flexibility to address areas of specific interest and relevance to 
each respondent. The primary aim of the IDIs in this study was to fully engage with the 
participants in order to explore detailed information on MetS. The in-depth interviews focused 
on how individuals live with and manage their health condition, the contexts and the meaning 
they describe as emerging from their health behaviour, and factors influencing the 
implementation of MetS treatment plan as well as the clinical utilisation of MetS concept. 
The following section illustrates some of the limitations of in-depth interviews followed by the 
implication of this data collection tool with regard to the study scope and setting. 
3.3.7.2 Limitations to in-depth interviews 
As with any data collection technique, in-depth interviews have limitations that may affect the 
quality of the data and eventually analysis. For example, interviews are social interactions that 
aim to assess participants' views and perceptions of a specific event or phenomenon; therefore, 
interview accounts are not objective but rather subjective representations of informants' 
realities, thoughts and actions. Blumer (1969) believed that humans are not passive conforming 
objects of socialisation but rather active and creative participants that have a role in constructing 
society (Blumer 1969; Silverman 1993; Charmaz 2006). In this respect, informants do not 
respond mechanically to the interviewer's questions, but rather they dynamically interact with 
the interview setting, are affected by the interviewer's past and immediate identities and, thus, 
think about their actions and responses. Therefore, it is imperative for the interviewer to keep 
attuned to how participants view them, to assess the situation and to act on their present 
assumption and past knowledge (Charmaz 2006). 
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Informants tend to speculate about interviewers' intentions and what they seek in an interview. 
Thus, informants may provide answers that meet with their expectations or that they think will 
satisfy the interviewer. They may also have their own agendas to take part in an interview and 
share information with the interviewer. For example, informants may present themselves as 
competent and responsible members of their community and seek to provide answers which 
portray socially acceptable thoughts or behaviours to reduce the extent to which their actions 
can be negatively judged by the researcher (Murphy and Dingwall 2003). They may defend 
themselves if they sense a conflict in viewpoints may arise during the interview by putting 
themselves in a positive light with regard to the explored issue. They may also show interest in 
the research topic and enthusiasm to take part in the interview, which may not have existed 
prior to the interview, in an attempt to 'please' the researcher. However, this does not mean 
that participants' responses during the research interview are false or not valid but that 
consideration must be given to the purpose of the explanations given and the influence of the 
context on participants' accounts (Murphy and Dingwall 2003). 
Interviews can also be used to access a wide range of information, such as participants' reports 
of a particular event or their opinions and thoughts. When researchers request participants to 
talk about their experience of a particular event, participants need to recall that event and 
interpret it, before formulating their description and then providing it during the interview. This 
may result in the generation of multiple valid accounts (Murphy and Dingwall 2003). Informants' 
responses may be influenced by what they have noticed during the event, what they remember 
during the interview, how they interpret what they observed or experienced and what they 
consider worthy of reporting or of importance to them or to the researcher. All these factors 
may impact responses during an interview. Therefore, each interviewee may provide a different 
report of events, but they could all be valid representations of the event and can be treated as 
such (Murphy and Dingwall 2003). Researchers should also acknowledge and be aware of the 
impact of differences between the interviewer and the informer with regard to race, age, gender 
and class as these differences might influence what happens during the interview process 
(Charmaz 2006). 
It is important to remember that people's opinions change depending on the context in which 
the interview was conducted and that ambivalence is common. This can result in varying 
responses according to the situation and the people present. It is important to consider how the 
interview context may influence the participant's responses during analysis of interview data to 
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ensure that bias is identified where possible. During interviews, especially when asking about 
participants' thoughts or opinions, researchers need to 'put themselves in the participants 
shoes' and to try to understand how the participant interprets the world around them. 
Interviews can provide access to otherwise unknown rationales and assumptions about the 
interview topic, but cannot be used to ascertain why people behave the way they do (Murphy 
and Dingwall 2003). 
3.3.7.3 In-depth interviews in this study 
The different IDIs conducted in this study sought to access the participant's perceptions of the 
clustering of CRFs or MetS, and their thoughts about a range of factors that might influence 
MetS management in the UAE. A number of influences may have affected the participants' 
responses during the interviews conducted (Murphy and Dingwall 2003). I will first consider 
influences on the patients' interviews. For example, gender segregation is common in health 
care facilities in the UAE female women health care providers usually attend to female patients; 
thus, the impact of the gender difference between me (a woman) and the participant is 
inevitable. A man and women of no marital or immediate family relation should not be alone in a 
closed room. As such, the interviewer (a woman) might not be able to conduct an interview in a 
closed room if the interviewee was a man. Minor technical adjustments might be helpful in such 
cases, such as conducting a telephone interview or keeping the door of the interview room 
slightly open. Concerns about socio-cultural rules are alleviated when interviewing HCPs, as they 
are used to gender mix in work places. Therefore, interviews with HCPs can take place within the 
realm of the health care facility they work at. 
The interview process could have also influenced patient accounts in a range of ways. As will be 
presented in more detail in Chapter 4, although the patient information sheet clearly stated that 
the study was interested in recruiting patients with MetS, most patients interviewed were not 
familiar with the MetS diagnosis. As presented earlier, patients may sometimes be keen to 
present themselves as supportive of the researcher or research topic due to an awareness of the 
researcher's interests. Thus, patients' motivation to take part in the research despite their lack 
of awareness of the MetS concept might have been engendered by curiosity, genuine or 
displayed interest in the MetS topic or their desire to show support to the researcher by 
participating in the interviews. During interviews, patients may have also strived to portray 
themselves as knowledgeable patients who adhere to their prescribed treatment plan, which 
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might impact their accounts when describing the challenges of MetS management. Patients who 
had good relationships with their HCPs may have also been influenced by a desire to praise or 
show loyalty to their HCPs. The fact that I am a pharmacist might have made patients reluctant 
to report negative views about their HCPs or the health care facility. In addition, some patients 
were interviewed in private rooms inside the clinic. This interview arrangement might have 
made it difficult for them to give negative accounts of their consultations or negative views of 
their HCPs due to the proximity of the HCPs offices. Patients may have felt more or less ` useful' 
to the study depending on their perceived seriousness of their condition or the number of 
medications they take and may have aimed to be as helpful to the study as possible during the 
interview. 
All of the HCPs participating in the study were aware of my background as a pharmacist. This 
may have influenced HCPs in a number of ways. Firstly, they may have felt that being researched 
by a fellow professional would allow a level of understanding of the participant's own 
environment. It would be expected that another HCP would understand the workplace 
pressures, difficulties, requirements, benefits and relationships without need for detailed 
explanation. This may have facilitated HCPs' responses and provided some encouragement that 
their views would be understood. However, my status as a pharmacist may also have hindered 
responses. The nature of the awareness and understanding outlined above could also enable me 
to judge their responses or actions in the interview based on my own knowledge. HCPs could 
have attempted to offer explanations to reduce any negative judgements of their performance, 
especially when enquiring about factors that render optimal control of cardiometabolic diseases. 
For example, talking about patients' related factors (i. e., poor adherence to prescribed 
treatment or of patients' low attendance rate at clinical appointments) or describing difficult 
working conditions would serve to limit the responsibility of HCPs for any poor performance. In 
addition, HCPs were aware that the study was exploring a wide range of factors influencing MetS 
management (e. g., patient-related and contextual factors). This may have led some HCPs such as 
pharmacists, dieticians and health educators to give greater emphasis to cultural related factors 
that hinder the management of MetS than they would outside of the study, in order to present 
helpful accounts for the research and to give a favourable view of themselves as HCPs concerned 
with MetS. All HCPs, expect for one, were interviewed at their own place of work. This may have 
served to relax HCPs as they were in a familiar and comfortable environment. The fact that all 
HCPs were recruited from the same health care facility may have influenced their responses 
especially if they were seeking to portray a particular image to their co-workers. A significant 
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influence to these interviews was the pressure of work commitments, shortage in time and 
other available medical staff. Although interviews were conducted at a time of the participant's 
choosing, the pressures of a busy working environment can pervade the interview space. 
In this study IDIs were used as a data collection method to gain an understanding of participants' 
views, opinions or accounts. It is important, however, to acknowledge that these offerings are 
valid representations of the notion described only when considered in the context in which they 
were given and with an awareness of the influences of each context upon those accounts. The 
context of each interview could have exerted a large number of effects on the accounts of the 
participants and these must be kept in mind when considering the data and analysis presented 
during this thesis. More detail about the topics discussed in the interviews conducted will be 
given in the data collection section of this chapter. 
3.3.8 Focus groups 
Focus group discussions (FGDs) allow a small group of participants with similar interests to 
converse and discuss a research topic with the guidance of a facilitator or moderator. FGDs were 
chosen as a data collection method to further explore themes indentified during the interview 
process. FGDs allow social interaction between the participants and the facilitator which 
stimulates thoughts and provokes discussions. In the setting of a FGD, participants have the 
opportunity to listen to each other and help each other in clarifying thoughts and assumptions. 
The FGD facilitator, on the other hand, has the opportunity to observe the dynamics of 
participants' interaction and their exchange of ideas and thoughts and to explore reasons behind 
disagreements or conflicts that might arise. FGDs can be used to generate constructs, develop 
models, guide product development and evaluate a given service or programme. FGDs are 
characterised by their flexibility and high validity. They are also cost effective and the results can 
be gathered within a limited period of time. FGDs allow researchers to increase the study sample 
size through groups rather than individual interviewing (Barbour 1995). 
FGDs as a qualitative data collection tool were previously used in a number of studies that 
explored women's health care issues in the UAE (Winslow, Honein et al. 2002; Ali, Bernsen et al. 
2009; Berger and Peerson 2009; Ali, Baynouna et al. 2010). FGDs were chosen because of their 
similarity to the native Bedouin patterns of socialisation where tribal members, although divided 
by gender, will occasionally gather to discuss issues in their homes or tents. FGDs were believed 
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to be ideal as a data collection tool because they resembled the Emirati traditional gathering of 
society members in a formal reception or large sitting rooms referred to as the 'majlis' in Arabic 
(Borkan, Morad et al. 2000). In this respect, FGDs were a feasible and successful data collection 
method that elicited women's concerns about their health and factors that impact the 
management of health conditions within the cultural context of the UAE. Nevertheless, these 
interviews were conducted in women-only FGDs. This arrangement can be explained by the 
researcher's desire to achieve homogeneity within the FGDs and to capitalise on women's 
shared experiences with health care in the UAE. A single gender FGD emphasises the constraints 
imposed by the UAE socio-cultural norms on mixed gender FGDs. Culturally, it is neither usual 
nor favourable in the UAE for patients to discuss their issues with strangers in groups of mixed 
gender. As such, there was a concern by the researcher that patients with MetS will not 
appreciate a mixed gender FGD, which will result in conducting two FGDs for each gender. 
Therefore, it was the perception of the researcher that this would require a significant amount 
of time in order to select, invite and conduct these separate MetS FGDs. HCPs working in the 
UAE, on the other hand, are familiar with mixed gender gatherings experienced in work settings, 
meetings and other official assemblies. It is, however, important to be aware of the impact of 
hierarchy within the HCPs' FGD which might affect the quality of data generated. Therefore, it 
was advisable to have separate FGDs for HCPs (e. g., physicians-only FGDs and pharmacists-only 
FGDs) so that one group of specialists did not feel inhibited by the presence of another specialist 
if they were grouped within the same FGD. 
3.4 Developing the research tools 
The qualitative tools chosen for this research were initially IDIs followed by FGDs to further 
explore identified themes from the IDIs. Two separate interview routes were developed to guide 
the interviewing process of the research. 
3.4.1 IDIs and FGD guide 
As participants were classified as patients and HCPs, there were two interview guides developed 
to lead the interview process (Appendices 6 and 7). The interview guide for patients was 
constructed to explore the meaning and consequences of living with the cardiometabolic 
anomalies of MetS. The guiding questions were designed to cover the following areas: (i) 
perceptions of MetS as a condition in its own right; (ii) the impact of MetS on patients' lives; (iii) 
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perceptions of MetS treatment plan; (iv) attitudes towards the health care system and HCPs, (v) 
barriers that affect the implementations of the treatment plan; and (v) existing facilitators or 
needs to enhance the management of MetS. 
The HCPs' interview guide was constructed to explore issues surrounding the management of 
MetS in the UAE. The interview guide covered the following areas: (i) perceptions of the MetS 
concept; (ii) factors influencing management of MetS; and (iii) facilitators or needs to improve 
MetS management. The FGD guide was developed in accordance with the identified themes 
from the individual IDIs conducted with patients and HCPs and was designed after all of the 
interviews took place. One FGD was conducted with a group of pharmacists to explore the 
following themes: i) the attitude of patients with MetS towards a pharmaceutical treatment 
plan, ii) pharmacists role in the MetS management plan, iii) barriers and facilitators to 
pharmacists contribution to the MetS management plan. Before the start of the FGD with 
pharmacists, a short PowerPoint presentation was given to brief the group about MetS and the 
aim of the FGD. The aim of this presentation was to prepare the group for the topic of 
discussion, stimulate discussion and generate ideas. It was also useful in helping the facilitator to 
control the discussion process and minimise topic diversion. 
3.4.2 Review of the interview guide 
The two PhD supervisors based at the division of social research in Medicines and Health in the 
University of Nottingham reviewed the research instruments. The interview guides were 
circulated to the supervisors for review and comments. All suggestions were considered and a 
subsequent draft of the interview guides was later re-circulated. During the data collection 
phase, monthly webcam meetings with the PhD supervisors were conducted to discuss the 
research progress and themes identified. These regular discussions helped highlight new areas 
that were worthy of further exploration such as the impact of patients' religious beliefs and 
social norms on the management of MetS. This also helped in the modification and expansion of 
the interview guide to include these new topics and investigate such factors with subsequent 
participants. 
However, after the data collection phase was completed, supervision recommenced in the UK 
where interviews were transcribed coded and analysed. Codes and themes were reviewed with 
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the two supervisors. Suggestions on areas to explore in following FGDs were highlighted and 
discussed during supervision meetings in the UK before going back to the UAE. 
Prior to conducting the fieldwork, the ethics committee of Sheikh Khalifa Medical City (SKMC) 
reviewed the study proposal and the interview guides. All interview guides were translated into 
Arabic and then back validated to cater for the Arabic-speaking patients and HCPs. Piloting of the 
IDIs interview guide enabled adjustment and paraphrasing of questions to simplify enquiry and 
remove ambiguity. SKMC also assigned a co-supervisor (a member of the ethics committee and a 
cardiologist) to help the researcher: (i) gain access to the research setting; (ii) identify patients 
and HCPs for interviewing and (iii) to follow research progress and give advice on issues arising 
during the data collection phase. The name and contact details of the research co-supervisor 
were provided in the participant research information sheet in case they needed to report a 
complaint or an issue with regards to the researcher or the interview process. The assigned co- 
supervisor reviewed the interview guides and provided advice on areas that could also be 
covered and explored with relation to MetS. She also gave advice on some of the researcher's 
observations and early findings, especially with regard to interviews with patients. For example, 
after the first two interviews that took place in the pilot study, it was evident that patients were 
not familiar with the term 'metabolic syndrome'. To avoid the dilemma of having to inform 
patients of a concept they were not familiar with, the co-investigator and the two research 
supervisors were informed of this finding. A decision was reached to continue the exploration 
process which was also approved by the study co-investigator. This decision was made based on 
the following points: 
1. The MetS is a term used to indicate the clustering of CRFs (Grundy 2006). All patients 
interviewed were aware of their presenting CRFs. Therefore, informing patients that the 
clustering of their CRFs is called MetS will not be considered as new information or a new 
diagnosis. Grundy (2006) argues that the concern about informing patients that they have a 
clustering of CRFs (Metabolic Syndrome) is difficult to understand since they are already 
assigned a diagnosis of diabetes, hypertension, dyslipidaemia and obesity. My opinion on 
informing patients of the MetS diagnosis agrees with that of Grundy's. 
2. Patients were informed by their HCPs (i. e., physicians or health educators) that CRFs pose 
cardiovascular risk that increases when coexisting with other factors, such as a family 
history of CVDs, the congregation of CRFs, obesity and other behavioural factors (i. e., 
smoking, sedentary lifestyle, unhealthy diet). As such, informing patients of the 
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cardiovascular risk associated with having MetS (clustering of CRFs) will not be considered 
as new information. 
3. Patients' responses with regard to perceptions of MetS might revolve around the diagnosed 
CRFs either individually or collectively depending on how patients choose to perceive their 
condition. However, patients are informed in the patient information sheet that the aim of 
the interview is not to explore an individual CRF but the 'clustered' CRFs they are presented 
with. 
4. Talking about MetS in an interview requires those involved in the discussion to address its 
individual components (i. e., the clustering CRFs). Thus, patients' accounts regarding their 
overall 'health condition' might inevitably reflect their views of their 'presenting CRFs' 
which is parallel to the essence of any discussion regarding MetS. For example, patients 
aware of their MetS diagnosis will also be aware of the individual CRFs that constitute MetS 
(i. e., diabetes, hypertension, dyslipidaemia and obesity). Therefore, when patients describe 
living with MetS they might eventually talk about the impact of these individual CRFs on 
their lives. 
5. The explanation provided in the patient information sheet will ensure patients are aware of 
the MetS definition and that the clustering of CRFs is also referred to as MetS. This 
arrangement will ensure that patients take part in the research knowing that they were 
invited because they fit the MetS definition. 
6. The researcher should not expose participants to harm or distress during the interview and 
maintain their safety and wellbeing. Informing patients that the clustering of their condition 
is also called MetS did not appear to cause harm or distress to any of the informants during 
interviews. 
7. The interview was conducted by an Emirati licensed pharmacist and is authorised by 
profession and by the research committee at SKMC to provide such information to patients. 
As a precautionary measure, if distress did occur, patients would be reassured by the 
researcher that MetS is another term for the clustering of their presenting CRFs and would 
then be referred to their physicians. 
8. The patient information sheet provided participants with the contact details of SKMC co- 
supervisor to report any of their complaints against the study or the interviewer. 
Throughout the data collection phase, cases of patients' distressed by the interview, 
interviewer, or information about MetS did not appear to occur and the co-supervisor did 
not receive any complaints from any of the informants (patients or HCPs) regarding this 
particular information or any other concerning the interview or the interviewer. 
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9. Physicians interviewed did not express objections or concern in regard to informing patients 
about MetS. For example, when they were asked about reasons behind patients' lack of 
awareness about MetS their encounters did not imply that such information should not be 
provided to patients by the researcher. Some physicians also stressed on the fact that the 
term 'metabolic syndrome' was another medical name for the clustering of CRFs. More 
information on this area will be provided in chapter 4. 
10. In their qualitative study, Kirkendoll and colleagues (2010) reported patients' lack of 
awareness of the MetS concept and the MetS diagnosis when they explored patients' views 
on lifestyle changes (Kirkendoll, Clark et al. 2010). During their focus group interviews, 
patients were informed that the clustering of their CRFs was also known as 'metabolic 
syndrome'. Patients' accounts indicated that they were not informed by their physicians 
about the MetS diagnosis or concept. However, the study authors did not report that 
patients' safety was jeopardized because of providing the study participants with such 
information. Kirkendoll et al's (2010) findings and approach validate the safety of such 
information and confirms that informing patients about MetS is not considered as a new 
diagnosis as long as patients are aware of their CRFs that constitute MetS. 
Overall, exploring patients' awareness of MetS provides knowledge about the public penetration 
of the 'metabolic syndrome' name and concept and an understanding of factors that limit such 
health awareness. The interview questions changed over time and were influenced by codes and 
categories developed from previous interviews. 
3.4.3 Conducting the IDIs and FGDs 
An interview guide with well-planned, open-ended questions and ready probes increases the 
confidence of the novice researcher. Therefore, an interview guide was used in each interview, 
including the FGD. The interview guides mapped out the areas that needed to be covered during 
the interview. Each area contained a number of subsidiary questions. The informants did not 
necessarily talk about the topics in the order in which they were printed on the interview guide 
sheet and, therefore, use of interview guide had to be flexible. This meant that the researcher 
had to be alert to those issues which had already been discussed and those which had yet to be 
mentioned. Familiarity was rapidly gained with the topic areas and reference to the prompt 
sheet was reduced as the interviews progressed. There were no interpreters used during the 
101 
Chapter 3 Methodology 
interviews. Interviews were conducted in the language chosen by the informants (Arabic or 
English). 
3.5 Ethical issues 
Anonymity, confidentiality and informed consent are three pillars of research ethics that concern 
qualitative researchers. Researchers, therefore, need to assure the study participants that these 
three elements are attained despite the challenge in achieving anonymity and confidentiality 
(Goodwin 2006). However, it was very important to ensure this study was conducted in an 
ethical manner and that participant' identities and wellbeing were protected and preserved. 
3.5.1 Anonymity 
Qualitative research requires a certain degree of detail to support research claims. In addition, 
the use of single or a limited number of research settings and the small number of participants 
rendered achieving anonymity problematic. Although the identity of all participants was 
anonymised and different names were assigned to each, the setting from which these 
participants were recruited was affirmed. HCPs were all recruited from one health care institute, 
and, thus, it is inevitable that an association of any of these HCPs with the researcher might 
indicate their participation in the study. However, the identities of the patients who participated 
in this study were not revealed to the study setting co-supervisor, their physicians or the PhD 
supervisors. Furthermore, quotes from interview transcripts were assigned pseudonyms. 
3.5.2 Confidentiality 
Participating in this study was voluntary and all participants signed a consent form prior to taking 
part in the IDIs or the pharmacists FDG. Participants' contact details were never requested and 
were not obtained during the data collection phase. All interviews either were conducted in an 
empty nurse preparation room that was provided to the researcher by the hospital 
management, patients' homes, HCPs offices or in private areas. The audio-recorded material was 
saved to a CD-ROM and locked in a filing cabinet. Transcripts were all stored in password 
protected Microsoft word documents. All data that might indicate and reveal participants' 
identity (i. e., pictures, names, passport photocopies, phone numbers and email accounts) were 
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erased, removed or shredded before the data analysis and, thus, were not and will not be 
included in reports or publications. 
3.5.3 Informed consent 
Informed consent (verbal and written) was obtained from participants before the initiation of 
the IDIs or the FGD. Details of the information provided to patients and the consent form are 
available in appendices 4 and 5, respectively. All participants were provided with the study's 
information sheet that included the aims and objectives of the study and all ramifications of 
taking part in the interviews. In a few cases, where participants requested immediate 
participation after invitation, the researcher read the information sheet aloud. Before the 
interviews commenced the researcher carefully described the nature of the interview and gave 
details of the content of the consent form. The researcher then gave participants time to 
contemplate and ask questions regarding the consent or information sheet, which were all 
answered and clarified before the interview began. As explained earlier, patients' unfamiliarity 
with the MetS diagnosis did not indicate their unfamiliarity with the clustering of their 
presenting CRFs, which complies with the MetS definition (see section 3.4.2). Patient 
information sheet included the MetS definition. The information provided, stated that MetS is 
defined as the clustering of CRFs that all patients in the study were aware of. Patients were 
aware of all the MetS features that they were diagnosed with and were willing to take part in 
the study to address issues related to their health condition. As such, patients apparently were 
aware of what they were consenting to, which is to take part in a research that explored the 
clustering of their CRFs, which agrees with the MetS MetS concept. 
3.5.4 Ethical approval 
The study protocol was reviewed and approved by the Institutional Review Board Medical 
Research Committee in SKMC where the study took place, which ensured that the methodology 
and procedures were in accordance with acceptable ethical standards. The committee also 
reviewed the study information sheet (Arabic and English versions), informed consent (Arabic 
and English versions) and the interview guide. According to the University of Nottingham policy 
and regulations on overseas research for the degree of a PhD, an ethical review for research 
conducted outside the UK is not required. Therefore, an ethical review for this study that took 
place in the UAE was not needed. 
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3.6 Selecting the study site and setting 
The study described in this thesis took place in Abu Dhabi, the capital city of the UAE and the 
second largest city of the 7 Emirates that constitute the UAE. Although MetS is a national 
problem that affects all of the UAE, Abu Dhabi was selected as the location of the research 
because it was the hometown of the researcher, which allowed easy access to health care 
facilities that the researcher was familiar with. The study proposal was posted with a covering 
letter to SKMC, which was approved in May 2008 (Appendix 1). SKMC was established in 2005 
because of the merger of all publicly held health care organisations in Abu Dhabi. SKMC has been 
managed by Cleveland Clinic since 2007 and serves as the flagship institution for Abu Dhabi 
health service company SEHA (Sheikh Khalifa Medical City). Participants were recruited from 
three outpatient clinics (i. e., cardiovascular clinic, internal medicine clinic and the diabetes and 
endocrinology clinic) and four family medicine clinics (i. e., Al Bateen, Al Khaleej, Al Mushrif and 
Al Rowda clinics). These clinics were chosen because of the higher chance of finding patients 
who fit the inclusion criteria and HCPs who deal with MetS patients. 
3.7 Selection of the study participants 
Patients were allocated from SKMC's OPCs (i. e., cardiology, internal medicine and diabetes and 
endocrinology clinics) and four family medicine clinics, also known as primary health care clinics 
that serve communities within different areas of Abu Dhabi. HCPs were also allocated from the 
same OPCs and FMCs. All participants met the study inclusion criteria (Table 3.1). 
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Table 3.1 Participants' inclusion/exclusion criteria 
Patients' inclusion criteria 
  
Fit into the IDF metabolic syndrome diagnostic 
criteria8 of MetS 
  age > 19 years old 
  
living in the UAE 
" therapeutically managed and followed by the 
study clinical setting 
Patients' exclusion criteria 
  
Patients with established CVD 
" Patients refusing or unable to consent to take 
part in the study 
Physicians, pharmacists, health educators or nurses 
  
Dealing with patients with MetS 
  
Have been working in the UAE and with MetS patients for >3 months before the start of the study 
Theoretical sampling is the sampling technique employed in GT. It is described as an iterative 
process because it involves redefining the ongoing sampling of participants in order to test and 
refine the characteristics of emerging themes after each interview (Glaser and Strauss 1967). 
However, researchers may find themselves using elements of different types of sampling 
procedures in one study, which may complicate defining the sampling procedure used (Smith 
2005). Participants' selection in this study adapted a purposeful sampling strategy to inform an 
understanding of MetS. The aim was to select participants who shared characteristics that were 
believed to be most informative in achieving the objective of the study. 
Sampling techniques in this study included snowballing, especially in identifying physicians and 
pharmacists. To invite HCPs to take part, the researcher needed participants' contact details, 
which were not always available and, therefore, had to rely on other HCPs for help. The sampling 
process can also be described as convenient, as those who participated were those who were 
enthusiastic and willing to take part and were the only ones available to interview (e. g., only two 
health educators were available at the time of the study). Sampling was guided by emerging data 
and continued until no new themes emerged. Saturation was reached with 25 patients and 23 
HCP interviews as no new themes emerged. An additional 4 patients and 4 HCPs were 
interviewed to confirm and ensure saturation of the themes. 
" IDF diagnostic criteria: Increased WC (or BMI > 30 kg/m? ) plus any 2 of the following: TG >150 mg/dL or on treatment, HDL-C <40 mgldL in men (or < 50 mg/dL in women) or on treatment; SBP >130 mmHg or DBP>85 mm Hg or on treatment for hypertension; BG >100 mg/dL (includes 
diabetes) 
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The available literature suggests that offering a monetary incentive or any sort of payment for 
taking part in the interview is not a common practice in studies conducted in the UAE (Winslow, 
Honein et al. 2002; Ypinazar and Margolis 2006). Therefore, no payment was offered to this 
study's participants. Nevertheless, pharmacists taking part in the FGD were offered 
refreshments (i. e., hot and cold drinks, sandwiches and snacks). The researcher introduced 
herself as a PhD student as this was in agreement with the information sheet participants were 
provided with that mentioned the researcher's vocation and the University of Nottingham name 
and logo. The researcher also added that the researcher was not an affiliate of or an employee in 
SKMC to ensure obtaining honest and accurate views from the participants. 
3.7.1 Recruiting patients 
To find patients with MetS I moved between seven clinic settings within SKMC. One week was 
assigned to each clinic where I had the ability to manually access the medical files of patients 
visiting the clinic any day during that assigned week. The recruitment process of patients started 
by first of all identifying suitable candidates for the interviews based on the study inclusion 
criteria. For example, I would visit a clinic early in the morning and sit in the administrator/nurse 
room where the medical files of patients who had appointments on that day would be arranged. 
I would then look through the medical files and apply the inclusion criteria. The names of 
suitable study candidates would then be documented in a separate sheet. When these patients 
came for their appointments, the nurse on the reception disk helped me identify them. I made 
sure I dressed appropriately and was carrying a visible identification card that had my picture, 
name and vocation and was similar to those carried by HCPs working in SKMC. This arrangement 
facilitated approaching patients and enabled patients to perceive me as an individual that 
belonged to SKMC and not as a stranger or an intruder. 
Inviting patients to interviews was arranged in a way to avoid putting patients under pressure or 
feeling obliged to take part in the study. This strategy took into account the importance of 
respecting people's values and autonomy. The plan was to provide all patients with adequate 
information about their involvement in the research and assure them that there was no deadline 
for reply to the invitation or taking part in the study. However, if a patient showed interest after 
sufficient patients had been recruited, they would be thanked for showing interest and informed 
that I was no longer recruiting. 
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Patients were approached either while they were waiting for their appointment or after they 
came out of the physicians' office. I would sit next to a patient while they were waiting, greet 
them, introduce myself and then talk to them in brief about the idea of the research. I would 
then hand them the information sheet and ask them to read it and reply any time by contacting 
me if they wished to take part. Not all patients who were scheduled for an appointment on the 
day of my clinic visit attended their clinic appointments and thus were not approached or 
invited. Other patients who attended their clinic appointment refused to take the information 
sheet or take part in the study. Patients who were invited to take part in the study after they left 
the physician's office where approached after they had all the time needed to talk to the nurse, 
collect their prescription medicines or attend their other scheduled clinic visits. A total of 61 
patients were invited to take part in the interviews. Each patient was provided with a study 
information sheet that contained the contact details of the investigator (Appendix 3). 
Patients were informed that there was no time deadlines set for making a decision about taking 
part in the study. It was made clear to the patients that they had the right to take as much time 
needed to think about taking part in the study and read the study information sheet in order to 
reflect on the study aims and objectives. This arrangement was to ensure patients were properly 
informed before consenting to taking part in the study. Patients were also given the freedom to 
choose between conducting a telephone interview or a face-to-face interview at their homes or 
in the clinic at any time of their preference. Male patients, who chose to conduct a face-to-face 
interview, were met in the clinic (n=3) or their work places (n=2) as this arrangement was ideal 
with respect to the socio-cultural norms of the UAE (further elaboration in the researcher's 
reflections). 
Out of 61 patients approached and invited, only 12 patients declined to be interviewed. Some of 
the patients who declined the invitation showed lack of interest in the study aims and others 
claimed to be 'in a rush' and had no time to listen to the researcher give a brief introduction to 
the study when approached. Six patients who scheduled for their interviews to take place during 
their following clinic visit did not attend their clinic appointment and, thus, were not 
interviewed. Another four patients were out of the UAE at the time of the research and did not 
take part in the study. 
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Nine of the invited patients preferred to take part in the IDIs immediately after invitation and 
verbal briefing of the study aims and objectives by the researcher. This group of patients were 
then verbally informed of the study's aims and objectives and the implications of agreeing to 
take part (e. g., patients' confidentiality, audio recording of the interview, the right to withdraw 
from the study at any point during the interview, the right to refuse answering any question 
when asked). Eight patients selected to be interviewed by telephone. Nine patients were 
interviewed in an empty preparation room which was provided to the researcher by SKMC 
administration. All patients interviewed signed the study consent form (Appendix 2) before 
taking part in the IDIs. Figure 3.1 illustrates the process of approaching and recruiting patients in 
the study these patients. 
i 
Patients not included (n= 32) 
" Declined (n=12) 
" Did not call to schedule for an interview (n=10) 
" Out of the UAE (n=4) 
" No show (n=6) 
Patients recruited for in-depth interviews (n=29) 
  
Women (n=16) 
" Men (n=13) 
Figure 3.1 Patients' sampling scheme 
The medical files of patients visiting three outpatient clinics (OPC) and four family medicine clinics (FMC) were assed 
manually. Sixty-one patients met the study inclusion criteria and were invited to participate in the study. Thirty-one 
patients did not participate due to the reasons presented in the diagram. A total number of 29 patients were 
interviewed. 
The IDIs were held with 29 respondents purposefully selected during visits to outpatient and 
family medicine clinics. Patients were of different nationalities and educational backgrounds as 
can be seen in Appendix 11. 
Since the introduction of the new health insurance scheme in 2007 and the privatisation of all 
health care facilities in Abu Dhabi, non-Emirati residents of the UAE started accessing hospitals 
and primary care centres that were previously limited to citizens of the country. This health care 
system reform explains the use of SKMC services by non-Emirati patients living in Abu Dhabi 
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during the data collection phase of the study. According to Malik and Razig (2008), the 
prevalence of MetS in the multiethnic population of the UAE was 40.5% applying the IDF 
diagnostic criteria of MetS. However, UAE nationals had the highest rate of MetS (41.8%) 
followed by South Asians (40.5%). MetS rates amongst other Arabic nationalities such as 
Shwams (35.9%) (i. e., Jordanians, Palestinians, Syrians and Lebanese), Egyptians (39.1%) and 
Sudanese (39.4%) were also reported (Malik and Razig 2008). These MetS prevalence rates 
illustrate the importance of including a variety of nationalities into the study to facilitate the 
understanding of factors influencing MetS management from the perspective of a wider range of 
patients of different ethnicities. In addition, non-Emirati residents of the UAE are users of the 
health care facilities in the country. Therefore, exploring their health needs within the context of 
MetS, allows for the understanding of how the UAE health care system caters for patients of 
different backgrounds. 
One drawback encountered during the data collection phase was the lack of information about 
patients' demographics in medical files (e. g., ethnicity, social class, employment, marital status 
and accommodation or location). Other behavioural risk factors were also absent from patients' 
medical files such as smoking status and alcohol consumption. Malik and Razig (2008) indicated 
that MetS prevalence was higher in the rural areas (44.3%) than in the urban parts of the UAE 
(39.6%) (Malik and Razig 2008). In addition, available literature indicates that cigarette smoking, 
excessive alcohol consumption, social background and stress are factors that influence MetS 
prevalence and should be considered when managing this group of patients (Chandola, Brunner 
et al. 2006; Kyung-Won, Ki-Hong et al. 2006). However, in this study patients' demographics 
were not available to inform the sampling strategy so as to invite patients of variable 
backgrounds to take part in the interviews. Interviews, therefore, were the researcher's only 
access to patients' demographic data and information about patients' education, work, marital 
and family status was collected during each interview. 
Four of the patients interviewed had one family member join them during the interview process 
at their request (one patient with his wife and three female patients with their daughters). One 
Persian patient wanted her daughter to act as a translator although she spoke and understood 
Arabic. It is very common in the UAE to see sons, daughters and spouses join patients during 
their clinic visits and attend clinic examinations; thus it was inappropriate to ask the family 
members to leave the interview room and it might have drawn suspicion from the patients. It 
was decided, therefore, to allow these family members to attend. Family members were 
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informed of the aims and objectives of the study and were requested to allow the questions to 
be answered by the patients and intervene only when requested by the patient or the 
researcher. All the family members who joined the interviews signed a consent form before the 
interview started in case they did participate by joining the discussion. 
3.7.2 Recruiting HCPs 
HCPs who were in direct contact with MetS patients through their work were considered to be 
suitable subjects for the study as they would be able to articulate issues surrounding MetS 
management through their experience in dealing with this group of patients. As such, physicians, 
pharmacists, dieticians and health educators were sampled and invited to take part in the 
interviews. The aim of including this variety of HCPs is to provide a rich and diverse professional 
insight on MetS management needs based on their experience and professional speciality. For 
example, physicians are responsible for diagnosing, initiating treatment and then following the 
treatment progress of patients with MetS. Therefore, their accounts would provide an insight 
into issues influencing: (i) the identification and diagnosis of this group of patients; (ii) 
therapeutic management; (iii) clinical outcome and control of CRFs; and (iv) the clinical 
utilisation of the MetS concept. Pharmacists, on the other hand, are responsible for supplying 
medicine and providing drug counselling to patients. Thus, by reflecting on their own experience 
in dealing with this group of patients, pharmacists can talk about issues related to medicine use 
and factors influencing adherence. Dieticians working in FMCS and OPCs are involved in tailoring 
lifestyle interventions to fit patients' daily lives. They might, therefore, be able to provide 
information on contextual as well as personal factors that impact patients' implementation of 
lifestyle interventions. Ideally, health educators have the role of assessing patients' health 
awareness and investigating issues surrounding their understanding of their condition and 
treatment plan. They were, thus, valuable informants in this research. 
3.7.2.1 Recruiting physicians 
At the beginning of the study an email list of 15 physicians was provided by the study co- 
supervisor at SKMC. All 15 physicians were emailed and invited to take part in the study. A copy 
of the study information sheet and consent form was attached to all emails. Four physicians 
responded and agreed to take part and gave the researcher an appointment to conduct the IDIs. 
Four physicians were recruited during the clinic visits and two were referred to by the previously 
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interviewed physicians. The researcher made sure that physicians knew of their option to take 
their time in reading the research information sheet before agreeing to take part, nevertheless, 
two of the physicians asked to be interviewed immediately after being physically approached 
and invited by the researcher. These two physicians insisted that they were "highly interested" 
in study aims and objectives and that "now" was a convenient time for them to take part in the 
interviews. All IDIs were conducted inside physicians' offices. 
3.7.2.2 Recruiting pharmacists 
Pharmacists took part in the IDIs (11 pharmacists) and one FGD (nine pharmacists). The first 
pharmacist interviewed (clinical pharmacist at the endocrinology and diabetes clinic) gave a list 
of 12 pharmacists who worked at different pharmacies within SKMC's outpatient and family 
medicine clinics. All referred pharmacists were invited via emails and six replied and agreed to 
take part in the IDIs. Another four pharmacists were recruited during the researcher's clinic 
visits. All pharmacists were provided with the study information sheet and signed the consent 
form before commencing the interviews. 
Recruiting pharmacists for the FGD took place five months after the IDIs were completed. This 
was to allow the researcher time for sufficient data analysis that would enable the identification 
of themes in need of further exploration through FGDs. Pharmacists were invited through the 
head of the SKMC pharmacy department who emailed all the pharmacists working within 
different family medicine and outpatient clinics. These emails included a brief introduction to 
the study and an attached information sheet. Nine pharmacists who did not take part in the 
interviews agreed to take part in the FGD. 
3.7.2.3 Recruiting dieticians and Health educators 
Dieticians (n=4) and health educators (n=2) were recruited during the researcher's visits to the 
clinics. All dieticians and health educators approached agreed to take part in the study. At the 
time of the study, there were only two health educators present. The researcher met all the 
recruited dieticians and health educators during her visits to the clinics and invited them to take 
part in the study. The IDIs took place in the dieticians and health educators' offices at different 
intervals during the data collection phase. 
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Sampling of HCPs resulted in the recruitment of 27 HCPs. Interviews were conducted with 10 
physicians, 11 pharmacists, 4 dieticians and 2 health care educators. Recruiting HCPs followed a 
mixed sampling strategy that started as purposeful sampling but incorporated snowballing and 
convenience sampling as the research progressed (Figure 3.2). 
It 4 Physicians included All included Pharmacists included (n=10) (n=6) (n=11) 
Healthcare professionals interviewed (n=27) 
Figure 3.2 HCP sampling scheme 
A total number of 44 health care professionals were invited for in-depth interviews. They were either approached 
during visits to SKMC, emailed or identified through snowballing. Only 2 health educators were available at the time 
of the study and both were invited. 
All HCPs interviewed were provided with the study information sheet and signed a consent form 
before interviews commenced. Appendix 9 and 10 illustrates the demographic data of the HCPs 
that participated in the IDIs and the FGD, respectively. 
By the end of the data collection phase, it was evident that a total number of 56 participants (29 
patients and 27 HCPs) were interviewed and one FGD was conducted with 9 pharmacists who 
did not take part in the interviews. 
3.8 Data collection and data management 
Data collection occurred in two phases. The first data collection phase involved collecting the 
IDIs data which was conducted between January and May of 2009 and the second data 
collection phase was in November and December of 2009 and involved recruiting participants to 
take part in the FGD. All IDIs and the FGD were conducted by the researcher. Appendices 9,10 
and 11 present the details of the study participants. 
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3.8.1 The IDIs and FGD data 
Interviews were audio-recorded using a digital interview recorder provided by the research 
institution. This generated a total of 29 hours and 27 minutes of recorded material. The shortest 
interview was with a patient and it lasted for 6 minutes and the longest interview was conducted 
with a clinical pharmacist and it lasted for one hour and 41 minutes. All recorded material was 
saved into a USB device as a windows media player or MP3 format which made the process of 
transcribing on the computer more convenient. All recorded material was transcribed verbatim 
by the researcher who conducted the interviews. 
IDIs conducted with HCPs and patients elicited information on participants' health behaviour and 
perceptions of the risk factors that constitute MetS. It also provided information on patients' 
attitudes towards their medicines and lifestyle interventions and the contextual factors that 
affect the implementation of the treatment plans. It is worth mentioning that HCPs were better 
at articulating themes drawn out by both patients and HCPs, and they were able to 
conceptualise some of the patients' health behaviour. This could be due to their educational 
background and experience in the health care field. Patients who had a university degree were 
also able to express their feelings about their condition and the impact that MetS has on their 
lives. They were also more aware of their role as patients and their expectations of the health 
care services in the management of their condition. This was evident from the IDis conducted 
with this group of patients that seemed to be longer than IDIs conducted with less educated 
patients. 
The pharmacists' FGD was conducted five months after all IDIs were completed. This allowed the 
researcher to analyse enough data generated from interviews and to identify themes that 
required further exploration. Conducting and controlling the FGD appeared to be more 
challenging than IDIs. In the FGD more participants (n=9) engaged in the discussion resulting in 
incidents where participants' voices overlapped or discussion diverted from the research focus. 
The PowerPoint presentation during the FGD helped the facilitator intervene at the right time 
and in a professional manner in order to bring the discussion back to MetS related issues. It also 
enabled the facilitators to have more control over the dynamics of the discussion and engage all 
the pharmacists in the discussion. The facilitator used the PowerPoint slides to point at titles or 
move between slides to bring the participants' attention back to MetS. The facilitator allowed 
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participants' 'rambling' as this helped unravel more themes and stimulated the interaction 
between participants. 
3.8.2 Managing unrecorded data 
Audio-recording facilitates accurate and verbatim transcribing of interviews. However, there was 
one case in this study when audio-recording was not possible. This resulted in manual 
documentation of this interview with a female dietician and in a few cases when the participants 
started talking about the research topic after the interview ended and the recorder was 
switched off. Manual transcription of interviews can result in incomplete data as the interviewer 
might lose focus and be distracted by writing down responses rather than listening carefully to 
participants to capture ideas and themes emerging during the interview. There is also the risk of 
paraphrasing responses with the researcher's interpretation of what was said which can result in 
subjective analysis of the data (Smith 2005). In this study one female dietician strongly refused 
having her voice audio-recorded during the interview. To minimise paraphrasing and personal 
interpretation, the researcher took short notes during the interview of the topics covered and 
issues raised by the dietician. She then reviewed all hand written notes with the dietician to 
make sure all disclosed information was documented in the researcher's notes and to allow a 
second opportunity to listen to how things were actually described by the dietician. Once the 
researcher left the dietician's office, the whole interview scenario was written explicitly to retain 
all verbal and non-verbal gestures, body language and some of the exact words that were used 
by the dietician to describe her perceptions and views. On other occasions participants started 
talking after the audio-recorder was switched off. In such cases, the researcher wrote down a 
summary of all relevant issues shared immediately after the participant left the interview room. 
3.8.3 Researcher's field notes 
The researcher kept a diary in which all observations and perceptions about the data collection 
process were documented using a word processor. Field notes were documented on a daily basis 
promptly after each clinic visit or interview to ensure that the researcher's observations and 
notes were captured and reserved while they were fresh in her mind. These notes aided in 
paraphrasing some of the interview questions or adding a new question to explore new ideas 
and themes that were identified in the preceding interview. These notes were also useful during 
the data analysis phase as they helped the researcher retrieve some of her feelings and 
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perceptions about the interview process, its dynamics, and why things were said and what 
provoked them. 
It is recommended that researchers keep a chart to check patterns of ideas and behaviours of 
participants which are then compared to the researcher's notes (Bernard 1988). This helps 
identify if participants behaviour during interviews is spontaneous (reflect collective culture) or 
influenced by the researcher (reflect researcher provoked statement). Patients' behaviour 
during IDIs and the FGD was taken note of and was used during the analysis. Photographs of 
interview settings, clinics visited, health clubs, public places and other locations that participants 
mentioned in interviews were taken using the researcher's mobile phone or digital camera. 
These photos were saved into the researcher's study diary alongside related notes. Such 
photographs helped the researcher to recall the context of the interview. This photographic 
diary proved helpful during the analysis process as it enabled the visualisation of some of the 
events and activities that participants talked about in their interviews. 
3.8.4 Transcription 
All IDIs and the FGD were transcribed verbatim by the researcher who conducted the interviews. 
This enabled the researcher to re-live the interview events during transcription and recall how 
things were said and what provoked them. It also enabled the researcher to add comments that 
reflected her observations and perceptions during the actual interview and compare the 
recoded material with the field notes to remove ambiguity, especially when participants' words 
were unintelligible or were obscured by background noises. The researcher's notes also aided in 
adding preliminary codes that describe the participants' non-verbal communications, hand 
gestures, body language, emphases on phrases and words, all of which helped in capturing the 
essence of the interview and the intensity of participants' expressions and disclosure. 
Preliminary codes helped the researcher understand some of the health concerns in MetS 
management, especially in the early stages where analysis was needed to identify emerging 
themes and categories that were within the researcher's interest. To ensure consistency of the 
transcription process some of the transcripts were read by the PhD supervisors to certify that 
the general rule of transcribing was adhered to. 
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3.8.5 Translation 
Methodology 
There were 36 IDIs conducted in Arabic; 26 of which were with patients, whilst the remaining 20 
interviews were conducted in English. Although three patients and four HCPs were non-Arabic 
speaking participants, another 13 participants (8 physicians and 5 pharmacists) chose to conduct 
their IDIs in English despite Arabic being their first language. The FGD was conducted with 
Arabic-speaking pharmacists and the discussion was in Arabic. The researcher did not impose a 
language on the participants and participants were given the freedom to respond in the 
language they preferred. All Us and the FGD were transcribed verbatim and in the language 
they were conducted in. This resulted in 37 Arabic transcripts (36 IDIs and the FGD). There was a 
need to translate all the Arabic transcripts into English as the two research supervisors were 
non-Arabic speakers. The bilingual researcher/interviewer translated all Arabic transcripts into 
English. To ensure the quality and accuracy of the translation process, 16 transcripts (43%) were 
back-translated and checked for consistency by bilingual individuals who spoke both Arabic and 
English fluently. It is worth mentioning that the Arabic intonations used in the interviews varied 
between participants, thus, some of the back translation was not identical to the original Arabic 
transcript but maintained a similar meaning. To further ensure that the meaning of the actual 
Arabic text was preserved in the English language, the researcher performed coding and analysis 
of the English translated scripts, whilst listening to the original Arabic audio-recordings of the 
interviews. This helped the researcher re-live the interview and retrieve the nuances of what 
was said. More information on translation dilemmas will be presented in the reflective section in 
Chapter 8 (section 8.5.2). 
3.9 Data analysis 
Qualitative data analysis in GT is not a separate activity that commences once data collection 
ends, but rather an integral ongoing component of the whole research process. Detailed 
information on qualitative data analysis in GT was provided earlier in this chapter (see section 
3.3.3). Qualitative data analysis is described as an iterative and inductive activity that requires 
extensive reflection on the data and identified themes. In GT, data analysis occurs 
simultaneously with data collection in a "zigzag" fashion. The researcher's visits to the data 
collection fields are interrupted by concurrent phases of data analysis (see section 3.3.3.1). This 
process is referred to as constant comparative data analysis where identified themes from 
subsequent interviews are compared to themes identified in previous interviews (Glaser and 
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Strauss 1967; Creswell 2007). The advantage of having a concurrent data collection and data 
analysis in GT is that it enables a clear understanding of the social and cultural factors that 
impact the phenomenon being investigated (Ulin, Robinson et al. 2005). This understanding 
provides the researchers with a cultural lens with which they can view and analyse the study 
participants (Ulin, Robinson et al. 2005). 
3.9.1 Organising the data 
All interviews were transcribed, and then uploaded into a computer programme called QRS 
NVivo® version 8.0. NVivo®, which enabled the categorisation and arrangement of the interview 
data. Texts were highlighted where examples of emerging themes were evident and then cross- 
referenced to other themes with similar meaning that were highlighted in another text. This 
scheme of coding and cross-referencing aided in developing the overall structure of themes. This 
programme was easy to use and flexible and facilitated the production of neat, colourful and 
easy to follow codes. 
The researcher's field notes and diary included diagrams of possible relationships between 
emerging themes. These diagrams were useful in retaining researcher's thoughts and ideas 
about themes and relationships between categories that were recorded at an early stage of the 
study. Despite using software to arrange themes and categories, tables of categories and 
subcategories were drawn on A4 papers and word documents. These tables displayed 
relationship between categories. Diagrams were also sketched manually or using word SmartArt 
to illustrate the coding paradigm of the analysis. The constant comparison method of data 
analysis is considered to have high internal and external validity (Creswell 2007). This method 
involved systematic analysis of interviews, comparing similarities and differences and generating 
concepts from a reasonable number of participants. Verbatim quotations were occasionally used 
to demonstrate a range of responses within and across the study. The study findings are 
represented in the subsequent chapters of this thesis. 
3.9.2 Coding of data 
Qualitative data collection generates a large amount of textual information in the form of 
interview transcripts, field notes and other written material. This calls for a systematic process of 
data analysis to transform these few hundred pages of text into meaningful data (Charmaz 
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2006). Following the GT guidance on interview coding (see section 3.3.3), data analysis in this 
study started with an open coding process where textual data were carefully read. Interviews 
conducted in Arabic were read in their original language to retain and reserve the meanings that 
informants conveyed during the interviews. The purpose of repeated and thorough reading was 
to identify similarities in the content between different interviewees. This resulted in 
segmenting the texts into units of meanings. Each group of units or segments of identical 
meaning were then labelled to form codes or categories to identify the property or 
characteristics of each theme. This process followed the techniques of constant comparison as 
explained in section 3.3.3.1. Further interview transcripts were compared with the themes 
identified to examine the similarities and differences in detail. This process enabled the 
modification of each category making them clear and more defined. Categories were later 
compared to each other and relationships between these categories were identified and 
examined in order to develop the overall structure. Deviant case analysis was also applied, 
where examples that did not fit emerging themes were examined to help redefine themes 
properties (Pope 2000; Charmaz 2006). 
Memos were written throughout the process of coding to keep track of ideas regarding data 
analysis. This process of creating codes, combined with reflections, was maintained while coding 
all interviews. They were also useful in keeping a note of thoughts without the pressures of 
having to immediately determine how ideas fit within the overall research findings and analysis. 
Memoing allowed the freedom to jot down ideas so that these could be sorted, categorised or 
discarded at a later point in time. A matrix of codes, properties and dimensions was devised as 
well as some comments and questions. This list of codes was revised continuously as more 
interviews were coded. The NVivo software aided in the coding process and allowed for 
searching of the interviews, re-sorting of material and consistent redefining of codes in order to 
support the analysis process. 
3.9.3 Data saturation 
During the phase of analysis, sampling and interviewing proceeded until it was felt that no new 
themes were emerging and further interviews appeared not to lead to new information being 
obtained. This provided an indication that saturation may have been achieved. Theoretical 
saturation of concepts marks the ending point of data gathering and analysis. Although this 
concept might sound logical, judging saturation remains unclear (Charmaz 2000). The elasticity 
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of this concept is evident in practice where it is obvious that the researcher has to make some 
pragmatic and rational choices as to when a category is saturated. Flick (1998) suggests a 
pragmatic approach to theoretical saturation. He states that researchers need to stop and reflect 
on categories identified, list results and balance them within a priority list and then decide which 
codes need further development in the light of the original research questions (Flick 1998). Both 
Charmaz (2006) and Flick (1998) point out that theoretical saturation is difficult to achieve since 
researchers will always be left with questions regarding their data. Therefore, theoretical 
sampling could result in never-ending/ ongoing integration of more interviews. In the end, the 
depth and extent of data collection and analysis must be sufficient to enable the researcher to 
tell a plausible story (Flick 1998; Charmaz 2006). 
In this study, data analysis and data collection were undertaken concurrently. The data were 
constantly revisited to seek evidence for the factors that I felt were underpinning barriers to the 
management of MetS in the UAE. Themes that were identified were regularly discussed with my 
supervisors through webcam meetings to identify areas in need of further exploration in 
subsequent interviews. As the data collection phase continued, accounts from consequent 
participants did not appear to provide new information on factors influencing the management 
of MetS. For example, accounts describing the impact of patients' religious practices on their 
therapeutic outcomes started to confirm previously identified themes and did not seem to 
highlight new information as more interviews were conducted. I felt that theme saturation was 
reached with 25 patients and 23 HCPs interviews as no new themes had emerged. To confirm 
theme saturation, an additional four patients and four HCPs were then interviewed. These 
additional eight interviews were not found to produce any new themes to what was previously 
identified. Thus, I felt that I had reached saturation and that coherent, substantive ideas were 
evident within the data. While data collection ceased at this point, analysis continued, 
particularly engagement with extant theoretical concepts. 
It is important to mention that some of the themes identified during the focus group did not 
emerge in the previous interviews. These new themes were concerned with the pharmacy 
profession and pharmaceutical care in the UAE and were not specific to MetS management. All 
participants in the focus group were pharmacists, which could explain why, at some point during 
the meeting, discussion diverted to include topics of shared interest, such as strategies to 
improve pharmacy practice in the UAE. Pharmacy profession-related themes were not discussed 
or included in this thesis but highlighted in areas for future research. Discussing emerging 
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themes with the research supervisors during meetings (webcam meetings whilst in the UAE and 
at the UK University of Nottingham campus) provided new perspectives and interpretations of 
the data which added credibility and reliability to constructed concepts. 
The process of data analysis, which also encompassed interview transcribing, translation, 
arranging, coding, memoing, and creating diagrams started in January 2009 and continued until 
the early stages of writing the results chapters of this thesis in May 2010. 
3.10 Reliability and validity of data and methods 
Researchers' concern with validity and reliability is a common feature of quantitative research; 
however, they are now increasingly being reconsidered in the qualitative research paradigm to 
achieve trustworthiness and transferability of data (Golafshani 2003). Qualitative data is 
constructed from participants' experience, views and interpretations of their experience with 
the researched phenomenon. Therefore, qualitative research is not easy to validate as the 
enquiry carries an element of subjectivity and personal bias. It has, therefore, been suggested 
that reliability and validity be achieved through the improvement of credibility of the research 
methods and data (Golafshani 2003; Silverman 2004). From this perspective, it is important to 
ensure the consistency of the study procedures, their comparability to other research methods 
and the ability to verify and elaborate findings (Silverman 2004). 
3.10.1 Reliability of the data 
In qualitative research, reliability relates to the reproducibility and stability of the collected data. 
As such, examination of trustworthiness is crucial to ensure reliability in a qualitative study 
(Silverman 1993; Golafshani 2003; Creswell 2007). Reliability in qualitative research is linked to 
aspects of conducting interviews, data processing and analysis. Thus, reliability can be enhanced 
by using a good-quality recording device, verbatim transcribing of the recorded data and by 
maintaining consistency with regard to data processing and analysis (Smith 2005; Creswell 2007). 
Developing a code book and using external checking on the highly interpretive coding process is 
another means of obtaining reliability in qualitative data (Silverman 1993; Smith 2005; Creswell 
2007). The use of electronic software that facilitates the coding process and data organisation 
such as Nvivo software is also encouraged (Creswell 2007). 
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3.10.2 Validity of the data 
Methodology 
Validity in qualitative research refers to how accurate the data gathered is representing 
participants' realities of the researched social phenomenon. There is general agreement that 
qualitative researchers need to determine if their data is plausible. As such, nine procedures 
were recommended to establish validity in qualitative research. These methods are 
triangulation, disconfirming evidence, researcher reflexivity, member checking, prolonged 
engagement in the field, collaboration, external audits and thick, detailed description (Maxwell 
1992; Creswell 2007). However, two dimensional frameworks help provide researchers with the 
rationale for choosing the best tool to validate their data. These two framework dimensions are 
the lens (viewpoint) researchers use to assess the credibility of their data and their own 
philosophical position (Creswell and Miller 2000). 
Unlike quantitative research where investigators are concerned with certain test scores that 
reflect the validity of the designs and tools, qualitative researchers rely on the lens established 
from the views of individuals who conducted, participated or read the study findings (Creswell 
and Miller 2000). If the researchers chose to use their own lens, they carry the responsibility of 
determining data saturation and data analysis progression through repetitive visits to the 
identified data codes and categories (Patton 1980). Alternatively, looking at data through the 
lens of the participants can assess data validity by comparing the accuracy of the data and 
themes against the participants' perception of the reality of the investigated phenomenon 
(Creswell and Miller 2000). The lens of external individuals who are not associated with the 
research can also help in establishing validity (Creswell and Miller 2000). Qualitative studies rely 
on those who conduct it; therefore, researchers should also acknowledge what they bring into 
the research as it influences what they see and how they analyse their data (Charmaz 2006). The 
philosophical assumptions regarding the qualitative study and the researcher's stance need to 
be addressed and established in order to assess validity (Guba and Lincoln 1994). 
The interview process, data processing and data analysis are three activities that need to be 
taken into account when enhancing the credibility of the qualitative data (Creswell 2007). Table 
3.2 illustrates measures considered during these three phases. However, this does not imply that 
findings from this study provide a fully accurate picture of all the issues surrounding MetS 
management in the UAE. 
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3.11 Dissemination of findings 
Although the research was undertaken with the intention of producing a PhD thesis, various 
aspects of the study findings were reported to a wider audience in the form of peer review 
posters, oral presentation at conferences and peer reviewed publications. Appendix 12 
illustrates abstracts and oral / poster presentations of some of the study findings. I will attempt 
to publish a few papers in the future as this will help disseminate the research findings to 
interested audience of academics, health care communities' and fellow researchers who might 
benefit from the research findings. 
3.12 Summary 
This chapter highlights the importance of choosing a research methodology based on the 
research questions that best deliver and achieve the study aims and objectives. On this basis, 
qualitative methods were ideal to explore patient and professional perceptions of MetS and its 
management within the socio-cultural context of the UAE. IDIs were chosen because it enabled 
in-depth exploration of participants' views and perceptions of the phenomenon in their own 
words. The FGD was also an ideal tool to help stimulate thoughts and discussion to further 
explore emerging themes and to achieve triangulation of data. The study draws on the broader 
principles of GT as it was best suited to explore participants' views and perceptions on MetS. 
This chapter outlines some of the limitations that were encountered during the participants' 
recruitment, interviewing, and data collection all of which emphasis the strong socio-cultural 
influence of the study setting on the research process. Constant comparative analysis of the data 
showed high internal and external validity of the data as it involved systematic analysis of 
interviews, comparing similarities and differences and generating concepts from a reasonable 
number of participants. Although little consensus is available on how to achieve quality in 
qualitative research, it has been argued that reliability and validity in qualitative research can be 
achieved through consistency of the study procedures, their comparability to other research 
methods and the ability to verify and elaborate findings. Detailed information was provided in 
this chapter regarding recruitment of the study participants, how IDIs and the FGD were 
conducted and how data was documented, managed and analysed. 
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The following five chapters present the findings from the study and conclusion. The following 
four chapters describe the main themes identified in this study which were: (i) perceptions of 
MetS; (ii) factors influencing patients' attitudes towards lifestyle intervention; (iii) factors 
influencing patients' medicine use; and (iv) facilitators to MetS management in the UAE. 
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Chapter 4 
4.1 Introduction 
Participants' perceptions of MetS 
This chapter presents themes that describe patient and professional perceptions of MetS. The 
first part of this chapter (section 4.2) presents themes about patients' awareness of their 
condition, their perception of risk and mechanisms of coping. The study interview guide for 
patients included topics that explored the impact of having MetS features on patients' lives and 
the lives of their families, their understanding of causes of their condition or poor control of 
their clustering CRFs and their awareness of the risk associated with having multiple 
cardiometabolic diseases. The second part of this chapter (section 4.3) presents professional 
views on MetS. The interview guide for the HCPs included topics that explored their perceptions 
of the MetS concept and definition and factors influencing the clinical utility of the MetS 
diagnostic criteria. Themes identified from patients' accounts that reflected the role of patients' 
awareness of their MetS diagnosis were also explored. These interviews helped elicit 
professional thoughts in the controversy surrounding the MetS definition and the usefulness 
limitations of the MetS concept in the identification and management of this group of patients. 
Semi-structured interviews were conducted with 29 patients (16 women and 13 men) the 
demographic data of which is summarised in appendix 11. Ten patients were Emiratis and 14 
were of other Arabic nationalities. The other five patients were of non-Arabic nationalities, such 
as, British, Indian, Bangladeshi, and Iranian. 
A total number of 27 HCPs (11 pharmacists, 10 physicians, 4 dieticians and 2 health educators) 
were interviewed (see appendix 9) followed by interviewing 9 pharmacists during one focus 
group (see appendix 10). All HCPs were in direct contact with patients who met the MetS 
diagnostic criteria through their clinic work and were able to provide information about the 
health needs of this group of patients from the perspective of their respective professions. HCPs 
came from different backgrounds and where of different nationalities, such as, Canadian, British, 
Egyptian and Sudanese, which also provided an outsider's perspective of the barriers to the 
management of MetS in the UAE. 
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By and large, the study participants displayed great interest in discussing health concerns 
surrounding MetS. This was reflected by the lively discussion during all interviews. There were 
topics that were talked about but were not included in this thesis as they were beyond the scope 
of this study, such as barriers to communication, limitations to pharmacists' role in the UAE and 
means of improving the pharmacy profession. What is presented in this thesis are issues that 
directly address the management of MetS that were identified through patients and 
professionals' accounts as they expressed their views surrounding the condition and factors 
affecting lifestyle and therapeutic intervention. Table 4.1 illustrates the key themes that will be 
presented in this chapter. 
Table 4.1 Summary of the key themes of MetS 
Patient perceptions of MetS 
  
Patients were unfamiliar with their MetS diagnosis or the MetS concept but they were aware of their CRFs 
  
Not all patients were aware of the cardiovascular risk associated with MetS. They were, however, conscious of 
the augmented risk resulting from the clustering of their presenting CRFs 
  
Many patients were also aware of the non-cardiac complications of CRFs such as renal failure, blindness and 
amputations 
  
The high prevalence of diabetes, obesity and other CRFs in the UAE gave patients a sense of commonness of 
MetS, which resulted in patients' understating of the MetS risk and in some cases grading the risk of CRFs 
" Patients' fatalistic statements about their condition were influenced by their awareness of the genetic 
predisposition and stress as two causes of CRFs. 
  
There were many factors that facilitated patients' acceptance and coping with their condition including the 
asymptomatic nature of MetS and some of the patients' religious practices and beliefs. 
Professional perception of MetS 
  
HCPs of different specialities did not have an equal level of awareness of the MetS concept or definition 
  
Most physicians believed in the legitimacy of the MetS concept and as a condition on its own right. 
  
Some physicians were concerned about the multiple definitions of MetS but agreed that the clustering of CRFs 
represented an augmented risk that required a holistic approach regardless of the condition's name and 
definition. 
  
The complexity of the MetS term and the unavailability of a simple Arabic alternative discouraged physicians 
from informing patients of their MetS diagnosis. 
  
HCPs were also used to the dichotomising of risk factors and documenting of individual rather than the use of 
the MetS term. HCPs did not see the added therapeutic value of informing patients of the MetS or its impact on 
their health behaviour. Thus, they rarely informed patients about the MetS concept. 
  
Although some HCPs agreed that the MetS definition provided an easy to use tool to identify patients at 
potential risk of developing cardiac complications or diabetes, they felt that it was better suited for CRF 
screening during outreach campaigns 
The following section presents the main themes that emerged during patients' interviews and 
from questions that explored their perception of their health condition and how they felt it 
affected their lives. It starts with a preface to patients' accounts of their awareness of their CRFs 
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followed by the four main factors that were found to shape their perception of their health 
condition: (i) awareness of the MetS concept; (ii) perception of MetS risk; (iii) coping with having 
CRFs; and (iv) patients' fatalistic attitude towards MetS causes. Case illustrations of five patients 
are presented in Boxes 1-5 in the first section of this chapter. These case illustrations are 
provided to help contextualise patients' accounts and to present their stories as they talked 
about their health concerns during their interviews. 
4.2 Patient perceptions of MetS 
Patients have their own perceptions as to what their cardiometabolic disease means and how it 
should be treated. Eliciting patients' interpretations of their illnesses provides a basis for 
understanding the way in which patients conceptualise the cause, course and appropriate 
management of an illness. Patients' attitudes towards their health conditions could be a result of 
numerous social and cultural experiences that may, in part, influence health outcomes, health- 
seeking behaviour and adherence to prescribed treatment plans (Leventhal, Benyamini et al. 
1997; Helman 2007). Therefore, it was important in this study to identify patients' perceptions of 
their clustering CRFs, causes and seriousness. 
Interviews with patients started by asking general questions about their health problems. Such 
questions included asking them to list all their diagnosed diseases and health problems, duration 
of illness and how they felt when they were first diagnosed with any of the CRFs. The aim of 
these initial questions was to familiarise patients with the interviewer and to gradually build up 
the discussion to the focus of the research which was identifying factors that influence the 
holistic management of MetS. 
Patients' accounts indicated that they were able to list their diagnosed CRFs that were 
documented in their medicinal files in addition to other non-cardiac health conditions, such as, 
back or knee pain, rheumatoid arthritis, asthma, peptic ulcer, skin problems and injuries from 
accidents. However, not all patients gave the accurate or exact medical terms of their health 
conditions and many used their own descriptions of such diseases such as 'sugar' for diabetes 
and 'pressure' or 'blood pressure' for hypertension. Most patients gave detailed descriptions of 
the events that proceeded or led to their diagnosis with one or all of the CRFs, how they became 
aware of their diagnosis and how they felt when they were informed by their doctors about 
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having any of the CRFs. For example, patient 10 talked about her annual visits to Egypt where 
she regularly had a clinical check-up and was first diagnosed with diabetes: 
P. I was diagnosed [with diabetes] five years ago. I was in Egypt at that time. I go there every 
year and see a doctor while I'm there. You know, the treatment there is very cheap compared to 
here [ 
... 
] so the doctor told me I might have developed diabetes because he found that my sugar 
was high. He didn't give me any tablets but told me to watch my diet and said that if that didn't 
work then he'll prescribe medicines for me. 
R: And how did you feel when he told you that you might have diabetes and you need to watch 
your diet? 
P: It made me scared. I didn't want to be diabetic. It does make you sad of course. You know, we 
all have difficulties in our lives, so to have diabetes on top of all these things this'll make you sad 
of course. But thank God for everything. You eventually cope, and I am ok now and I'm taking 
my medicines and everything is controlled. 
R: Yes 
P. When I came back [to the UAE] I went to the clinic and they gave me Glucophage®. They said 
these tablets will help me reduce my weight as well. So I took them and so on. 
Patient 10, woman, 50 yrs, Palestinian 
The example demonstrates how patients were able to narrate the history of the first time they 
were informed of one or some of their presenting CRFs. They were also able to describe their 
immediate feelings towards that information. Another group of patients indicated that they 
experienced signs and symptoms that clued them to their diagnosis before their physicians 
informed them. Some patients described headaches and tremors that they believed indicated 
uncontrolled blood pressure. Others described excessive urination, sweating, feeling breathless, 
general body weakness and tooth loss, which they believed were early signs of diabetes or 
elevated blood sugar. Such symptoms prompted this group of patients to screen for CRFs in their 
family medicine clinics, which eventually led to their diagnosis. For example, when I asked 
patient 6 about the time of his diagnosis with diabetes and blood pressure, he talked about 
losing most of his teeth and how that was interpreted by one of his friends as a sign of having 
diabetes. 
R: When where you diagnosed with diabetes? 
P: About twelve years ago 
R: Yes 
P: When I was having my dinner, my tooth fell off without blood. I thought to myself. 'that's 
strange! ' Then another time, another tooth fell off without any blood. so I asked someone, he 
said: 'see these are the early signs of diabetes'so then every month or two I would lose another 
tooth, so diabetes started through my tooth loss problem, and that is how 1 knew that 1 had 
diabetes. 
R: And did you see a doctor when you felt that you have diabetes? 
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P: Yes. I then went to the clinic and told them [the medical staff] '1 feel I have diabetes'. They 
made the blood tests and my blood sugars were high [ 
... 
] then one year later my blood pressure 
was also going up and the doctor said I should take medicine for that too. 
Patient 6, man, 65 yrs, Yemeni 
Box 1 contains a case illustration of patient 6. Some of the health concerns and disease 
interpretations of this patient are addressed in following sections and chapters. 
Box 1: Patient 6 
Patient 6 was a 65-year old man who came to Abu Dhabi from Yemen to work for an oil company in 
1977. I met him in a family medicine clinic when he came for his three-monthly routine visit. His 
medical file indicated that he was diagnosed with high blood pressure, diabetes and elevated lipid 
profile. He appeared enthusiastic to take part in the study and the interview. However, when I asked 
him to talk about his health problems and list his diseases he stated that he did not have any but that 
he only had diabetes. When I further enquired to clarify what he meant by not having an illness 
although he was in the clinic to collect his regular medication, he explained that there were many 
people in the UAE with conditions like his; therefore, he felt that it was normal to have diabetes. He 
further explained that in his understanding, a disease was something that hindered and prevented 
people from living their normal lives and because diabetes did not prevent him from living his normal 
life, he did not consider it as an illness. However, later in the interview he talked about his eagerness to 
adhere to his prescribed medicines and lifestyle adjustments to help control his 'blood pressure, 
diabetes and cholesterol level in the blood'. 
Patient 6 also talked about how he liked to learn about his health condition through his physicians, 
friends, television and reading materials provided by his family clinic. However, towards the end of the 
interview he admitted his fear of starting insulin therapy because he did not want to 'get dependent on 
an injection' for the rest of his life. He reported that he had a good relationship with all his physicians, 
which enabled him to talk to them about his habit of chewing khat9 during his trips to Yemen. He 
claimed that chewing khat helped lower his blood sugars and that his physician did not mind that as 
long as it did help his condition. His inability to exercise and walk like he used to, because of the pain in 
his knees, made him feel sad and sometimes depressed. He also indicated that he never missed a dose 
of any of his prescribed medicine although he was not happy with taking them because they were 
'harmful chemicals anyway'. However, he was keen on getting the original brands, as they were 'more 
efficient than the locally manufactured ones'. 
Other patients in the study believed that having a family history of diabetes or 'heart problems' 
was a strong indicator of their susceptibility to developing some of MetS features. For example, 
while patient 13 was talking about the events that led to changing his blood pressure 
medication, he remembered how his doctor warned him of his susceptibility of developing 
diabetes because of his family history: 
I Khat is a flowering plant that is grown in East Africa known for its stimulating and euphoric effect. It is popular plant in Yemen, and people chew its 
fresh leaves to achieve this effect. Chewing khat in this part of the world and other African cities is considered legal. 
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P: I started with Tenormin. No not Tenormin. [Patient coughing] well at that time I happened to 
be in India for my vacation, so there I went to the doctor. He also checked me and he told me 
two things, two things that is. 'your BP is on the higher side and you have borderline diabetes'. 
Yeah, then warned me: 'because your mother had it this is a gift that you will get from your 
mother, be careful' he said. 
R: So he told you that you'll get diabetes because of the family history? 
P: Yes. She had diabetes also but only at a later age. She's had it for a long time, you know, for 
almost 10 years and then she passed away. So it's hereditary also. So I had to be careful because 
I knew I will also get it 
Patient 13, man, 49 yrs, Bangladeshi 
Box 2 presents a case illustration of patient 13. Some of the issues identified are presented in 
this chapter in following sections and in chapters 5 and 6. 
Box 2: Patient 13 
Patient 13 was a 49-year old Bangladeshi man who came to the UAE in 1991 to work as an 
administrator for a private company. I met him in the diabetic centre when he came for his 
appointment with the dietician. He was first diagnosed with elevated blood pressure eight years ago 
and was later diagnosed with diabetes in 2005. He also had a foot injury that prevented him from 
exercising. When I asked about the causes of his condition he said that he believed that he 'inherited' 
most of his health problems from his mother who was also diabetic and died a few years ago of a heart 
attack. However, during the interview he indicated that work pressure and being overloaded with 
domestic chores were the cause of his health problems and the difficulty to control his blood pressure. 
He believed that his strong faith and knowing that he was under God's care helped him withstand his 
health problems and other family issues. He also felt lucky that he was working in the Emirates because 
he was always surrounded by Muslim colleagues that greeted him and smiled whenever they saw him. 
In his opinion, working in an Islamic environment helped him to withstand stress and cope better with 
his health condition. 
Although patient 13 admitted that his doctor did not inform him about the MetS concept or MetS 
diagnosis, he was happy about their relationship and indicated that he receives all the information he 
needs about his health from his doctor. He was also convinced that doctors' instructions should always 
be followed because they were 'the experts' and knew what he needed. Because of that, he took his 
medicines as directed and kept them all in a box to remember taking them on time. Although he 
expressed keenness to adhere to treatment, he also admitted that he was not satisfied with the high 
number of medicines he was taking. It was later apparent that his previous experience with one of his 
medicine's adverse effect made him doubtful of drugs' safety and admitted stopping medicine-taking 
'every two months or so' to minimise drugs harmful effects and combat their addictive nature 
therefore, enabling his body to regain its strength and natural defence mechanisms. He was also 
looking for alternative therapies such as herbs and traditional remedies that he believed would help 
him reduce the number of his prescribed medicines. 
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One thing that was also noted during patients' interviews when they talked about their health 
condition was their tendency either to address each CRF individually (i. e., talking about each 
separate CRFs) or collectively (i. e., talking about their health condition as a whole). This way of 
describing their CRFs could have been related to the nature of the MetS and the fact that it is 
composed of three or more CRFs. This might have inclined patients to talk about each CRF as 
they saw relevant or more important to their overall health. The examples illustrated previously 
in this chapter illustrate this point clearly, as the extract shows how patients sometimes talked 
about one or two CRFs and not all their CRFs. Further analysis of patients' accounts of their 
health condition identified four key themes: (i) patients' awareness of MetS diagnosis, (ii) 
patients' perceptions of MetS risk, (iii) fatalistic attitude towards condition, and (iv) patients' 
coping strategies with MetS. The following four sections describe these four themes in more 
details and demonstrate the questions that helped elicit these themes. 
4.2.1 Patients' awareness of the MetS concept 
As mentioned earlier in this chapter, all patients were able to list all their diagnosed CRFs. 
However, when patients were asked if they knew that the clustering of these CRFs was also 
called the metabolic syndrome, patients' responses indicated that they were not informed of 
this prior to the interview. The following extract from the interview with patient 23 illustrates 
how patients' lack of awareness of the MetS concept was identified. 
R: Can you please tell me what health problems you have? 
P: Ah [laughing] the list is long. You probably saw what I have in my [medical] file. 
R: Yes, that's true I did see your file, but I want to make sure I have the right information, so I 
prefer to hear it from you. 
P: Well, I have diabetes of course. That's why I come here (the diabetes centre). I also have high 
blood pressure; I have cholesterol which is ok now thank God. I had that six months ago, I think, 
but now it's under control. I am a little bit overweight [laughing] just a bit, don't look at my belly 
it's always been that big [laughing]. That's about it thank God. Did I forget something? You tell 
me (laughing). 
R: No. you remember very well [laughing]. Do you know that the grouping of these diseases is 
called metabolic syndrome or in Arabic (the name in Arabic)? 
P: No. I did not know that before. 
R: Did your doctor talk to you about metabolic syndrome? Or that having diabetes with blood 
pressure with cholesterol with obesity, you know, all these conditions is also called metabolic 
syndrome? 
P: My doctor never told me that I have this (MetS), this is the first time I've heard about it really. 
I don't know. Maybe he did and I wasn't paying attention? Because he did talk to me about 
having many diseases. He said I needed to follow all the instructions carefully. Exactly follow 
them you know? Otherwise I'll have many other problems. 
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Patient 23, man, 55 yrs, Emirati 
Although MetS was documented as a diagnosis in the patient's medical files, the account of 
patient 23 indicated that he was not aware of the MetS concept prior to the interview and was 
not certain if his physicians informed him about the MetS concept. The patient information 
sheet, which was provided to each patient as they were invited to take part in the study, 
included information about MetS and the aims of the study. However, on the day of the 
interview, patients claimed that they were not familiar with the term 'metabolic syndrome' and 
were not informed by their doctors that the clustering of their CRFs was called 'metabolic 
syndrome'. As the above extract illustrated, providing patients with this information during the 
interviews did not appear to cause anxiety or shock to any of the patients in the study. Another 
example that illustrates this point further is an extract from an interview with patient 5 who 
showed an interest in reading about MetS to learn more about it: 
R: Did you know that having all of these diseases diabetes, blood pressure, cholesterol and 
obesity, is also called metabolic syndrome? You know, that the grouping of these conditions all 
together make up the metabolic syndrome? 
P: No. not really. I read that in the information sheet you gave me, remember? 
R: Yes. And did your physician talk to you about it? 
P: No. He did not. I googled it, you know. And I plan to talk to him about it when I see him. But 
very interesting stuff. I am really interested in these things. I like to read everything about my 
condition, so I am interested to know more. 
R: lt is basically the group of health problems that you have. You know. Having diabetes and 
(patient interrupts) 
P: Yes. yes I read that in the paper [information sheet] you gave me 
R: So I'Il be asking you about this today. About you know managing all these problems.. you 
know? Not just diabetes or hypertension 
P: That is good. You know because I don't have just one problem I have many problems 
[laughing] 
Patient 5, man, 50 yrs, Indian 
The above extract is one example of many others that illustrates how patients reacted to the 
information about the MetS diagnosis. It also demonstrates my attempts to remind patients that 
the aim of the interview is to investigate their perception of the aggregated CRFs and not a 
single CRF. 
Section 3.4.2 illustrated the steps taken to resolve the dilemmas regarding the potential risks of 
informing patients about MetS. It also stated the rationale of proceeding with this enquiry with 
all patients who participated in the study. As all study participants had the information sheet in 
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advance of the interview and signed the consent form, it was anticipated that they read and 
comprehended the information provided about the MetS concept and were, therefore, giving 
their informed consent. Therefore, it was inevitable for the researcher to assume that patients 
had read the information sheet before agreeing to take part in the study. Patients' medical files 
had MetS documented as a diagnosis; thus, it was difficult for the researcher to assume 
physicians did not inform these patients of their MetS diagnosis. However, because the 
responses of patients indicated lack of awareness about the MetS concept, they were all 
reminded of the MetS definition during the interview by restating the information already 
provided to them in the patient information sheet. Patients were also reminded that the aim of 
the interview was to gain an understanding of health issues relevant to all their CRFs (i. e., the 
components of MetS) rather than individual diseases. 
As illustrated in the quotes above, all patients' interviewed were able to list their documented 
health problems. They also gave responses that indicated their perceptions of the collective 
diseases (see sections 4.2.2,4.2.3 and 4.2.4). However, in many parts of the interview some 
participants tended to refer to the most prominent CRF presented to them at their diagnosis. For 
example, participants with diabetes, in addition to other features of MetS, referred mostly to 
their 'sugar' (i. e., diabetes) as they conveyed their feelings about their health and treatment 
plan. On the other hand, participants that were not diagnosed with diabetes referred in their 
accounts mostly to 'obesity' or 'pressure' (i. e., elevated blood pressure), if they were diagnosed 
with hypertension. 
As some patient talked about their diagnosed CRFs, their accounts reflected their sense of the 
grouping of their diseases by using words that indicated their feeling of the CRFs aggregation. 
For example, patient 3, who was diagnosed with all MetS features, used the word 'cocktail' 
when I asked her to list all her health problems during the interview: 
R: Can you please talk to me about the health problems that you have? 
P: You mean everything? 
R: Yes. Yes everything you have.. and.. 
P: I have everything, a cocktail of diseases. [Laughing] I have diabetes, pressure, I have 
cholesterol. Thanks to God i have everything [laughing]. 
Patient 3, woman, 69 yrs, Yemeni 
It was not merely the words patients used to describe the aggregation of their CRFs but also the 
way in which they described the impact this aggregation had on their health that actually 
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indicated their sense of the augmented effect this clustering caused. For example, patient 4 felt 
that having more than one cardiometabolic disease made his body weaker than it should be at 
his age. 
R: How do you feel about having all these health problems? 
P: I am ok thanks to God. I don't think about that all the time you see. But I know that it's very 
dangerous when you have more than one thing [CRF]. Just like fighting more than one enemy at 
the some time. Your heath and energy are consumed faster and you're left with little energy to 
carry on living. I know that very well. 
Patient 4, man, 60 yrs, Palestinian 
For patient 4, fighting could have also meant adhering to the management of all these diseases, 
coping with them and living with all the implications of having these CRFs. In another part of the 
interview patient 4 indicated that he was getting ready for his retirement and felt that he looked 
older than his actual age because of having all the illnesses that he was diagnosed with in 
addition to all the stressful events and domestic responsibilities he needed to deal with. The 
following quote was taken from his interview as he was talking about the impact of having CRFs 
on his life: 
You look at me and you think I must be 70 (laughing). It is all these diseases that affect you, you 
know? And on top of all of that you also have other responsibilities that you need to take care 
of, you know, the family, do this do that, go here go there, bring this bring that [laughing], that's 
life anyway and you live and cope so.. And as they say in English: 'life goes on' (laughing). 
Patient 4, man, 60 yrs, Palestinian 
As some patients listed the names of their health conditions or CRFs they also conveyed a sense 
of an augmented hazard caused by having all CRFs as the above examples illustrate. Further 
investigation of patients' perceptions of their condition and the associated cardiovascular risk 
was carried out. The following theme illustrates patients' perceptions of cardiovascular risk 
associated with having multiple CRFs and factors that influenced their views. 
This section presented data from patients' accounts that demonstrated their unfamiliarity with 
the MetS diagnosis or concept but awareness of the individual cardiometabolic diseases that 
they were informed about. Some patients also used words to describe the aggregation of these 
CRFs conveying at the same time their sense of the augmented effect that clustering had on 
their health. More data on patients' perceptions of the risk of MetS features is presented in the 
following section. 
134 
Chapter 4 Participants' perceptions of MetS 
4.2.2 Perceptions of the risk of MetS features 
As presented earlier in section 4.2.1, some patients described the clustering of CRFs using words 
such as 'cocktail', 'more than one enemy', 'mixture of this and that' and 'I have everything'. This 
description may have reflected patients' sense of the CRFs' aggregation and the associated 
amplified risk. None of the study participants had a history of cardiac complications, such as 
angina, myocardial infarction or stroke and 17 patients (59%) were diagnosed with diabetes. 
During the interviews, patients were asked to describe their feelings about having multiple CRFs 
in order to gain an understanding of their sense of the seriousness of their health conditions. 
However, patients' attitudes towards the CRFs risk was also elicited as they talked about the 
impact of their health conditions on their lives and reasons for adhering or not to their 
prescribed treatment plans. Data analysis of patients' accounts revealed that they had a range of 
attitudes towards the seriousness of CRFs. These views included: (i) awareness of cardiac and 
non-cardiac risk; (ii) downplaying the seriousness of MetS features; and (iii) grading the 
seriousness of CRFs. This section presents this range of patients' views accordingly. 
A few patients specifically mentioned cardiovascular risk, such as, the development of cardiac 
complication as a consequential health hazard of having a number of CRFs. This awareness could 
be attributed to the higher educational background of this group of patients or their exposure to 
multiple sources of health information that highlighted the cardiovascular risk of having multiple 
CRFs. For example, patient 5 who was a university graduate and worked in an oil company, 
indicated that he was informed about the risk of developing heart disease by his physician. He 
also stated that he gained a lot of his information from the internet and through exchanging 
emails about the topic with his work colleagues. The following quote illustrates this point. 
R: Did your physician talk to you about the risk of having diabetes and high blood pressure? 
P: You mean heart problems, kidney problems? 
R: Yes.. can you talk to me about this please? 
P: Yes. Yes of course. Normally my doctors talk to me about risks and stuff but 1 don't wait. I am 
very curious and like to learn. I read in the internet and magazines that diabetes, pressure and 
all can lead to heart problems. I use Google and sometimes many employees here [in the 
company] circulate information through emails and when I find something I email it to them too. 
We share information because there are many of us with diabetes here [laughing]. 
Patient 5, man, 50 yrs, Indian 
Although not all patients talked about the development of heart disease as a risk associated with 
having any of the CRFs, many patients talked about the risk of developing other non-cardiac 
complications such as kidney failure, blindness and limb amputations that could result from poor 
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control of blood pressure or diabetes. It became apparent, during the interviews, that the 
perception of many of these patients regarding non-cardiac complications was influenced by 
many sources of information, such as the health education sessions they received in the clinic, 
the diabetes-specific public awareness messages and the experiences of others who developed 
such complications, such as, friends, neighbours or family members who have MetS features. For 
example, patient 29 talked about her fear of blindness because her mother lost her sight due to 
her uncontrolled diabetes. 
P: I make sure that I take my medicines, you know. It is very important to keep everything under 
control. My mother lost her sight because her diabetes was always high and she was not careful 
with her diet. 
R: And is that why you stick to your diet and medicines? 
P. Yes. You know. I am afraid of that. You read about diabetes complications and my doctor 
always warns me about it. God protect us all. I don't want to become blind or have other 
problems. 
Patient 29, woman, 34 yrs, Emirati 
Witnessing the experience that her mother went through made patient 29 realise the 
seriousness of having diabetes and she became conscious of the importance of controlling her 
CRFs to prevent a similar experience form happening to her. As this extract demonstrates, such 
statements indicating patients' awareness of the risk associated with having CRFs were made as 
patients talked about reasons for adhering to their recommended treatment plan. Another 
example can be seen in the following extract from the interview with patient 12 where she talks 
about her fear of developing kidney failure and explains how this fear drives her eagerness to 
adhere to the treatment plan. 
R: Are there any issues with your treatment? You know, medicines? diet? Exercising? 
P: I take all my medicines on time. I've never missed a dose, you know? Really, I always make 
sure that I take my medicine on time always. 
R: And why is it important for you to take your medicine? 
P: Well.. I have to so that I don't get worse you know? I don't want to get worse, you know? I 
don't want to have more problems like kidney failure, or.. you know, I am very scared of this 
kidney failure and I just don't want to end up like that you know? 
Patient 12, woman, 43 yrs, Palestinian 
As these extracts from different patients' illustrate, the risks that patients were referring to were 
not necessarily confined to the development of cardiac complications or heart problems but 
sometimes encompassed other complications of CRFs such as renal failure and blindness. It was 
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also evident from patients' accounts, that their concern about developing non-cardiac 
complications underpinned their eagerness to adhere to their prescribed treatment plan. 
Other patients' accounts indicated an understating of the seriousness of their CRFs. This attitude 
was noticed as some patients talked about the impact of having any of the CRFs on their lives. 
The accounts of this group of patients indicated that they undervalued the seriousness of having 
CRFs and perceived them as normal or common conditions. Further analysis of the responses of 
these patients showed that downplaying risk was engendered by two main factors: the high 
prevalence of MetS features in the UAE and the treatability of CRFs. 
Some patients believed that diabetes was a 'common' disease that was highly manifested in the 
residents of the UAE. As such, viewing diabetes and other CRFs as common illnesses minimised 
their seriousness. For example, when patient 6 was asked to explain why he did not view 
diabetes as an illness, he indicated that the high prevalence of diabetes in the UAE made 
diabetes a normal condition that many in the UAE were diagnosed with (see box 1). In the 
following extract he explained his view point towards being diabetic and hypertensive. 
P. I don't have any health problem. Thank God I am ok. 
R: Why do you think you don't have a health problem? You just told me you had diabetes and 
pressure? 
P: Yes, it's just diabetes and pressure. 
R: And you don't see these as diseases? 
P. I see diabetes as a common thing, you know? It is normal nowadays to have diabetes. Look 
around you. 35% to 45% of the population here have diabetes. So why should one worry? Really. 
R: So you are not worried about your diabetes and blood pressure... 
P. I take my medicines, I eat right foods. When you do the right thing, you should not worry. 
Patient 6, man, 65 yrs, Yemeni 
The above interview extract illustrates that the commonplace of diabetes in the UAE facilitated 
this patient's sense of the normalness of having such condition. Although patient 6 
acknowledged his diagnosis and the need to adhere to treatment to control his diabetes, the fact 
that diabetes was highly prevalent in the UAE reduced its seriousness in his point of view. 
Another example was found in an interview with patient 20 who viewed having diabetes or high 
blood pressure as having a headache. He believed that such diseases were the 'by-product' of 
civilisation. 
R: How do you feel about having these health problems? 
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P: Of course, I will not be happy to be sick [laughing]. Maybe in the beginning you get shocked to 
know that your blood pressure is high and nothing works in your body. You get afraid at the 
beginning you know? Because people tell you diabetes is dangerous, you will die, you know? but 
then you discover that you can live with it, you know? And today having diabetes or blood 
pressure is like having headache [laughing] 
R: Really?... 
P: Yes. I'll tell you. In this century, everyone has elevated sugars or high blood pressure. In the 
past people used to make a huge deal about headaches. But then they started taking Panadol® 
and they stopped complaining. It's no difference with diabetes and pressure because there are 
tablets for those too. If you take them you'll be ok 
Patient 20, man, 37 yrs, Emirati 
Patient 20 continued to explain that the urbanisation of the UAE has introduced the society to 
new unhealthy life styles that resulted in the manifestation of diseases such as obesity and 
diabetes. However, the availability of treatment to control or manage such CRFs made them less 
dangerous. The following extract from patient 20 explains this point: 
We used to live simple lives in the past. We ate fish and dates. Everything was simple and 
healthy. There were no Kentucky [KFC®] or McDonald's®. You ate fresh food and drank clean 
water you know? Now everything is in cans and plastic bags and has preservatives and this is 
what is causing all these illnesses [... ] with every new disease comes new drugs, new disease 
new drugs, and like that you know? 
Patient 20, man, 37 yrs, Emirati 
Similar to the previous example, patient 14 believed that every century was marked with an 
illness indicating that obesity, diabetes, and elevated blood pressure are the illnesses of the 21' 
century. 
Obesity is the illnesses of the modern days. In the past, it was the measles or the cholera. Now it 
is obesity [ 
... 
] it is the by-product of civilisation and technology. And that's life. So we shouldn't 
worry because 10 years from now it'll be a thing of the past and they'll find something new to 
scare people with. 
Patient 14, man, 73 yrs, Sudanese 
As the above extracts illustrates, some patients downplayed the risk of having CRFs as they 
attached attributes such as commonality, manageability, and temporariness to their presented 
diseases. For example, because diabetes had high prevalence in the UAE it was compared to 
other highly common illnesses such as having a headache, which was not perceived as a life- 
threatening condition. In addition, the availability of treatment rendered CRFs manageable and 
thus less serious than diseases that have a complex therapeutic treatment such as cancer. 
Another factor for the downplaying of perceived risk is that such CRFs are contemporary 
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disorders that are receiving a significant amount of attention but that but will wane with time as 
other new diseases are discovered. 
Unlike study participants who understated diabetes risk because of its high prevalence in the 
UAE, as presented in the previous section, another group of patients tended to rank the risk of 
the individual CRFs. This group of patients felt that diabetes held the highest health hazard when 
compared to other CRFs. This attitude can explain these patients' constant referral to diabetes 
rather than all their CRFs during interviews. For example, patient 21, who was diagnosed with all 
the features of MetS, felt that diabetes posed a higher risk compared to the other CRFs. The 
following quote illustrates this point 
R: Talk to me about your conditions. What do you feel about having all these health problems 
you have just mentioned? 
P: I don't complain. I am happy really. You know? What can you do? If you think about it 
diabetes is a plague from God sent upon the people living in the Emirates [laughing] it is a 
plague believe me. You look around you and everyone you see has diabetes. On TV, they always 
talk about how widespread it is and that everyone has diabetes. It is unbelievable. The worst 
thing of all diseases is diabetes and it is what everyone here seems to have. 
Patient 21, woman, 49 yrs, Emirati 
Although patient 21 was asked to describe how she felt about all her health problem, it was clear 
during the interview that she was mainly concerned with diabetes and continued to refer to it 
throughout the interview whenever she talked about different aspects of living with or managing 
her diseases. She also talked about other members of her family and some of her friends who 
also were diagnosed with diabetes. 
This attitude was also evident in patients who were not diabetic as their accounts indicated that 
they viewed diabetes as a more serious illness that they were grateful for not having. For 
example, patient 2 who was not diagnosed with diabetes, believed that developing diabetes 
marked a higher level of a health alert. In the following extract, patient 2 was explaining why he 
was not worried about his health. 
R: And how does that [having elevated blood pressure] make you feel? 
P: I'm ok. I don't think there is anything wrong with me it's just blood pressure. I mean I don't 
think / am as serious as someone who has diabetes and take 20 tablets per day, you know? If 
you have diabetes you have crossed the red line and you should be really careful. My doctor told 
me that I have high blood sugars but I am not yet diabetic so I have not crossed the red line yet. 
still have a chance thanks to Allah [laughing]. 
Patient 2, man, 32 yrs, Emirati 
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Patient 2 had an elevated blood glucose level but was not diagnosed with diabetes and was not 
taking medicines for prediabetes. His account was similar to a number of patients who were not 
diabetic. These feelings were engendered by their belief that diabetes was a more serious and 
risky condition than the other CRFs they were diagnosed with. Not having diabetes despite 
having other cardiac diseases created a sense of relief in some patients, which was apparent in 
their accounts as they talked about the list of their presenting CRFs. Health information that 
highlight the prevalence of diabetes, its risk and associated complications might have enhanced 
patients' perception of diabetes risk superiority when compared to other CRFs. 
The accounts of all patients indicated their awareness of a risk associated with their present 
CRFs. Although patients' attitudes towards MetS risk ranged between downplaying, grading or 
being concerned about developing complications, these attitudes indicated that they 
acknowledged some type of risk attached to having any of these CRFs. Patients' realisation of 
the potential risk associated with such diseases triggered their adherence to their prescribed 
treatment as illustrated in previous interview extracts. However, only one patient [patient 1, 
man, 45 yrs, British] in this study claimed to have a 'carefree' attitude towards his treatment 
plan because he did not 'grasp the seriousness' of his condition. In the following extract, patient 
1 explains reasons for his poor adherence: 
R: So even when your medicines are available you will still forget to take them? 
P: Yes. I mean my problem is.. Like today I forgot to [take my medicine] and I'm very.. a bit 
relaxed in thinking because of my lifestyle and my health condition. I really don't grasp the 
severity of it, and I am very care free so I don't realize the risk that what one day missing one 
tablet would do. Yes I am very carefree. 
Patient 1, man, 45 yrs, British 
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A case illustration of patient 1 is presented in box 3. 
Box 3: Patient 1 
Patient 1 was a 45-year old Scottish man who had lived in the UAE for the last 18 years. He worked 
nightshifts as an entertainer in one of Abu Dhabi's hotels. The interview took place in SKMC outpatient 
clinic. He attended the interview with his wife because she looked after his medicines and he believed 
that she could help him answer questions regarding his treatment. He has had high blood pressure for 
about 12 years. He was overweight but said that he had been slim until 16 years ago. He had a family 
history of high blood pressure but there was only mild diabetes in his family; therefore, he believed 
that the cause of his health problems were likely to be hereditary. 
When he talked about his medicines, I sensed that he was frustrated because he explained that despite 
taking 8 or 9 tablets a day his blood pressure was still uncontrolled. He stated that he struggled more 
with controlling his diet and exercising. The fact that he worked long night hours made it very difficult 
for him to have any routine for his diet and relied on the hotel restaurant that provided him with free 
meals that were not always healthy. He also felt that his wife did not help as she prepared lots of sweet 
food for him when he got home late at night. He was not interested in joining the gym and described 
gym equipments as dinosaurs that he could not relate to. He lacked motivation and said that he needed 
'someone to grab' him and take him to exercise for him to 'actually do it'. However, he believed that 
his 'carefree' attitude was because he did not 'grasp the seriousness' of his condition. He did not like 
the attitude of his doctor who never asked him about his work circumstances or showed concerns 
about his emotions and how much he struggled with dieting and exercising. He felt that his doctor 
cared more about his lab results and was 'all about figures and numbers'. He believed that if she talked 
to him like he was talking to me during the interview and listened to his concerns she would have been 
able to tailor his treatment to meet his needs. He, therefore, felt hopeless because his doctor could not 
help him to control his blood pressure. 
It was difficult, after meeting patient 1, to determine the main factors that resulted in the 
suboptimal control of his CRFs since, as his story in box 3 illustrates, there were many other 
issues in his life that affected his adherence to his prescribed medicines. Although he admitted 
that his inability to grasp the seriousness of having all the CRFs he was diagnosed with 
contributed to his failure to comply with the needs of his therapeutic management, he 
contradicted this statement when, in another part of the interview, he admitted his awareness 
of the consequential complications of failure to control his CRFs. These contradicting accounts 
of patient 1 could suggest that 'grasping' the seriousness of an illness encompasses far more 
than being 'informed' of risk to include different aspects, such as patients' perceptions, 
reasoning, judgment and how much preventing risk fit into the social context and patients' 
everyday life. Patients 1 had different social limitations that might have overshadowed his 
attempts to comply to his treatment despite his awareness of the potential risk of poor 
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adherence. The word 'grasping' that patient 1 used to describe reasons for his 'carefree' attitude 
could have implied that his perceptions of this risk was still in a level that was weaker to combat 
all the barriers to adherence and trigger behaviour change towards his health condition. 
This section illustrates the range of attitudes that patients in this study had towards the 
seriousness of MetS features. These attitudes included being concerned about developing 
cardiac and non-cardiac complications, downplaying risk and grading risk. Patients' accounts 
indicated that many factors influenced their perceptions of risk, such as health information they 
received from their physicians, health educators, friends, the mass media and through observing 
the experiences of others. However, and as was also presented through the story of patient 1, 
patients' awareness of risk might not always guarantee a positive change in health behaviour 
and better adherence to treatment as there are many contextual and emotional factors that play 
a significant role in determining patients' attitudes towards their treatment. More data about 
factors influencing patients' attitude towards lifestyle and medicine interventions are available 
in chapters 5 and 6, respectively. 
The next section will present data describing patients' fatalistic attitude towards acquiring MetS 
features. 
4.2.3 Patients' fatalistic attitude towards MetS 
In this study, fatalism was characterised by patients' perception of CRFs as inevitable conditions 
that they predicted and awaited to be diagnosed with. The fatalistic attitude of some patients 
when describing causes of CRFs or failure to control them was evident as they used some 
fatalistic statements to indicate inability to counteract or combat elevation of blood pressure or 
blood sugar. The genetic predisposing factor to some of MetS features and the impact of leading 
a stressful lifestyle on developing CRFs made some patients feel that acquiring any of the CRFs or 
inability to control them was beyond their control regardless of their efforts to prevent such 
diseases. This section presents these views. 
The accounts of some patients showed that fatalistic statements occurred as they talked about 
their family history of CRFs to explain reasons for acquiring their cardiometabolic disorders. Such 
accounts indicated that they forecasted their diagnosis with some or all of MetS features 
because another family member had that diagnosis. For example, when patient 29 was asked 
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about the causes of her condition she talked about the family history of diabetes and heart 
problems. 
R: Do you know the causes of your condition? 
P: It's hereditary, my mother has (diabetes), my father died because of heart problems, and now 
my kids are overweight, we eat a lot because we inherited a strong appetite for food. We all love 
food and if we are not careful the kids will end up diabetic as well. 
R: Yes.. 
P: You, whatever you do, you have it in your blood. You know that one day you will have it 
(diabetes). You are always at that risk and you try to delay it but it is waiting for you. 
Patient 29, woman, 34 yrs, Emirati 
Patient 29, later on during the interview, gave examples of different strategies that she used to 
prevent the development of diabetes, such as dieting, exercising and using sweeteners instead 
of sugar in her tea. However, she believed that regardless of all her attempts she ended up 
developing diabetes. As can be seen in the previous extract, patient 29 also blamed excessive 
consumption of food on family history. Another example was found in the interview of patient 5 
who indicated that he predicted being diagnosed with diabetes because other members in his 
family were also diabetic. In the following quote, he stated this point when he described the 
events that led to his diagnosis. 
R: When were you diagnosed with diabetes? 
P: I was first diagnosed. I think. Maybe 10 to 12 years ago. But before I was diagnosed I knew it 
was a matter of time because I come from a family of heart problems. My younger brother 
recently was diagnosed with diabetes. So it runs in the family. 
R: And so did you get checked regularly for diabetes and blood pressure before you were 
diagnosed? 
P: No I would go to the doctor for other things. But you know here [in the company] we are told 
to have checkups every year, for blood and pressure and also urine samples. So the doctor of 
course when they see something not going well, they tell you. So they follow me. But I knew 
would be diabetic one day because of the family history and all that. You know. So I was not 
surprised. 
Patient 5, man, 50 yrs, Indian 
These statements and others bring to light that these patients believe that the genetic factor 
would defeat their personal control over health. Therefore, familial risk was perceived as an 
unavoidable factor that eventually resulted in acquiring any of MetS features. However, in other 
parts of the interview, patients tended to stress the importance of adhering to the treatment 
plan in order to control CRFs and minimise risk. For example, although patient 25 mentioned 
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family history as the cause of his diabetes and high blood pressure, he also emphasised the role 
of diet in controlling CRFs when he was talking about his treatment plan. 
R: What about the diet? Are you following a special diet? 
P: Yes. Diet is important. Very important. 
R: Why do you think it's important? 
P. You see it's your tummy that brings all the health problems. Whatever you eat has an impact 
on your health. Sitting and doing nothing instead of walking and playing sports is another cause 
for diabetes and obesity. So you need the exercise and you need the medicine to stay safe. 
Patient 25, man, 60 yrs, Egyptian 
Similarly, when patient 20 was asked about the causes for his uncontrolled diabetes, he 
acknowledged the importance of taking medicines and adjusting his lifestyle to improve his 
health condition. 
R: You told me that you take your medicines regularly and don't... 
P: Yes. yes. I do. I take them always. 
R: Do you think there is a reason why your diabetes is still uncontrolled although you take the 
medicines? 
P: I don't know.. but I think it's all to do with the body type. You how much you can fight it. 
R: How is that? Can you please explain more? 
P. You see it's (diabetes) hereditary, there is no question there, so maybe the type (of diabetes) I 
inherited is very strong you know? And will always be high. But maybe now I can minimise the 
problem by taking medicine and eating and exercising. Doing all I can to help myself feel better 
and keep it in control. But there will be times when it will still be high because this is how my 
diabetes is. 
Patient 20, man, 37, Emirati 
The abstract above illustrates the health uncertainty of patient 20. Although he expressed 
persistence in adhering to his treatment and still not controlling his diabetes, he then 
acknowledges that failure to control his blood sugars are beyond his control. Patient 20 again 
throws the blame at his genetic makeup that determined his 'type of body' and the 'type of 
diabetes' he has inherited to justify his failure to control his condition regardless of his 
adherence to treatment. 
Leading a stressful lifestyle was another factor that some patients believed was unavoidable and 
affected their health condition. Stressful and strenuous events in life were also blamed by some 
patients for hindering optimal control of their CRFs, despite adhering to their recommended 
treatment plan. Patients used the word 'stress', 'tension' and 'pressure' to describe the 
outcome of leading a hectic lifestyle, encountering strenuous events in life and dealing with daily 
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hassles. Such strenuous events included housework, stress at the workplace, domestic chores 
and other family-related issues. Some patients explained that being overloaded by 
responsibilities at home or at work caused psychological distress that eventually elevated their 
blood pressure or blood glucose levels. They also believed that stress was a powerful factor that 
overwhelmed the effect of their medicines. For example, patient 13, who worked in a private 
company as an administrator, believed that work pressure was responsible for his uncontrolled 
blood pressure. He also talked about other family responsibilities that contributed to the 
difficulty of controlling his blood pressure. 
R: You said that in your last clinic visit your blood pressure readings and cholesterol level were 
high? 
P: Yes, that's correct they were high. Both [blood pressure and cholesterol levels]. I had the 
blood test before but when I went to the clinic the doctor had the results. Everything was ok 
except for the cholesterol, a little bit high. That was last month. Yes. 
R: Why do you think your blood pressure and cholesterol were high? Is it the medicines? What 
did the doctor tell you? 
P: You know the problem is not my medicines. I take my medicines always. I mean even with 
that I still have high blood pressure sometimes. I think it is work pressure. I can say that the 
reason for my condition is work tension. If your life is tension free you won't have all these 
health problems. The kids and life responsibilities add to the stress and tension and that's why 
you develop pressure and diabetes and all the other stuff. 
Patient 13, man, 49 yrs, Bangladeshi 
Another example was patient 18 who also talked about the pressure and tension that resulted 
from being overloaded with domestic responsibilities. Based on her account, such factors were 
also responsible for preventing her from controlling her diet. Patient 18 indicated that stress 
caused her blood pressure and blood glucose to elevate even though she took her medicines as 
prescribed. She also found psychological comfort in eating and described her over-eating habit 
as an 'escape' from all the hassles she faced in life. 
P: The hospital gave me meters for my pressure and sugar. I use them always and document the 
readings. But they are usually high (laughing). 
R: Why is that do you think? 
P: Believe me I do everything I should. I tried eating healthy. I work at home and I don't stop 
moving, I take the kids to school, I cook the food so I must lose all the fat with all these things 
I'm doing. But no, nothing. But I think it is life and stress, you know? 
R: Can you explain please? 
P: You know, life problems will never go away and they are the main cause for my pressure and 
diabetes. It's all the pressure that affects you from inside you know? The kids, the husband. I 
mean everyone has a problem that causes stress, which eventually elevates your blood pressure, 
the blood sugars, and it even makes you eat more because you try to escape from all these 
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problems by eating (laughing). I mean I try to stick to a diet. But you can't with all this in your 
life. 
Patient 18, woman, 54 yrs, Sudanese 
As can be seen in the above extracts, patients believed that leading a stressful lifestyle or having 
strenuous circumstances in their everyday life were one of the main causes of their uncontrolled 
CRFs. Some patients also believed that stress was the cause of their CRFs despite their 
adherence to their medicines or lifestyle interventions. The overwhelming power of stress over 
health made sense to many patients with MetS who might have tried to find an explanation for 
their failure to control their health. 
Listening to some patients talking about the causes of their health condition, it became clear 
that their fatalistic statements were made as a way of making sense of their failure to achieve 
treatment goals despite their personal control and attempts to adhere to treatment regimens. 
These fatalistic statements did not indicate a neglectful attitude towards health but rather a 
pragmatic negotiation and explanation of power-differences. In that sense, patients' behaviours 
were not to be blamed for failure to prevent the development of MetS or control CRFs because 
they have done what was expected of them, such as, adhering to their treatment regimen. In 
their belief and from their experience, genetics and stressful lifestyle were beyond their control 
and therefore an overwhelming power that defeated biomedical rules. 
With this in mind the next section presents results that describe patients' strategies of coping 
and accepting their CRFs 
4.2.4 Coping with MetS features 
Having MetS means having three or more CRFs that require continuous follow-up, monitoring 
and adherence to lifestyle and pharmacological interventions. Therefore, coping with MetS 
features and the treatment requirements can sometimes be quite challenging. Coping is a 
response aimed at diminishing the physical, emotional and psychological burden that is linked to 
stressful life events and daily hassles (Lazarus and Folkman 1984). Addressing the ramifications 
of an illness can be a difficult and a lifelong process. Therefore, it was important in this study to 
explore the impact of living with multiple CRFs and identify patients' ways of coping with their 
health condition. The following sections describe two coping strategies that patients indicated as 
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they described the impact of having CRFs on their lives and the role of religion in managing MetS 
features. These two elicited strategies were feeling normal and religious practices. 
4.2.4.1 Feeling normal 
Many patients in this study said that they felt 'normal' when they were asked to describe the 
impact of having multiple CRFs on their lives. Patients usually explained that such diseases did 
not cause significant change to their routine daily lives or their families. Despite having chronic 
cardiometabolic disorders that required taking medicines on a daily basis and adjusting their 
diet, patients felt that they were still able to maintain living the way they used to before 
developing these illnesses. In their opinion, implementing lifestyle changes and adhering to their 
prescribed medicines were an expected consequence to seeking management for their illnesses. 
They also believed that such treatment needs were achievable and did not alter their normal 
lives. The following extract is from the interview with patient 12 who explained this point: 
R: How did having diabetes and blood pressure affect you? You know, did it affect your life? 
P: No, not really. I don't think anything changed. I am not different. Nothing has changed in me 
or my life. I feel I'm normal. It is only these medicines that 1 need to take morning and evening 
but other than that I am who I am and I still live my life the way I used to. Nothing has changed 
and 1 feel normal. 
Patient 12, woman, 43 yrs, Palestinian 
Patient 12 talked at length about her family life. It was clear that her family and social life played 
a great role in her health. Although maintaining the same routine family life despite having CRFs 
made her feel normal, she also admitted that this same family life, with its obligations, was the 
source of stress that prevented her from controlling her blood pressure. As such, family life and 
domestic responsibilities had a dual role in patients' attitudes towards health, reinforced their 
sense of normal being and at the same time justified their inability to achieve optimal control of 
their CRFs (see section 4.2.3). 
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Box 4 contains a case illustration of patient 12 that illustrates her health concerns that affected 
her health behaviour and management of her clustering CRFs. 
Box 4: Patient 12 
Patients 12 was a 43-year old Syrian housewife who lived with her husband and seven children. From 
the beginning of the interview she was keen to ask me about starting insulin and whether it was the 
best treatment for her since she is failing to control her blood sugars. I met her at her home in Abu 
Dhabi where she served me some drinks, sweets and homemade pastry. She promised that she 
followed the diet instructions of her dietician and that she only bought the sweets and made the pastry 
because I was visiting her on that day. She also pointed at her treadmill where she had it displayed in 
the living room and told me that she used it for half an hour every day. However, she felt that despite 
taking her medicines on time and improving her lifestyle, her blood sugars were always high. She was 
adamant that the reason behind her uncontrolled diabetes was the stressful life she was leading 
'everyone is demanding in this house; the kids and my husband. They drive me crazy'. I could sense 
during the interview that there were many issues in the family life of patient 12 that seemed to annoy 
her. She believed that family affairs were a strong factor that affected her health. She was also worried 
about her husband who suddenly stopped taking his medicines. He had diabetes and elevated blood 
pressure for 11 years but 'suddenly decided that he had enough of all the drugs he was taking'. She was 
concerned that his health will deteriorate and indicated that that added to her agony and worsened 
her health condition. 
Despite all the stressful events that patient 12 talked about during the interview, she stated that she 
'felt normal' and that having diabetes and elevated blood pressure did not change her life. In her 
perception she felt that having the same day-to-day issues and concerns such as cleaning the house 
and attending to her husband's and kids needs meant that her health condition had little impact on her 
life and the lives of her family members 'they [husband and kids] are the same, they don't pay 
attention to my condition they still want the same attention and care from me. Nothing has changed'. 
She kept all her medicines in a bag and had an A4 paper where she glued pieces of all her medicines' 
packs that displayed the trade names of these medicines. She told me that she always carried this 
paper in her bag to remind herself of what she was taking when visiting new doctors. She took her 
medicines because she was scared that she might develop renal failure or heart problems. She 
indicated that she had a good relationship with her current physician and took her advice on using 
traditional remedies or bloodletting to which her physicians did not object. She was, however, 
disappointed with the new health insurance scheme and felt that it added to patients' burden, 
especially because not all medicines were covered by the scheme and an approval was always needed 
from the insurance company before the initiation of any blood test or X-ray. 
Maintaining a normal life with its usual daily hassles and hectic events despite having CRFs was 
described in other interviews as a 'good distraction' that prevented patients from over worrying 
about their diseases. Competing demands such as childcare and household tasks distracted this 
group of patients from giving their full attention to their health condition. According to their 
accounts, being busy with everyday activities facilitated coping with their illnesses. In the 
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following example, patient 12 believed that being overwhelmed with domestic chores diverted 
her attention from her health and enabled her to cope better with her diseases: 
My condition did not affect my family's life at all. They still have the some needs that require my 
full attention. lt didn't affect them at all [laughing] so many things in life need your focus and 
attention and this is a good distraction because you don't want to be reminded constantly of 
what you have 
Patient 12, woman, 43 yrs, Palestinian 
Again, this example illustrates how domestic life and competing demands had two contrasting 
roles when it came to patients' attitudes towards their health. While hectic life caused stress 
that resulted in patients' failure to control CRFs (see section 4.2.3), they also seemed to help 
patients cope with these diseases by distracting their attention from overstressing about having 
CRFs. Another example that illustrate the role of competing demands in patients' ability to cope 
with illness was in the interview of patient 23 who indicated that his children's needs distracted 
his attention from his health condition. 
R: Did having all these health problems [diabetes, high blood pressure, elevated lipid profile and 
obesity] affect you or your life? Did it have an impact on you or your family for example? 
P: No, not really. Everything is as it is. Everything is normal. 
R: And why do you think it did not change anything? Can you say more please? 
P: I mean the diseases didn't change my life much. I still worry about the kids who need help in 
their studies. It is these issues that take over, and you don't pay attention to your health. Life 
goes on like they say and nothing around you changes. 
R: What about the people around you? Your family for example? Where they affected by your 
health condition for example? 
P: No. no. Why would it affect them? (laughing) no.. I mean they care about me of course. But I 
mean they are not affected by it or anything thank God. 
Patient 23, man, 55 yrs, Emirati 
In other interviews, it was apparent that patients' feeling of being normal was engendered by 
the asymptomatic nature of MetS features. The asymptomatic nature of MetS features meant 
that patients live with physically unnoticeable CRFs. In the absence of excruciating or hindering 
symptoms, patients were not conscious of their CRFs and carried on living their lives as they did 
before the diagnosis. As previously illustrated in section 4.2.2, patient 6 understated the risk of 
having diabetes because of the high prevalence of CRFs in the UAE. In his account, he also 
indicated that he defined illness through its physical signs and the severity of its impact on an 
individual's quality of living, such as, the ability to walk, see, and perform. The following quote 
from his interview illustrates this point: 
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In my opinion, illness is something that hinders you, something that stops you from living your 
life. Like paralysis and losing your sight. In my case, I have nothing like that. My illness does not 
do that to me, so I feel ok and normal. 
Patient 6, man, 65 yrs, Yemeni 
The fact that MetS features did not have physical or strenuous attributes enabled patient 6 to 
continue living and engage in his normal daily chores without a constant reminder of his illness 
or being confined by a disability. As such, patient 6 was able to retain his normal self even in the 
presence of chronic diseases, such as CRFs. 
What further clarified this analysis were the accounts of other patients who were more alert to, 
and annoyed by, other symptomatic coexisting conditions when they talked about the impact of 
their health problems on their lives. In such interviews, physical conditions such as knee and 
back pain, dermatitis, gastrointestinal problems and other symptomatic conditions were 
perceived as life-changing conditions more than CRFs. For example, when patient 15 was asked 
to talk about the impact of having a number of CRFs on her life she indicated that she was more 
concerned with the pain in her legs than her diabetes. Diabetes did not have noticeable 
symptoms and was, therefore, tolerable. On the other hand, the pain in her legs was unbearable 
and as such had a more significant impact on her life than did having diabetes. The following 
extract from her interview illustrates this point. 
R: can you please talk to me about your condition? 
P: Thanks to God everything is ok. 
R: Thanks to God. And your blood pressure and diabetes.. are they controlled well? 
P: Yes, everything is well. Thanks to God. 
R: Ok.. Can you talk to me about how, you know, how having these problems [diabetes, blood 
pressure, high lipid levels and obesity] affect you.. Your life for example? 
P. I am used to it now, I don't think about it and I don't pay it attention. It's the pain in my legs 
that is really bothering me, otherwise everything has become part of the norm because you get 
used to it after a while and you don't notice it anymore 
Patient 15, woman, 55 yrs, Yemeni 
The accounts from the interview of patient 15 illustrated how much she was concerned about 
her leg and lower back pain. During the interview it was clear how significant the impact of these 
two strenuous health conditions were on her daily life. Although she was diagnosed with all 
MetS features, they were lightly mentioned throughout the interview. A summary of her 
interview is provided in box 5. 
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Box 5: Patient 15 
Patient 15 was a 55-year old Yemeni widow who lived with her three daughters and married son. When 
I met for the interview, she insisted that her daughter attended the interview. She sometimes asked 
her daughters to confirm some of her answers when I asked for more details. Her medical file indicated 
that she had all of the MetS features. However, during the interview it was apparent that she was 
mainly concerned with the pain in her legs. She also talked about her back pain and believed that her 
doctor could not treat this problem well because she still suffered from the pain despite taking the 
prescribed painkiller. When I asked her about her diabetes, high blood pressure and weight problem, 
she indicated that they were all well-managed but that it was the pain in her legs that she could not 
tolerate because it prevented her from sleeping. She expressed the pain in her body by saying: 'my 
daughter, it feels like stabbing in my back' and gestured with her fist indicating a stabbing motion. 
She felt that her physician failed to treat her leg problem because she did not listen to her needs and 
did not answer her questions. She said that the medicine prescribed for her leg and back pain did not 
work and that the physician refused to believe her when she brought that to her attention. When I 
asked her about the treatment plan for her CRFs, she reported that she had no problem with adhering 
to her medicines. However, her daughter insisted that she had difficulty sticking to the healthy diet 
recommended by her dietician. The daughter also stressed that her mother was 'stubborn' and 'did not 
care for her health and exhausted herself by taking care of her grandchildren and standing in the 
kitchen for long hours' which caused her leg and back pain. When I asked patient 15 to talk about the 
issues that would help improve her condition, she once again mentioned her leg pain and indicated 
that solving this problem would make her feel better. 
The next section describes the role of religious practices in coping with illness. This factor was 
elicited when patients were asked to talk about the role of their religious beliefs in the 
management of their CRFs. 
4.2.4.2 Religious beliefs 
The second method of coping with having multiple CRFs was through religious practices. The 
impact of religion on patients' ability to cope was evident as some patients talked about the role 
of their faith on the management of their CRFs. Previous qualitative studies on different patient 
groups living in the UAE found that religious beliefs influenced patients' perception of their 
health (Ypinazar and Margolis 2006; Winslow and Honein 2007). Therefore, it was important in 
this study to examine the influence of participants' religious beliefs on their perceptions of their 
health condition and their attitude towards their treatment plan. During the interviews, patients 
were asked to talk about the role of religion in their health and whether they believed that their 
faith had an impact on the therapeutic outcome of their CRFs. The responses of some patients 
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indicated that religion served as a calming tool that helped them accept their health conditions 
and eventually cope with it. For example, when patient 14 was asked about the impact of his 
religion on his health he praised a strong faith and believed that it provided him with inner 
strength and tranquillity when dealing and living with MetS. 
R: Can you talk to me about the role of religion in your health? 
P: Well.. having a strong faith is a great thing. 
R: How is that.. I mean can you explain please? 
P: Well.. for example.. When you are sick. When you are in a good relationship with God you feel 
peace and tranquillity. When you know you are with God you gain strength and that helps you 
cope with hardship and illness. 
Patient 14, man, 73 yrs, Sudanese 
The role of faith in illness, as patient 14 described it, was gaining strength from knowing that you 
are under the control of 'God' or a powerful entity. This realisation provided patient 14 with the 
reassurance and the strength to withstand 'hardship and illness'. Another group of patients 
claimed that the calming effect of religion lies within religious practices, such as reading the 
Qur'an or praying. Patients 21 and 29 explained how such rituals helped them cope with their 
illness. Their statements came after they were asked how they believed religion contributed to 
the management of their CRFs. 
Reading the Qur'an and praying does not improve my condition in the medical sense but it 
relaxes me and it fixes my mood. This brings me relief from all stressors and joy like no other 
thing. 
Patient 21, woman, 49 yrs, Emirati 
Diabetes will always be with you but with praying you feel a psychological comfort which 
relieves some of what you are going through. Your mind becomes clear, your heart becomes 
light and you stop worrying. 
Patient 29, woman, 34 yrs, Emirati 
As the above quotes illustrate, religious practices were not perceived as disease curing tools or 
methods that had a direct impact on health. Religious practices as described by patients 21 and 
29 served as tranquillity and stress-relieving facilitators that indirectly helped patients cope with 
illness. Another group of participants in this study believed that illness was a 'test from God' 
for their 'patience and gratitude'. Participants in this sense felt a responsibility towards their 
health and an obligation to accept, cope and adhere to treatment. The following quotes of 
patients 19 and 24 explain this point. 
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Sometimes I say this [illness] is a test from Allah and I'll be reworded for my patience. You just 
have to be patient, take your medicine, rely on Allah and hope for the best. 
Patient 24, woman, 46 yrs, Emirati 
I always say thanks to Allah. There will always be good things as well as bad things in everyone's 
life and illness is one of the bad things. But you have to persevere and be strong because it is a 
test from Allah to test your patience and gratitude. 
Patient 19, man, 67 yrs, Emirati 
A majority of participants in this study shared parallel views about the role of God in health and 
illness that helped them cope with and accept the lifelong management of MetS. 
I have this condition [Mets] and I have to live with it because there is no other choice. You 
cannot run away and so you need to accept it and deal with it. And you don't lose hope along 
the way, because you know that everything is in Allah's hands. 
Patient 8, woman, 52 yrs, Iranian 
I have come to the realisation that this is my life and this is how I should live it [adhering to a 
lifelong treatment] and I have accepted it and I'm happy. These diseases (CRFs] will never go 
away. I will always need to take these tablets to survive and I have accepted that. You trust that 
Allah chose the best for you and so if this is what he chose for me then let it be. 
Patient 22, woman, 52 yrs, Emirati 
Perceiving illness as a test from God might have encouraged some patients to accept it as a way 
of showing obedience and submission to the will of their creator. Viewing bodies as gifts from 
God might have also engendered a sense of ownership and responsibility towards preserving 
and protecting health. In addition, in some Islamic scripts, believers who treat hardship with 
patience, tolerance and acceptance are promised spiritual benefits for their physical suffering 
(Adib 2004). This was always apparent in most interviews, as patients would usually narrate 
sublimations or words indicating gratitude and appreciations for God's will every time they 
talked about a management setback, such as 'I take ten types of medicines, but thank God for 
everything' or 'I have diabetes and pressure, but thank God, I'm coping well'. Patients might 
have been inclined to accept illness and demonstrate ownership of their bodies by protecting 
them from harm as a way of showing gratitude and appreciation of their creator. 
As the previous quotes on the role of religion in the management of MetS features show, 
religion and religious practices functioned as facilitators to coping with illness in providing 
tranquillity, calmness, motivating patients to cope and accept. Patients' feeling that they were 
under the protections of a God or a greater power facilitated a sense of reassurance and 
support. In addition, perceiving bodies as gifts might have also generated a sense of ownership 
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and empowerment, which might have enabled patients to accept illness and then accept the 
management needs to improve the conditions of their bodies. 
In this study, there were two main strategies for coping with MetS features, which were feeling 
normal and religious practices. However, as explained earlier, participants' fatalistic talk and 
attempts to understate MetS risk could have been used to indirectly communicate patients' 
other strategies of coping with MetS as reported in available research (Scrandis 2005; Keeley, 
Wright et al. 2009). Downplaying the seriousness of an illness might have been patients' 
attempts to perceive disease with a more positive light. Patients' fatalistic talk that indicated 
power differences and the limitations of their personal control over their health might have 
been patients' attempts to avoid self-blame and feelings of guilt for failure to control CRFs or 
prevent illness. Although such fatalistic statements were made as patients were talking about 
the cause of their illness, they might have still served as a way of reaching acceptance and 
coping with the ramifications of having multiple CRFs. 
As illustrated in this section, there were many factors that influenced patients' perceptions of 
the features of MetS. Such factors were elicited as this group of patients talked about their 
illness, how it affected their lives, their causes and methods of coping. Patients' perceptions of 
MetS may influence their willingness to adhere to MetS treatment plan. Therefore, 
understanding such factors can help HCPs understand factors that shape patients interpretations 
of their disease, seriousness and causes. 
The following section illustrates themes that described factors influencing HCPs' perception of 
MetS and how their perception influenced the clinical implication of the MetS definition. 
4.3 Professional perceptions of MetS 
HCPs' perception of MetS is an important indicator of their attitudes towards utilising MetS 
diagnostic criteria to identify patients at high risk of developing CVDs or diabetes when not 
diabetic. Although the UAE acknowledges the importance of preventing and managing MetS as a 
separate condition, professional opinion of the value of MetS in clinical practice can be swayed 
by ongoing reports about the controversy surrounding MetS (Suppes, McElroy et al. 2007; 
Hughes 2010). Thus, it was important in this study to explore HCPs' perceptions of MetS in the 
UAE. Professional perceptions of MetS were influenced by three main factors, as interview data 
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analysis revealed. Those factors were: (i) awareness of MetS, (ii) authenticity of MetS, and (iii) 
MetS clinical utility. 
4.3.1 Awareness of the MetS concept 
One main finding in this study was that interviewed HCPs did not have equal levels of awareness 
about the MetS definition. For example, physicians were able to articulate their perception of 
MetS better and more knowledgably than did other HCPs. This could be attributed to physicians' 
higher exposure to MetS information through weekly meetings and workshops, as well as to 
patients who fit into the MetS definition. In the following extract, physician 4 who worked in 
SKMC outpatient clinics describes the high manifestation of MetS cases in the clinic as well as 
the efforts made to keep updated with literature about MetS: 
R: From your experience, how significant is the MetS problem here in the UAE? 
Physician: Metabolic syndrome is an important thing and it is something that we talk about 
here. Unfortunately, l don't think there are statistics that show us how wide spread it is here but 
we see many metabolic syndrome cases every day. It's a huge problem in the UAE [ 
... 
]. There has 
been a lot of research around metabolic syndrome in the past few years [ 
... 
] here in the family 
medicine clinics we have weekly seminars where we sometimes talk about this big problem. 
Physician 4, woman, Jordanian 
Working as physicians in outpatient clinics as well as primary care clinics exposed general 
physicians to cases as well as to updated information about the MetS concept and management 
needs. This might explain physicians' ability to show greater knowledge about the MetS concept, 
the manifestation of this health problem in the UAE and patients' treatment needs based on 
their clinical experience. On the other hand, only a few pharmacists had similar levels of 
awareness about the MetS concept. Pharmacists with specialist degrees such as clinical 
pharmacy or other postgraduate degrees were aware of the MetS definition prior to 
participating in the study. For example, pharmacist 7, who was a clinical pharmacist, talked in 
detail about the health needs of patients with MetS. Her account, as she talked about the 
potential role of pharmacists in the management and prevention of MetS, indicated that she was 
aware of the different MetS definitions. 
You know, pharmacists can easily use the MetS definition in their daily practice. All we need is a 
measuring tape. We can scan patients prescription for medicines used for hypertension and 
diabetes and dyslipidaemia. And even if a measuring tape is not available or the pharmacist felt 
uneasy about asking the patient to have his waist measured. we can just look at the patients' 
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waist and decide. You know? I even don't need that (measuring patients' waist-circumference] 
because if I'm using the America Heart Association definition we just need any three factors. You 
know pharmacists can actually be very effective in dealing with this issue [identifying patients 
with MetS]. 
Pharmacist 7, woman, Emirati 
Other pharmacists, mainly those in charge of non-clinical tasks, admitted that their first 
encounter with the MetS definition was through the information provided in the study 
information sheet. Pharmacist 10 explained in the following extract how she learned about MetS 
when she decided to take part in the study. In her interview, I asked her whether she knew 
about the MetS concept before taking part in the study. My question came because of previous 
cases where pharmacists admitted their limited awareness of the syndrome. 
R: Did you know about the MetS before the interview? 
Pharmacist: No, not really. I think when I read the information sheet you emailed me I 
understood what MetS was. But I initially linked it to obesity. I saw the word metabolism and 
thought that it must be a disease that slows down the rate of metabolism and makes you gain 
weight [laughing]. 
Pharmacist 10, woman, Emirati 
A number of pharmacists interviewed, especially during the focus group, indicated that their 
work responsibilities were confined to dispensing and drug supply, which limited their exposure 
to clinical practice and therapeutic management of illnesses such as MetS. During the focus 
group discussion, pharmacist 12 explained that pharmacists' lack of awareness about MetS was 
because of their limited clinical role. 
We don't do rounds, we don't do rounds alongside doctors, and we don't attend their 
workshops. We are not really involved in the clinical management of these patients [patients 
with MetS]. That is why we are not always updated or aware of something like metabolic 
syndrome. 
Pharmacist 12, man, Syrian 
Other pharmacists who were not familiar with the concept of the MetS indicated that they were 
familiar with the therapeutic needs of patients with the MetS features and were, therefore, 
capable of providing help and advice to this group of patients. They explained that they only 
lacked information on the MetS concept. During the focus group discussion, pharmacist 19 
illustrated this point in the following quote. 
Maybe we are not familiar with the metabolic syndrome, you know? That's true. but every day 
we deal with patients that are diabetic, hypertensive, taking statins, you know. We see this 
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group of patients every day and they are probably two-thirds of the patients here. But we are 
not informed of new things [diseases]. we need this kind of information so that we can see the 
bigger picture of what we are dealing with. 
Pharmacist 19, woman, Jordanian 
As it became clear from early interviews that not all HCPs were familiar with MetS, dieticians, 
pharmacists and health educators were asked if they were aware of the MetS concept at the 
beginning of each interview. Although dieticians and health educators claimed to be aware of 
the MetS concept during interviews, they were not always able to accurately define MetS or list 
all CRFs that contribute to MetS diagnosis. Instead, they abridged the MetS to obesity and 
diabetes only. For example, when dietician 4 [woman, Emirati] was asked about her perception 
of the MetS health problem she referred entirely to obesity. 
R: Were you aware of MetS before I gave you the information sheet? 
Dietician: Yes. Yes of course. 
R: And what are your views about it? 
Dietician: It's a huge problem here. I mean there are many obese patients here and we get 
referrals from all the clinics. It's a serious thing, although people might not be aware that 
obesity is the root for diabetes and heart problems and that it can also kill them. 
Dietician 4, woman, Emirati 
HCPs of different specialties, such as pharmacists, dieticians and health educators, provide care 
and advice for patients with MetS features on a regular basis. It is therefore vital that they also 
be alert to and knowledgeable about the MetS definition, risk and management needs. In this 
study, a group of pharmacists were not aware of the MetS definition prior to their participation 
in the study. Physicians in this study had a general tendency to refer to diabetes or obesity 
rather than the clustering of CRFs when addressing MetS health-related issues during interviews 
despite their awareness of the MetS definition. This could be attributed to the fact that most 
patients with MetS might have been identified after the establishment of diabetes. Obesity or a 
BMI > 30 kg/m2 is a prerequisite for the diagnosis of MetS according to the IDF definition 
(Alberti, Zimmet et al. 2006). This could explain why most physicians referred to obesity rather 
than the clustering of CRFs during interviews. 
Data concerning professional perceptions of MetS were mostly generated during interviews 
conducted with physicians. Data analysis identified two central themes concerning professional 
perceptions of MetS: (i) authenticity of MetS, and (ii) clinical utility of the MetS definition. The 
following sections describe these themes. 
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4.3.2 Authenticity of the MetS concept 
Participants' perceptions of MetS 
All HCPs, at the start of all interviews, were asked about their perception of MetS as a condition 
in its own right. The majority of participants, especially physicians, described MetS as a real 
condition that is highly manifested in the UAE. Participants' belief in the genuineness of MetS 
was prompted by three main factors: (i) their awareness of the literature on MetS, (i) identifying 
a high number of MetS cases during their clinical practice, and (iii) the reported high prevalence 
of MetS in young adults and children in the UAE. Physician 7 describes how MetS gains its 
legitimacy from the high manifestation of MetS cases in patients visiting his practice. Physician 2, 
on the other hand, talks about literature that supports the existence of MetS. 
R: Can you please talk to me about your views on the MetS? 
Physicians: It [MetS] is a big problem here in the UAE [the physician, talks about the prevalence 
in the UAE and factors influencing the prevalence] 
R: What about the controversy that surrounds the MetS? 
Physician: No. Actually there is no doubt in my mind that MetS exists. About 90% of patients 
that visit my clinic every day fall into the MetS definition. If you spend one day in this clinic I'll 
show you their files and you can judge by yourself. It's unbelievable how widespread it is in this 
country. MetS is a real condition and highly prevalent in the UAE. 
Physician 7, man, Egyptian 
R: What is your opinion on the controversy surrounding the MetS? 
Physicians: Yes. That is true. There were different opinions and disagreements on the MetS. In 
the beginning when the syndrome was first introduced by the WHO people where not confident 
about it. But in the last ten years, the literature became flooded with articles on the MetS. So we 
have no doubt now that it's a primary cause of heart diseases and diabetes. With all this 
scientific evidence no-one can argue about MetS anymore. 
Physician 2, man, Sudanese 
The high prevalence of MetS in young adults and children was another common topic amongst 
interviewed physicians. Such participants felt that the high number of younger patients fitting 
the MetS definition boosted MetS realness. Physician 4 talks about how her personal experience 
with MetS influenced her perception of MetS. 
We started seeing MetS amongst school children now. Two of my kids are obese and my friend's 
kids are obese. I'm scared because there is little I can do for them now except monitor their diet 
and push them to exercise. This makes it so real for me in particular. I strongly believe in MetS 
more than ever. 
Physician 4, woman, Jordanian 
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A few physicians expressed concerns about the controversy surrounding the MetS concept. Such 
participants were concerned with the disagreeable definitions and pathophysiology of the MetS. 
In their perception, having multiple diagnostic criteria for one condition confused clinicians and 
discouraged them from using any of the MetS definitions. Physician 8 illustrates this point in the 
following quote as he was talking about the controversy surrounding the MetS. 
One of the main concerns with this Syndrome is the many definitions it has like the IDF and the 
WHO. It can confuse doctors and make them doubt whether it exists or not. Why can't they just 
agree on one definition? This will make it more reliable. 
Physician 8, man, Iraqi 
The multiple definitions of MetS were believed to cause confusion and disagreement between 
physicians on the features that confirm a MetS diagnosis. Physician 8 gave an example of the IDF 
and WHO as two differing definitions of the MetS concept. For example, the IDF states that an 
individual with a BMI > 30 kg/m2 and another two CRFs meets the diagnostic criteria of the MetS 
(Alberti, Zimmet et al. 2006). The WHO definition of MetS, on the other hand, includes insulin 
resistance as a prerequisite for a confirmed MetS diagnosis (WHO 1999). 
Participants' statements about the differing definitions of MetS were made before the 
harmonisations of the MetS definitions in October 2009 (Alberti, Eckel et al. 2009). As can be 
understood from the account of physician 8, the MetS concept would be more reliable if an 
agreement on the MetS diagnostic criteria became available. Therefore, concerns about MetS 
legitimacy might have weakened if the harmonisation of the MetS definition was published 
before the study was conducted. 
Despite the variation between different MetS definitions that existed at the time of the study, 
physicians admitted that the elevated cardiovascular risk associated with the clustering of CRFs 
was alarming and called for the attention of the medical profession. Physician 6 explains in his 
quote why more focus should be directed towards the management and prevention of MetS 
despite its controversy. 
The definition is not always agreeable, but I think in the lost ten years there is more acceptance 
that these collections of symptoms do represent a risk factor for CVDs. I think we need to 
overlook these controversies and concentrate on finding effective ways to identify people at risk. 
If MetS can help us achieve this through its criteria then I don't see why not. 
Physician 6, man, Egyptian 
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One physician was inclined by a recent publication to use a different name for the constellation 
of CRFs. The multiple names of the MetS indicate the varying and unstable underlying causes of 
the syndrome. Research on the aetiology of MetS continue to generate new information of 
possible underlying causes of the syndrome. The account of physician 7 highlighted the lack of a 
clear and defined pathophysiology of MetS. However, his argument was interwoven with 
emphasis on the need to address the risk of clustering CRFs, regardless of the naming. In the 
following extract, physician 7 talks about MetS aetiology as he was addressing some of the 
syndrome's controversies: 
Physician: There is also the issue of MetS causes and aetiology 
R: Can you clarify please 
Physician: You probably know this from your research. You know, there have been a lot of 
arguments on what exactly to call it [MetS], and I heard recently some people calling to 
emphasise the inflammatory and prothrombotic aspects of the syndrome. They want to call it 
the inflammatory thrombotic syndrome. Whether you have to call it MetS or otherwise, there is 
a definite indication that obesity and its associated multitude of symptoms, like central obesity, 
dyslipidaemia, hypertension, are contributing to a state of inflammation as well as to a state of 
thrombosis. So I do believe something exists. We may differ about the nomenclature, but there is 
some syndrome that exists and it is observed more with the epidemic of obesity 
Physician 7, man, Egyptian 
As the presented accounts illustrate, some physicians expressed concerns about the absence of 
a widely accepted consensus defining the diagnostic criteria that make up the components of 
MetS. Others argued whether the naming reflected the actual underlying pathology of MetS. 
However, such statements were interlaced with recognition of the elevated cardiovascular risk 
of clustering CRFs. In their opinion, the arguments surrounding MetS naming or definition, 
however legitimate, were of limited clinical importance compared to the risk MetS imposes. 
4.3.3 MetS clinical utility 
Clinical utility of MetS in this study was indicated by participants describing factors that 
enhanced or hindered the use of MetS diagnosis or diagnostic criteria in identifying patients at 
high risk of developing CVD or diabetes, if not yet diabetic. Using the MetS definition to identify 
patients was not performed by pharmacists, dieticians or health educators and was confined to 
physicians only. This could be due in part to the practice relevance of MetS management across 
organisations. Data analysis identified four categories that described MetS clinical utility in the 
research setting: (i) applicability of the MetS definition; (ii) using the MetS diagnosis; (iii) 
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informing patients of MetS diagnosis; and (iv) drug therapy for MetS. Each category presents a 
number of factors that influenced the clinical utility of MetS. The following sections will describe 
these factors in details. 
4.3.3.1 Applicability of the MetS definition 
Clinical implications of the MetS definition in this study were characterised by physicians' ability 
to use the MetS definition in identifying patients at risk of developing CVDs or diabetes. 
Worldwide, The IDF and the AHA/NHLBI diagnostic criteria are the most commonly used in 
identifying patients with MetS in clinical practice (Sadikot and Hermans 2010). There are slight 
differences between the two MetS definitions. The IDF definition considers an ethnicity specific 
waist circumference or BMI > 30 kg/m2 as a prerequisite for MetS diagnosis (Alberti, Zimmet et 
al. 2006). On the other hand, the AHAH/NHLBI definition of MetS states that having any three of 
the five CRFs confirms MetS diagnosis (Grundy, Cleeman et at. 2005). Other internationally 
recognised MetS definitions, such as the WHO, necessitates a positive insulin resistance test as a 
requirement for MetS diagnosis (World Health Organization 1999). Using different MetS 
definitions within the same health care setting may result in disagreements between HCPs in the 
legitimacy of a MetS diagnosis and the need for therapy initiation. Therefore, it was important in 
this study to find out the definition of choice amongst physicians in the study and reasons 
behind their preference. All physicians interviewed preferred using the IDF definition of MetS. 
According to their knowledge, IDF was the latest published MetS definition that took into 
account the ethnic specificity of screened individuals. Other physicians applauded the 
applicability of the IDF definition within a clinical setting as Physician 7 describes in his quote. 
It is a simple procedure now. You just look at the patient's waist, and decide whether this patient 
is at risk of CVDs or even diabetes. Just by looking at his waist you know? The IDF made it simple 
" 
and easy and this is how it should be. 
Physician 7, man, Egyptian 
A number of physicians felt that the practicality of the MetS diagnostic criteria would be of 
greater benefit if applied in primary care settings or during outreach campaigns. In their 
perception, the MetS diagnostic criteria was a simple tool that enables primary care physicians 
and other HCPs to identify hard to reach individuals through random screening of CRFs. In the 
following quote physician 9 explains the limitations of using the MetS diagnostic tool within his 
daily practice or in speciality clinics. 
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The problem is that we see patients who already have diabetes and heart problems. I think MetS 
as a tool will be of significant value when applied in outreach campaigns. Because there are 
always those hard to reach patients that will never visit the clinic and they are the ones that we 
need to target. And MetS can facilitate that. 
Physician 9, man, Palestinian 
When patients decide to visit their family medicine clinic, they usually present with established 
CRFs and are, therefore, in need of both lifestyle and pharmaceutical interventions. According to 
the account of physician 9 and others who shared his view, this late identification of CRFs 
increases the complexity of management and achieving behavioural change. Thus, the MetS 
diagnostic criteria provides an easy to use tool to identify individuals at risk of developing CVDs 
before the establishment of chronic cardiac diseases such as hypertension or diabetes (Grundy 
2006). The MetS definition can be utilised by different HCPs of different specialties during 
outreach and public awareness campaigns. 
4.3.3.2 Documenting MetS diagnosis 
Findings from the study suggest that MetS diagnosis was not always documented in patients' 
medical notes and patients were not informed of their MetS diagnosis. Identifying factors that 
prevent physicians from using the MetS code for diagnosis is important to understand the extent 
of the clinical utilisation of the MetS concept. During the process of identifying patients with 
MetS, it was noted that few physicians used MetS as a diagnosis. Therefore, only a limited 
number of manually accessed patients' medical files had MetS documented as a diagnosis for 
patients who had a clustering of three or more CRFs. Physicians talked about two main reasons 
that they believed contributed to the low use of MetS as a diagnosis in patients' medical files. 
These two factors were: (i) familiarity with dichotomising CRFs; (ii) not including MetS in the list 
of reimbursed medical diagnoses. 
All interviewed physicians were asked about the limited documentation of the MetS diagnosis in 
patients' medical files. Some physicians believed that more time was needed for physicians to 
change their diagnosis habits and consider MetS as an additional diagnosis that can be listed 
after all risk factors are identified. Physicians' responses indicated that they were familiar with 
dichotomising risk factors rather than grouping them under MetS terminology. Hypertension, 
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diabetes and obesity were all definitions commonly used in clinical practice and each 
represented an instance where a continuous risk factor has been dichotomised. 
Most doctors are comfortable with diagnosing patients with individual risk factors rather than 
calling the sum 'metabolic syndrome'so they are just used to writing the list of problems. I think 
it is a habit. But with time and more focus on the MetS concept physicians will start 
documenting MetS as a diagnosis. 
Physician 1, man, Sudanese 
Other physicians talked about the impact of medical reimbursement on limiting documentation 
of MetS as a diagnosis in patients' medical files. Physicians needed to abide by the medical 
insurance regulations in order for patients' medical treatment expenses to be refunded by 
medical insurance companies. 
You'll notice that the MetS is not listed in physicians' reimbursement scheme that's purely the 
reason why we don't include it in the list of diagnoses otherwise we would. Treatment will not 
be approved and patients will end up paying for their drugs. I spoke to people from DAMAN 
[national health insurance] regarding this issue but they just don't get it. 
Physician 3, woman, Emirati 
As this section illustrates, there are still limitations to the use of the MetS diagnosis in clinical 
practice, such as the absence of the name for the list of reimbursed diseases and physicians 
preference of documenting individual CRFs in patients' medical files. 
4.3.3.3 Informing patients about MetS 
Patients' lack of awareness of their MetS diagnosis was noticed during patient interviews as 
previously discussed in section 4.2.1. This finding was enquired about during physicians' 
interviews. A group of physicians admitted that during patients' clinic visits they usually 
informed patients of the individually presenting CRFs (i. e., diabetes, hypertension, dyslipidaemia 
and obesity). According to interviews, physicians' rarely talked about MetS to patients or 
referred to their clustering CRFs as MetS. Physicians agreed on the importance of addressing 
MetS as an entity rather than individual CRFs. Yet, they had doubts about the added therapeutic 
value of involving patients or informing them of the MetS concept. Physician 10 (woman, British) 
illustrates this point in her quote. 
R: I have noticed from my interviews with patients that they were not aware of the MetS 
diagnosis or definition when I interviewed them 
163 
Chapter 4 Participants' perceptions of MetS 
Physician: Maybe they were not told. I usually don't mention that to my patients either 
R: Is there a reason why you don't inform patients of the MetS 
Physician: I never thought of that to tell you the truth. I mean they get told that they have the 
components. They know they have diabetes and the other risk factors. I mean I don't see the 
need to tell them about MetS. 
R: Do you think patients need to know or will benefit from information on the MetS diagnosis? 
Physician: I don't know if patients would react differently if they got told that this is your 
disease: 'metabolic syndrome'. Instead of saying you've got all these individual risk factors give 
it the name "metabolic syndrome"? I don't really know if it would make a difference? 1 don't 
know! I haven't really thought about it, it might, I'm not sure about that actually. 
Physician 10, British, woman 
Physician 7, on the other hand, felt that informing patients of their individual presenting CRF5 
would suffice and would be effective in communicating the seriousness of their health condition 
and the cardiovascular risk it imposes. 
What is important is for patients to know that they have the individual risk factors and that they 
are dangerous for their overall health and need treatment. I don't think talking to them about 
the 'metabolic syndrome' will add extra benefit to their understanding or commitment to 
treatment. 
Physician 7, man, Egyptian 
The complexity of the term 'metabolic syndrome' discouraged some HCPs from informing 
patients of the diagnosis, especially patients with poor educational backgrounds. Physician 3 
explains this point in her quote. 
Certainly, you don't tell them: "listen you have something called metabolic syndrome". No. We 
don't do that, because first of all there is no Arabic alternative for the word "metabolic 
syndrome" and some of these patients won't be able to remember it. 
Physician 3, woman, Emirati 
Acknowledging patients' educational background calls for simplifying educational approaches. 
The two educators interviewed perceived "metabolic syndrome" as a complex disease name that 
might not always be understood by patients, especially the uneducated or the elderly who do 
not speak English. The following quote illustrates this point. 
Simplicity is important. The idea of educating patients is to go to their level. We have patients of 
different educational backgrounds who find medical terms difficult to remember. Even the 
educated ones call hypertension 'pressure' and dyslipidaemia 'cholesterol'. All this should to be 
taken into account when talking to patients about their conditions. 
Educator 2, woman, Jordanian 
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In this study, HCPs rarely informed patients of their MetS diagnosis due to three main factors: (i) 
The complexity of the MetS term, (ii) the absence of a simple Arabic alternative name, and (iii) 
uncertainty in the therapeutic value of informing patients of an additional new diagnosis. 
Physicians' accounts indicated they felt that patients lacked the intellectual ability to understand 
the MetS concept. Others felt that the name 'metabolic syndrome' was avoided during patients' 
educational sessions in an attempt to simplify medical information and to avoid using medical 
jargon. Physicians were also reluctant to use the term 'metabolic syndrome' during patients' 
clinic visits because of its linguistic complexity. Physicians' attitude towards informing patients' 
of their MetS diagnosis presented in this section may explain patients' lack of awareness of the 
MetS name and definition presented earlier in this chapter (see section 4.2.1). 
4.3.3.4 Treating patients with MetS 
The primary goal of clinical management in individuals with the MetS is to reduce risk for CVDs 
and first-line therapy is directed toward the major risk factors: dyslipidaemia, hypertension and 
diabetes. The prime emphasis in management of MetS is to mitigate the modifiable, underlying 
risk factors (obesity, physical inactivity, and unhealthy diet) through lifestyle changes. However, 
if absolute risk is high enough, consideration can be given to incorporating drug therapy to the 
regimen. The priority of drug therapy is elevations of dyslipidaemia, blood pressure and glucose. 
In case a drug intervention is needed, current clinical guidelines for the management of CRFs 
should be followed such as the clinical guidelines for the management of diabetes and 
hypertension (Grundy, Cleeman et al. 2005; Alberti, Zimmet et al. 2006; Alberti, Eckel et al. 
2009). 
Impaired fasting glucose (IFG), which is one of the five CRFs in MetS, is defined as a prediabetes 
state that indicates an increased risk of developing diabetes. Preventing diabetes is another 
important goal in MetS management. Data about the impact of oral anti-diabetic agents, such as 
metformin and thiazolidinediones, in reducing cardiovascular risk in patients with prediabetes, 
but with other CRFs, is insufficient. Therefore, the use of oral anti-diabetic agents in this group of 
patients is discouraged (Grundy, Cleeman et al. 2005; Alberti, Zimmet et at. 2006). 
In this study, a group of participants expressed willingness to start pharmacological interventions 
to treat MetS patients without diabetes. They were, however, discouraged because of the 
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unclear MetS treatment guidelines regarding initiating pharmacological therapy in prediabetes. 
This point is illustrated in the following quote. 
If we start the prediabetes where patient's abdominal area is getting bigger and bigger and 
there is maybe borderline impaired glucose tolerance, you know, one of the drugs is metformin 
we like to use it very early with this group of patients. In the US, metformin is used in obesity and 
has shown good results. MetS treatment guidelines are not clear in this area unfortunately. 
Physician 6, man, Egyptian 
Another group of participants felt that the MetS definition did not provide novel management 
guidelines for the clustering of CRFs. Participants admitted that patients' are managed based on 
clinical guidelines of the management of individual CRFs. In their perception, the use of the MetS 
definition was limited to providing a simple tool of identifying individuals at risk of CVDs, as 
physician 7 explains in the following quote. 
I think MetS is not useful in providing guidelines for management because it repeats what the 
other guidelines said. So it did not give the world of medicine something new, or something we 
did not know about before. lt just lumped diseases and made you view them in a different light. 
Physician 7, man, Egyptian 
Physician 7, in other parts of the interview, referred to measuring patients' waist circumference 
that was recommended in the IDF definition of MetS as a tool that simplified cardiovascular risk 
assessment (section 4.3.3.1). In his perception, the originality of the MetS definition lay with the 
use of waist circumference as an indicator of CRFs. Other physicians reported using other clinical 
guidelines for the management of CRFs, such as the American, Canadian and sometimes British 
guidelines. Study findings suggest that physicians perceive MetS as a screening tool more than a 
clinical guideline for the management of clustering CRFs. This perception may explain why a 
group of physicians felt that MetS was better suited for CRFs screening during outreach 
campaigns (section 4.3.3.1). 
4.4 Summary 
The data presented in this chapter illustrates both patient and professional views of MetS as a 
condition in its own right. An interesting finding, in this study, was that patients lacked 
awareness about their MetS diagnosis and that physicians rarely told patients that they had a 
diagnosis of MetS and rather focused on the clustering of CRFs. However, all patients conveyed 
their sense of the augmented risk associated with the clustering of their risk. The high 
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prevalence of MetS in the UAE is usually publicised in the mass media in an attempt to increase 
public awareness of the risk of CRFs. Findings from the study, however, showed that CRFs were 
normalised in patients' perception because of their high prevalence in the UAE and 
controllability by available and affordable therapy. Contrary to this finding, patients usually 
graded their CRFs and ranked diabetes as the most serious. This in part could be due to the high 
number of public health awareness and prevention campaigns that are mainly dedicated for 
diabetes management and prevention in the UAE. It may also be due to patients' unfamiliarity 
with the MetS concept and, thus, their unawareness of the greater risk of the whole syndrome 
versus that of individual CRFs. Fatalistic talk was used when patients communicated their 
understanding of the MetS causes. Patients felt that MetS was an inevitable consequence to 
familial risk and a stressful lifestyle. Fatalistic talk co-occurred with statements that emphasised 
the important role of behaviour change in MetS management. As such, fatalistic talk may have 
been used as a stress relief or to avoid self-blame. Other coping measures that patients used in 
MetS were normalising living with MetS and religious practices. Patients' feelings of being 
normal were engendered by the MetS asymptomatic nature and self-distraction. Patients 
associated illness with physical signs, such as pain and disability. Having MetS did not alter 
patients' daily lives, which eventually helped them accept and cope with the ramifications of 
MetS. Competing demands that required patients' full attention, such as households and family 
matters, distracted patients from overstressing about their health condition. Religious practices 
provided patients with psychological comfort and tranquillity and were believed to enhance 
their acceptance and coping with their condition. Patients' belief that illness was in God's hands 
and a test of patience and gratitude gave patients a sense of acceptance and responsibility 
towards health. 
HCPs of different specialties did not have an equal level of awareness of the MetS. Physicians 
were the most informed and were able to articulate their views of the syndrome from practice 
and exposure to the latest research about MetS. Pharmacists in charge of non-clinical tasks were 
the least familiar with the MetS name and definition. The majority of HCPs believed in the 
realness of the MetS concept. The high prevalence of MetS in both adults and children in the 
UAE attracted physicians' attention and increased the legitimacy of MetS in their perception. A 
group of physicians had concerns regarding the naming and multiple definitions of MetS; 
however, they all agreed that controversy around MetS was clinically insignificant when 
compared to the cardiovascular risk associated with the clustering of CRFs. Data analysis showed 
that the clinical utility of MetS by clinicians was limited by four main factors. These factors were: 
, _; 
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(i) MetS definition ambiguity regarding pharmacological treatment in prediabetes; (ii) 
uncertainty over the added value of the MetS definition compared to existing clinical guidelines; 
(iii) lack of medical reimbursement for MetS diagnosis; (iv) familiarity with dichotomising CRFs. 
These factors reduced the dissemination of the MetS concept within the clinical setting. This 
poor utilisation of the MetS definition in clinical practice was manifested in the physicians' 
attitude towards MetS. Physicians' attitudes towards the MetS concept were observed as they 
indicated using the MetS criteria primarily as a tool for the screening of CRFs in addition to other 
tools, such as Framingham Risk Score. It was also evident when they expressed how they 
perceived MetS as medical jargon that was avoided during patient education sessions. This could 
in part explain patients' unfamiliarity with their MetS diagnosis. HCPs' responses demonstrated 
how MetS as a concept was not firmly embraced in clinical practice. 
This study identified factors influencing physicians' utilisation of MetS in their clinical setting. 
Physicians' attitude towards the MetS definition and legitimacy as a condition was also linked to 
patients' attitude towards their health condition. These findings reflected a more realistic 
picture of the practicality of the MetS definition in the UAE. The findings also identified HCPs' 
assumptions about patients' ability to comprehend their MetS diagnosis and associated risk. This 
finding may indicate the need to explore patient-physician communication within the UAE and 
MetS context. Unfortunately, exploring patient-physician communication and factors influencing 
information exchange was not the scope of this study but could be recommended for future 
studies. 
The following chapter will present data that describes the factors that influence patients' 
attitudes towards their treatment plan. 
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Chapter 5 
5.1 Introduction 
Factors influencing lifestyle intervention 
This chapter presents factors that influence lifestyle interventions in patients with MetS living in 
the UAE. Patients' attitudes towards MetS management were elicited through exploring patient 
and professional perceptions of barriers and facilitators to management and adherence to the 
MetS treatment plan. Patients, in this study, were asked general questions about their 
experience of living with MetS and issues encountered when adhering to the prescribed 
treatment. The interview guide included topics such as barriers to lifestyle and pharmacological 
interventions and the impact of the UAE socio-cultural and religious context on the MetS 
management. HCPs were asked to talk about issues patients with MetS faced and disclosed 
during counselling and education sessions. They were also asked to give their perceptions on 
management needs from their own experience in the UAE. The interviews provided an 
opportunity for the participants to talk about anything important to them that was related to 
MetS management. 
There were other themes that emerged from the data analysis which included: limitations to the 
role of pharmacists in counselling and patients' care plans; shortage in health care workers; lack 
of incentives for additional health care services; and Abu Dhabi health care reform. These 
themes are not discussed further within this thesis, as they were not exclusive to MetS nor 
directly influenced the management of patients with MetS. Themes that describe factors 
influencing pharmacological intervention will be presented in chapter 6 while this chapter will 
focus on factors influencing lifestyle interventions. Table 5.1 illustrates a summary of the key 
themes presented in this chapter. 
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Table 5.1 Summary of identified factors influencing MetS management in the UAE 
Influencing factors Main findings 
Health awareness " HCPs felt that the lack of health education promoting a healthy lifestyle in the school 
education system resulted in the lack of an exercise friendly culture in the UAE 
  
HCPs also believed that being overweight was perceived to be healthy in the UAE and 
was therefore culturally acceptable. This cultural belief affected women's motivation to 
manage their weight 
Socio-cultural 
  
Restricting women from exercising outdoors 
context of the UAE   Lack of culturally sensitive health clubs 
  
Traditional clothes were perceived hindering to hinder weight management 
  
Eating-centric gatherings, traditional foods and eating habits 
  
Food misconceptions 
" Using cars instead of walking was a socially constructed behaviour. Using cars was linked 
to social status and discouraged some patients from walking on streets 
Affluence " Excessive use of cars for transport limited physical activity 
  
Total reliance on domestic workers for cleaning, limited women's physical activity at 
home 
  
Relying on domestic workers to prepare meals prevents effective diet monitoring 
Environmental   HCPs talked about aspects of the urban planning in the UAE that did not encourage 
factors pedestrian activities 
" Patients were concerned with the introduction of fees to previously accessible free of 
charge beaches which they believed limited their physical activities 
  
The hot climate in the UAE did not encourage residents to undertake outdoor activities 
  
The widespread availability of fast food restaurants and the limited healthy options 
available in them hindered diet control 
Coexisting health Coexisting health conditions such as rheumatoid arthritis, back and knee pain, and physical 
conditions injuries limited patients' abilities to engage in physical activity 
Personal factors Lack of time, motivation and willpower hinder both physical activity and diet control in 
patients with MetS 
The management of MetS involves both lifestyle (i. e., diet and physical activity) and therapeutic 
interventions. Current clinical guidelines for the treatment of MetS propose lifestyle changes as 
a first-line intervention (Grundy, Cleeman et al. 2005; Alberti, Zimmet et al. 2006). A number of 
studies that investigated the impact of lifestyle modifications in patients with MetS features 
found that reduction in body weight improved CRF parameters (Despres, Lemieux et al. 2001; 
Neter, Stam et al. 2003). Adopting a healthy lifestyle that incorporates a balanced diet and 
regular physical activity requires a series of behavioural changes that might be difficult to 
achieve or maintain (Kappagoda and Amsterdam 2007). For many individuals, there are several 
constraints beyond personal motivation to adopting a healthy lifestyle. Cultural barriers, 
socioeconomic factors, psychological trauma, perceptions of health and illness and alternate 
health-seeking behaviours are just a few of the constraints that are likely to have a detrimental 
impact on health in patients with MetS (Kappagoda and Amsterdam 2007). Identifying 
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limitations to a healthy lifestyle will enable HCPs to consider such constraints when developing 
and planning lifestyle interventions or health promotion programmes. Although some obstacles 
and barriers to management might be similar in all patients with MetS, regardless of their race 
or cultural background, it is likely that other barriers might emerge specifically in the UAE given 
its unique cultural and religious characteristics. Therefore, it was important to explore factors 
influencing MetS management in patients living in the UAE. 
In this study, patients' responses indicated that they found adhering to lifestyle interventions 
challenging compared to pharmacological interventions. All patients in this study were aware of 
the importance of a healthy lifestyle in the management of MetS. They were also conscious of 
the behavioural changes they needed to adopt in order to achieve a healthier lifestyle. However, 
patients admitted that they sometimes failed to maintain such changes. Patients reported a 
number of barriers that altered adherence to lifestyle interventions. Patient 20 Patient 20 
reflects his struggle to adhere to lifestyle interventions in the following quote: 
Doctors tell you about so many things [lifestyle interventions] that you need to do but they are 
very hard to implement, and considering my circumstances, it is even harder for me to 
implement them. Life is not straightforward. There are ups and downs and they affect how you 
think and how you live your life and how you take care of your health. 
Patient 20, man, 37 yrs, Emirati 
Patient 20, being recently divorced, having full custody of his three children, and working in one 
of the northern Emirates, talked about the difficulty to find the time to cook healthy food or 
exercise on a regular basis. He reported that he mainly relied on fast food for lunch and dinner 
and also discussed the difficulty of finding the time to walk when he returns back from work. 
Therefore, implementing the lifestyle changes that his physician recommended were very 
challenging considering his personal and work circumstances. 
All HCPs agreed that lifestyle interventions were the most challenging to patients. Compared to 
patients' responses, HCPs gave a wider range of factors influencing MetS management that 
belonged to personal, environmental, cultural and educational aspects of patients' lives. 
Therefore, patients were asked to give their opinion on a number of these factors if they were 
not instinctively mentioned during the interview. Differences between patient and professional 
perceptions of factors influencing MetS management are presented accordingly in this chapter. 
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Factors influencing lifestyle intervention 
All patients in this study agreed that having an active life was important to control their 
presenting CRFs and described means by which they try to maintain active. However, both 
patients and HCPs talked about a number of factors that hindered the ability of patients to 
maintain physically active lifestyles. Data analysis revealed six main factors that altered physical 
activities in the UAE: (i) lack of exercise culture (ii) socio-cultural norms, (iii) coexisting health 
conditions (iv) affluence; (v) environmental factors, and (vi) personal factors. Figure 5.1 
illustrates factors influencing lifestyle modifications in patients with MetS. 
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Figure 5.1 Six categories of identified factors influencing lifestyle intervention 
Barriers identified belong to five main categories: socio-cultural, educational, environmental, affluence and personal 
factors. Most reported barriers by study informers revolved around limitations to physical activity. Each of these 
categories impact lifestyle as can be seen in the above diagram. 
5.2.1 Lack of an exercise culture 
Some HCPs justified patients' reluctance to maintain a physically active lifestyle by the lack of 
exercise culture in the UAE. Although patients were aware of the importance of physical activity 
to their health, they lacked commitment and enthusiasm towards initiating and maintaining an 
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active lifestyle. Many HCPs agreed that living in a society where exercise is not part of its culture, 
engendered such an attitude towards exercise. Physician 3 and pharmacist 6 explain this point 
when they were asked why they believed exercise was challenging for patients. 
Exercise, it is not something that is part of our lifestyle. In western countries even senior citizens 
get up in the morning and walk or run. In our culture, it's a different story. I mean we are 
starting to change, and there are elderly patients that walk for one hour every day or swim, so 
you see there are some. But these examples are few. 
Physician 3, woman, Emirati 
Exercise doesn't seem to be part of the culture here at all. People are not used to a healthy 
lifestyle and some of them have never exercised in their lives or seen any members of their 
families do. 
Pharmacist 6, woman, British 
Elderly patients in particular were believed to be the least engaged in exercise and physical 
activity in the UAE. Apart from the lack of an exercise culture, these patients were not able to 
comprehend the meaning of the word exercise when used by HCPs and were clueless on how to 
perform exercises. Pharmacist 7 explains this point in the following quote. 
don't think it's appropriate to tell a 50 or 60-year old woman from this culture to exercise. How 
would a woman of that age from this culture comprehend what exercise is or how it should be 
performed? Maybe if you talk to a 60-year old European woman about exercise she'll know 
what you're talking about, but the concept of exercise is not something older people in the UAE 
can identify with and understand, it's an odd term to them 
Pharmacist 7, woman, Emirati 
Pharmacist 7 blamed the inappropriate educational approach used with patients that does not 
take into account a patient's age, educational and cultural backgrounds. Failing to acknowledge 
patients' educational needs especially in promoting physical activity resulted in failure to achieve 
behavioural change. Other HCPs felt that most patients, regardless of their age, were unfamiliar 
with exercise and a healthy lifestyle because it was absent from the Emirati school educational 
system. In their opinion, emphasising the importance of a healthy lifestyle in schools' 
curriculums may help build an exercise friendly culture. Physician 8 explains this point in the 
following quote. 
The lack of education in schools and homes about healthy lifestyles is having a major impact. It 
is part of the curriculum in the UK as probably you know. They do educate kids in elementary 
schools what they should and should not eat. They teach them the importance of exercise. The 
some thing in US schools. As far as I know it is zero here. 
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Physician 8, man, Iraqi 
One pharmacist believed that the Emirati culture applauded obesity in women and perceived it 
as a beauty feature. From their perception, some women might not be encouraged to lose 
weight by their families. 
I think there's a big cultural acceptance of being large. I think that Arab men like large women; i 
think they find them very attractive. So if you are a woman growing up in this culture you won't 
be thinking of exercising as part of your daily programme because it is not needed. 
Pharmacist 6, woman, British 
Most responses from patients, however, indicated that they saw physical activity in the broad 
context that covered a range of activities. A number of patients were able to define exercise as a 
subset of physical activities that are planned, structured, repetitive and have a final or 
intermediate objective. However, most participants described daily activities such as sweeping, 
vacuuming and walking within the office during working hours as physical activities. Participants 
considered such incidental activities as physical activities that fulfilled part of their MetS 
management plan. Although a small number of patients engaged in leisure or recreational types 
of physical activity, most of the physical activity undertaken by participants originated from daily 
incidental activity or walking to the mosque for prayers. Furthermore, when discussing physical 
activity the majority of participants used the terms physical activity and exercise 
interchangeably, which suggests that they were not clear on how each differed from one 
another. 
All participants indicated the importance of maintaining a physically active lifestyle in the 
improvement of CRFs. None of the patients interviewed had views that indicated otherwise. 
5.2.2 Socio-cultural norms 
In this study, certain aspects of the UAE socio-cultural context were believed to affect the 
implementation of physical activity. The role of the UAE culture was first mentioned by a 
dietician as she described constraints that Emirati patients experienced as they attempted to 
adhere to their treatment plan. 
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There are many cultural chains tying this society and stopping it from becoming more physically 
active. I think the problem sometimes is not in individuals, it is in the whole society and how this 
society thinks and behaves and in what it believes too. 
Dietician 1, woman, Jordanian 
The role of the Emirati culture in patients' physical activity was further explored in the following 
interviews with all participants. Data analysis revealed that some Emirati social norms restricted 
women from exercising outdoors, and called for more culturally sensitive health clubs to be 
established. The following sections present these findings in more details. 
5.2.2.1 Women's outdoor exercising 
Despite increased public awareness campaigns on the importance of exercise to health, HCPs 
felt that the reason behind the observable lack of exercise by women stemmed from some 
socio-cultural norms in the UAE. HCPs believed that in some families, husbands or fathers 
disallowed their wives or daughters from running and power walking in public places. Such 
activities were sometimes permitted when in groups or in the company of a male family 
member. Physician 3 explains this point in the following quote. 
Some husbands will not allow their wives or daughters to exercise. They might not be 
encouraging: 'I don't like her to go out a lot'so we ask them to, at least, exercise indoors. Or to 
buy equipments that they can use inside their houses. 
Physician 3, woman, Emirati 
Only three female patients interviewed indicated that some Emirati traditions constrained their 
physical activity. Such participants admitted that they willingly refused outdoor exercising to 
avoid scrutiny or disdainful comments by passerby if they try to brisk walk. A daughter of a 
female patient explained this point as she was talking about exercise options her mother could 
engage in. 
My mother won't walk in public places. She is an old woman who wears a veil and Abaya and it 
will look awkward if she does. She won't because she'll be scrutinised and will hear silly 
comments from people in the streets. We have a big garden in the house. She can freely and 
peacefully walk there. 
Daughter of patient 22, woman, 56 yrs, Emirati 
It is important to mention that the type of activities participants were referring to in this section 
were brisk walking, jogging and running. Public places that such activities were performed 
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included public gardens and Abu Dhabi's seafront referred to as 'the Corniche' (see Table 5.2). 
The cultural beliefs that restrict women from exercising were sometimes interpreted as an 
excuse to escape physical activity. Physician 4 explains this in the following quote: 
Families not allowing women to exercise is not a valid excuse. They can always do something 
else. These women can join a gym club or exercise indoors. Sometimes they just use these 
excuses to avoid exercising. 
Physician 4, woman, 45 yrs, Jordanian 
Table 5.2 A photographic illustration of 
a, 
aces where residents of Abu Dhabi exercise 
Abu Dhabi Corniche or seafront is one of the public places 
many residents of the city use to walk, brisk walk, run or jog. 
The cornice stretches along Abu Dhabi's coast. In the picture, 
you can see two men walking and a woman walking and 
wearing the veil. 
A picture of a public gardens recently established in Abu 
Dhabi. Such gardens are equipped with devices that visitors 
can use to workout different body muscles. In the picture, two 
women are engaging in two different physical activities. 
Women wearing the veil while walking in part of Abu Dhabi 
Corniche. Some women prefer to walk in groups or in the 
company of a male member of the family (Debelkova 2010). 
Other participants felt that the Emirati society has changed and has become more liberal. Some 
participants indicated that the modernisation of the UAE in the last three decades has led to 
greater flexibility in gender rules, which allowed women to work alongside men in different 
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places. In that sense, social norms that constrained women from being openly active in public 
places were waning with time. Pharmacist 2 explains this point in the following quote: 
Yes, that is true. There are families that disallow their daughters from exercising outdoors, but 
this is changing. Today families and people are more flexible. Society is changing with time. 
People travel to other countries and learn from what they see. We are also open to other 
societies and we learn new ways of living. So this habit is getting weak as time passes by. 
Pharmacist 2, woman, Emirati 
One health educator explained that women's avoidance of outdoor exercise is due to fear of 
being identified. Although walking outdoors in gardens and the seafront is not a dishonourable 
act, women in the UAE are very conservative and like to maintain their privacy. Educator 1 
usually asked this group of patients to wear veils while exercising to avoid being identified by the 
public. 
I usually advise women to cover their faces with a veil. Some say that they won't be able to 
breathe: 'I will suffocate, I won't be able to breathe' she would say. I ask them to wear 
something light or porous so that the air will penetrate and they'll be able to breathe. They just 
don't want people to recognise them and say: 'oh! we saw the wife of so and so walking on the 
beach yesterday'. It is a very conservative and private society. 
Educator 1, woman, Bahraini 
The quote from Patient 22 presented earlier, suggests that female patients might still not take 
part in outdoor exercising, regardless of whether they have their faces covered. However, this 
view might also be influenced by the participant's age and status in her family as her daughter 
indicated (i. e., a mother of 56 years of age). Contrary to this view, two female patients' 
interviews admitted that power walking outdoors was an acceptable activity because it was 
performed while wearing veils. Patient 28 explains this point. 
I always go out with my veil. Not just for exercising. I feel comfortable wearing it and free to 
walk fast and sometimes run. Nobody knows you and nobody judges you. lt could be a bit 
suffocating when the weather is hot but you get used to it. 
Patient 28, woman, Emirati 
It is important to mention that other women that participated in this study said that they walked 
in public places like public gardens and Abu Dhabi's Corniche on a regular basis. They did not 
indicate that walking was an unacceptable activity in their families or that their husbands and 
fathers opposed it. This suggests that all women living in the UAE do not necessarily experience 
the socio-cultural factors that might limit women's participation in outdoor exercise. Therefore, 
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generalisation of socio-cultural factors should be avoided and other factors such as personality 
and age should be considered when promoting physical activity. 
5.2.2.2 Lack of culturally sensitive health clubs 
The UAE has many women-only health clubs that exclusively cater for the female population of 
the country. Some of the women-only clubs are fenced buildings with security guards that do not 
allow men to access or use these facilities. However, in this study some HCPs talked about 
women's reluctance of joining women-only health clubs because of the presence of security 
cameras referred to as 'hidden cameras'. Female patients also feared mobile phone cameras 
that might be secretly used by other female members to take their pictures whilst exercising. 
HCPs reported that some conservative women were mainly scared of having their pictures 
distributed to strangers or posted on the internet. In their perception, such an act would 
jeopardise their reputation and dishonour their family names. Dietician 2 explains reasons 
behind women's fear of women-only gyms in the following quote. 
Some ladies think there are hidden cameras in gyms that will take their pictures wearing 
exercise outfits and then distribute them on the internet. Many of the women-only health clubs 
have a bad reputation because of this rumour. So women decide to avoid them altogether. 
Dietician 2, woman, Emirati 
Women's reluctance to join health clubs because of fear of security cameras was explored 
further with female patients in this study. Only one female patient interviewed shared similar 
concerns regarding cameras in women-only health clubs. In the following quote, she explains 
why she left her previous women-only health club and joined a new one. 
The health club 1 used to be in was good. [ 
... 
]. But my friends told me it had hidden cameras. My 
husband asked around and he heard rumours too. So I stopped going there. Now I go to another 
one, my husband said it was safe and it has a good reputation. 
Patient 24, woman, Emirati 
Cultural specifications in women-only health clubs included the need for women-only walking 
tracks and open swimming pools that allow women to exercise outdoors without wearing 
traditional black garments or veils. One patient was saddened when her health club that 
provided options for outdoor activities was closed. 
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We would walk or swim wearing our training outfits and swimsuits. [women-only health clubs] 
provided freedom and privacy. God forgive them, they closed it and now we walk in the Corniche 
with our abayas and veils in the extreme hot weather or we go to these closed gyms. But it was 
different then. 
Patient 29, woman, 34 yrs, Emirati 
Culturally-related barriers to exercising were not entirely specific to female patients with MetS. 
Some male patients participating in the study indicated the lack of culturally sensitive health 
clubs that respected their Islamic religious beliefs. Mixed sex health clubs were another indoor 
exercising option for men in the UAE. However, a group of male patients perceived mixed sex 
gym clubs to be disrespectful of the UAE's religious and cultural values. A number of patients 
indicated that such clubs were avoided. Outdoor exercises were an alternative but were 
sometimes avoided during the extremely hot and humid months of the year. Patient 14 narrates 
the events that led him to stop going to a gym club. 
I used to be a member in a good gym. There were special hours for men, and special hours for 
women and the times never overlapped. But years later the club management allowed women 
to come during men's exercise hours. When that happened, I was annoyed and felt sorry for 
these women. How can she degrade herself by wearing these revealing clothes? It was very 
offensive. I thought I shouldn't expose myself to these sins, so I stopped going there. 
Patient 14, man, 73 yrs, Sudanese 
Patient 14 felt that mixed sex health clubs subjected him to mix with and observe women 
wearing revealing exercise outfits. This setting antagonised his Islamic disciplines and was 
believed to be unacceptable culturally and religiously. 
5.2.2.3 Traditional clothes 
Both old and young Emirati men still prefer to wear the traditional dresses called the dishdasha, 
which is an ankle-length white shirt. Women, on the other hand, wear the traditional long, black 
over-garment, called the abaya, on top of their dresses. HCPs felt that such attires obscured 
body changes due to weight gain and prevented them from noticing any increase in their waist 
circumferences. Some patients resisted the idea of wearing contemporary clothes, such as 
trousers or exercise outfits. As such, HCPs felt that men's and women's traditional clothes were 
inconvenient for efficient physical activity. In the following two quotes, two HCPs describe how 
Emirati traditional clothes hinder weight management. 
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It's really hard for a dishdasha to get very tight, you don't realise that you're getting a bit fatter 
when you're always wearing it. 
Pharmacists 6, woman, British 
They also dress in these loose traditional clothes that hide their bellies. I ask them to wear 
trousers, at least at home, but they refuse. 
Educator 1, woman, Bahraini 
Others felt that such modest, long clothes could be uncomfortable when exercising outdoors 
during hot climates. In their perception, exercise was a complex activity and clothes that hinder 
movement can add to its complexity and alter patients' adherence to regular exercising. Patients 
interviewed did not equally share such views regarding the impact of their traditional clothes on 
their physical activity. 
Women here are fully covered and that is a barrier to exercise. They must be feeling really hot 
under all that fabric. 
Physician 10, woman, British 
When patients were asked if their clothes hindered their exercising or movement, patients made 
quick remarks such as: 'my clothes are fine', 'no problem with my clothes'. Others indicated that 
they usually dress in appropriate exercise clothing when attempting to exercise. Although most 
patients did describe the UAE's hot climate as a limiting factor for exercising, patients did not 
associate annoyance with the traditional clothes they wore. 
Although all patients in the study acknowledged the importance of exercising in the 
improvement of their MetS features, they admitted that their reluctance to exercise was partly 
due to cultural barriers. Such barriers included: (i) constraints on women's outdoor exercising; 
(ii) lack of culturally sensitive health clubs that prohibit the use of cameras; and (iii) traditional 
clothes. Other HCPs suggested strategies that took into account Emirati's societal rules and at 
the same time facilitated patients' engagement in physical activity. Such strategies included 
advising women to wear a veil when exercising outdoors or walking in closed malls while 
shopping. This can be an ideal alternative for outdoor brisk walking especially for women 
wanting to avoid public scrutiny and the hot climate of the UAE. 
It is important to mention that socio-cultural barriers to exercise do not necessarily affect all 
residents of the UAE. The UAE population are of different nationalities and communities of 
variable cultural and religious backgrounds and might not all experience similar barriers to 
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physical activity. Before 2006, SKMC used to be a government owned health care service 
dedicated to Emirati citizens only. As part of Abu Dhabi's health care reform, the national health 
insurance scheme (DAMAN) was implemented. This was subsequently followed by the 
privatisation of all Abu Dhabi's government health care services. As a result of this, all residents 
of Abu Dhabi, citizens and expatriates, became medically insured and were able to access all Abu 
Dhabi's health services, including SKMC. In this study, many of HCPs' views on the impact of the 
Emirati culture on MetS management were discussed with UAE citizens as the reference 
population/group. This may have resulted as data were collected a couple of years after Abu 
Dhabi's health reform and in reality SKMC was still providing health care mainly to Emirati 
citizens. With this in mind, diligence was exercised to ensure that interview questions would not 
further reinforce this inherent bias and questions were designed to capture the views of the 
other nationalities that might be using SKMC services. Participants' answers indicated what 
patient group (citizens or expatriates) they were referring to. 
It is important to acknowledge that other individual factors such as age, gender, level of 
education, personality, intelligence, experience, occupation and socio-economic factors might 
come into play and impact patients' health behaviour. Thus, broad generalisations in explaining 
people's beliefs and behaviours should be avoided. 
5.2.3 Coexisting health conditions 
Coexisting health conditions in this study refers to diseases that impaired patients' movement or 
hindered their ability to engage in physical activity and exercise. Most patients interviewed 
indicated that coexisting health conditions were a significant barrier to exercising. Rheumatoid 
arthritis, knee and back pain or, in some cases, injuries from accidents were the most talked 
about barriers by patients. 
I used to walk. And I did that regularly until l got this fracture in my foot. Now I can't walk like I 
used to. It is very painful when I step on my foot. I had this fracture for 5 months now and it is 
still painful. 
Patient 13, man, 49 yrs, Bangladeshi 
Most patients interviewed looked forward to maintaining a routine exercise regimen but felt 
inhibited by coexisting symptomatic health conditions. Some patients, on the other hand, 
commenced different physical activities due to coexisting illnesses. Swimming was the most 
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popular alternative to walking and other forms of physical activity by most of this group of 
patients. Patient 3 illustrates this point: 
In the house my movement is limited. Since / was diagnosed with rheumatoid arthritis I can't 
move like i used to. So I decided to swim. My daughters said that swimming would be gentle on 
my knees. So now I swim once sometimes twice a week. 
Patient 3, woman, 69 yrs, Yemeni 
A group of patients interviewed were dissatisfied with their inability to exercise due to coexisting 
health conditions. Their limited physical activity resulted in more weight gain, which made them 
feel hopeless and powerless. Patient 6 explains this point in his quote: 
You feel hopeless because you can't do anything. I want to move and walk like I used to but the 
pain in my knees, in my back are not permitting me. I sometimes feel like crying and feel 
depressed. 
Patient 6, man, 65 yrs, Yemeni 
HCPs on the other hand indicated that such health conditions were consequential complications 
to uncontrolled MetS. In their perception, patients needed to realise that muscle and joint 
injuries and inflammations could have been avoided if patients reduced their extra weight. 
Physician 4 explains this view in the following quote: 
Patients always complain of their joints and knees. But they need to understand that all these 
problems are because of the extra weight. It's a vicious cycle and the more they ignore 
exercising the more their condition deteriorates. 
Physician 4, woman, Jordanian 
HCPs felt that coexisting physical barriers and diseases could hinder movement and result in 
more weight gain that can eventually worsen these coexisting diseases. Swimming was one of 
the alternative physical activities that most physicians advised this group of patients to take part 
in. However, swimming might not be attainable or acceptable by some patients due to cultural 
obligations. Crosson and authors (2010) explored physicians' perceptions of barriers to control 
CRFs among patients with diabetes. Interviews were conducted with 34 physicians from five 
states in the USA. Coexisting diseases such as pain and depression were believed to compete 
with patients' efforts to control CRFs. Such competing conditions limited patients' ability to 
exercise, distracted patients and physicians from addressing diabetes management and resulted 
in patients' depression (Crosson, Heisler et al. 2010). Similarly, in this study, lack of movement 
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due to coexisting health conditions altered lifestyle intervention and in some cases resulted in 
feelings of hopelessness and sometimes depression (see patient6). 
5.2.4 Affluence 
In this study, HCPs used the term affluence to describe patients' affordability of luxurious living. 
Affluence, in their perception, resulted in patients' sedentary lifestyle and poor adherence to 
physical activity and, as such, was one of the contributing factors to the high prevalence of MetS 
in the UAE. Excessive use of cars for commuting and the total reliance on domestic workers were 
two by-products of affluence that limited patients' physical activity. 
Some HCPs felt that such behaviours were exclusive to the Emirati population of the UAE. They 
felt that Emirati patients with MetS indirectly associated the use of cars with social status, and 
they perceived walking in the streets as degrading to one's social class. The following quote 
explains this point. 
You rarely see people walk! I wish I could see an Emirati walking in the streets. I am serious. I 
wish I could see an Emirati crossing the road on his feet. lt makes me wonder why? Why don't 
they walk or cross the street like other nationalities that live here. If they go to shops they'll park 
their cars exactly in front of the entrance and don't mind getting a ticket as long as it'll spare 
them a few steps. It's outrageous, you know? I feel it's in their blood and in their social system. 
They think it's degrading to be seen walking in the streets (laughing). 
Dietician 1, woman, Jordanian 
Dietician 1, who was born and brought up in the UAE, believed that Emiratis total reliance on cars 
for transport was alarming. During the interview she recalled many examples from her memory 
as a student and then as a health care professional dealing with Emirati patients with MetS. She 
implied that Emiratis avoidance of walking in streets, through using cars or disallowing women 
from walking in public, stemmed from unique and newly constructed social beliefs. 
I don't know honestly why Emiratis behave in such a way. In the past, they were not like that, 
mean, I've lived in this country my whole life. I was born here in '79 and I know the changes this 
country went through, and this helps me a lot in my work. But these beliefs are not restricted to 
driving cars, there are other things that are new to this society like women not being able to 
power walk in public places or in the Corniche. Even if she was allowed, she'll be teased by young 
men and she won't feel comfortable. 
Dietician 1, woman, Jordanian 
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Another aspect of affluence was the use of domestic workers in homes for cleaning, cooking, 
gardening and babysitting. The increased number of domestic workers and servants in Emirati 
homes reduced the amount of physical activity available for female patients. In many cases 
when female patients complained about the lack of time available to perform exercise, engaging 
in house work as another form of physical activity was prevented by their total reliance on their 
house domestic workers. Dietician-4 explains this point in the following quote. 
There are a lot of house cleaners and servants in one house. There isn't just one house cleaner 
there is more than one. So what is left for the mother or daughter? Nothing. There is no physical 
activity for the mother or wife to do while at home which adds to the problem 
Dietician 4, woman, Emiroti 
Conversely, in this study, many patients interviewed did not refer to the use of cars or domestic 
workers as a barrier to their physical activity. Cars and domestic workers were perceived as help 
and methods that facilitated a better quality of life. In their perception, the hot climate of the 
UAE mandated the use of cars for commuting. In addition, many female patients believed that 
domestic workers were there to help and make time for themselves and their families. The 
following quotes explain patients' views on cars and domestic workers. 
The hot weather leaves you no option [but to drive a car]. When I travel abroad I walk so I have 
nothing against walking. When I come back from work exhausted, you won't expect me to also 
walk in the heat to the mall. No. You'll think I'm mad (laughing). 
Patient 20, man, 37 yrs, Emirati 
Patient 18 indicated that having a housecleaner allowed her to have time for exercising. In this 
regard, house chores were not always regarded as a workout that aids in weight loss. Domestic 
workers were needed to free time for structured exercising. 
/ work in the house. The house cleaner doesn't do everything of course. Having a house cleaner 
will not make you fat like they say on TV. There are other factors in life that would. The house 
cleaner is there to help. Because I need time for myself, for my family, to do exercise, you know, 
to take care of myself in general. 
Patient 18, woman, 54 yrs, Sudanese 
The attitude of patients towards the use of domestic help is similar to what Winslow and Honein 
have identified. In their study, they explored the health needs of Emirati women through focus 
groups. The findings showed that women perceived domestic help as a bridge that helped with 
various domestic responsibilities. Domestic workers were also perceived as a barrier because 
they jeopardized the confidentiality and privacy of families they worked for. However, domestic 
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workers were not perceived as a barrier because they reduced the amount of physical activity 
women could have engaged in (Winslow and Honein 2007). 
5.2.5 Lack of time and motivation 
Some patients interviewed indicated personal factors that prevented them from frequently 
exercising. Personal factors included lack of motivation and social and family support. Some 
patients lacked motivation to join the gym or exercise on regular basis. Family and social support 
were perceived as motivating factors that might enhance patients' engagement in exercise. 
Other patients lost the motivation and willpower to exercise because of long working hours and 
exhaustion. Patients 1 and 9 illustrate this point. 
To me exercise facilities look like a bunch of metal dinosaurs just setting there. lt feels alien to 
me to go to the gymnasium. But it would help if I can find someone that will push me, will 
encourage me, you know? 
Patient 1, man, 45 yrs, British 
I'm very lazy to do any exercise; I come back from work at 5 [pm] I come back tired and wanting 
to eat, watch TV and sleep. You lose motivation and energy. There is no energy left to keep you 
going. 
Patient 9, woman, 43 yrs, Palestinian 
Losing motivation to perform exercise was engendered by competing demands and lack of time. 
Patients felt that long working hours, constant travelling, running family chores, childcare and 
other social and family responsibilities frequently prevented them from undertaking physical 
activity. In the following quote, patient 29 illustrates this point: 
You know? 1 work from 7 am until 3 pm and when I'm back I need to do the cooking, help the 
kids with their homework. Suddenly it's bed time. So I can't have time for exercise in this busy 
schedule. 
Patient 29, woman, 34 yrs, Emirati 
All HCPs agreed that lifestyle intervention and behavioural change required an intrinsic patient- 
related driving force and was not something they could influence by their actions or advice. The 
quote from Physician 7 illustrates this point: 
Lifestyle is difficult. We understand that patients are under great pressure, because it requires 
strength and willpower. Lifestyle is difficult because it is self-motivated. There isn't much that 
we as physicians can do about it except give advice and encouragement 
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Physician 7, man, Egyptian 
One study investigated barriers to physical activity in patients with diabetes attending the 
Diabetes Clinic in Dundee through interview questionnaires. Findings suggested that lack of time 
and distraction by other activities were among the barriers to physical activity (Thomas, Alder et 
al. 2004). Another study explored barriers to lifestyle interventions in 450 patients attending a 
primary health care centre in Saudi Arabia. The lack of willpower was ranked the second most 
hindering factor to exercise. In addition, 76.8% of participants reported lack of social support as 
another barrier to physical activity and 73.2% felt that they lacked the energy to perform 
exercise (AlQuaiz and Tayel 2009) 
5.2.6 Urban planning and accessibility 
Some HCPs and patients indicated that the urban planning of Abu Dhabi did not encourage 
pedestrian activities. The lack of arcade zones such as walkways, and covered passages 
throughout the city meant that residents were not able to commute on foot and had to rely 
mostly on cars and buses. Walkways and cycling tracks were available only in the Corniche area 
or in public gardens. Daily walking can increase mobility and lessen sedentary habits. However, 
the lack of pedestrian-friendly zones in Abu Dhabi made it difficult for patients to include foot 
transportation in their daily incidental exercise. Physician-10 compared the urban planning of 
Abu Dhabi to European countries and found that the latter facilitates unofficial exercising which 
is not the case in the UAE. 
I think it's just very difficult to walk around the cities the Emirates. In Europe you go shopping, 
you take public transportation, you walk or you cycle. You're getting all that sort of unofficial 
exercise every day. Here it's geared for the car. Urban planning here forces you to drive 
everywhere. Even when the weather is nice and you could walk, it's dangerous to walk and 
everything is spread out so people take the car. 
Physician 10, woman, British 
A few patients also talked about the inaccessibility to free exercise facilities, such as beaches for 
swimming. The recently introduced beach entry fees were believed to reduce the use of such 
facilities by residents in the city. Thus, reducing accessibility to physical activity. Patient 6 
described in his interview how his habit of swimming every day was affected due to privatisation 
of beaches. 
186 
Chapter 5 Factors influencing lifestyle intervention 
I used to come back from work, rest fora couple of hours and then go to the beach and swim for 
at least half an hour. The beach is across the road from where I live which helped a lot. Now they 
closed [the beach], they blocked all entrances. They closed it for renovation. And to start 
charging people entrance fees. So I don't swim at all now. 
Patient 6, man, 65 yrs, Yemeni 
In this study, a number of patients indicated their commitment to daily or regular exercising. 
Some were members of or frequent visitors to a gym or a health club. Others talked about 
strategies they followed to maintain a physically active lifestyle. These strategies included 
women engaging in house chores, using stairs instead of lifts, walking in the house back garden, 
brisk walking in public places with other family members or walking to the nearby mosque for 
prayer five times a day. 
I like walking, especially in between prayer times. I walk from my house to the nearby mosque. 
After the early evening prayer, I walk around the block. When it calls for the last prayer of the 
night, I pray and then head back home. 
Patient 17, man, 60 yrs, Jordanian 
Of note, patients' responses indicated that coexisting diseases and lack of time and motivation 
were the most limiting factors to physical activity. HCPs mostly indicated other factors such as 
the socio-cultural norms and affluence. This may suggest a patient-professional communication 
gap, which may have resulted due to differences in how patients and professionals perceive 
barriers to lifestyle interventions. Communication was not the focus of this study, therefore 
themes that reflect that aspects will not be presented in this thesis. 
The flowing section illustrates and discusses factors that influenced adherence to healthy diet 
identified in this study. 
5.3 Factors influencing diet control 
Diet control is the other component of lifestyle intervention recommended by the IDF and 
AHA/NHLBI for the management of patients with MetS (Grundy, Cleeman et at. 2005; Alberti, 
Zimmet et al. 2006). In addition to other factors related to other lifestyle habits, the impact of 
a healthy diet has been confirmed in many studies (Bianchi, Penno et al. 2008; Al-Sarraj, Saadi 
et at. 2009). Increasing scientific evidence has emerged indicating that diets rich in fruits, 
vegetables, whole gains, fish, nuts and low-fat dairy products have protective health effects 
(Grundy, Cleeman et at. 2005). However, there are many factors that influence adherence to a 
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healthy diet regimen that can include both personal and environmental factors. Therefore, it 
is important to identify and understand such factors in order to construct effective 
interventions that improve patients' adherence over time (Fappa, Yannakoulia et al. 2008). In 
this study, participants indicated a number of factors that were believed to influence patients' 
adherence to a healthy diet. These factors included social gatherings and eating habits, 
traditional foods, fast food and lack of willpower. The following sections illustrate these 
factors in more details. 
5.3.1 Eating-centric social activities and traditional foods 
Social norms and cultural factors were elicited as HCPs talked about barriers to diet control. 
Three main aspects of culture work hand-in-hand when influencing patients' adherence to their 
recommended diet regimen. These were: (i) eating-centric social activities, (ii) traditional foods 
and cuisines and (iii) sharing one plate of food. This section presents these themes as described 
by the study participants. 
Many HCPs indicated eating-centric social activity to be one of the main factors that limit 
patients' ability to adhere to their diet plan. Social gatherings and events where food is served in 
abundance are very popular activities in the UAE. In the UAE, like in many countries in the 
Middle East, people have the habit of serving food during social gatherings of families and 
friends or in weddings and lunch invitations. During such gatherings, guests are served lots of 
food and lavish choice of expensive delicacies in abundance. In the Arabic tradition, it is 
considered courteous of the guests to eat what they are served. To refuse such hospitality when 
offered can cause offense to the host. Several health professionals, as well as patients said that 
this hinders adherence to healthy diet programmes. Patient 20 talks about this factor in the 
following quote: 
We have our culture, our customs that play a huge role in our lives. For example there are the 
food invitations that you cannot escape. I remember I stopped having late dinner for two weeks 
but then all my plans were ruined because of (food) invitations. In the beginning, I used to refuse 
but people disapproved. You know, in our tribe we should accept invitations otherwise your 
people (tribe) won't be pleased with you. 
Patient 20, man, 37 yrs, Emirati 
Traditional foods served at homes or during these events were also a concern and believed to be 
damaging to patients' healthy diets. Participants described traditional cuisines as unhealthy 
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foods that were rich in carbohydrates and saturated fat content. Physician 5 explains this point 
in the following quote. 
Our culture depends on socialising lunch and dinner invitations, big feasts, it's a way of showing 
hospitality and one's generosity, so people indulge when it comes to food, especially and mainly 
with carbohydrate based meals, rather than vegetable based meals, so all of this, and you can't 
do much about it because it's a custom, it's a culture. 
Physician 5, woman, Jordanian 
Dieticians also talked about some eating-customs practiced by a number of patients that 
affected diet control. Some Emirati families still practice the tradition of eating foods such as rice 
by sharing one large plate. This eating-custom made portion size and plate size difficult for 
patients to implement in their daily lives. Dietician 4 explains this point in the following quote. 
Some families, especially those living in the west part of the Emirates, still eat from one plate. In 
such cases, it's difficult to ask them to monitor their portion size or their plate size. This habit is 
on the decline but we do come across patients who just can't control their diet because of this 
custom. 
Dietician 4, woman, Emirati 
Family gatherings where food is shared in one large plate was a barrier to diet control indicated 
by HCPs in another recent qualitative study in the UAE (Ali, Bernsen et al. 2009). This habit was 
also common in other Arab countries like Somalia and Oman and were also considered to hinder 
lifestyle intervention (Owens, Piccinin et al. 2009; Al-Sinani, Min et al. 2010). 
5.3.2 Misconceptions about dates and honey 
A number of HCPs in this study talk about patients' excessive consumption of dates and honey, 
which have high calorie content. People in the UAE have the habit of eating dates throughout 
the day while drinking the traditional Emirati coffee. Among all HCPs, only dieticians and health 
educators talked about patients' overconsumption of dates and honey. This could be explained 
by the nature of their health care service that explores patients' lifestyle and attitudes towards 
treatment plans. Such HCPs found that convincing patients to reduce their daily consumption of 
dates or honey was very challenging because of the religious and traditional value of these 
foods. 
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Some patients with diabetes insist on drinking honey and eating dates simply because it is 
mentioned in the Qur'an as a cure for illnesses. In this case, I cannot contradict their religious 
beliefs this is what they believe in, so i don't argue. 
Educator 1, female, Bahraini 
Date palms have a religious and traditional value to many Muslims around the world. Religiously 
the date palm is mentioned 20 times in the holy Qur'an and is described as the 'blessed tree'. 
Dates are also an essential food item that Muslims break their fasting with during the holy 
month of Ramadan. Muslims follow the actions of the Prophet Mohamed when he used to break 
his fasting with three dates. The prophet also praised the nutritional value of dates and advised 
his followers to consume them daily (Adib 2004). The UAE is believed to have the highest 
number of date palm trees in the world with 42 million trees (Salem 1996; UAE Interact 2010). 
One of the UAE's ways of preserving its heritage and traditions is to annually celebrate date 
harvesting. Farmers from all over the country exhibit their date produce where people and 
visitors from different parts of the world come to witness this celebration (UAE Interact 2010). In 
almost all Emirati homes, dates are always served on large plates that are placed in sitting rooms 
or on coffee tables. 
Honey, on the other hand, gained a lot of its popularity in the UAE and other Islamic countries 
from traditional Islamic medicine. Both the holy Qur'an and the Hadith1° mention honey and 
emphasise its therapeutic benefits. Thus, honey is one of the main ingredients that is used to 
medicate patients in Islamic medicine (Adib 2004; Deuraseh 2006). The health educators 
interviewed indicated that patients' misinterpretation of the Islamic scripts fuels their attitude 
towards honey. In their perception, health care professionals need to be equipped with Islamic 
knowledge in order to rectify patients' belief about the consumption of dates and honey. 
Some patients have poor educational backgrounds so they interpret these Islamic scripts 
wrongly. Our role is to educate them. So it is important that we have a good understanding of 
the Islamic teachings and scripts so that we can rectify their misinterpretations and convince 
them. I tell them: 'honey is good for health but it is mainly for wound healing and diabetic foot. 
And dates are rich in fibres and vitamins but you have to take them moderately'so I don't totally 
oppose their beliefs, but/ amend them. 
Educator 1, woman, Bahraini 
Most patients interviewed talked about the health benefits of dates and honey but stated that 
they consume small amounts according to their dietician's recommendations. Patients 
'° Hadith: are narrations concerning the words and deeds of the Islamic prophet Mohamed. Hadith are regarded by traditional Islamic schools of jurisprudence as important tools for understanding the Qur'an and in matters of jurisprudence 
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interviewed were aware of the risk of over consuming such foods to their CRFs. This was due to 
previous educational sessions with health educators and dieticians as the following quote 
illustrates: 
eat dates and honey of course. I mean who doesn't? But I eat them with balance. I only drink 
honey when friends bring me some from Yemen. But I don't drink a lot. And dates just like my 
dietician told me, three to seven, not more. Don't worry, I know the risk to my health and I am 
very careful. 
Patient 21, woman, 49 yrs, Emirati 
Dietary misconceptions were assessed in 1,039 patients with diabetes living in Saudi Arabia. The 
results of the survey showed that 34.3% and 17.0% of the participants believed that honey and 
dates were good food items for diabetics, respectively. (Al-Saeedi, Elzubier et al. 2002). 
Misconceptions about the value of honey in diabetes were also identified in a study that 
surveyed the knowledge, perceptions and barriers to diabetic care of 240 Arab patients with 
diabetes living in Israel (Khatib, Efrat et al. 2007). The study also reported that 56% of the 
participants believed that honey did not affect blood glucose levels. In both studies, patients' 
attitudes towards honey and dates were attributed to inaccurate Islamic and culturally-bound 
beliefs. In this study, HCPs talked about patients' culturally influenced beliefs about dates and 
honey benefits and the impact it had on their dietary habits. However, culturally competent 
health education programmes provided to patients with MetS included such topics and worked 
on rectifying patients' dietary misconceptions. 
5.3.3 Lack of willpower 
Lack of self-control and willpower was cited as a barrier to patients' adherence to a healthy 
diet by both patients and HCPs in this study. Patients' reported that difficulty in controlling 
their appetite for food was mostly experienced during family gatherings for foods. 
Frankly speaking, at home it is very hard to restrict yourself to a specific diet. Anyone who 
claims they do is saying nonsense. At home, the whole family is eating normal food and I'm 
the only person who is not. This huge temptation is hard to resist. So I end up joining them 
and eat what they are eating. 
Patient 14, man, 73 yrs, Sudanese 
In the case of patient 14, the external environment further weakened his self-control and ability 
to adhere to a healthier diet. Other patients believed that healthy diets consisted of 'salads' or 
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only vegetables. The fear of being deprived of meat or carbohydrates discouraged some patients 
from starting a healthy diet regimen. Patient 1 illustrates this point in the following quote: 
I don't like salads and green stuff. I've tried this since I was a child and failed. But I really did try 
to change my lifestyle. I tried it for four months but I just could not continue. I could not stop 
eating the things that 1 like. 
Patient 1, man, 45 yrs, British 
One health educator felt that such factors come into play in lifestyle interventions. She also felt 
that personal factors could be utilised to motivate patients to adhere to their treatment plan. 
Single women are always motivated for reasons other than their health. They think they will kill 
two birds with one stone, you know, look attractive and be healthier. Married women, you look 
at them and they just don't have this additional factor. They think 'we already have husbands, 
so why work harder' [laughing] but / tell them: 'you don't want him to go around and get a 
second wife who is slimmer and healthier' believe it or not, sometimes it works [laughing]. 
Educator 1, woman, Bahraini 
This finding suggests that messages that remind people of other advantages to implementing a 
healthy lifestyle, such as looking attractive or preventing husbands from getting a second wife, 
can sometimes be incorporated into health promotion strategies. Such messages and others that 
encompass socio-cultural and personal factors can sometimes motivate patients and increase 
their willpower to follow lifestyle interventions. In addition, more attention should be given to 
the environment patients live in and how much it contributes to patients' weak willpower (see 
patient 14). The spread of fast food chains and the limited number of restaurants that serve 
healthy foods or diabetes-specific diets were believed to worsen patients' self-control and ability 
to adhere to their diet regiments. Patient 29 explains this point: 
When I go with my kids to the mall, 1 look for restaurants that might serve healthy food, but I 
don't find any. All you see is Kentucky jKFC®], McDonald's® Burger King®. The kids scream, they 
want food, and you become hopeless. I end up buying these things and joining them as well. 
That's what makes diabetes prevalence worse in this country. 
Patient 29, woman, 34 yrs, Emirati 
Relying on servants to prepare meals in some families was another factor that prevented 
patients from taking control of their diet. Servants would cook without being monitored by any 
family member. Thus, they might use unhealthy ingredients, such as saturated fats or high 
quantities of salts. Dietician 3 explains this point in the following quote: 
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There is also the problem of the house cook who prepares the food in his own way. Even when 
they give him instructions on what to use and how much to add of this and that, you are never 
certain they will always follow the instructions. They're not aware of their employers' condition 
and they might be uneducated. 
Dietician 3, woman, Emirati 
The high number of fast food restaurants in the UAE, like in many countries around the world, is 
an environmental factor that can compete with a person's intention to maintain a healthy diet. 
5.4 Variation in patient and professional views 
Factors that affect lifestyle interventions, which were identified in this study, are grouped into 
internal and external factors. Internal factors include lack of motivation and willpower and 
coexisting health conditions. External factors, on the other hand, include the UAE socio-cultural 
context, environmental and affluence-related barriers. Data analysis found that patients' views 
about the most influential factors varied from those specified by HCPs. 
HCPs were aware of many of the barriers identified by patients in this study or barriers reported 
in previous studies, such as the role of the socio-cultural context of the UAE, social support and 
patient-related factors. However, the responses of many HCPs indicated that external factors 
were strongly influential in patients' implementation of physical activity and diet control. 
Internal factors such as coexisting health conditions, on the other hand, were perceived as 
consequences of an unhealthy lifestyle that worsened with MetS. In many interviews, the 
educational system was blamed for nurturing sedentary lifestyles and creating generations that 
were unaware of the importance of healthy living. Socio-cultural norms were perceived 
responsible for women's inability to engage in outdoor activities. 
Patients, on the other hand, were mainly concerned with personal factors such as lack of 
motivation and willpower to engage in regular physical activity or adhere to a healthy diet. The 
coexistence of other health problems such as rheumatoid arthritis, back and knee pain, and 
physical injuries were detrimental to their physical activity and hindered them from participating 
in many forms of exercise. Restricting women's outdoor exercising was expressed by a few 
female patients in the study. Others believed that many of the Emirati social-norms and 
traditions were waning with time due to development and exposure to other societies and 
cultures. Traditional clothes that were perceived as a barrier by HCPs were utilised by other 
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participants (i. e., health educators and female patients) to facilitate women's outdoor exercising. 
Wearing veils was recommended to women who feared societal scrutiny but at the same time 
wanted to perform outdoor activities. Other female patients did not feel physically hindered 
when wearing traditional attires and indicated that such clothes provided obscurity and privacy 
while exercising, hence facilitating outdoor exercising. 
Interestingly, patients found the UAE socio-cultural norms to strongly influence their dietary 
control and were, therefore, strong detrimental factors to physical activities. Patients' 
statements about their inability to control their diet were usually interwoven with statements 
about societal rules that render weight management challenging. Ziebland et al (1998) assessed 
the relationship between reported barriers to lifestyle preventions and subsequent behavioural 
changes. Results of the survey showed that participants who reported internal barriers were less 
likely to take more exercise than those who cited only external or mixed barriers to changing. 
These findings emphasise the importance of acknowledging internal barriers as strong 
limitations to behavioural change (Ziebland, Thorogood et al. 1998). 
A number of physicians described patients' lack of motivation or willpower to exercise or control 
diet as 'laziness' and 'sheer excuses'. Many HCPs agreed that adherence to lifestyle interventions 
are in the patient's hands and often felt that 'nothing I do will change anything'. Others 
expressed frustration because of their inability to improve patients' adherence. Many HCPs also 
believed that many local residents of the UAE were resistant to exercise and lifestyle concepts 
because of the absence of an exercise culture. Conversely, patients were able to see physical 
activity in the broad context that covered a range of activities. Patients also described daily 
incidental activities as physical activities that fulfilled part of MetS management. Interestingly, 
none of the HCPs interviewed identified their actions or inactions in care provision as a barrier to 
patients' poor adherence to lifestyle interventions. Barriers in their perception were either 
patient behaviour-related or enhanced by external factors. Thus, when patients fail to meet 
treatment targets they are usually labelled noncompliant (Anderson and Robins 1998). Variation 
in perceived barriers between HCPs and their patients can indicate patient-provider 
communication issues where patients' experiences and concerns about their health may not 
have always been communicated to HCPs (Abdulhadi, Al Shafaee et al. 2007). 
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5.5 Summary 
Factors influencing lifestyle intervention 
Study participants revealed a number of factors that affected the implementation of lifestyle 
interventions in patients with MetS living in the UAE. These factors belonged to six main 
categories: Educational, socio-cultural, environmental, personal, affluence and coexisting health 
conditions and physical injuries (Figure 5.1). 
The lack of an exercise culture in the UAE was apparent in residents' impartial attitude towards 
exercise and physical activity. The UAE's socio-cultural factors were believed to affect both 
physical activity and diet control. These factors included social norms that restricted women's 
outdoor activities and discouraged them from joining health clubs. It also included traditional 
clothes that HCPs believed hindered efficient physical activity and weight management. Socio- 
cultural factors were not equally perceived as barriers to physical activity by patients but were 
believed to be detrimental to a healthy diet. The UAE's hot climate during most months of the 
year discouraged many patients from outdoor exercising and encouraged the overuse of cars in 
transportation. A few HCPs indicated that Abu Dhabi's urban planning limited pedestrian activity. 
Coexisting health conditions and physical injuries along with lack of time, motivation and 
willpower were believed to be damaging to physical activity by many patients in the study. The 
impact of affluence on lifestyle interventions were manifested in patients' excessive use of cars 
for commuting and their total reliance on domestic workers for house cleaning and meal 
preparation. 
Data analysis showed that there were variations in professional perceptions of barriers to 
lifestyle interventions compared to patient views. HCPs were mainly concerned with external 
factors such as environmental and socio-cultural related factors. Patients' responses, on the 
other hand, indicated that internal factors (i. e., lack of motivation, time and willpower and 
coexisting health conditions) were more detrimental to physical activity and diet control. This 
may suggest an inefficient communication of patients' factors during provider-patient 
encounters. Exploring patient-provider communication was beyond the scope of this study, 
therefore, themes that might have implied a communication related issues would not be 
included of further discussed in this thesis. 
The following chapter presents factors that affect patients' attitudes towards their prescribed 
medicines. 
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Chapter 6 
6.1 Introduction 
Factors influencing medicine use 
This chapter presents themes that describe barriers to patients' adherence to medicines. These 
themes were elicited as participants talked about issues affecting both lifestyle and 
pharmacological interventions in the management of MetS. Clinical guidelines for the 
management of MetS recommend adjusting patients' lifestyle to target underlying risk factors 
such as obesity, inactivity and an unhealthy diet. Medicines are prescribed if patients present 
with diabetes, CVDs or if the 10-year risk as determined by Framingham Risk Score, is relatively 
high. In such cases, prescribing medicines for the management of established cardiometabolic 
diseases should follow the recommendations of specialised clinical guidelines (e. g., clinical 
guidelines for diabetes, hypertension, CVD prevention) (Grundy, Cleeman et al. 2005; Alberti, 
Zimmet et al. 2006). 
In this study, 19 patients were diagnosed with diabetes but none had a history of cardiovascular 
complications. The treatment plan for all patients included advice on lifestyle adjustments and 
medicines for their presenting CRFs. Different combinations of oral anti-diabetic agents, 
antihypertensive agents, statins and other lipid lowering agents were regularly prescribed to the 
study participants. Other medications such as multivitamins and non-steroidal anti- 
inflammatories were also prescribed in some cases. A few patients were also on insulin therapy 
and some were prescribed orlistatll. All patients interviewed received their prescribed medicines 
from pharmacies located in outpatient or family medicine clinics. Under the new national health 
insurance law, patients also had the option of collecting their medicines from private 
pharmacies. All study participants were asked to talk about their medicines and to describe 
issues that affected adherence to their prescribed medicines. Table 6.1 illustrates a summary of 
the key findings identified in this study concerning factors affecting pharmacological 
interventions. 
" Orlistat Is an anti-obesity agent licensed for use in obese patients whose BMI >30 kg/m2 or in individuals with a BMI of 28 kg/m2 in the presence of 
other isk factors such as We 2 diabetes, hypertension, or hypercholesterolaemia 
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Table 6.1 Summary of identified factors influencing medicine use 
influencing factors Main findings 
Patients beliefs about   Patients believed that medicines were addictive harmful chemicals 
medicines   Patients preferred western manufactured brands of medicines 
  
HCPs did not object to patients' use of complementary medicines but were 
concerned with the safety, reliability and effectiveness of such therapies 
Polypharmacy " HCPs believed that polypharmacy led to patients' confusion and forgetfulness 
which eventually affected their adherence 
  
Polypharmacy increased patients' concern about side effects and encouraged them 
to look for alternative natural therapies 
Accessibility to medicine   Changes in medicine brands or doses resulted in patients' confusion and sometimes 
poor adherence 
  
Some patients' health insurance policies did not cover the costs of specific types of 
medicine such as statins. Others were not always able to afford prescription 
copayments 
Poor drug education   HCPs reported that patient beliefs about medicines were largely due to poor 
awareness about health and medicines 
  
Patients' attitudes towards provided health information and the underutilisation of 
pharmacists in patients' health education were the two overlapping factors 
contributing significantly to patients' attitudes towards their prescribed medicines 
Not all patients were able to remember or accurately pronounce the names of their prescribed 
medicines. However, they were able to describe their prescribed medicines by referring to their 
physical attributes such as colour, formula and strength. Most patients claimed to take their 
medications as prescribed, and a few of them said they occasionally omitted taking a dose due 
to forgetfulness. None of the HCPs interviewed reported factors concerning novel 
pharmacological management of MetS. Most of their concerns regarding pharmacological 
interventions revolved around factors influencing patients' perception of and attitude towards 
their prescribed medicines. According to most interviewed HCPs, poor or nonadherence was one 
of the main limitations to MetS treatment success. Nonadherence to prescribed medicine and 
lifestyle interventions resulted in poor control of CRFs. Data analysis of interviews found that 
factors influencing patients' attitudes towards prescribed medicines belonged to four categories: 
(i) beliefs about medicines, (ii) polypharmacy, (iii) medicine accessibility, and (iv) information 
about medicines. 
6.2 Patients' beliefs about medicines 
Patients' beliefs about medicines may affect their adherence to their prescribed medicines. Even 
before developing a disease, people have general beliefs about their medicines that orient them 
either toward or away from prescribed medication (Horne, Weinman et al. 1999). Data analysis 
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found that patients had three beliefs about their prescribed medicines that might have affected 
their adherence: (i) perceiving medicines as addictive and harmful chemicals; (ii) beliefs about 
different brands of medicines; and (iii) beliefs about complementary medicines. The following 
three sections present and discuss these findings in detail. 
6.2.1 Medicines are addictive and harmful chemicals 
The word 'addiction' was used by a number of patients to indicate their fear of becoming totally 
dependent on medicines. This group of patients believed that medicine use would deprive them 
from ever being able to live without them. Patients' beliefs about the addictive nature of their 
medicines discouraged them from adhering to their medicines. One patient believed that the 
body loses its ability to combat diabetes because of getting used to medicines. 
I have to admit that at the beginning, when I was first diagnosed (with diabetes) I didn't want to 
take my medicines. I was scared I'll get addicted to them. The body becomes lazy when you use 
medicine. Then it can't function on its own. And then you end up depending on it for the rest of 
your life. 
Patient 28, woman, 45 yrs, Emirati 
An interesting finding in this study was patients' habit of abruptly stopping their medicine-taking 
for a few days. The notion of getting addicted to medicines encouraged a number of patients 
interviewed to frequently stop taking their medications for one or two days. They believed that 
such behaviour enabled their bodies to regain strength and independence. The following quote 
was taken from an interview with Patient 13. 
P: I stop taking my medicines sometimes. Not for long. One day every two months or so. I don't 
want my body to get dependent on the medicines. It's good to allow your body to function on its 
own. Shocking your system and waking it up. You know. It's reassuring especially when nothing 
goes wrong when you stop, you know, like my blood pressure is ok, my diabetes is ok. Like that. 
You know? 
R: What does your doctor think about it? 
P: I don't think he noticed. Because like I said, you know, my health is not affected. 
Patient 13, man, 49 yrs, Bangladeshi 
A few HCPs were aware of patients' fears of addiction but felt that such attitudes were only 
apparent when attempting to add another oral drug or insulin injections to the treatment plan. 
However, none of the interviewed HCPs were aware that patients' fears of addiction to 
medicines resulted in planned treatment being abruptly stopped. Many HCPs strongly believed 
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in the effectiveness of education in rectifying patients' beliefs about their medicine and their 
fear from getting addicted. The following quote illustrates this point. 
I normally find that adherence is affected when they are about to switch into a basal insulin 
programme. They are scared of needles, they think it's serious. They fear getting dependent on 
medicines and that scares them. Yes. I think adding insulin is the hardest challenge we face here. 
Pharmacist 2, woman, Emirati 
A few patients who were either on or in the process of starting on insulin therapy as part of their 
treatment plan expressed uneasiness towards the use of insulin. This discomfort was 
engendered by two main factors: (i) associating insulin therapy with diabetes complications or 
the seriousness of their health condition; and (ii) the fear of getting dependent on insulin 
therapy for the rest of their lives. Patients believed that insulin was the last resort therapy that 
doctors prescribe when oral medicines fail to deliver therapy goals. Therefore, insulin therapy 
indicated a worsening of their diabetes. Patients also associated insulin therapy with total 
dependence on an injection for the rest of their lives. These thoughts made some patients 
reluctant and sometimes resistant to insulin therapy. Patient 6 narrates his experience with oral 
medicine and insulin in the following quote: 
You know, to think that you'll always need tablets or injections to stay alive is a terrifying 
thought. Before / become diabetic I never understood that. I used to feel sorry for my [diabetic] 
friend. Before we started a meal, he would have to leave the gathering and go somewhere 
private to inject himself. Now that I am diabetic, I am scared of starting insulin. The memory of 
him taking a corner and injecting himself scares me to death, you know? I don't want to be 
hopeless and unable to eat without having to inject myself first. 
Patient 6, man, 65 yrs, Yemeni 
Another group of patients in this study perceived medicines as chemicals that are harmful to 
their bodies. Patients' awareness of the potential side effects of drugs fuelled their belief in the 
detrimental characteristics of their prescribed medicines. 
Medicines are useful I have to admit. They fix your blood pressure and your diabetes. But in 
reality they are chemicals and not natural things. They are made in laboratories. Chemicals can 
destroy your body, can affect your heart, your brain, your kidneys. So they damage one while 
fixing another. 
Patient 16, man, 57 yrs, Palestinian 
In this study a group of patients reported that medicines were addictive harmful substance. 
Some also indicated that such a perception affected their adherence to their prescribed 
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medicines. HCPs were mainly aware of these types of patient concerns about initiating insulin 
therapy. However, none of the interviewed HCPs articulated concerns similar to what patient 6 
expressed in the previous quote. 
6.2.2 Different brands of medicine 
A group of pharmacists in this study talked about the impact of the brands of medicines on 
patients' adherence. Medicine shortages were occasionally resolved by a temporary supply of 
different brands of the same medicines. These changes, however, where not always welcomed 
by patients when visiting the pharmacy for prescription refills. Some patients believed that 
different brands of the same medicine varied in their efficacy, side effects and potency. Patients 
sometimes refused to have their medicine brands replaced by another. Pharmacists believed that 
patients' perception of the brand of their medicines affected their adherence to the treatment 
plan. 
Patients are used to one brand and they don't want us to change it for them. They sometimes 
argue: 'why did you change my medicine? This one won't work. Now my blood sugars will 
elevate'. So they're either psychologically affected by the change in the brand or the new brand 
is actually not giving them good results. 
Pharmacist 10, woman, Emirati 
The first policy on the prescribing of generic medicines in Abu Dhabi was published in May 2010 
(HAAD 2010). Before that date, physicians in the UAE were encouraged to prescribe using 
generic names rather than brand names of medicines. Most physicians in SKMC prescribed using 
generic names of medicines. However, SKMC's drug formulary contained branded medicines 
that were subject to change upon medicine contract renewal or whenever there was a shortage 
of certain brands. This meant that patients would sometimes receive different branded 
medicines depending on the availability of that specific brand. According to participants' 
responses, most patients noticed the change to the brands of their prescribed medicine. 
Patients' reactions towards brand changes varied but was mostly characterised by disapproval 
and sometimes resistance. In the following two sections, the views of patents and professionals 
are presented to facilitate a deeper illustration of this factor's impact on the pharmacological 
management of patients with MetS. 
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One important finding in this study was patients' perceptions of western manufactured brands 
of medicines (WB). Pharmacists talked about cases where patients' refused to receive equivalent 
non-western branded (NWB) medicines of their regular drugs because they believed western 
brands were more effective. Some patients did not mind waiting for a WB of their chronic 
medicine to become available and collect it later. Although pharmacists explained to patients 
that NWBs were as good as WBs, patients usually insisted on taking the WBs. Pharmacist 2 
talked about her experience concerning this point in the following quote: 
Patients like Amoxil® Tenormin® and Glucophage®, you know, all the western brands. When 
they see Julphar® [a local UAE drug manufacturer] they immediately say: "1 want the original 
not the copy. If you give us this we won't take it". I try to explain that we don't have a stock of 
the brand they want, they say they'll wait for it until it arrives. It is very hard to deal with this 
problem. If I put myself in their place I would probably do the some. 
Pharmacist 2, woman, Emirati 
The drug market in the UAE includes drug products manufactured by many global, regional and 
local drug companies. The UAE ministry of health (MOH) mandates that all branded and generic 
medicines be supported by studies of bioequivalence and to pass quality assurance tests in local 
drug laboratories. Drugs are licensed to be sold in the UAE market only when these two 
requirements are met (MOH 2010). NWBs of medicines are not generics but rather branded 
medicines that drug manufacturers in the UAE or other Arab countries manufacture after the 
original brand, which is in most cases a patent-expired WB, (Figure 6.1). Many pharmacists 
interviewed indicated that patients preferred WBs over NWBs of the same generic. 
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Figure 6.1 Example of western branded and non-western branded medicines 
Zocor' 40mg (on the left) is the original patent brand of simvastatin manufactured by the western drug company 
Merck & Co. Simvasta 40mg (on the right) is the local brand of simvastatin manufactured by the Emirati drug 
company Julphar. Both Zocor® and Simvast® are branded medicines and not generics. Many patients indicated that 
they preferred WBs to NWBs of medicines. 
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In the current study, patients were asked about their perceptions of different brands of their 
medicines. They were also asked whether they preferred a WB to a NWB of the same generic 
and how they believed this affected their health and medicine use. A number of patients 
believed that NWBs were 'cheap copies' of the 'expensive original' WBs indicating the 
superiority of WBs over NWBs in efficacy and quality. Other patients supported their claims with 
details of suboptimal therapeutic outcomes experienced with NWBs. 
We all know that these [NWBs] are copies. A copy is always a copy, it is never the original 
thing. I tried Atenol® [a local atenolol brand] once and my heartbeats shot up to the roof. It is 
not the some as Tenormin®. I tried it and I can assure you that there is a difference between the 
two. Even when you look at the price of these copies they are always cheaper because they 
(manufacturers) know it's not as good [as WBs]. 
Patient 4, man, 60 yrs, Yemeni 
Patient 20 felt that only chronic conditions required the use of WBs to ensure efficacy. In his 
perception, diseases such as diabetes and blood pressure were 'serious conditions' that required 
'serious drugs'. 
don't mind using [locally manufactured] cough syrup and Adol® [paracetamol] they are ok. But 
for my blood pressure and diabetes I prefer the real thing. These are serious conditions [blood 
pressure and diabetes] and for a serious condition you need to take a serious drug, you know? 
Patient 20, man, 37 yrs, Emirati 
A few patients believed that WBs sold in their countries of origin were of superior efficacy and 
quality to identical WBs sold in the Emirati drug market. They indicated the differences in 
packing and their own experiences as proof of differences in quality between the two identical 
WBs. 
/ had some stock of the medicine I received when I used to live in London. Although they give me 
similar medicines here, they are not like the ones sold over there. They send us rubbish, you 
know? The stuff that they won't allow their people to take. Even their Panadole is different from 
ours. The packing, the shape of tablets, the taste it's all different. You take it and five minutes 
later the headache is gone. The Panadol® we buy here works after one hour and sometimes it 
does not work at all. There everything is fresh and better. Here it's probably old stock that 
doesn't work. 
Patient 22, woman, 52 yrs, Yemeni 
The viewpoint of patient 22 could explain the negative perception of another group of patients in 
this study towards WBs. A distrustful attitude towards western foreign policies made some 
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patients suspect that western products available in developing countries and the Middle East to 
be harmful. Patient 20 explains why he preferred local brands of medicines to WBs in the 
following quote: 
Drugs are harmful chemicals especially the ones that come to us from the west because they 
don't care about us. Anything that has defaults or errors in the chemical mixture, they won't 
throw away, no, they'd rather make money from it, so they will sell it to us because they see us 
as stupid and unworthy of living. I believe that all medicines are harmful because they are 
unnatural. But if we are going to buy these chemicals anyway we should at least support our 
local companies. You know? (Laughing). 
Patient 20, man, 37 yrs, Emirati 
Some patients believed that all medicines were harmful chemicals regardless of where they 
were manufactured. These patients did not mind using NWBs as they did not see any difference 
in efficacy between the two brands, because they believed all medicines to be unnatural 
substances. 
take anything. I don't mind. If they want to give me on English drug, that's good. If they want 
to give me an Egyptian drug that's good as well. At the end they are all chemicals. You swallow 
them, they go into your stomach, do their thing and then your blood pressure is ok. 
Patient 5, man, 50 yrs, Yemeni 
Another patient said that she preferred a NWB to a WB of medicine because it did not cause her 
irritation. Although this patient has medical insurance and does not pay for her medicines, in her 
story she revealed how the pharmacist tried to advocate for the western brand by implying that 
it's 'original', 'better' and 'more expensive'. The pharmacist did not have the non-western brand 
that she wanted and wanted to convince her of the only brand he had in his pharmacy stock. 
Neurobion ® does not suit me, you know, I wanted the other one, you know? The Jordanian one, I 
can't remember what it's called. The pharmacists said: 'take this [Neurobion J. It's the original; 
it's more expensive than the other one. it's better' I told him no. I don't like it, because it did not 
suit me. 
Patient 9, woman, 43yrs, Emirati 
In the current study, some patients showed indifference to medicine brands. However, this 
attitude was sometimes engendered by patients' beliefs that all medicines are chemicals 
regardless of their country of origin. Others preferred NWBs to WBs because of positive 
experiences with the former. This could suggest that patients' perceptions can change based on 
positive outcomes that they experience with medicine brands. 
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Pharmacists interviewed were more familiar with patients' attitudes towards medicine brands 
compared to other HCPs in this study. This could partially be due to their speciality that enables 
them to interact with patients through the process of prescription refills and medicine supply. 
HCPs believed that patients' attitudes towards medicine brands were due to: (i) patients' 
negative experiences with NWBs; (ii) lack of education about medicines; (iii) the influence of the 
society that promotes western manufactured products; and (iv) the influence of physicians. An 
interesting finding was HCPs positive perception of WBs that enabled them to sympathise with 
patients' disapproval of a NWB medicine substitute. Pharmacist 7 illustrates this point as she 
narrates her own experience with WBs and equivalent NWBs: 
To tell you the truth, I agree with these patients [who refuse NWBs]. I myself don't use local 
[brands of] antibiotics. From my experience they are not as good [as WBs] and I'm honest here. 
So they have the right sometimes. I think patent medicines should always be prescribed, 
especially with diabetes, heart diseases and infections. 
Pharmacist 7, woman, Emirati 
HCPs also believed that patients' preference of WBs was worthy of further investigation to 
explore NWBs efficacy through empirical studies. HCPs believed that such studies would help 
determine the legitimacy of patients' claims. Other pharmacists felt that patients' familiarity with 
and trust of their regular brands was responsible for their attitude and not necessarily the 
manufacturing country of the branded medicine. One physician felt that the western 
manufactured products in general received high praises from media and society. This, in her 
perception, might have contributed to patients' biased attitudes towards WBs of medicine. Her 
following quote explains this point: 
We love anything that comes from the west, we like their cars, their clothes, their drugs and 
their food. In the media, we praise everything that comes from the west. And it affects the 
ordinary people. If you ask me sometimes it is a bit of this attitude, you know? If it is from 
America or from Europe then it must be the best. 
Physician 4, female, Jordanian 
Some pharmacists believed that physicians' attitude towards WBs of medicine influenced 
patients' beliefs about the brands of their prescribed medicines. In the following quote 
pharmacist 2 explains this point as she describes her experience with patients refusing to have 
their WBs changed to NWBs. 
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Our problem is the doctors. They don't prescribe generics, and they write specific brands on the 
prescriptions. Sometimes they tell patients to refuse any other brand. I think doctors are brain 
washed by medicinal representatives. And then doctors brainwash patients to believe that 
certain brands are better than others. 
Pharmacist 2, woman, Emirati 
Physicians interviewed did not express any preferences for specific brands of medicines. They 
reported that patients are prescribed evidence-based medicines. They indicated that most 
medicines used for the management of CRFs are patented brands of medicines, which can 
sometimes be western manufactured brands of medicines. This, they explained, was the reason 
they sometimes used the brand rather than the generic name of medicines in patients' 
prescriptions. Physicians also stressed the importance of including brands that have undergone 
quality assurance tests in the hospital formulary. 
I don't accept any drug to be included (in the drug formulary) if it did not pass the quality 
assurance test. It has to be trialled and proved to be excellent and able to deliver the therapeutic 
goal. Everything needs to be evidence-based. Those are the medicines that we need to prescribe 
for our patients if we truly care about them and we want to provide them with the best quality 
of health care. 
Physician 7, man, Egyptian 
Abdul Rasool et al (2010) assessed physicians' prescribing habits in the UAE by screening 150 
prescriptions and surveying the perceptions of 100 physicians about irrational use of medicines 
in the UAE. All prescriptions scanned were issued by the participating physicians in the survey. 
Although 72% of physicians reported the use of generic names of medicines in their 
prescriptions, prescription analysis showed that only 7.35% of medicines were prescribed by 
their generic names (Abdul Rasool, Fahmy et al. 2010). Another European survey investigated 
physicians' attitudes towards the prescribing of generic medicines. Results showed that one 
quarter of the 117 general practitioners that participated in the survey reported their need for 
additional clinical trials on the effectiveness generics. They indicated that such studies would 
encourage them to switch from prescribing branded medicine to prescribing generics. These 
findings suggest that although physicians acknowledge the importance of generic prescribing, 
this belief was not always translated into practice (Kersnik and Peklar 2006). HCPs' attitudes 
towards the use of generics in prescribing can affect patients' perceptions of the brands of their 
medicines. In a qualitative study that explored patients' attitudes towards generic 
antihypertensive medicines, a number of Norwegian patients indicated that they trusted their 
physician's choice of medicines. They were, therefore, left uncertain when pharmacists changed 
the brands of their medicines (Toverud, Roise et al. 2010). 
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In the current study, some HCPs also believed that idealising western products in general 
through media and society influenced patients' preference towards WBs. One patient who 
preferred NWBs reported that pharmacists sometimes unintentionally promoted WBs in their 
attempt to convince her to accept having her medicine brand changed (see patient-9 in section 
6.3.2.1). This example illustrates how some HCPs may unintentionally emphasise the medicine 
brands to patients rather than the generic component. This example and others in this section 
also highlight the significance of medicine brands and their manufacturing countries as a 
powerful factor that influences both patient and HCP perceptions of medicine in the UAE. To our 
knowledge, this is the first study that identified such findings where patients talked explicitly 
about reasons behind their preference of WBs or NWBs. 
6.2.3 Complementary therapy 
Complementary therapy in this study refers to patients' use of unconventional medicines or 
strategies in the management of their presenting CRFs. Based on HCPs' experience, 
complementary therapy was very popular amongst people living in the UAE and especially 
patients with MetS. HCPs felt that there were two main factors to patients' preference of 
complementary therapy: patients' awareness of the potential side effects associated with their 
conventional therapy and perceiving medicines as harmful chemicals (see section 6.2.1). 
They love complementary medicine in this country. Oh my God! They have a plant or a remedy 
for every problem. Sometimes they use herbs that their grandfathers used. And you never find 
out because they drink it like they drink water. They think such therapies are safer than 
conventional medicine. They see herbs as normal and natural so they think they are safer than 
taking a tablet or an injection 
Physician 2, man, Sudanese 
Participants in the study reported a number of alternative therapies used by their patients such 
as herbal medicine (e. g., Myrrh, Ginger, Thyme, Senna and Black seed), ozone infusion therapy, 
and wet cupping. This section presents three main forms of alternative therapies that were 
believed to be popular amongst patients with MetS living in the UAE: (i) herbal medicine; (ii) 
ozone infusion therapy; and (i) Islamic medicine. 
Herbal medicines are defined as preparations containing plant components in a raw, semi- 
processed or processed state, which are used for the treatment or prevention of diseases. 
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Individuals living in the UAE can easily purchase herbal medicines from specialist outlets known 
as 'condimental' shops or through other retail outlets such as pharmacies, health food shops and 
supermarkets (AlBraik, Rutter et al. 2008). In this study, HCPs believed that patients with MetS 
frequently used herbal medicine alongside their conventional prescribed medicines. Many HCPs 
did not object to patients' use of herbs but were mainly concerned over the quality, safety and 
efficacy of herbal remedies and the potential herbal/conventional medicines interaction caused 
by their concurrent use. 
I don't mind them using green tea, or senna, or any of their Yaddoh [grandmother] remedies. 
These are not harmful herbs. But I'm really worried about these capsules that some patients get 
from somewhere or someone trying to rip them off. It could damage their kidneys or interact 
with their medicines. 
Pharmacist 6, woman, British 
A number of patients interviewed reported that they were either using or used herbal 
medicines in previous occasions. Some patients indicated that herbal medicines were used 
conjointly with conventional medicines to help achieve better therapeutic outcomes. Others 
indicated that using herbs was intended to avoid the need to add or increase the dose of 
prescribed medicines (see sections 6.2.1). 
I take a mixture of ginger and fenugreek which helps with my blood pressure and cholesterol. I 
do not want my doctor to give me more medicines. So far, I take five medicines for everything. 
And this mixture I take will add extra benefit 
Patient 24, woman, 46yrs, Emirati 
Ozone infusion therapy was another alternative therapy that HCPs believed was popular 
amongst MetS patients in the UAE. Ozone infusion therapy refers to the use of ozone in limited 
doses to help heal various medical conditions. During an ozone infusion therapy session, the 
patient's blood is drawn into a bottle where it is infused with ozone and then transfused back 
into the patient. Ozone therapy claims to improve the body's immune system, blood circulation 
and to activate cellular metabolism (Cassileth 2009). HCPs talked about the popularity of ozone 
infusion therapy amongst patients with MetS or CVDs in the UAE. Patients use ozone infusion 
therapy to normalise their lipid profile and treat other cardiac conditions. Despite the weak 
evidence in support of its effectiveness, many patients undergo ozone therapy due to their fear 
of side effects from prescribed medicines. 
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Ozone therapy is very popular here. Patients travel to India or to one of the centres here. They 
pay a lot for one session. They believe that it gives the body energy, rebuilds normal coronaries 
or the vasculature system in the body, and reduces cholesterol and many things. People have 
doubts about conventional therapy and instead go for these things. Psychologically they feel 
better. Patients think that it's a natural therapy so it's better than taking chemicals. But is it 
really effective? I don't think so. 
Physician 4, woman, Jordanian 
Only one patient reported using ozone therapy to help 'cure' her diabetes. Patient 29 travelled 
to Jordan after reading about it in a magazine and discussed going through a single session. She 
did, however, indicate that such an attempt was made at the onset of her diagnosis with 
diabetes and she was only prescribed a single anti-diabetic agent at that time: 
1 did one session of the ozone therapy at the beginning of my diagnosis [with diabetes]. 
thought maybe it will reverse the diabetes or stop it from progressing since I was at the first 
stages and was taking only two tablets of metformin®. But it did not work. Maybe I needed to 
do more sessions but I didn't notice changes so I stopped. 
Patient 29, woman, 34 yrs, Emirati 
Patients' fear of the side effects of conventional medicine drove them to seek complementary 
treatments. HCPs did not disapprove of ozone therapy or feel that it endangered patients' 
adherence to prescribed medicines. Their responses mainly indicated their doubts about the 
effectiveness of ozone infusion therapy. 
Islamic medicine or Arabic medicine refers to the traditional medicine that is partially inspired by 
Islamic teachings and aims at treating or preventing a number of diseases (Saad, Azaizeh et al. 
2005). Islamic medicine originates from the time of the Muslim prophet Mohamed when he gave 
his followers some medical advice on the treatment of specific illnesses, such as diarrhoea, 
constipation and headaches. More methods were added throughout the years by scholars and 
other Muslim traditional healers. However, three methods of healing that the prophet used 
were documented, which included honey, cauterization and hijama or wet cupping (Adib 2004). 
Hijama, which is Arabic for wet cupping, was a practice HCPs talked about and believed patients 
performed to help manage some of their health conditions (Figure 6.2). 
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Figure 6.2 A man undergoing hijama or wet cupping 
Hijama is one of the traditional practices of Islamic medicine that is encouraged by the Muslim prophet Mohamed. 
Blood is released through vacuuming from a small skin incision and collected into a small glass cup. It is believed to be 
beneficial in many conditions such as headache, general body pain and elevated blood pressure. 
Many HCPs considered hijama to be part of the preserved Islamic medicine tradition, which is 
practiced by many licensed Islamic medicine health centres in the UAE, and they did not object 
to having it done for conditions such as high blood pressure and migraine. They were mainly 
concerned about the competency of the healing centres at which such practices were 
performed. 
I have a lot of patients who do hijama. Recently I had a patient who said: 'I've done it lost 
month. I'm very healthy, and 1 have to repeat it again every six months'. I don't mind that at all. 
I'm only concerned about blood-borne infection, this is really my nightmare so I advise them to 
do it somewhere reliable. (... J 1 believe in the therapeutic value of the hijama. It is mentioned in 
the Hadith and there is scientific evidence that supports that. 
Physician 6, man, Egyptian 
Only one patient interviewed admitted undergoing sessions of hijama twice a year to prevent 
regular migraine attacks and improve her blood pressure. Another two revealed their intention 
of performing it in the future. In all three cases, patients indicated that their physicians were 
informed of their plans and that they gave them their approval and support. 
I do hijama twice a year for my migraines. I usually tell my doctor before I do it and she doesn't 
mind at all. I tell her about everything I'm planning to do because there are people who sell you 
things [herbs] and she usually advises me and tells me whether something [herbal medicine] will 
work or not. 
Patient 12, woman, 43yrs, Palestinian 
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HCPs' attitudes towards Hijama stemmed from their understanding that such practices did not 
harm patients' health or alter their conventional management of MetS. Others believed in the 
therapeutic value of such practices and therefore gave their approval or encouraged patients to 
perform such therapies. Hijama or wet cupping is an ancient medical technique. It is also 
currently practiced in many parts of Europe and the East (Haller 1973; Ban 2010; Cao, Han et al. 
2010). The therapeutic benefits of hijama in health conditions such as blood pressure and lower 
back pain were explored and identified through a number of randomised control trials (Ahmadi, 
Schwebel et al. 2008; Farhadi, Schwebel et al. 2009; Lee, Choi et al. 2010). The use of hijama by 
people in different communities was also explored through qualitative studies conducted in 
Israel and Iran (Tandeter, Grynbaum et al. 2001; Rahnama, Hidarnia et al. 2010). However, the 
use of hijama in patients with MetS in the UAE is not adequately reported in literature. Other 
HCPs, in this study, believed in the therapeutic value of such practices and therefore gave their 
approval or encouraged patients to perform such therapies. In general, HCPs did not object to 
patients' use of complementary medicines but were mainly concerned about the quality safety, 
efficacy of such therapies (i. e., herbal medicines, ozone therapy or Islamic medicine). However, 
they agreed that patients' misconceptions about their prescribed medicines must be rectified 
through education and proper medicine use assessment. 
6.3 Polypharmacy 
Polypharmacy is a commonly used term that means the use of multiple medications by the same 
patient (Lee 1998). Patients with MetS have a clustering of CRFs that may require a complex 
therapeutic regimen to ensure control and achieve therapeutic goals. In addition to lifestyle 
interventions, patients with MetS might end up taking antihypertensive medicines, oral anti- 
diabetic agents, medicines for dyslipidaemia and sometimes anti-obesity agents. Patients with 
MetS might also need to take more than one agent for the management of a single CRF. Thus, 
polypharmacy is one of the consequences of pharmacological interventions in patients of with 
MetS (Grundy 2006; Kappagoda and Amsterdam 2007). 
All patients interviewed had four or more medicines prescribed for the management of their 
clustered CRFs. During interviews that took place inside patients' homes, patients usually 
showed the researcher their 'bag of medicines', a plastic bag used to store all their prescribed 
medicines. In interviews conducted in other places or over the phone, patients reported similar 
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methods of storing drugs. Patients' narratives indicated their sense of polypharmacy and the 
large number of medicines they were prescribed. 
Look [pointing at the plastic bag of medicine] I keep all my medicine here. I'm a walking 
pharmacy 
-laughing- they prescribed everything they could for me. Anything people [with MetS] 
use I have here. Drugs for the (blood) pressure, for diabetes, for cholesterol. vitamins. Panadol ®. 
Medicine for my back. Medicine for my knees. Everything you can think of is in this bag 
[laughing]. 
Patient 3, woman, 69 yrs, Yemeni 
HCPs cited polypharmacy as the most influential factor in regard to patients' attitudes towards 
their prescribed medicine and as a major limitation to patients' adherence. They believed that 
polypharmacy complicated MetS management and subjected patients to the problem of 
forgetfulness and confusion, especially patients with poor educational backgrounds. 
Polypharmacy is the patients' main problem. Having to take between 10 to sometimes 15 
medicines can confuse some or make them forget what they took and what they didn't. Some 
are illiterate and can't remember drug indications, what tablets are for diabetes and what 
tablets are for hypertension, you know? 
Pharmacist 12, man, Syrian 
A few pharmacists felt that polypharmacy was not a critical barrier especially with patients on 
chronic medications. In their perception, patients with chronic diseases such as MetS develop 
strategies that facilitate their adherence. The following quote illustrates this point: 
Maybe on diagnosis patients might struggle with their medicine, but with time they know 
everything and remember everything. Taking medicine becomes second nature. They also 
develop techniques to remind themselves of medicine and we help them with that. They put 
their medicines in plastic bogs so that they don't lose anything. They mark their medicine to 
know which is for what. They become the experts. 
Pharmacist 14, woman, Egyptian 
Most patients interviewed reported strategies similar to those described by pharmacist 14 to 
facilitate their adherence. Many patients did not express or report difficulty in adhering to their 
multiple prescribed medicines. Patients also showed techniques that they used to remind 
themselves of their drug names and indications. An example of such a techniques was keeping 
all medicine in one location (i. e., plastic bag or a box) and writing indications on top of the 
medicine packs. If the patient was illiterate, lines or numbers would replace words to indicate 
number of doses per day on the top of medicines boxes. Pharmacies usually gave dosette boxes 
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mainly to illiterate patients or elderly patients who did not have a carer to assist them in taking 
their prescribed medicines. 
Another group of patients in the study expressed uneasiness towards having many drugs 
prescribed for them. However, they were mainly concerned with the chemical impact of these 
medicines on their bodies and potential side effects. This group of patients' perceived medicines 
as chemicals that cause damage to their bodies. Such patients believed that increasing the 
number of medicines increased their exposure to chemicals and eventually the risk of being 
harmed. Patient 13 explains this point in the following dialogue with the researcher: 
R: Are you happy with the amount of drugs you are taking? 
P: No. no. I'm not happy 
R: Why is that? 
P: /feel I'm taking more medicines than I should. You know? These [medicines] are chemicals. 
They're all made of chemicals. And I'm taking too much. This may harm my other organs like my 
kidneys and my liver. 
R: What do you do about that? Do you stop taking them? Do you tell your doctor? 
P. She knows I'm not happy, she says: 'no they are good for you'. So I'm looking for a good 
remedy [herbal medicine] to reduce the intake of these tablets. 
R: And if you find this remedy, will you stop taking these tablets? 
P: No. no. I just want to reduce the number of tablets, so if I can find a herb that will fix my 
cholesterol I won't be needing Lipitor®. You know what I mean? 
Patient 13, man, 49 yrs, Bangladeshi 
Difficulty in coping with and adhering to multiple medicines was not a direct cause of these 
patients' discontent with polypharmacy. Perceiving medicines as harmful chemicals that might 
damage vital bodily organs was the main reason behind patients' dissatisfaction with 
polypharmacy (see section 6.3.1.1). 
A number of pharmacists believed that the use of drug combination formulations would help 
lower the impact of polypharmacy in the management of MetS. Drug combination formulations 
would reduce the number of tablets taken by patients with MetS on a daily basis and would, 
therefore, reduce confusion and forgetfulness. 
One of the best solutions to avoid polypharmacy to give patients drug combinations. You know. 
Combinations will reduce the number of tablets patients will need to take every day. They won't 
miss their medicines or get confused. 
Pharmacist 16, female, Egyptian 
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Other pharmacists reported the use of dosette boxes more frequently with older patients or 
those with MetS. Adherence to medications among patients with chronic conditions is 
disappointingly low. The pharmacological treatment of patients with MetS results in prescribing 
complex drug regimens that might affect patients' adherence (Kappagoda and Amsterdam 
2007). HCPs concerns about polypharmacy where not equally shared by patients. The accounts 
of many patients indicated that what they found challenging was not the number of medicines 
but rather their lack of competence during the start of the treatment regimen. However, they 
explained that with time they acquire the necessary skills to manage their medicines more 
effectively. The following extract is taken from an interview with patient 16. He was asked to 
describe how she felt towards taking 10 tablets every day: 
R: So how many tablets do you take? 
P: I take about 10 everyday [patients gives detailed explanation about each drug] 
R. And how is that with you? Is it difficult? You know.. to take them and remember them? 
P. Oh no. not at all. I just take them. You get used to it. I mean they were not that many when I 
was first started [taking medicines] But they increased with time (laughing). No it is not difficult. 
Maybe in the beginning because you are new [to taking medicines] but the doctor explains to 
you everything. And you take them as directed. 
R: And do you take them every day? Or do you forget them sometimes? 
P: No. no. I never forget taking them. 
Patient 16, man, 57 yrs, Palestinian 
As illustrated in this section, although polypharmacy was an issue that concerned HCPs, patients 
expressed skills and competence when it came to managing their medicines. However, 
increasing the number of prescribed medicines enhanced patients' concerns about the safety of 
these medicines. 
6.4 Medicine accessibility 
Medicine accessibility in this study referred to factors that impact patients' access to their 
pharmacological management. HCPs and patients cited medicine shortages and the new medical 
insurance scheme as the two main factors that affect patients' accessibility to their drugs. 
Patients' overuse of medicine was also reported by participants. The following sections present 
these findings. 
A number of pharmacists and patients in the study reported cases of unavailability of medicines 
or unavailability of required dosage/strength at times of prescription refill. Medicine shortages 
213 
Chapter 6 Factors influencing medicine use 
were often resolved by temporary replacements with other brands, agents or doses (Figure 6.3). 
This, in their perception, confused patients and further complicated their management (see 
section 6.3.1.3). Pharmacist 8 explains this point in the following quote: 
Sometimes it is our fault that patients don't take their medicines because we sometimes run out 
of some drugs. I remember at one time we ran out of Co-Diovan® 160/25mg, so we gave 
patients two tablets of the Co-Diovan 80/12.5mg. When we ran out of that we gave them 2 
tablets of Diovan 80mg and half a tablet of the hydrochlorothiazide 25mg. And all this confuses 
patients. Not to mention changing brands, which is another problem. 
Pharmacist 8, woman, Emirati 
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Figure 6.3 Example of multiple medicine dosages that can result in patients' confusion 
In the previous quote narrated by pharmacist-8, the shortage in Co-Diovan® 160/25mg (the pack in the middle) was 
replaced by two tablets of Co-Diovan® 80/12.5mg (pack on the right). Such changes in doses can sometimes result in 
patients' confusion and errors in doses. 
In the following quote, Patient 8 narrates her experience when her regular insulin brand was 
short of supply. The quote illustrates how medicine shortages can indirectly affect patients' 
adherence with their pharmacological interventions. 
A few months ago [the pharmacy] ran out of the insulin needles [insulin in vials] and wanted to 
give me [insulin] pens. I said no. I don't like pens I like the needles. So I told them no way. They 
said that I'll wait for a long time and I can't stay without insulin, you know. So I said yes. And 
they showed me how to use it. I took them and it was a very bad experience, you know? Really 
bad. I felt I was going to die. I could not use them well. Maybe the doses were not accurate. I 
don't know. Three days later I bought the insulin from a private pharmacy. I spoke to my doctor 
and told him I was going to die because of these pens. 
Patient 8, woman, 52, Iranian 
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Other patients indicated that when the required medication, dose, form or even brand was not 
available in the hospital, they were purchased from private pharmacies. This in some cases could 
be linked to patients' brand preference, which was discussed in section 6.2.3. 
6.4.1 The impact of health insurance 
The Abu Dhabi national health insurance scheme was another factor that participants in this 
study believed limited patients' accessibility to medicine. Before January 2007, the UAE 
government provided free health care service, including treatment to all residents of the 
Emirates. Due to the country's high expenditure on health care, a new comprehensive health 
insurance law was enforced on all residents of Abu Dhabi where costs are shared between 
employers and employees. However, there are different types of health insurance policies that 
vary according to a working individual's monthly income. Employees of low monthly income are 
provided with basic medical insurance that covers the treatment of defined chronic illnesses and 
specific drug types (HAAD 2005). Patients with basic health insurance policies do not have all 
their chronic medicines covered, which was either solved by patients paying for the full price of 
these medicines or not collecting them at all. 
Low-income people cannot afford the drugs even with DAMAN. Their medicinal insurances does 
not cover everything, especially if they have the basic plan, which doesn't cover everything. And 
of course they stop taking medicines that they can't afford. Their lipid profile would usually be 
very high. But we can't prescribe a statin because we know that the medical insurance doesn't 
cover it. Statins are expensive and so they end up unable buy it. 
Pharmacist 5, woman, Jordanian 
The issue of medicine costs or prescription copayments was reflected in pharmacists' various 
strategies to reduce medication cost for patients such as: (i) splitting prescribed medicine over 
two prescriptions to reduce the copayment charges, (ii) offering financial support to such 
patients during prescription refills or more commonly (iii) using free samples of medicines 
provided by medical representatives. A group of pharmacists talked about a number of cases 
where they paid prescription copayments for patients who could not afford it. Pharmacist 17 
from the focus group illustrates this in the following quote: 
When the patient is in the pharmacy I try to amend and adjust the prescription so that he'll pay 
the least amount of money and at the some time get all his medicine. Sometimes I help him 
financially. Sometimes we [pharmacists] collect money from each other and pay his copayment 
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charges. Not all of patients can [pay]. We help them for Allah. We get more blessings when we 
help them. So we do help. 
Pharmacist 17, woman, Egyptian 
A few patients talked about the impact of the new health insurance programme on their 
adherence. This could be explained by the small number of patients with the basic health 
insurance policy taking part in this study. These patients were concerned with the additional 
prescription copayments that affected their monthly expenditure. Patients described different 
strategies used to reduce their prescription costs such as omitting some of the prescribed items 
at the time of prescription refill, or taking a smaller dose or buying a cheaper over-the-counter 
product from a private pharmacy. The use of free medicine samples or medicine returns offered 
by pharmacists and physicians was also mentioned. Patient 10 talked about her pharmacist's 
attempt to help by providing her with medical samples of her monthly statins and insulin pens. 
Thank God for [pharmacist name] he gave me some Lipitor® and Mixtard® pens. He had some 
extra or samples I think. He managed to get me two Mixtard ® pens and said he will call me as 
soon as he gets more. Doctors also help me and give me some samples too. So I manage, but if it 
wasn't for them I would have paid a lot. 
Patient 10, woman, 50 yrs, Palestinian 
Another patient was mainly concerned with the time she spent waiting in the hospital for the 
health insurance company to authorise her medical tests such as laboratory tests, X-rays and 
MRI scans. 
lt is no longer a [medical] service now. You wait for ages for the hospital to contact the 
insurance company to see if your health policy covers the medical tests. They should provide a 
better service. We are paying more now for everything but the service is deteriorating. You come 
out of the hospital sicker than when you came in. 
Patient 12, woman, 43yrs, Palestinian 
Findings from this study indicated that medicine inaccessibility was significant amongst patients 
with the basic health insurance plan. Pharmacists and physicians were aware of the impact of 
the national health insurance on medicine accessibility and its effect on patients' adherence to 
prescribed treatment. They also reported strategies used to help this group of patients 
overcome copayment difficulties. The privatisation of the health care service in Abu Dhabi 
affected medicine accessibility and resulted in inequality of health services amongst the 
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country's residents. During this study, literature that explores the impact of Abu Dhabi's new 
national medical insurance schemes on patients' health outcomes was not available. 
6.4.2 Irrational use of medicines 
Irrational use of medicine, in this study, referred to patients' unmonitored excessive supply of 
their regular medicines or the use of unneeded medicines. HCPs reported two behaviours of 
patients that result in irrational use of medicines: (i) visiting different private clinics or travelling 
abroad for treatment; and (ii) requesting additional medicines from their physicians. Some HCPs 
referred to such behaviour as 'medicine shopping' indicating patients' unreasonable tendency to 
collect extra or unneeded medicines. HCPs talked about patients' habit of visiting other private 
clinics for the management of their CRFs despite receiving monthly treatment from one of 
SKMC's family medicine clinics. 
Patients in the UAE like to go to different doctors and so sometimes it is hard to follow your 
patients and they go here and there and everywhere and get different advice, different medicine 
and they get confused, the doctors get confused. We call that 'medicine shopping' and we really 
don't want patients to end up taking double the recommended doses. 
Physician 10, woman, British 
Pharmacist 1 felt that such behaviour increased the risk of double dosing and toxicity. She also 
indicated that a centralised database to monitor patients' visits to different clinics in the UAE 
would help update patients' medicine profile. This type of information would enable HCPs, 
including pharmacists, to monitor patients 'medicine shopping' behaviour. 
There is no computer system that's universal that looks at it so that any pharmacist or any 
physician who goes into the system can see that there is a potential problem. Patients go to 
different clinics and have different medical files in each of these clinics. We need a system that 
will allow us to see what these patients were prescribed. 
Pharmacist 1, woman, Canadian 
Other HCPs talked about patients' habits of demanding certain types of medicine in every visit to 
the clinic. Based on their experience, patients demanded physicians to prescribe at least three 
medicines in every visit regardless of the actual purpose of the visit. In some cases, patients' 
irrational demands forced physicians to prescribe unneeded painkillers or nutritional 
supplements to satisfy their needs. 
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Some patients love medicines. They will not be happy if they leave [the hospital] without a 
prescription. They think that doctors should prescribe something in every visit even if they have 
no problems. I sometimes feel sorry for the doctors here because they are under constant 
pressure from them. Some doctors end up prescribing multivitamins or Ponodol* you know? Just 
to keep them quiet. 
Pharmacist 10, woman, Emirati 
When patients were asked about the 'medicine shopping' behaviour, a group of patients 
admitted visiting private clinics and sometimes travelling abroad for medical treatment. Patients 
referred to such behaviour as 'double checking' and indicated that they aimed to get second 
opinions about their health conditions. They also talked about special measures used during 
these visits to avoid double dosing of their medicines. Other patients indicated that they tend to 
see other physicians when they are about to undergo surgery or other invasive interventions. 
Patient 11 illustrates this point in the following quote. 
My children pushed me to do it (see doctors abroad). My daughter was there with her husband 
for general health check-ups and she said: 'come on mother, since you're here [Bangkok] you 
should see the doctors to' my daughter wanted to make sure I'm ok. But I took all my medicine 
with me and showed it to the doctor there. I told him: 'see. This is what they give me in the 
Emirates. So if you're going to prescribe me something make it something new' [laughing]. 
Patient 11, woman, 67 yrs, Emirati 
People in the UAE have the right to seek treatment anywhere they choose. However, they are 
not encouraged to visit more than one health facility for the treatment and follow-up of their 
diseases. Findings from this study indicated that patients' attitudes towards seeking health 
treatment contributed to the irrational use of medicines. HCPs in this study felt that patients' 
irrational use of medicines was enhanced by the lack of a centralised patient medical records 
database that would enable HCPs to closely monitor updates on patients' pharmacological 
treatment resulting from their uncontrolled visits to private clinics, 'medicine shopping' and 
mobilisation between private clinics. Interestingly, patients in this study had a positive opinion 
regarding seeking other clinics and travelling abroad for treatment. In their perception, seeking 
treatment was to 'double check' their health status and to provide themselves and their 
concerned family members with psychological comfort that they did not need further 
intervention. Patients' irrational use of medicines described in this section is not parallel to 
patients' negative perception of medicines presented in sections 6.2 and 6.3. The fact that two 
conflicting views towards medicine were identified in this study highlights the importance of 
individualisation during education and counselling sessions. One-to-one communication with 
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patients will enable HCPs to identify patient-specific educational needs and design the right 
educational intervention. 
6.5 Patients' poor education about medicines 
In SKMC, health educators provide patients with information about their diagnosis and 
management needs during one-to-one education sessions. However, HCPs reported that patients 
had limited ability to obtain, process and understand basic information about their prescribed 
medicines. They believed that such factors were responsible for patients' wrong beliefs about 
medicines, their unrealistic expectations of the therapeutic outcomes of their prescribed drugs 
and their failure to adhere to their medicines. However, HCPs did not define this barrier as a 
provider-related barrier. To HCPs' understanding, patients received adequate health education 
sessions about their diseases and treatment needs from the treating physician, the pharmacist or 
the health educator. HCPs also described various methods used during clinic visits to ensure 
patients understand and are able to retain information about their drugs and appropriate use. 
Such methods included the use of written material, pictures for illustration, Arabic printed drug 
instructions on medicine boxes, the use of dosette boxes to facilitate adherence, avoiding the 
use of medical jargon and the use of an interactive communication loop. HCPs believed that 
factors outside the realm of their responsibility resulted in patients' poor drug education and 
consequential poor adherence. In the following quote, physician 2 expresses his frustration as he 
attempts to identify the entities responsible for patients' poor education and adherence: 
There is nothing more we can do. We talk to them, give advice, prescribe the top and up-to-date 
treatment for them. We refer them to health educators. We encourage them and we motivate 
them. Our resources and expertise have been drained to the last drop. I think the ball now is in 
the court of the patients themselves and the health care system to try and improve patients' 
sense of health and responsibility. 
Physician 2, man, Sudanese 
HCPs reported a number of factors that they believed affected patients' health education. These 
factors included: (i) limited number of medical staff to cater for patient educational needs; (ii) 
high patient-to-provider ratio, which limited the time available for patient education during 
routine clinic visits; (iii) patient-related factors that hindered adequate education (i. e., patients' 
educational background and high no-show rate to health education session); and (iv) lack of 
collaboration between the health care system and other governmental and private authorities in 
health promotion campaigns. However, underutilisation of pharmacists in patient education and 
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patients' attitudes towards health education were the two overlapping factors that were 
reported in most of the interviews. The following two sections present these two factors in more 
details. 
Most pharmacists in the study indicated that their limited participation in patients' treatment 
plans and health education was partially responsible for patients' attitudes towards medicines. 
Five pharmacists interviewed had a more clinical role that allowed them to assess patients' 
medicine use in one-to-one sessions. However, physicians referred patients to clinical 
pharmacists in cases of suboptimal therapeutics outcomes where nonadherence was suspected 
as a contributing cause. Other pharmacists interviewed were assigned non-clinical 
pharmaceutical tasks that included medicine supply and prescription refills. For this group of 
pharmacists, patient-pharmacist interaction was achieved during medicine dispensing only. In 
such occasions basic information about medicine indication, doses and proper use was rapidly 
provided through a narrow dispensing window. Patients usually lined up in long queues, which 
prevented privacy, and discouraged patients from enquiring about drug-related issues (Figure 
6.4). 
I 
Figure 6.4 The pharmacy setting that limited efficient patient counselling 
The pharmacy layout did not permit efficient patient counselling or assessment of medicine use. Pharmacies have two 
windows for dispensing, men's and women's. The close proximity of these windows and the queuing of patients 
(there was a person in front of the man in the white shirt) prevents privacy, thus discouraging patients from enquiring 
about their medicine. 
Pharmacists suggested that improving the pharmacy layout would facilitate their educational 
role and would eventually rectify patients' beliefs about medicines and improve their adherence. 
Pharmacist 13 explains this point in the following quote. 
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If you look at the pharmacy layout you'll immediately realise that whoever designed it wasn't 
aware of pharmacists' important role in patients' education. Narrow windows that you can 
barely communicate to patients through, no waiting area, patients queuing, no privacy, no 
counselling rooms. But despite all of this, we do our best to tell patients all the information they 
need with the limited resources we have. 
Pharmacist 13, man, Palestinian 
In this study, pharmacists' counselling skills were reserved for cases of suspected patient 
nonadherence only. This limited the proper utilisation of pharmacists and hindered pharmacists 
from delivering proper drug education and counselling to patients with MetS. Although 
pharmacists had the opportunity to provide patient-oriented pharmaceutical care at each 
patient encounter (clinic visits, prescription refill, etc. ), technical barriers such as the pharmacy 
layout hindered pharmacists' full contribution to patients' medicine use assessment. In a study 
by Skomo et al (2008) patients indicated that they would be encouraged to ask pharmacists 
questions about their medicines if the pharmacy layout was improved to facilitate counselling 
and access to pharmacists' advice. 
Several pharmacists reported that many patients refused their invitations to have their 
medicines use assessed or to receive detailed information on medicine use and indication during 
prescriptions refill. They believed that patients' familiarity with the use of their monthly 
medicines, lack of time and the pharmacy setting discouraged patients from accepting 
pharmacists' invitations to have their medicine use reviewed. 
We [pharmacists] want to help them. If I offer to give them explanations, they shout: 'no. no 
we're in a hurry'so sometimes you're scared to even ask. And sometimes they are embarrassed 
to ask because the pharmacy is crowded with patients and they don't want people to overhear. 
Pharmacist 3, woman, Sudanese 
Patients' responses about the contribution of their HCPs to their health awareness or drug 
knowledge varied between different patients regarding different HCPs. Patients were mostly 
critical of their physicians for not being patient-centred in their approach. They indicated that 
physicians usually ignored or did not enquire about their needs during regular clinic visits. Some 
patients reported physicians' lack of eye contact and others indicated physicians robotic and 
predictable responses and activities. Patient 1 illustrates this point in the following quote: 
The moment ! walk in [to the doctor's office] she barely looks at me. And then she immediately 
starts writing my refill prescription. There is no eye contact. There is no "hi how are you? How 
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are you feeling today? " There is no proper conversation, you know. They don't seem to be 
interested in you, they're all figures and numbers. 
Patient 1, man, 45 yrs, British 
The interview analysis revealed patients' sense of their pharmacist's busy working schedule. A 
busy pharmacist seemed to justify both the pharmacist's lack of attention to patients' 
educational needs and patients' reluctance to enquire about their diseases or medicine. 
Different patients gave different examples of scenarios where an opportunity to enhance their 
health awareness was lost because they were embarrassed to interrupt the work flow of their 
HCPs. One example was given by patient 19 when he was explaining why he never asked 
pharmacists for information about his medicines. 
Pharmacists are very busy people. When / go to collect my medicines, they are talking to this, 
giving medicines to that, writing papers, standing all day on their feet. I feel sorry for them. And 
despite all of this they prepare my medicine for me, label them, put them in a bag and give it to 
me with a big smile. 
Patient 19, man, 67 yrs, Emirati 
In the current study, HCPs believed that patients' lack of health education that included 
comprehensive information about their MetS and its management was responsible for patients' 
attitudes towards their prescribed pharmacological treatment. HCPs reported many factors that 
altered efficient health education that were either health care system-related or patient-related. 
However, underutilisation of pharmacists in patient drug education and patients' attitudes 
towards health education were the two most reported factors in the HCP interviews. 
Pharmacists cited many technical barriers that hindered their contribution to patients' health 
awareness. Patients, on the other hand, expressed reticence towards pharmacists and were 
sensitive to their hectic working hours. 
6.6 Summary 
This chapter presented four main factors that affected patients' attitudes towards their 
prescribed medicines. These factors were: (i) patients' beliefs about medicines; (ii) polypharmacy 
and treatment complexity; (iii) accessibility to medicines; and (iv) patients' poor drug education. 
Patients' beliefs that medicines were harmful and addictive substances drove some to look for 
natural alternatives, such as herbal medicine and ozone therapy. In some cases, patients 
intentionally stopped taking their medicines for a few days to avoid getting addicted to them. 
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Changes in medicine brands, form or doses that occurred in cases of medicine shortages resulted 
in patients' confusion and were sometimes rejected. Many patients believed that western 
manufactured brands of medicines were better, more effective and more potent than equivalent 
non-western manufactured brands. HCPs believed that polypharmacy complicated the 
management of MetS and influenced patients' adherence to their treatment plan. A number of 
patients struggled with prescription copayments, while others had a basic health insurance plan 
that did not cover all prescribed medicines. HCPs also believed that patients' ability to visit 
different private clinics or travel abroad for treatment resulted in duplication of their 
medications and overdosing. HCPs felt that patients' attitudes towards their medicines was 
engendered by their poor awareness about medicines. 
The following chapter will present themes that describe facilitators to the management and 
prevention of MetS as suggested by the study participants. 
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Chapter 7 
7.1 Introduction 
Facilitators to MetS management 
This chapter presents facilitators to the management and prevention of MetS in the UAE as 
suggested by the study participants. As participants reported barriers to MetS management, 
they also spontaneously suggested interventions that they believed would either limit or 
counteract the barriers' impact. However, at the end of each interview, all participants were 
specifically asked to propose solutions that might improve the management of MetS or prevent 
an increase in its prevalence in the UAE. Interestingly, HCPs were able to articulate a wider range 
of facilitating strategies than patients did during interviews. HCPs responses indicated that they 
were more concerned with solutions that addressed the management and prevention of MetS 
on a population level, such as public health awareness, disease prevention strategies and health 
research. 
Patients' responses, on the other hand, addressed gaps within existing health care practices and 
their own contribution or lack of contribution to their overall health status. Such solutions 
included improving patient-provider communication, patient behavioural change, resolving 
barriers to lifestyle interventions, such as coexisting health conditions and lack of motivation. 
Patients were also asked to share their perceptions of some of the facilitators suggested by 
HCPs. Table 7.1 presents the key facilitators that are discussed in this chapter. 
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Table 7.1 Summa 
Facilitators to MetS management 
in the UAE 
  
HCPs believed that health education provided in primary health care settings or through health promotion 
campaigns were effective tools in providing the population with skills to protect and control their health 
  
Intersectoral health alliance, research and Emiratisation were perceived as key factors that can improve health 
promotion and patients' behavioural change 
  
UAE government, mass media and school health were the three main non-health sectors that were perceived as 
highly influential in enhancing health promotion in the UAE 
" HCPs reported a lack of health needs assessment, which were perceived as vital for constructing and 
remodelling public health policies 
 A number of HCPs indicated that Emiratisation of health professionals could achieve cultural concordance 
between HCPs and patients 
" Emirati athletes and Emirati women exercise instructors can be used as role models to improve patients' 
attitudes towards exercise and minimise socio-cultural limitations to lifestyle interventions 
" Some HCPs talked about plans to incorporate religious teachings that advocate for healthy lifestyles into the 
health promotion programmes as well as using some religious figures as role models 
Strategies to improve management of MetS within the clinical setting 
" Improvement of MetS management within the clinical setting was the focus of patients' responses with regard 
to facilitators 
  
Patients talked about the need to improve their health behaviour towards lifestyle interventions 
  
Patients cited that listening skills and time issues during counselling needed to change in order to improve their 
management. In their perception, physicians needed to listen to their personal concerns and views about their 
life and treatment 
  
Other strategies to resolve previously reported barriers, such as patients' empowerment, eliminating or 
reducing the impact of barriers to adherence to the treatment plan, were also reported 
Looking back at participants' responses, it is evident that replies indicating barriers and 
facilitators that hindered or promoted the management of MetS belong to different stages of 
the MetS prevention and management cycle (Figure 7.1). There were many factors that 
increased an individual's chance of developing any of the CRFs that make up MetS (phase 1). 
Such factors encompassed a genetic predisposition to developing CRFs and patients' health 
behaviour (i. e., unhealthy diet and sedentary lifestyle). Individuals with clustering CRFs were not 
always detected or identified. Outreach CRFs screening campaigns and public health awareness 
were believed to enhance these individual's chances of being diagnosed together with 
unplanned clinic examinations (phase 2). Many of the HCPs' responses regarding facilitators to 
MetS management indicated the need to tackle factors in phases 1 and 2. They also believed 
that factors that either increased public chances of developing MetS or reduced their chances of 
being diagnosed needed to be addressed and targeted through disease prevention and health 
promotion strategies. 
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Phase 1 Phase 2 
" Genetic predisposition 
" Public health awareness campaigm 
" Sedentary lifestyle 
" Outreach screening for CRFs 
" Unhealthy diet 
" Accidental diagnosis through routine 
" Socio-cultural factors clinic visits 
" Environmental factors 
" Lack of health awareness 
AO " 
Phase 4 
" Adherence to Lifestyle intervention Phase 3 
Adherence to prescribed Medicines Referral to family medicine clinics 
I" Clinical follow-up " Refe rral to dieticians & health educators " Patient health education " Accessibility to medicine 
Figure 7.1 Strategies for MetS prevention and management 
Participants' responses indicated that MetS development and management fall into four main phases. Phase 1: factors that increase 
an individual's chances of developing MetS. Phase 
2: factors that enhance the identification and diagnosis of patients with MetS. 
Phase 3: factors that facilitate the management of patients with MetS. Phase 4: factors that help patients control their presenting 
CRFs. Public health promotion strategies should minimise the impact of phase 1 and enhance phases 2 and 4. Other strategies 
should target factors increasing patients' diagnosis, treatment, 
follow-up and adherence to the treatment plan 
Patients, on the other hand, were mainly concerned with addressing factors that affected their 
accessibility to treatment (i. e., health insurance), their own health behaviour (i. e., adherence to 
physical activity and healthy diet) and their relationship with their HCPs. All these factors aligned 
themselves with phases 3 and 4, as can be seen in the diagram. These factors were presented 
and discussed in previous chapters. Therefore, the beginning of this chapter is mainly dedicated 
to new facilitators that revolve around the utilisation of health promotion and disease 
prevention strategies in MetS. A summary of all the facilitators that were perceived to enhance 
MetS management within the clinical setting are provided towards the end of this chapter. 
Facilitators that are presented in the following sections were mainly reported by HCPs. However, 
patients' perceptions on such strategies were also investigated and will be presented when 
applicable. Facilitating strategies in the following sections are: (i) health education and health 
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promotion; (ii) intersectoral health alliance; (iii) national health research; (iv) Emiratisation; and 
(v) religion. 
7.2 Health promotion and disease prevention 
Health education, health promotion and disease prevention were terms that participants used 
interchangeably during interviews. Such terms were used to indicate methods of changing 
patients' health behaviour and improving their lifestyle. Health education provided in primary 
health care settings or through health promotion campaigns was believed to be an effective tool 
in informing patients of the importance of protecting and controlling their health. Health 
promotion in MetS, which HCPs discussed, encompassed more than promoting for a healthy 
lifestyle and included the importance of early screening of CRFs and adherence to the treatment 
plan when diagnosed. HCPs believed that if patients were constantly provided with appropriate 
information about all aspects of disease prevention and healthy living, this would guarantee a 
change in attitude and in turn would directly influence their behaviour. 
I think people need health education, people need to be aware, empowered and in control, the 
public health in this country needs to focus on health education just like what we have in the UK 
(... J. Send people strong messages, you know, like those N ads about the consequence of not 
using a seatbelt while driving. Many people here have started using them since these messages 
started. So the stronger and the more frequent the messages, the stronger the impact on 
people's health behaviour. I think health awareness and health promotion is what this country 
needs to tackle a problem like the MetS. 
Pharmacist 16, woman, Jordanian 
In the study setting, most patients were usually referred to a health educator upon diagnosis or 
when specific health knowledge-related gaps were identified. During interviews, patients were 
asked about their perception of the health education sessions and its impact on their health 
behaviour. All patients who admitted receiving a one-to-one health education session reported 
their satisfaction with the service and indicated its role in enhancing their health awareness and 
rectifying some of their health beliefs. However, some patients admitted that internal and 
contextual factors were more influential on their health behaviour than becoming more health 
informed. Patient 19 explains this point in the following extract from his interview: 
R: Did the health educator explain to you everything about diabetes, the diet (... ]? 
P: She explained everything. She also gave me a small book with pictures. 
R: Did this information change the way you eat or make you exercise more? 
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P: [laughing] not everything. I did not change me 100% because of this visit. Whoever tells you 
that is a big liar [laughing] 
R: Can you explain, was the information not suitable for you? 
P: No, it's not that. You see when you listen to her [educator], you say to yourself: 'wow, this 
sounds great' but in real life there are other things that come in the way and prevent you from 
following these instructions, even though you know they are not good for you. You are a human 
being, you crave for things. You want to eat this, to eat that. Some days you don't feel like 
exercising. Sometimes you want to just set, you know? 
Patient 19, man, 67 yrs, Emirati 
HCPs responses indicated that health promotion strategies could be improved through three 
main strategies: (i) intersectoral health alliance; (ii) local and national health research; (iii) 
Emiratisation. The following three sections present these three strategies in detail. 
7.2.1 Intersectoral health alliance 
HCPs perceived MetS as a national health burden that needed to be addressed at a population 
level. HCPs believed that a conjoined effort of stakeholders, such as government departments, 
health authorities, educational authorities, the mass media, urban planning, and even members 
of the Royal family, would help address MetS holistically and not in a merely treatment-oriented 
manner. They also felt that intersectoral health alliances would enable the targeting of services 
based on wider consultation and pooling of knowledge and expertise and would enable the use 
of different tools and strategies that cater for different community needs, thus narrowing the 
gaps. 
I really think that the government, the media, N, newspapers, social network, schools, even 
women's organisations, I think they all should join in this mission [health awareness]. I think we 
should address MetS through the joint efforts of different sectors. They all should promote for 
health through using different tools. This is a big step and it might take time, but it's an 
important step to take for the whole population of the UAE. 
Physician 9, man, Palestinian 
Health Promotion involves various players through the intersectoral or multisectoral approach. 
An increasing number of players are being introduced to health promotion concepts and 
practices, including those practicing in the non-health sectors. Health promotion strategies have 
been integrated into many health and development programmes. Intensified focus on the 
'healthy settings approach' has paved the way for partnerships with government sectors and the 
private sector. Therefore, a comprehensive health promotion system highlights the importance 
of coordinated action at multiple levels (i. e., national, local, organisational and programme 
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levels). Health, in such a case, becomes the collective responsibility of the whole society and not 
an individual's alone (Naidoo and Wills 2009). The UAE government, mass media and education 
authority were the three most talked about stakeholders in the ideal non-health alliance and 
were perceived as the most influential in driving health promotion and behavioural change. The 
following three sections discuss their role as perceived by the study participants. 
7.2.1.1 The role of the government 
Many HCPs agreed that the UAE federal government represented the most senior authority that 
can enhance the development and implementation of health promotion activities through its 
supervision and sponsorship. In their opinion, a health promotion system needs a stable basic 
infrastructure or system building blocks, such as finance, workforce, resources, information 
systems and organisational and intersectoral teams and partnerships. These building blocks are 
harnessed to work together as a system through governance arrangements and consequent 
policy and planning framework. Dietician 1 illustrates this point in the following quote: 
I think a health problem like MetS needs to be addressed from a higher managerial level. I think 
a national health promotion strategy should be included within the country's public health 
policy, which the government is authorised to do. The country's need to prevent and manage 
MetS should be assessed, goals determined, framework or an action plan designed and then 
implemented and then assessed. If I try resolving a national health problem like MetS through 
one department or sector, through local policies, then I'm only solving a small portion of the 
problem. I think the government needs to set a policy at a national level. 
Dietician 1, woman, Jordanian 
According to the 2008-2013 WHO action plan report for the prevention and control of 
noncommunicable diseases, government elaboration is needed to provide high-level policies and 
plans, as well as programmes related to advocacy, community mobilisation, environmental 
interventions, health care system organisation and delivery, legislation and regulations (WHO 
2008). Some HCPs reported the absence of collaboration between local health authorities (i. e., 
Abu Dhabi and Dubai's health authorities), independent health organisations and the UAE 
ministry of health. HCPs believed that such collaborations would result in health equity and 
would emphasise the need to address MetS as a national burden that affects all residents of the 
UAE. HCPs talked about the lack of coordination between the health authorities of different 
Emirates or between health authorities and the country's ministry of health (MOH). Physician 5 
explains this point in the following quote: 
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There are [health promotion] initiatives scattered here and there, but because they're not under 
one umbrella the effort is segmented. Abu Dhabi has its own programmes, Dubai health 
authority has its own programmes. Not to mention the northern Emirates that have their own 
health issues. So all these efforts are not augmented, they are not unified. What we need is a 
role played by the government, something that will unite all these health institutes and 
authorities. This will create health equity, and the establishment of powerful health promotion 
strategies that are applicable to all residents of the UAE. And when it's a policy produced by the 
government it can be easily enforced and no authority can argue with it you know? So when 
there is such unity, such collaboration, better programmes and better implementation will 
follow. 
Physician 5, woman, Jordanian 
The health care services of Abu Dhabi were regulated, operated and financed by the UAE 
government through the MOH. However, in 2006, Abu Dhabi health reform resulted in the 
breakdown of the MOH's responsibilities and the formation of three independent bodies 
responsible for regulating (HAAD), operating (SEHA) and financing (DAMAN) the health care 
services of Abu Dhabi alone. Ever since, Abu Dhabi has worked on establishing an independent 
strategy for the Abu Dhabi health care system which is fully aligned with the Abu Dhabi 
Government 2010-2030 Strategy Map (HAAD 2009). The current role of the MOH is to unify the 
health policies in the country and develop a comprehensive nationwide health service. 
Many HCPs in the study gave examples of health promotion campaigns that were organised and 
operated by different organisations within the city of Abu Dhabi or through the whole of the 
UAE. Some of these examples were reported in chapter 2 (Table 2.3). Diabetes, obesity in adults 
and in children, as well as CVDs, are health burdens that are recognised by all health 
organisations in the UAE and receive great attention and focus by health promotion and public 
awareness organisers; however, the UAE still lacks a unified national health policy that addresses 
such anomalies as a national health burden. 
Some participants perceived the lack of a clear health strategy in the UAE as an obstacle that 
prevented structured prevention and management of MetS. In their perception, strategies 
declared by health authorities in the country are ambiguous and unrealistic. HCPs indicated that 
most health promotion campaigns address individual CRFs, such as Diabetes and obesity, with 
little or no focus on MetS as a predisposing factor to Diabetes or CVDs, which are both health 
burdens in the UAE. Pharmacist 10 illustrates this point in the following quote: 
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The health promotion approaches give a lot of attention to diabetes. I mean, that's 
understandable since we have the second highest prevalence of diabetes. But what about 
prediabetes, what about MetS? I think the government needs to look at diabetes from its roots 
and that is through MetS. There should be a policy and a clear plan regarding the prevention of 
MetS and health promotion. Instead of focusing on one risk factor we should have a policy that 
addresses all the risk factors, but see them as one risk and the MetS concept enables this. 
Pharmacist 10, woman, Emirati 
As previously identified and presented in this study, the medical term 'metabolic syndrome' was 
not as well known as other conditions, such as diabetes or hypertension. No patients were 
familiar with the term 'metabolic syndrome' as a diagnosis for their condition. The unavailability 
of an Arabic alternative to the MetS term and uncertainty about patients' ability to comprehend 
the MetS concept were among the factors that discouraged health care professionals from 
informing patients of their MetS diagnosis. MetS was the top priority on the list of public health 
priority target health problems produced by HAAD in 2010; however, most of health promotion 
strategies that are organised and sponsored by HAAD address individual components of MetS 
with great focus on diabetes and obesity. This may be an additional factor in patients' lack of 
awareness about the MetS concept compared to other anomalies such as obesity, diabetes, and 
hypertension. It also indicates a lack of penetration of the MetS concept into public awareness. 
Comprehensive and integrated national approach to the MetS can help of arresting this public 
health epidemic. 
7.2.1.2 The role of schools 
The role of schools in health promotion was elicited as HCPs talked about the lack of an exercise 
culture in the UAE (see section 5.2.1). Participants felt that learning about health-related 
knowledge, attitudes and behaviour at an early age would help create generations that were 
more health conscious. Schools were another context for health promotion, because they reach 
a large proportion of the population for many years. They also stressed the importance of 
including health education in school curriculums to allow ongoing and progressive health 
programmes that build on previous learning and allow children to extend their knowledge and 
skills appropriate to their stage of development. Some HCPs used their own experience of 
western schooling systems to help explain the value of targeting younger generations for health 
promotion. Physician 7 explains this point in the following quote: 
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I had my training in Scandinavia and they have a beautiful system of having an active health 
education, they call it school nurse and school doctor. Their function is to teach children about 
healthy food, exercise. They arrange trips to the woods making them familiar with a healthy 
environment and nature. Sometimes they campaign for health where parents can also get 
involved. It was a great experience and my kids learned a lot. We need something like that here. 
I don't know if exercise is thought of in school curriculums here, but I believe that structured 
health education from a young age will influence people's behaviour. 
Physician 7, man, Egyptian 
One patient in this study indicated health education at schools and universities as a key factor in 
resolving the high prevalence of MetS. Patient 2 was asked about his view on the solution to his 
health condition. He stated that narrowing the gap between the health care system and the 
education system in the UAE will help tackle the country's health challenges. 
P: There's a gap between the health care system and the educational system. There's no link 
between the two. 
R: And how do you think this has affected your health? 
P. Because I am the product of this system. Although in my time, things were much better. But if 
look at the students' diet at schools, they eat junk and are allowed to order burger delivery too. 
There is no focus on exercise. They're only interested in football, but they don't think about the 
concept behind football, they're not told to see the whole picture. You know, they're not told 
that exercise is part of a lifestyle, healthy diet is part of a lifestyle. They don't know that. They're 
not informed about the health risks in this country. You know why? [... ] Because the government 
doesn't have a vision, if they did they would address this problem from all aspects starting from 
kindergarten to the work place. But they don't have a vision and this is why we're suffering now 
and will continue to produce unhealthy generations. 
Patient 2, man, 33 yrs, Emirati 
In the Emirates, there were a number of school focused health promotion interventions such as 
'The Fat Truth' (Ministry of Health 2009) and 'No to Obesity' (Ramandeep 2010) that addressed 
obesity in children and teenagers living in the UAE. Seminars, oral presentations and workshops 
concerning diabetes and obesity were also among health promotion activities that were 
sponsored by the health authority of Abu Dhabi (Diabetes UAE 2007; HAAD 2010). Such 
interventions came in response to the high prevalence of MetS, and obese and overweight 
children and teenagers living in the UAE (Eapen, Mabrouk et al. 2010; Ministry of Health 2011). A 
systematic review looked at the effectiveness of school-based lifestyle interventions in the UK 
that aimed at changing children's attitudes towards diet and physical activity. Findings suggest 
that the impact of such interventions were inconsistent and short-termed (Brown and 
Summerbell 2009). This suggests the importance of having an ongoing and progressive health 
promotion programme that is built into the school's curriculum in order to achieve a long-term 
effect. However, there is no available data in the UAE that indicates whether a whole school 
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approach to health promotion has been implemented apart from the existing short-term 
lifestyle interventions. However, HCPs aspired to have something similar to the Healthy Schools 
Programme in the UK. The Healthy Schools Programme is a joint initiative between the 
Department for Children, Schools and Families and the Department of Health. Their main goal is 
to achieve locally agreed health and well-being outcomes for children and young people. Healthy 
schools that have been established since 1999 promote a whole school / whole child approach 
to health by introducing the health promotion concept into the school philosophy. An annual 
assessment of the success of the Healthy Schools Programme is needed to maintain the 
foundation of health and well-being which is achieved through the National Healthy School 
Status (Healthy Schools 2009). In the UAE, a whole school approach to health promotion 
programmes within a MetS context might be an idea worthy of consideration. 
7.2.1.3 The role of the mass media 
The mass media are tools for the transfer of information, concepts and ideas to both general and 
specific audiences. Mass media is defined as any printed or audio-visual material designed to 
reach a mass audience, such as newspapers, radio, television, internet, posters and magazines 
(Naidoo and Wills 2009). All HCPs in this study cited mass media as an important tool in 
advancing public health goals. They believed that health messages could reach a wider audience 
and hard to reach individuals that could have developed MetS features, but are still unidentified 
or undiagnosed. Although HCPs talked about different types of media that can be utilised in 
health promotion, they mainly focused on health promoting messages communicated through 
the television. Media was perceived to be effective in rectifying some of patients' cultural beliefs 
or social norms that might counteract their implementation of lifestyle interventions. HCPs' 
responses indicated great optimism that regular strong health messages would induce a massive 
shift in patients' attitude and health behaviour and thus improve their lifestyle. 
The level of reading in this country is not as impressive as watching N and other media sources. 
But I don't think TV and media sources have done enough to emphasise the problem or the 
epidemic of MetS, or how much it's really important to change lifestyle to improve health, or 
changing diet, in addition, or smoking and many other culturally influenced habits. People 
believe what they see. Media influences people a lot. We experience the impact of media on our 
youngsters, and women as well. And we can use that in health as well and change people's 
behaviour. 
Pharmacist 15, man, Palestinian 
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The mass media are able to deliver short-term, intermediate-term, and long-term effects on 
audiences. Short-term objectives include introducing health concepts; increasing awareness and 
knowledge; updating old or rectifying inaccurate information; and enhancing audience recall of 
particular advertisements or public service announcements, promotions or programme names. 
Intermediate-term objectives, on the other hand, include all of the above, as well as changes in 
attitudes, behaviours and perceptions of social norms. Long-term objectives include all of the 
aforementioned goals, as well as focused reform of perceived social norms and maintenance of 
behaviour change (Mcdermott and Albrecht 2011). HCPs' responses indicated their aspiration to 
an intermediate or a long-term effect of the mass media or the use of television in podcasting 
health messages. However, available data suggests that the impact of media facilitated health 
promotion campaigns on health behaviour with regard to physical activity and diet control are 
usually short-term changes (Marcus, Owen et al. 1998; Bauman, Bellew et al. 2001). Using the 
media to communicate health promotion messages can only produce short-term effects and, 
therefore, needs to be set against the persistent influences of social and structural factors, 
settings and reinforcements for sedentary behaviour. Integrated efforts, involving health 
education, motivation, verbal reinforcement and other tools are necessary to maintain and build 
on the initial changes of health behaviour obtained using the mass media. 
In their responses, patients mainly referred to written and televised health promotion messages. 
Patients' perceptions about the role of the media in their health awareness or health behaviour 
belonged to three main categories: (i) appreciation of information; (ii) pessimism towards the 
role of the media in influencing behavioural change; (iii) discontentment with the style in which 
health promotion messages were delivered. However, the three groups did not value media 
facilitated health promotion massages as a tool that guarantees behavioural change. Data 
previously presented in this thesis, illustrated examples of patients using the internet and 
printed material to gain information about the cardiovascular risk associated with MetS (section 
4.2.2). Some patients complimented the current government's efforts and felt that it provided 
them with more information than they had received from their care provider. 
Public awareness is good, because it makes you careful. There are things that you've never 
heard of from your doctor or nurse so when you hear about it in the media you don't do them 
again and you become wiser. On TV they talk about real things, things from people's experience. 
Doctors don't talk about real life, they only tell you what they learn in books, but TV 
programmes add a bit of reality to the illness. 
Patient 6, man, 65 yrs, Yemeni 
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Other patients believed that the media role was confined to conveying basic information about 
diseases and was, therefore, more useful to newly diagnosed patients. However, the media 
usefulness was limited with regard to complex information about diseases or influencing the a 
shift in their behaviour. 
1V ads won't help you. Maybe it's useful for people who don't know or those who are newly 
diagnosed, you know? But it doesn't make you careful, or eat less, or exercise more. No. because 
you can watch all the TV programmes in the world, you can read all the medical magazines in 
the world, but if you don't have the willpower and desire to change within you, you won't 
change. No force in this world will change you, right? -laughing- 
Patient 24, woman, 46 yrs, Emirati 
Other patients felt that the current messages broadcast on television and sometimes published 
in newspapers need to cater for different patients of different educational and cultural 
backgrounds. Complicated medical jargon or imbedding English words in the midst of Arabic text 
were frequently noticed in televised health promoting programmes. 
think media needs a bit of improvement, because it doesn't appeal to everyone. My parents are 
illiterate and they don't always understand what the TV presenters are saying. They use a lot of 
medical jargon. The presenter will be saying something like: 'you must do exercise' [in English] 
when he should've said exercise [in Arabic]. They should consider people who might not 
understand English or don't have a medical background. 
Patient 28, woman, 34 yrs, Emirati 
In the UAE, a variety of health messages about diabetes, physical activity and diet have been 
part of broadcast media (particularly television) for a couple of years. In addition, pamphlets and 
posters are everywhere in patients' surroundings, including public places or in clinics. However, 
little is known about the efficacy of media-based methods in promoting higher levels of physical 
activity behaviour among patients with MetS or any other health condition in the UAE. Despite 
HCPs' enthusiasm towards the use of the media in health promotion and their optimism of its 
impact on patients' health behaviour, findings from this study reflect the findings also reported 
in the literature, which suggest that such a tool is only useful in the short-term (Marcus, Owen 
et al. 1998; Bauman, Bellew et al. 2001). More investigation should take place to identify 
appropriate and culturally sensitive strategies that the media can adapt when facilitating health 
promotion messages. 
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7.2.2 The role of local research 
Facilitators to MetS management 
Over the past decade, investment has increased in the infrastructure for health research in the 
UAE; however, many HCPs believe that gaps still remain and additional work is needed to aid the 
reduction in the high prevalence of MetS and its constituting CRFs. They also felt that the unique 
socio-cultural context of the UAE highlighted the importance of local empirical research to 
identify the specific health needs of the country's population. According to HCPs' responses, 
local or national health research was capable of delivering four main objectives: (i) assess health 
needs of patients with MetS living in the UAE; (ii) provide a guide to improving the UAE health 
care system (iii) develop new initiatives for health promotion and health education campaigns 
for patients with MetS; and (iv) reduce health care inequalities throughout the UAE. Pharmacist 
7 explains this point in the following quote: 
We don't have documented data or statistics here unfortunately. There is no research on the 
Arab population or MetS patients here. Nothing. So how can I know what this population needs? 
From my observations from my experience, I might have a slight idea, and I can act upon this 
knowledge at work, but it could've been better if there was reliable data from trials or studies. 
Our problem is that we don't have health research in the region that can reflect reality. We have 
studies from the west, but it doesn't say anything about the people here. We need research, to 
tell us what patients in this region need that guide us when we come to design our health policy. 
mean, let's be honest, we bring western experts or we buy ready-made policies with millions? 
Why do we do that when we can simply look at ourselves and see what is right for us? 
Pharmacist 7, woman, Emirati 
The role of research was also linked to the efficacy of health promotion strategies used in the 
UAE for lifestyle. Few HCPs indicated that effective and realistic planning of health promotion 
campaigns should be based on public needs assessment. Imported interventions or health 
promotion templates are compatible with the health needs of patients living in western societies 
and might not cater for all the health needs of patients living in the UAE. They also reported the 
lack of impact and outcome assessments of existing health care policies or promotion strategies. 
Educator 1 explains this point in the following quote: 
All the interventions that we use here are imported from the west. We think that if it worked 
there, it will definitely work here. But that's not always true. If you see the campaigns they run 
every year, I know organisers are Emiratis, which is good, but the approach is very western, 
when I talk to patients here in the clinic, I can see they're simple people, some are religious, so 
these health promoting strategies might not be acceptable for them, 
Educator 1, woman, Bahraini 
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Assessing the population's needs is the first step in establishing a health promotion programme 
and health promotion activities. The reason for assessing the health needs of a specific 
community or population is to identify both positive and negative influential factors that should 
inform the development process of health promotion programmes (Naidoo and Wills 2009). 
However, an initial community health needs assessment was not reported in the disease 
prevention programmes (Hajat and Harrison 2010; WEQAYA 2010) or the health promotion 
programmes (Diabetes UAE 2007) presented earlier (see section 2.4). In addition, an assessment 
of efficacy through measuring clinical outcomes for these programmes was not available. Such 
data could be useful in identifying gaps and areas of improvement if similar programmes are to 
be launched in the future. Data that describes public perceptions of health campaigns in the UAE 
was not available. Walk-UAE, which is one of the "Diabetes-Knowledge-action" public awareness 
campaigns, advocates for physical activity through an annual walkathon (Diabetes UAE 2007). 
This aims at encouraging the public to engage in brisk walking, jogging and other outdoor 
activities (Figure 7.2). 
Figure 7.2 WALK-UAE is part of the "Diabetes-Knowledge-Action" campaign 
WALK-UAE is part of a health promotion campaign that is held annually to advocate for physical activity and healthy 
lifestyles (Diabetes UAE 2007). Findings from the study indicated that some socio-cultural norms might prevent some 
women from participating in this activity. Health needs of communities should be assessed to identify positive and 
negative factors that might influence lifestyle interventions. Such findings can inform the framework of health 
promotion programmes. 
In 2010, the Municipality of Abu Dhabi City has distributed sports and fitness equipment to a 
number of public parks and open spaces free of charge to be used by the public (Municipality of 
Abu Dhabi 2010). This step came in conjunction with the UAE government's quest to improve 
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and develop social lives and provide an environment to enhance a healthy lifestyle (Figure 7.3). 
However, findings from this study cited many cultural and religious limitations to the 
implementation of lifestyle interventions, one of which was restrictions on outdoor activities. 
AMMMS V 
Figure 7.3 Gym equipment in Abu Dhabi public parks 
The municipality of Abu Dhabi city has fitted public parks and open spaces with gym and exercise equipment in 
conjoint efforts with the government of Abu Dhabi to create an environment that will encourage and facilitate 
exercising (Municipality of Abu Dhabi 2010). Findings from this study identified culturally-related barriers that might 
limit or prevent women's use of such equipment. 
One of the scopes of the public health and policy division is the establishment of a research 
regulatory framework in collaboration with other UAE regulators and development of a funding 
process to promote and sponsor research into Abu Dhabi's disease priorities (HAAD 2009). Part 
of the social sustainability initiatives of HAAD, as stated in the same report, was to evaluate 
effectiveness, accessibility and quality of personal and population-based health services, and to 
conduct research for new insights and innovative solutions to health problems in the UAE (HAAD 
2009). Exploring health policies in the UAE was not part of the study aims and objects. HCPs 
indicated policy-related factors that might have indirectly affected MetS prevention and 
management strategy. However, this remains an area worthy of further investigation in future 
research. Relevant findings presented in this thesis could be used to guide the design of research 
in variable areas that were indicated by the study participants. 
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7.2.3 The role of Emiratisation 
Facilitators to MetS management 
Emiratisation is a term used to describe the process of nationalisation of human resources in the 
UAE. Emiratisation is a government initiative that started in the mid 1990's and works towards 
an organised and efficient employment of Emirati citizens in the local and private sectors 
(Emiratisation 2009). Emiratisation was implemented to help the UAE face some of its political, 
economic, environmental and societal challenges. It was also created to minimise the country's 
high reliance on expatriate workforces and encourage the active participation of national 
Emiratis in the industrial society (Randeree 2009). Although, only eight of the HCPs interviewed 
were Emiratis (1 physician, 4 pharmacists and 3 dieticians), the role of Emiratisation in MetS was 
also reported by other non-Emirati HCPs. Emiratisation was repeatedly indicated by many HCPs 
as one way of minimising the cultural gap between patients and their HCPs. In their perception, 
Emirati HCPs are more aware of the socio-cultural needs of Emirati patients and are, therefore, 
more capable of addressing culturally-related barriers to management, while designing patients' 
treatment plans. Dietician 4 (woman, Emirati) explains this point in the following quote: 
As an Emirati professional you know the culture and the tradition of the country. And you'll be 
able to guess what some patients need, you know? You'll be able to talk and communicate with 
them on this level. Some physicians are not aware of people's eating habits, for example, and so 
they don't use examples from patients' culture when they give advice on diet, for example. 
Dietician 4, woman, Emirati 
Emiratisation of social workers was applauded during many interviews with expatriate HCPs. 
Emiratis working with patients and their families would enable patients to communicate their 
social and cultural issues. Emiratis in these posts would work jointly with other HCPs on social 
matters that may affect patients' present and future health. They can also coordinate between 
patients and HCPs and resolve any treatment choice disputes that may evolve due to cultural 
incompetence. Physician 10 explains this point in the following quote: 
I think social work is where UAE people need to be. This is something that they can do well, you 
know, like public relations officers who've got social work degrees and that's something this 
country needs, social workers, I mean, in the UK we have social workers for lots of reasons, they 
are the patients' advocates, but they have to understand the culture of these patients. 
Physician 10, woman, British 
The word Emiratisation was also used when HCPs were talking about ways to increase patients' 
interest in exercising. Identifying Emirati women as being involved in professions such as sports, 
cookery, and exercise instructors might shift women's perception towards engaging in sports or 
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even exercising outdoors. The latter example seemed a bit ambitious given the socio-cultural 
structure of the UAE; however, pharmacist 6 was convinced that Emirati role models for active 
healthy lifestyles might result in behavioural change. 
People will understand the importance of exercising when Emirati ladies become gym 
instructors, Emirati ladies putting out videos, you know? Like all the western celebrities putting 
out fitness videos, why can't some of the Emirati ladies put out fitness things? You've got some 
wonderful, wonderful Royal family members here that are fit, very active; they're all in this 
sporting team here in Abu Dhabi Dubai, why can't they do something you know? 
Pharmacist 6, woman, British 
Patients' responses regarding their views of having an Emirat! HCP indicated satisfaction and 
sense of national pride. Feeling 'proud' when seeing an Emirati as a physician, pharmacist, or 
occupying any other health care profession was perceived as a 'great achievement' and a 
'triumph' for the country. They also felt that Emiratis in such positions would facilitate 
communication and appreciation of their traditional heritage when designing a treatment plan. 
P: lt is a joy to see a doctor from your country. This is a great achievement for the country and it 
makes you raise your head up high. 
R: What about treatment? Are they better than non-Emirati doctors? 
P. They are all good. All the people working here are competent and the country makes sure 
they have genuine certificates and years of experience, I have to say the truth. But with 
someone from your country you feel relaxed like seeing a member of your family, like seeing 
your son or your daughter. You have this great trust that you are at home that you are in good 
hands. They'll know my culture, they'll know how to show respect to me and treat me as their 
father. 
Patient 19, man, 67 yrs, Emirati 
Racial concordance between patients and physicians was reported to affect patients' satisfaction 
with and use of health care in the literature. For example, Saha et al (1999) found that black 
patients were more satisfied with the care they received from black physicians as opposed to 
non-black physicians and were more likely to report receiving preventive care and necessary 
medical care than blacks with other-race physicians (Saha, Komaromy et al. 1999). Another study 
that examined the impact of patients' ethnicity/race and gender on their assessment of shared 
decision-making showed that patients seeing physicians of their own race rated their physicians' 
decision-making styles as more participatory. Similarly, participants from this study highlighted 
the importance of achieving cultural concordance between patients and HCPs through the 
process of nationalisation or Emiratisation. Although improving cross-cultural communication 
can be attained through training HCPs about the health needs of Emirati patients', some HCPs 
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were convinced that cultural concordance could increase patients' satisfaction with health care 
and eventually affect their health behaviour. Emiratisation was also perceived as influential in 
the healthy lifestyle promotion process. Emirati sport elites or even women exercise instructors 
can change patients' attitude towards exercise and probably alleviate some of the socio-cultural 
limitations to women's participation in exercise. 
7.2.4 The role of religion 
The use of the Islamic teachings in promoting a healthy lifestyle was indicated by many HCPs, 
including non-Muslims. Religion as a culturally constructed institution influenced people's 
behaviour with regards to health and healthy lifestyles, and HCPs were aware of the role of 
religion as part of people's lives in the UAE. HCPs talked about using Islamic teachings on issues 
pertaining to health and illness and focusing on a healthy lifestyle as a means of protecting one's 
body to promote physical activity, diet control and smoking cessation. They believed that linking 
various Islamic concepts to contemporary health promotion campaigns was capable of bringing 
about desired behavioural changes in patients with MetS. 
We can use Islamic teachings to encourage people to change their diet and exercise more. The 
Islamic teachings that instruct people to take care of their body, you know. Like reminding them 
of prophet Mohamed's teachings to divide your meal into three sections: 'one third for your solid 
food, one third for your water and one third for the air you inhale'. To move and exercise, to only 
eat when hungry and stop before you're full, all these are the Islamic messages that we can use 
in our health promotion programmes. And people like religion, they are convinced more, and 
when it is conveyed through a health worker that augments its impact. 
Dietician 3, woman, Emirati 
Other HCPs talked about the use of religious scholars and famous religious role models to send 
health messages and teach people about the importance of adopting a healthy lifestyle. The 
Islamic law contains many teachings and provisions that urge fostering of one's health and 
preserving it against factors that might weaken it or increase its susceptibility to disease. Laws 
that forbid alcohol and smoking, and encourage the adoption of healthy diet, seeking treatment, 
taking medicine and engaging in sports can all be incorporated into religious lectures and during 
Friday prayer. This point is illustrated in the following quote: 
One of the ideas that we thought about for our health promotion programme was the use of 
some religious leaders and role models to help us promote a healthy lifestyle and living habits 
like not smoking. I don't think that smoking had been banned by religious leaders in the UAE, but 
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I know Islamic scholars in Saudi Arabia and in Egypt did. So maybe at some point in some of the 
outreach programmes we can invite some of these religious leaders to give a talk and play an 
active role in promoting smoking cessation, exercise, good eating habits. Basically reminding 
people of the Islamic view of lifestyle 
Physician 8, man, Egyptian 
A study conducted in the USA explored the role of Muslim Imams in promoting healthy lifestyles 
in their communities. Semi-structured interviews were conducted with 12 Muslim community 
leaders. Results indicated that Imams can promote a healthy lifestyle through the use of 
scripture-based messages during Islamic events and by evaluating health care decisions for 
Muslim patients (Padela, Killawi et al. 2010). 
In the current study, religion was also viewed as a means to encourage patients' adherence to 
treatment plans, because Islamic teachings instruct Muslims to seek treatment and to medicate 
when ill; religion was perceived as an adherence-promoting factor. Such teachings can be used 
to motivate patients also to adhere to lifestyle interventions. Physician 1 explains this point: 
We, as Muslims, refer to the Qur'an and teachings of the prophet. Both instruct us to seek 
medication and treatment, our prophet said that God has created a treatment for every illness that 
he's created. This was a call from the prophet to go and seek treatment. So with this in mind, 
Muslims are encouraged to adhere to treatment to prevent their bodies from harm and make it 
better. 
Physician 1, man, Palestinian 
Available literature reported the relationship between religion and positive health behaviour, 
such as adapting a healthy lifestyle, hygiene and early screening for noncommunicable diseases 
(Hill, Ellison et al. 2007; Grace, Begum et at. 2008; Harrigan 2009; Naewbood, Sorajjakool et at. 
2010). There is also support for health-education interventions at places of worship and 
evidence demonstrates that some church-linked health programmes are effective for modifying 
unhealthy behaviour (Kelly and Huddy 1999 ). Similarly, the idea of utilising Islamic lifestyle 
teachings in health promotion programmes to encourage behavioural change is not new. The 
World Health Organization Eastern Mediterranean Regional Office (WHO-EMRO) in Cairo is 
actively carrying out research on health promotion within an Islamic perspective. They have 
published several articles under the series of health education through religion (WHO-EMRO 
2009). The series included articles such as: (i) Islamic Rulings in Smoking, (ii) Health Promotion 
through Islamic lifestyles; (iii) The Role of Religion and Ethics in the Prevention and Control of 
AIDS, (iv) Health, an Islamic Perspective, and (v) Health as a Human Right in Islam. 
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In the UAE, where religion is so much a part of people's daily life, Muslims and Muslim 
organisations can easily ascertain all they need to know through the deployment of Islam. Islam 
places health as a fundamental right of every human being, which makes it a powerful source of 
guidance and information when it comes to issues related to disease prevention and health 
promotion. Islam prioritises health, placing it as second in importance to faith. Embedded in the 
very essence of the Islamic law is the protection of the five essential needs to human fulfilment, 
which are faith, life, progeny, property and mind. Three out of the five, namely life, progeny and 
mind, cannot be adequately safeguarded without the protection and preservation of health. 
Patients indicated in their interviews that religion played a psychological role and influenced 
their ability to accept negative health conditions and to cope with stressful events. They also 
indicated the importance of seeking treatment, taking medicine and protecting the self from 
harm and linked these concepts to religious teachings. Patient 19 explains this point in the 
following quote: 
Religion has a very strong role in my condition. God instructed us to consider all causes and effects 
when handling any matter and this applies to illness, so you pray and ask Allah for help, but you take 
medicine as well, so / take the tablets, two tablets twice and so on. 
Patient 19, man, 67 yrs, Emirati 
Muslim's behaviour and actions are governed by the tenets of Islam, which are well outlined in 
the Qur'an and the prophets' teachings. Therefore, HCPs' use of Islamic teachings might have 
been built upon their assumption that such rules can trigger behavioural change and govern 
treatment choices. However, HCPs need to be reminded that patients' normative beliefs and 
social pressures could also affect their health behaviour. In the study, some HCPs talked about 
using Islamic laws that ban certain risk behaviours in order to encourage behavioural change. 
HCPs need to also be reminded that a primary objective of health education is to allow 
individuals the freedom to choose among health behaviours or, at the very least, voluntarily 
participate in health-related behaviour (Naidoo and Wills 2009). Therefore, the use of religious 
teachings as an additional option can produce a more acceptable education tool without 
jeopardising patients' empowerment or freedom to choose. 
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7.3 Improving MetS management 
Facilitators to MetS management 
Data presented in previous chapters indicated distinct barriers to management of patients with 
MetS. These barriers belong to five main categories: (i) participants' awareness of the MetS 
concept and definition; (ii) clinical utility of the MetS definition; (iii) implementations to lifestyle 
interventions; and (iv) patients' attitude towards prescribed medicines; Facilitators were 
discussed earlier in relative chapters to maintain consistency and to limit repetition of themes 
across chapters. Table 7.2 provides a summary of the barriers and facilitators to MetS 
management, as indicated by study participants and reported in chapters 4,5 and 6. 
Participants' responses indicated different layers of factors that affect the MetS prevalence and 
management in the UAE. 
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Chapter 7 Facilitators to MetS management 
As seen earlier and as presented in previous chapters, HCPs' responses regarding barriers and 
pertinent solutions were mostly population-focused. HCPs indicated that health awareness and 
empowering patients were two key factors to achieve patients' autonomy and shared decision- 
making. They also called for more health education programmes and ongoing health promotion 
strategies to influence patients' behavioural change and adherence to the treatment plan. 
HCPs did not report any practice-related factors that can be improved or remodelled to deliver a 
better MetS management. On the other hand, patients' responses regarding facilitators to 
improving MetS management revolved around either their own attitude towards their treatment 
plan or their patient-physician encounter. This could be partially due to the phrasing and timing 
of the question asked and how patients understood it. Throughout the interviews, patients were 
able to articulate a wide range of barriers and, equally, suggested solutions to these barriers 
(table 7.2). However, towards the end of the interview, and when they were asked about means 
of improving "their" condition, patients' answers were focused around self-behaviour and the 
patient-physician relationship. With that last question, their immediate attention might have 
been drawn towards their personal contribution or lack of contribution towards their health. 
This section of the chapter is dedicated to presenting patients' views regarding factors that will 
improve their treatment outcome which are: (i) changing health behaviour; and (iii) patient- 
physician relationship. 
7.3.1 Changing health behaviour 
The need to change health behaviour was the most reported facilitator by patients who believed 
that the key to improving their health was self-determined. This group of patients praised their 
health care facility, medicines and HCPs, but displayed self-blame for failure to adhere to 
lifestyle interventions. Patients indicated that the key to their health improvement was their 
unattained adherence to physical activity and/or diet control. Many patients explained that lack 
of willpower to control their diet or maintain regular exercising was the 'weakest link' in their 
treatment plan as patient 5 explains: 
To stay healthy I need to maintain three factors: food, exercise and medicine, but I know that I 
am bad with two factors, food and exercise; they are gone. So if I don't take my drugs as well, 
then I'm left with nothing to control my diabetes. [ 
... 
]for me I think if I'm able to be good in my 
diet and exercise, my health will improve significantly. Diet and exercise are my weakest link. 
Patient 5, man, 50 yrs, Indian 
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Patients' self-blame was sometimes interlaced with hopelessness and despair about improving 
their condition. Failing to reduce weight despite dieting and exercising and inability to control 
CRFs resulted in patients' confusion and despair. Patient 1, who previously admitted his lack of 
motivation and willpower to exercise or control his diet, believed that there was no solution to 
his uncontrolled CRFs. 
There is nothing left I can do. Now /just come in to pick up the medicines for refill and stuff like 
blood tests. My physician said to me that she's giving me all the tests that she knows in all the 
books, but she still doesn't know why I am this size or why my BP is so high. She's looking at me 
for help. She told me to exercise many times, but I just can't. So If she is telling me that she is 
stuck at a crossroads then. Well, I'm no doctor and I don't know what more I can do. 
Patient 1, man, 45 yrs, British 
Coexisting health conditions that limited patients' physical activity were another factor that 
engendered patients' despondency. Many patients expressed sincere aspirations to start or 
resume exercising but were hindered by conditions that limited their mobility, such as body 
injuries or rheumatoid arthritis. Patient 6 who previously expressed his hopelessness and 
depression because of his inability to exercise (section 5.2.3), reiterated his concern when he 
was asked about solutions: 
R: What do you think will help improve your condition? 
P: I know that the only thing that I'm not doing now is exercising. I really want to. I want to walk 
like I used to, but my knee problems are preventing me from doing so. I think that's the only 
thing that will make a difference. But 1 just can't now. 
Patient 6, man, 65 years, Yemeni 
Chapter 5 presented patients' responses about external and internal limitations to lifestyle 
interventions. As patients answered questions about facilitators to MetS management, they 
expressed self-blame and lack of contribution to management because of their pooradherence 
to lifestyle interventions. However, self-blame was sometimes accompanied by statements 
about their struggle to adhere because of internal limitations (i. e., lack of motivation or physical 
injuries) and feelings of hopelessness. Chapter 4 presented a number of patients' strategies to 
cope with their presenting CRFs that included normalisation of MetS and competing demands. 
Patients' self-blame might be another strategy used to reach acceptance of their failure to 
improve treatment outcomes. As such, HCPs need to take into account patients' coping 
strategies when evaluating the impact of MetS on their psychosocial wellbeing. Exploring 
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patients' coping strategies might help HCPs identify patients in need of counselling or social 
support. 
7.3.2 Patient-physician relationship 
Improving patient-physician encounters during consultations was a popular facilitator that many 
patients reported during interviews as they gave their views on methods to improve MetS 
management and their health condition. Patients exclusively referred to their physicians in their 
answers, which illustrates that physicians were the key players in delivering MetS patient care. 
Patients indicated that attentive listening to their complaints and treatment concerns was 
missing during counselling sessions. Patients believed that listening had a positive impact on 
their health because it allowed physicians to know their circumstances and eventually design an 
appropriate treatment plan. In their perception, a treatment plan that acknowledged their needs 
was easier to follow and adhere to. Patient 19, who has diabetes, felt that physicians applied a 
standardised treatment to all patients. He believed that his treatment plan should be tailored to 
his needs, which can only be achieved if his physician listened attentively to his concerns: 
The doctor needs to listen to me, because not all diabetic patients are the same, just like the 
fingers in your hands they are not the some. The same thing applies to patient, but the doctor 
never asks me anything about me about what I like. Because if he did, he will know what type of 
treatment will work best for me. 
Patient 19, man, 67 yrs, Emirat! 
Patients described their physicians' robotic prescription refill writing during routine visits with 
minimum eye contact and conversation. This description was expressed again as patients talked 
about facilitators to improving their condition with more emphasis on listening and showing 
compassion. Patient 21 believed that her physician's exclusive attentiveness towards her 
medical profile, rather than her views, contributed to his poor therapeutic outcomes: 
My doctor does not seem to look into my eyes much when she's talking to me. She's always 
down on the paper and not interested in what I need to say. She pretends to be listening, but I 
know that she's not. I know that if she did she'd do a better job and she'll prescribe something 
better. The medicine doesn't suit me and if she just listens to me, really listens, she'll understand 
what works for my body. 
Patient 21, woman, 49 yrs, Emirati 
Patients' views on facilitators to MetS management reinforced the belief that attentive listening 
of physicians to their patients positively influences the healing process and improves therapeutic 
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outcomes. Experiencing physicians' attentive listening and compassion motivated patients to 
disclose their views, concerns and circumstances. 
7.4 Summary 
This chapter has illustrated how both patients and HCPs perceived facilitators to MetS. Although 
both participant groups reported a wide range of barriers to MetS prevention and management, 
they provided limited but distinct answers as they were asked direct questions about facilitators 
to MetS management. This could be attributed to the phrasing of the question and the way 
participants interpreted it. HCPs thought of solutions that would be applicable to the whole 
population; therefore, they mainly cited public health policy and health promotion programmes 
as key tools to MetS prevention and behavioural change. Patients, on the other hand, talked 
about solutions that affected their own performance in the management process. They talked 
about their attitude towards their treatment plan and factors that could improve their patient- 
provider encounters. Facilitators were orientated into two main categories: (i) disease 
prevention and health promotion strategies; and (ii) strategies to improve MetS management 
within clinical settings. 
HCPs believed that the incorporation of non-health sectors as facilitators to health would help 
address MetS holistically and not in a merely treatment-oriented manner. The UAE government, 
schools and the mass media were the three main stakeholders that HCPs believed to be highly 
influential in public health promotion. Cross-governmental collaboration in health promotion 
was perceived as key in MetS prevention and management and reflects the UAE public health 
vision for its population. HCPs also called for coordination between different health authorities 
across all Emirates of the UAE to achieve unity and prevent disparity. Preventing MetS in 
children and young adults through engaging schools and introducing health concepts into school 
philosophy was a popular view amongst most HCPs interviewed. The mass media, particularly 
television, was also applauded by all HCPs and believed to be a powerful motivator to 
behavioural change. Emiratisation of health care professionals and the use of Emirati role 
models for sports and exercise training was also suggested. Emiratisation was believed to bridge 
the communication gap and enhance cultural concordance in clinical practice. The idea of using 
religion in promoting healthy lifestyles was engendered by an awareness of Islamic teachings 
that urged fostering of health and protecting the body against diseases. HCPs, however, felt that 
research that assessed population health needs was lacking in the UAE. There was also a call for 
249 
Chapter 7 Facilitators to MetS management 
research that assesses the health impact and effectiveness of existing health promotion 
programmes. 
Patients' answers to direct questions about facilitators included their genuine desire to improve 
or adhere to lifestyle interventions. However, patients' self-blame was sometimes interwoven 
with feelings of despair and hopelessness in achieving further therapy progress. This may 
indicate signs of anxiety and depression, which highlights the importance of assessing patients' 
psychological wellbeing. Patients stressed the importance of physicians' attentive listening and 
claimed that this was influential in their treatment outcome. 
The following chapter will present the discussion of results presented in chapters 4,5,6 and 7. 
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Chapter 8 
8.1 Introduction 
Discussion, implications and reflections 
This final chapter discusses four main areas of this thesis: Section 8.2 discusses the study findings 
and demonstrates how they relate to the literature, especially the literature on factors influencing 
the management of MetS in the UAE and perceptions of MetS. The implications of the study 
findings for patients, professional practice, health service and society are discussed in section 8.3. 
The limitations of the research are also discussed in section 8.4. The chapter then presents the 
researcher's reflections on the research and the dilemmas faced during translation from Arabic to 
English in section 8.5. The chapter concludes with proposals and suggestions for future work that 
were elicited as a result of this study. 
The overall aim of this research was to elicit factors that impact the management of MetS in the 
UAE through exploring patient and professional perceptions of MetS and its management. The 
study objectives as outlined in section 1.2 were addressed in detail in different chapters 
throughout the thesis. Health concerns in patients with MetS remain under-reported in the 
literature (section 2.9), which inspired the study aims and objectives. A qualitative approach that 
drew on the broad principles of grounded theory was undertaken to meet the aims of the study. 
Constant comparison analysis was employed to help identify factors that influenced patients' 
health behaviours and attitudes towards their MetS treatment plans. The study aims and 
objectives were all met and the findings are set out in this section. 
This study has made use of two research methods (in-depth interviews and a focus group 
interview) in order to explore patient and professional perceptions of factors affecting the holistic 
management of MetS. Using two methods of data collection enabled a greater depth of 
exploration than might have been achievable by a single method. The use of a qualitative 
approach was successful in accessing detailed data that illustrated factors affecting MetS 
management in the UAE. Common themes were found throughout the data from multiple 
participants, both patients and HCPs. This allowed for contrast and comparison of the data. Two 
examples are the impact of socio-cultural norms on lifestyle interventions and factors affecting 
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patients' medicine use. These topics emerged in both HCPs and patient interviews and the 
similarity of opinions voiced by both groups supports these themes. 
Not all themes were found to be supported by all sources of data. For example, when participants 
were asked about facilitators to MetS management, HCPs were mainly concerned with health 
promotion strategies that can result in behavioural change. In contrast, patients' responses 
conveyed their sense of hopelessness in adhering to lifestyle interventions because of coexisting 
health conditions or physical injuries. This disparity may suggest the need for more patient- 
centred health approaches that explore patients' views and concerns rather than public-targeted 
approaches that might fail to cater for patient-specific health needs. The emergence of repeated 
themes throughout the data sets again adds to the validity of the results by supporting and 
enhancing each theme. Additional perspectives can be added to the interpretation of the data 
and this is a major strength of the research presented here. 
In the following sections, the different themes will be discussed and compared to existing 
literature to highlight new areas that are specific to this study population. 
8.2 Discussion of key findings 
This section discusses the study results, which are: (i) factors influencing patients' perceptions and 
beliefs about their condition; (ii) factors influencing the clinical utilisation of the MetS concept; 
and (iii) factors affecting patients' attitudes towards their treatment plans. 
8.2.1 Factors influencing patient perceptions of MetS 
Illness perceptions are organised cognitive representations or beliefs that patients have about 
their illness (Conner and Norman 2008). Although scientific descriptions of disease provide an 
understanding of cause and process, they fail to depict patient experiences of the disease. 
However, this does not indicate that lay perceptions lack awareness of the natural processes and 
determinants of the illness. They actually encompass all aspects of a disease that include: (i) 
aetiology (its cause); (ii) disease onset noted by signs and symptoms; (iii) pathophysiology (how 
the disease will progress and what is wrong); (iv) treatment; (iv) prognosis (the future); and (v) 
overall effect on lifestyle (Pollock 2005). The perception that a patient holds toward all these 
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aspects of a disease could be the product of a number of influencing factors, such as his or her 
experiences, learned knowledge, and interactions with other people. 
The way in which individuals perceive their illnesses is likely to affect many aspects of their health 
behaviour, including seeking help, the particular nature of the help that may be sought, 
adherence to the prescribed treatment and the likelihood of response to such treatment. 
Research investigating the role of illness perceptions in medical conditions has grown rapidly in 
recent years mainly due to the strong associations found between patients' perceptions of their 
illness and behavioural outcomes. Eliciting patients' interpretations and perceptions of their 
illnesses can provide a base for understanding the way in which patients conceptualise the cause, 
course and appropriate management of these diseases, and it can clarify the factors that helped 
shape the understanding of these diseases. This information can eventually lead to improved 
quality of care, which is more responsive to patients' specific needs. It was, therefore, important 
in this study, as part of identifying factors that influence the management of MetS, to explore 
patients' perceptions and beliefs about having MetS and the clustering of CRFs that constitute the 
definition of the MetS. 
8.2.1.1 Awareness of the Mets concept 
One of the limitations of this study was patients' unfamiliarity with their MetS diagnosis or the 
MetS concept prior to taking part in the interviews (sections 4.2 and 4.2.1). Although the MetS 
diagnosis was documented in the medical files of some of the study participants, patients 
admitted that they were not informed about MetS by their physicians prior to reading the study 
information sheet. It was, therefore, hard to investigate their perception of the MetS concept or 
their feelings towards being diagnosed with MetS as a condition in its own right. An awareness of 
the MetS concept would have included awareness that the clustering of three or more of patients' 
presenting CRFs was termed 'metabolic syndrome' and that such clustering increased their 
chances of developing diabetes and heart problems. As people with an illness obtain new 
information about their condition (e. g., informing patients of the MetS diagnosis and concept by 
their physicians during any phase of their treatment) they might simultaneously evaluate their 
attempts to moderate, cure or cope with its effects which could result in the formation and 
development of new interpretations of their disease based upon these experiences. Illness 
representations are in effect cumulative, with information being adopted, discarded or adapted 
as necessary. Thus, it is unclear how this information might have informed the patients' accounts 
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had it been provided to them by their physicians at one point during their treatment phase. For 
example, Grundy (2006) argues that informing patients of the significance of the clustering of 
CRFs on their health will communicate a greater sense of urgency for intervention than would the 
awareness of the risk of a single CRF, thus motivating their behaviour change. One qualitative 
study that explored Chinese diabetic patients' perceptions about illness and treatment strategies 
found that the patients' focus on reducing sugar intake only was related to the Chinese name of 
diabetes, which translates into sugar-in-urine (Lai, Lew-Ting et al. 2004). The study authors 
suggested that using the term 'metabolic syndrome' instead of diabetes may rectify patients' 
misconception of diabetes dietary requirements and will encourage a holistic approach towards 
diabetes management (Lai, Lew-Ting et al. 2004). Similarly, if we are to apply these arguments 
into my study, patients' awareness of the MetS concept might have generated different accounts 
to those disclosed in this study. 
As study participants admitted their lack of familiarity with the MetS concept or diagnosis, it was 
difficult to link all their perceptions of illness exclusively to MetS as a concept and a diagnosis. 
However, patients' responses in this study reflected their perceptions and experiences of living 
with a clustering of CRFs, which also agrees with the essence of the MetS concept. Thus, patients' 
accounts of their disease experience might be similar to that expressed by patients aware of their 
MetS diagnosis. The literature review did not identify studies that explored patients' perception of 
the MetS concept. Only one qualitative study explored the impact of having knowledge about the 
MetS risk on the health behaviour of 13 adult Swedish patients (Frisman and Bertero 2008). 
Findings from that study showed that despite participants' awareness of their diagnosis and the 
cardiovascular risk associated with having MetS, contextual factors hugely influenced their health 
behaviour and resulted in their inability to maintain a healthy lifestyle (Frisman and Bertero 
2008). Results also suggest that having awareness of the MetS name, meaning and risk was not 
solely sufficient to guarantee behaviour change. Other factors such as patients' contextual 
settings and motivation need to be addressed when managing patients with MetS. These results 
also suggest that awareness of MetS might not have stimulated different attitudes towards 
treatment or a better behaviour change than an awareness of the risk of individual CRFs. 
Despite patients' lack of knowledge of the MetS concept, they were informed about all their 
presenting individual CRFs. Patients' accounts also reflected their understanding of having 
multiple CRFs (i. e., hypertension, diabetes, elevated lipid profile and obesity) using words such as 
'cocktail' (referring to having a mixture of CRFs) and 'more than one enemy' (as patients talked 
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about the augmented impact that the cluster had on their health) to describe the clustering of 
such diseases. In their description of their health condition, patients talked about the causes of 
these CRFs, factors affecting their control and their risk concerns. These accounts were 
categorised into three subcategories: (i) perception of risk; (ii) coping; and (iii) fatalism. 
8.2.1.2 Perception of MetS risk 
In their interview, patients indicated the augmented burden that the clustering of these CRFs had 
on their health. Patients felt that having multiple CRFs 'weakened' and 'exhausted' the body. One 
patient described it as 'fighting more than one enemy' indicating the augmented fatiguing and 
draining impact these multiple CRFs had on his body. However, few patients talked specifically 
about the risk of developing CVDs and mentioned a number of sources to their knowledge such as 
their physicians, the mass media or other social interactions with friends and work colleagues. 
Other patients were more concerned with developing non-cardiovascular complications, such as 
renal failure, blindness and limb amputations as a result of nonadherence and/or failure to 
control their CRFs. 
The available literature shows that patients generally have insufficient knowledge about CVDs 
(Merz, Buse et al. 2002; Goldman, Parker et al. 2006; van der Weijden, van Steenkiste et al. 2007). 
For example, in the USA, Merz et al found that 68% of their surveyed diabetic patients (n=2008) 
did not consider CVD to be a serious complication of diabetes and were more likely to be aware of 
complications such as blindness (65%) or amputation (36%) rather than heart disease (17%), heart 
attack (14%) or stroke (5%). In addition, a significant number of the patients in that study did not 
name any cardiovascular condition as a serious complication of diabetes (Merz, Buse et al. 2002). 
Findings are also similar to those identified in the qualitative study of Lai and colleagues (2007) 
where a number of patients in Taiwan expressed more concern towards developing diabetes 
complications that would result in undergoing dialysis or limb amputations than they did towards 
developing CVDs (Lai, Chie et al. 2007). 
In this study, patients' awareness of the risk of developing CRFs complications was also apparent 
as they talked about reasons for adhering to their treatment plan. In many interviews patients 
repeatedly indicated that they were keen to adhere to their prescribed medicines and lifestyle 
advice because they wanted to avoid developing such complications. Multiple theories and 
models have been developed to try and explain how people make decisions, particularly those 
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related to risk (see section 2.6). For example, the HBM suggests that an individual's engagement 
in a particular behaviour such as taking medications is a function of their beliefs about the 
perceived threat of the disease and an evaluation of the risk/benefit of the recommended course 
of action (Horne and Weinman 1998). This study did not use any of the existing health models as a 
framework for data analysis; however, this particular aspect of the HBM is consistent with 
patients' accounts as they expressed their eagerness to adhere to their treatment plans to 
prevent complications resulting from suboptimal control of the CRFs. One patient in the study 
indicated that his 'carefree' attitude towards his health was because he did not comprehend the 
severity of his condition and that resulted in his frequent forgetfulness to take his medicines on 
time. He believed that a better understanding of his condition and the risk it holds might improve 
his adherence. 
Further analysis of patients' accounts revealed a range of views regarding how they perceived the 
seriousness of these cardiac conditions. Apart from talking about the complications of 
uncontrolled CRFs, some patients' accounts indicated downplaying of the risk of having Mets 
features. Another group seemed to rank diabetes as more serious than other CRFs. For example, 
the responses of a group of patients indicated downplaying of diabetes or hypertension risk. 
There were two main factors that resulted in patients' downplaying of risk: (i) awareness of the 
high prevalence of these CRFs in the UAE; and (ii) the curability or treatability of such diseases. 
Some of the patients' accounts indicated that due to the high prevalence of these CRFs in the 
UAE, which they claimed to be aware of, they had a sense of how common these diseases were 
and, therefore, a sense of them not being so severe or important. Some even suggested that it 
was 'normal' to have an individual with diabetes or hypertension in every house in the UAE. 
Others believed that such anomalies were the result of the modernisation and urbanisation of the 
UAE that began with the booming of the oil industry. This finding is also comparable to a study 
from the USA, where Wang and others (2009) examined individuals' perceptions of risk, worry, 
severity and control for six common chronic illnesses such as heart disease, diabetes, stroke, and 
breast, ovarian and colon cancer. They found that diabetes was perceived to be the least severe 
condition amongst study participants (Wang, O'Neill et al. 2009). In the UK, a qualitative study by 
Walter and Emery (2006) examined and compared the perception of risk between individuals with 
a family history of common diseases such as cancer, heart diseases and diabetes. Results showed 
that participants viewed having a family history of diabetes as the least threatening. Participants 
had a lower perceived risk of diabetes due to the availability of medicines to control the disease 
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and their association of old age with the cause of the condition (Walter and Emery 2006). 
Literature in health psychology has also shown that people's interpretation of an illness or their 
judgement of how much medical attention it needs is affected by their knowledge of the 
prevalence of that illness and its symptoms (Jemmotta, Croylea R. T. et al. 1988). In Jemmotta et 
al's study (1988), participants who estimated the prevalence of a condition as relatively high also 
rated that condition to be less serious than conditions with lower prevalence. In addition, 
participants who had a history of a health condition ranked this condition less serious than those 
who did not. Authors of that study argued that this tendency towards the 'normalisation' of risk 
of some health conditions could impact patients' health behaviour with regards to seeking help or 
adhering to the treatment plan (Jemmotta, Croylea R. T. et al. 1988). In the UAE, publicising the 
prevalence of diabetes, obesity and MetS through health awareness programmes and health 
promotion campaigns (see section 2.4) aims to increase public awareness of the risk of MetS 
features. However, findings from this study showed that this target was not always attained as 
some of the interviewed patients understated the risk of developing such conditions and 
perceived them as 'common' conditions that many are susceptible of developing. In addition, 
patients also felt that CRFs were a consequence of the urbanisation and modernisation of the 
UAE. They felt that obesity, diabetes and hypertension were a by-product of leading a western- 
inspired lifestyle, where fast food chains and inactivity dominated people's lives in the UAE. This 
finding is similar to that in Herzlich's (1973) research, which found that most people perceived 
illness as an external product of a way of life, precisely urban life (Herzlich 1973). 
Another factor that engendered patients' understatement of the risk of their CRFs was their belief 
that such conditions were treatable through the use of medicines. For example, one of the study 
participants compared diabetes to headache because such conditions were managed using drugs. 
In his perception, the availability of a therapeutic management for an illness undervalued the 
perception of the risk of that condition. Many illness representation models have been developed 
to help understand factors influencing people's perception of diseases. For example, Leventhal et 
al (1980) proposed the illness representation model which consists of five attributes: (i) disease 
identity (i. e., the labels placed on the disease and the symptoms patients view as being part of the 
illness); (ii) timeline (expectations about the duration and the characteristic course of the 
disease); (iii) consequences (the expected outcomes and sequences of the disease and effect on 
patients and their families); (iv) causes (personal ideas about the causes of the illness); and (v) 
controllability/ cure (beliefs about the degree to which the disease is amenable to control or 
cure). Studies that used such a model to examine patients' perceptions of their illness found that 
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the ability to control and cope with a condition lowered patients' perception of risk (Walter and 
Emery 2006; Lai, Chie et al. 2007). In addition, Weinman and Petrie (1997) stated that there are 
logical interrelationships between different components of the illness representation model. For 
example, believing that an illness is controllable and treatable is associated with perceptions of 
lower seriousness and associated risk (Weinman and Petrie 1997). This interrelationship may 
explain findings from my study where patients understated the risk of having any of the CRFs 
because of the availability of therapeutic management. 
Contrary to the downplaying of risk, another group of patients ranked the seriousness of 
individual CRFs. This attitude could be attributed to the fact that patients had a constellation of 
CRFs and their perception of risk varied across the different CRFs in their diagnosis. For example, 
some patients indicated that diabetes was the most serious illness when compared with 
hypertension, obesity and dyslipidaemia. Most of the patients interviewed were diagnosed with 
diabetes in addition to the other CRFs and they also received their health care from SKMC diabetic 
primary care centre. Other patients that were not diagnosed with diabetes received their health 
care from other general family medicine clinics that were not specific to individual CRFs (i. e., 
hypertension, obesity and dyslipdaemia). The specialised health care dedicated to patients with 
diabetes, which is not provided to other individual CRFs, could explain patients' tendency to rank 
diabetes with a higher level of risk compared to hypertension, dyslipidaemia and obesity. In 
addition, the higher media attention to diabetes and the diabetes-specific public awareness 
campaign in the UAE (section 2.4.2) could have encouraged this perception, which was also 
evident in patients' accounts. Patients' perception about one illness not only has implications on 
how they view their other illnesses, but also the preventative actions they take to minimise the 
risk of their diagnosed illnesses. Existing perceptions for one disease might also influence the way 
patients interact with new health information relating to this or other diseases (Wang, O'Neill et 
al. 2009). None of the patients interviewed were familiar with the MetS concept, which states 
that risk of the whole syndrome is greater than the sum of its parts (see sections 1.2 and 2.8). This 
may also explain why patients' perceived risk was not the same for all their diagnosed CRFs. 
8.2.1.3 Coping with MetS features 
Coping is defined as a response aimed at diminishing the physical, emotional and psychological 
burden that is linked to stressful life events and daily hassles (Lazarus and Folkman 1984). Coping 
includes anything an individual does to reduce the impact of a perceived or an actual stressor. 
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Thus, it can operate by either altering or reducing the negative emotions associated with the 
experience of an illness, such as positive thinking and distraction, or by targeting the actual 
stressor, such as learning new skills to combat stress or seeking new information about the 
condition (Lazarus and Folkman 1984). Coping is also a dynamic process that involves a 
constellation of both cognitive and behavioural strategies. Cognitive strategies are those that 
control emotional responses to an event, including denial, minimalisation and partialisation. 
Behavioural strategies are those that deliver better knowledge about the condition and allow 
patients to become more involved in their health care (Corbin and Strauss 1988). In the literature 
there are many overlapping terms used to describe patients' strategies in coping with their illness. 
However, the two main categories that encompass both cognitive and behavioural coping 
strategies are the problem-focused and emotion-focused strategies (Lazarus and Folkman 1984). 
Emotion-focused strategies include cognitive coping efforts such as positively reappraising the 
illness in order to see it in a more positive light; seeking emotional support; self-distraction, 
venting and praying. Such strategies allow patients to process emotions by acting and thinking 
and, thus, managing the emotional response to their illness. Problem-focused strategies, on the 
other hand, are instrumental coping efforts that are directed at the illness to either reduce its 
demand or increase the patients' resources. Problem-focused coping efforts include changing 
behaviour to control illness; repressing competing activities in order to focus more on the illness 
and on ways to resolve it; and seeking support (Lazarus and Folkman 1984). Emotion-focused and 
problem-focused coping strategies may be used simultaneously or alternately. Therefore, it is 
difficult to distinguish between them in the coping process (Folkman and Moskowitz 2000). 
Patients' ultimate goal of coping is to adapt to their chronic illnesses by creating a situation where 
the illness is being acknowledged but does not affect their family, decisions and daily activities 
(Dimond 1984). In this study, coping was evident in patients' accounts as they talked about 
different aspects of their condition, such as risk, the impact of having multiple CRFs on their lives, 
and the role of religion in the management of their CRFs. 
When patients were asked to describe how having multiple CRFs changed their lives, almost all 
patients indicated that they felt 'normal'. Patients usually stated that having these CRFs had an 
insignificant impact on their lives or the lives of the people around them. Patients in that sense 
did not deny having multiple CRFs, however, they claimed that adjusting and coping with such 
conditions was attainable because these CRFs did not alter their normal activities or their family 
life (Dimond 1984). Normalisation is another coping strategy that has been reported in the 
literature (Sharpe and Curran 2006). Patients who display such an attitude do not deny having an 
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illness or the symptoms experienced with their illnesses. However, they see such symptoms as 
normal consequences of having these illnesses. For example, patients diagnosed with rheumatoid 
arthritis might claim that they feel normal despite the fact that there were days when they 
experienced severe pain (Scharloo, Kaptein et al. 1998; Sharpe and Curran 2006). In addition, 
patients with diabetes might report feeling normal although their therapeutic management 
requires the use of insulin injections and alterations to their diet (Sharpe and Curran 2006). 
Similarly, patients in this study, although diagnosed with multiple CRFs, repeatedly reported 
feeling normal and indicated that taking medicines and adjusting their lifestyle was not difficult to 
cope with. The word 'normal' that patients used in their responses to describe how they lived 
with their CRFs was not used to indicate their sense of an illness-free state or illness denial, but 
rather their sense of maintaining a normal life activity despite having multiple CRFs. Further data 
analysis of patients' responses regarding the impact of having multiple CRFs showed that 
normalisation was engendered by two main factors: the asymptomatic nature of these CRFs and 
having other responsibilities in life that distracted their attention from worrying about their 
diseases. 
The asymptomatic nature of the CRFs meant that patients were not constantly alerted by these 
diseases. Patients' accounts indicated that they were more concerned with coexisting 
symptomatic health conditions, such as injuries from accidents, back and knee pain and 
rheumatoid arthritis. Patients indicated that such non-cardiac health conditions had a higher 
impact on their daily lives than did their presenting CRFs. For example, a painful knee or lower 
back pain prevented some patients from sleeping and a leg injury prevented others from 
exercising. On the other hand, their presenting CRFs did not have a similar impact on their 
physical activity, their lives or the lives of others around them, because they did not have 
strenuous or intolerable symptoms. When some of the patients were asked to elaborate, their 
responses indicated that their interpretation of illness drew on physical signs in the body, such as 
feelings of pain or the inability to see and walk. Ypinazar and Margolis (2006) identified similar 
findings in their study of the health beliefs of elderly Emiratis. In their study, patients' perceptions 
of illness was associated with apparent physical symptoms and pain. Physical functionality and 
vitality, such as the ability to do what needs to be done, were also rated the most important 
determinants of 'health in previous studies (Benyamini, Leventhal et al. 2003; Hughner and Kleine 
2004). 
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Patients in this study were able to normalise living with MetS features because of the absence of 
physical signs of their CRFs. This finding could also be comparable to findings from a qualitative 
study conducted in the USA, which explored the perceptions of 39 patients with diabetes 
(Olshansky, Sacco et al. 2008). A key theme identified from data analysis was 'normalising identity 
as a person with diabetes' where participants in the study viewed themselves as healthy, normal 
people. Maintaining the lifestyle changes prescribed while also seeking a sense of normalcy was 
participants' way of coping and dealing with their new identity as patients with diabetes. 
Normalising patients' identity enabled patients to perceive prescribed lifestyle interventions as a 
factor that improved their health and wellness. Normalising identity also included identifying 
themselves as a 'person with diabetes' rather than 'a diabetic person'. In this sense, diabetes 
became less central in their personal self-definition and was therefore viewed as something that 
is part of who they are (Olshansky, Sacco et al. 2008). Similarly, a group of participants in this 
study referred to themselves as normal individuals who happened to be diagnosed with multiple 
CRFs. Adhering to their prescribed medicines, adjusting their diet and increasing their physical 
activity were not perceived as significant alterations of their previous lifestyle but rather a normal 
consequence to their illness and their means of restoring and maintaining their normal health and 
normal selves. 
Competing demands, such as 'house chores', 'helping the kids with their homework', and 
'attending to the needs of the family', was another factor that engendered patients' 
normalisation attitude. Most of the study's participants were married and had families that they 
were responsible for. This group of patients indicated that their health condition did not alter 
their domestic life or daily routine. Apart from having a clustering of CRFs, taking prescribed 
medicines, adjusting their diet and improving their physical activity, these patients felt that their 
health condition had little impact on their lives and families. They also believed that daily 
competing demands were not altered by having CRFs or adhering to the prescribed treatment 
plan. However, they indicated that these competing demands distracted them from constantly 
worrying or thinking about their illnesses. Tuncay and colleagues examined the coping strategies 
used by 161 Turkish adults with type 1 and type 2 diabetes and found that self-distraction, such as 
engaging in activities to distract oneself from worrying about health, was among the most 
frequently used coping strategy, in addition to religion and venting. The study also found that 
lower levels of anxiety were associated with increased use of self-distraction for diabetes-related 
emotional distress (Tuncay, Musabak et al. 2008). As explained earlier self-distraction is one of the 
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emotion-focused coping strategies used by patients with chronic illnesses and evidence from my 
study shows that patients with MetS features also used such strategies to cope with their CRFs. 
Another coping strategy that patients might have used to adapt to their condition was the 
downplaying of the risk of CRFs that was discussed earlier in this chapter. Some of the study 
participants perceived diabetes, hypertension and other CRFs as common illnesses because of 
their high prevalence in the UAE. In addition, the curability or controllability of such CRFs also 
rendered these diseases less serious or with lower risk. Patients' tendency to downplay the risk of 
their CRFs could also indicate one of the patients' coping strategies with such diseases. 
Understating the risk of CRFs could be classified as a cognitive strategy that patients adopted to 
facilitate coping with and accepting these diseases. Viewing such illnesses with a more positive 
light (i. e., common illnesses and of less seriousness) enabled study participants to cope with such 
chronic and lifelong conditions. This finding is also comparable to those identified in the 
qualitative study by Scrandis (2005) where she explored the extent and process by which women 
with postpartum depression seek social support. The result of her study found that the 
development of interpersonal relationships between participants and other women with 
postpartum depression made them aware of the commonness of this condition among women 
after giving birth. The fact that this disorder was so commonplace facilitated feelings of being 
normal and enhanced coping in that group of women (Scrandis 2005). 
As explained earlier, religion and faith are considered two of the emotion-focused efforts that 
some patients use to help them adapt to chronic illnesses (Lazarus and Folkman 1984). This was 
also identified in patients' accounts as they answered questions about the role of their religious 
practices and religious beliefs on their health condition. Patients did not report that faith had a 
direct effect on the management of their clustering CRFs. However, they indicated that having 
faith helped them find tranquillity and calmness which might have indirectly helped control their 
CRFs. Words such as 'empowering', 'tranquillity', 'calmness', and 'acceptance' were used by 
participants to describe the impact of religion on living with MetS (see section 4.2.4.2). They also 
talked about the role of a strong faith in accepting the illness and eventually coping with it and its 
therapeutic demands. Winslow and Honein (2007) found similar results in their study that 
explored Emirati women's health needs. Women in their study believed that part of the impact of 
religion on health was due to the relaxing and psychological comfort it provided (Winslow and 
Honein 2007). Another group of patients' perceived illness as a 'test from God' for their 'patience 
and gratitude', which they believed provided them with inner strength to withstand illness and 
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adhere to the treatment plan. Perceiving illness as a test from God was also identified in other 
qualitative studies on patients with similar religious backgrounds (Abdoli, Ashktorab et al. 2008; 
Azaiza and Cohen 2008). For example, Abdoli et al (2008) found that patients' beliefs that illness 
was in God's hands enabled them to accept having diabetes and endure it. According to Islamic 
scripts, Muslims are instructed to view sickness as a test from God and tolerate it with patience, 
acceptance and gratitude. They are also instructed to view their bodies as gifts that they need to 
protect and take care of and, thus, they are obliged to medicate and seek treatment when ill. In 
the Islamic scripts it is also stated that believers who display such attitudes are promised spiritual 
benefits for their physical suffering (Adib 2004). These scripts and Islamic teachings might have 
influenced patients' attitudes in this study as they felt that it was their role as believers to accept 
and tolerate illness. Available literature also reports that religion, among groups of different 
religious beliefs, provided a profound guiding role during illness (Koenig, Larson et al. 2001). 
Religion helped patients of different faiths cope with diverse medical conditions, such as cancer, 
asthma and diabetes (Koenig, Larson et al. 2001; Koenig 2004; Winslow and Honein 2007; Azaiza 
and Cohen 2008). Similarly, some patients in this study utilised their religious beliefs to cope with 
their health condition through gaining acceptance, tranquillity and empowerment. 
8.2.1.4 Patients' fatalistic attitude 
Another theme identified in this study was patients' fatalistic attitude towards acquiring MetS 
features (see section 4.2.3). This was apparent when patients used fatalistic statements to talk 
about the causes of CRFs or factors preventing optimal control of such diseases. Patients' 
accounts indicated that, among other factors that caused the development or poor control of 
CRFs (e. g., sedentary lifestyle and excessive eating), family history and stress were the most 
reported causes by many. For example, patients believed that developing MetS features was 
unavoidable if they had a family history of such diseases and some suggested that they forecasted 
their diagnosis and that 'it was a matter of time' before it was confirmed by their physician. 
Genetic determinism claims that a human's genetic makeup determines their behaviour and is 
used sometimes to justify the unhealthy activities of individuals, such as over eating and a 
sedentary lifestyle (Wang and Coups 2010). Although the causes of obesity are multi-factorial, a 
number of studies confirmed the presence of a genetic predisposing factor to obesity, diabetes 
and other CRFs (Walley, Asher et al. 2009). Researchers argue that patients' awareness of the 
existence of an obesity gene might negatively affect patients' beliefs about their health and their 
role in managing obesity. Patients' awareness of the genetic predisposition to their CRFs can 
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result in their genetic deterministic attitude and failure of behaviour change (Marteau and 
Weinman 2006). 
The available literature reports that perceived family history of diseases, such as cancer and heart 
disease was associated with a fatalistic attitude towards health behaviour and in some cases 
failure to change behaviour (Marteau and Lerman 2001). In this study, although patients indicated 
the role of family history in acquiring CRFs, they did not report their unwillingness to take their 
medicines, eat healthily or increase their physical activity. During interviews, patients' fatalistic 
talk was intertwined with emphasis on the importance of adherence to their treatment plans in 
the management of their presenting CRFs. This attitude is comparable to results from other 
studies that investigated the association of patients' knowledge of their familial risk of developing 
diseases and fatalistic attitude. In such studies little evidence was found to confirm such a claim 
(Hunt, Davison et al. 2000; PijI, Timmermans et al. 2009; Wang and Coups 2010). For example, PijI 
et al (2009) conducted a small randomised control trial that assessed the influence of informing 
patients of their familial risk of diabetes through self-reported behavioural outcome for three 
months. The results showed that the group of patients that received familial risk information 
reported greater control over preventing diabetes and eating more healthily when compared to 
the group that received general risk information. Wang and Coups (2010) investigated whether 
endorsing the idea of genes as a cause for obesity may increase genetically deterministic beliefs 
and reduce patients' motivation to adhere to lifestyle interventions. The results from their survey 
showed that only 19% of the respondents believed in the profound role of the genetic 
predisposition as a direct cause of obesity compared to 72% who agreed that an unhealthy 
lifestyle was a direct cause of obesity (Wang and Coups 2010). 
Fatalistic statements also occurred as patients talked about the impact of life hassles on their 
health and failure to control their presenting CRFs. In their perception, strenuous life events (i. e., 
domestic chores, work place pressure, being overloaded with family responsibilities and other 
family-related issues) resulted in poor control of their blood pressure and blood glucose levels. 
They also indicated that despite their adherence to the treatment plan, such external factors 
affected their health problems. They also reported that, such life hassles, were unavoidable which 
further hindered their attempt to control their CRFs. This attitude is similar to that identified in a 
qualitative study that explored the perceptions of 13 Hispanic women with diabetes about their 
health problems (Adams 2003). The study found that patients referred to stress as a cause of 
diabetes and reported encountering immensely stressful events at least one year prior to their 
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diagnosis (Adams 2003). Another study identified a social gradient in work stress and MetS, which 
suggests greater exposure to work stress among less advantaged social groups (Brunner, Marmot 
et al. 1997). In addition, Chandola et al (2006) found that exposure to chronic work stress 
increased men's and women's risk of developing MetS by two and five-folds, respectively, when 
compared to individuals who were not exposed to similar work stress. They also identified a dose- 
response relation between exposure to job stress and the MetS (trend P<0.05 for men; P<0.01 
for women) (Chandola, Brunner et al. 2006). 
In this study fatalistic talk occurred when some patients described the causes of developing CRFs 
or failure to control their diagnosed CRFs. Patients mainly referred to the genetic predisposing 
factors and the impact of leading a stressful lifestyle and believed that such factors were 
unavoidable and uncontrollable which hindered their attempt to improve their health condition. 
Rotter (1966) also reported that people's locus of control (LC) determines the extent to which 
they feel that they have control over a situation or that the situation is being controlled by 
external factors such as fate, luck or chance (see chapter 2 section 2.6.4). For example, a patient 
with an external LC would be more likely to believe that outside circumstances control their 
health while a patient with an internal LC would take responsibility of what happens to their 
health (Horne and Weinman 1998). Wallston and Wallston (1978) referred to external factors as 
'chance' and 'powerful others' when they applied the LC concept to health and called it the 
multidimensional health LC (Wallston and Wallston 1978). Similarly, some patients in this study 
indicated that external factors such as leading stressful lifestyle and having a family history of 
CRFs where uncontrollable factors that influenced their chances of developing CRFs or hindered 
the control of their illness despite their adherence to the treatment plan. Many studies used the 
health LC to predict patients' health behaviour. For example, some studies found that 49 
individuals high in internal locus of control were more likely to adhere to HIV (Molassiotis, Nahas- 
Lopez et al. 2002), hypertension (Kirscht and Rosenstock 1977) and diabetes medication regimens 
(O'Hea, Grothe et al. 2005). Overall, it has been found that the health LC is relatively weak in 
predicting health behaviour including adherence to medication and accounts for only small 
amounts of the variance in patients behaviours (Conner and Norman 2005). 
As explained earlier, patients' fatalistic talk was interlaced with statements that endorsed 
compliance with lifestyle and pharmacological interventions. As previously presented in chapter 2 
(see section 2.5.1.1) Keeley et al (2009) found that fatalistic talk was a socially constructed activity 
used to negotiate power-differences, express limited power to control one's health and reflect 
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the complexity of illness prevention. Similarly, patients in this study might have used fatalistic talk 
to express their limited power to prevent the development or control of their presenting CRFs. 
They believed that a stressful lifestyle, life hassles and a genetic predisposing factor were external 
factors that were beyond their control. They also believed that despite their adherence to their 
treatment plan, they could not overcome the impact of such factors on their health. However, 
such fatalistic statements were interwoven with statements that emphasised the importance of 
adhering to treatment and leading a healthy lifestyle, which confirms Keeley et al's argument that 
fatalistic talk, in such cases, indicated uncertainty and the inability to find explanations or causes 
for illness despite changing behaviour or leading a healthy lifestyle. As such, fatalistic talk was 
used by patients to convey their realistic understanding of issues outside their control that can 
result in illness despite prevention measures (Keeley, Wright et al. 2009). 
As discussed in this section, patients' attitudes towards their condition was influenced by many 
factors, such as the asymptomatic nature of the MetS features, competing demands, life hassles 
and leading stressful lifestyles, the high prevalence of CRFs in the UAE, the availability of 
therapeutic management and treatability of such diseases, awareness of complications and their 
religious beliefs. Although such factors might have resulted in patients' underestimation or 
ranking of the seriousness of CRFs, that did not stop patients from emphasising the importance of 
leading a healthy lifestyle and adhering to their recommended treatment plan in order to control 
such anomalies. The findings also suggested patients' attitudes towards their health problem 
could have been a coping strategy that enabled them to accept these CRFs and withstand 
treatment needs. Such coping strategies included normalisation, fatalism and downplaying the 
seriousness of CRFs. A noteworthy finding was patients' unfamiliarity with the MetS concept and 
diagnosis. This issue was further explored with the physicians who participated in the study and is 
discussed in section 8.2.4 and 8.2.4.4. It might still be unclear how information on the MetS 
diagnosis and definition provided by HCPs might have influenced patient perceptions of their 
condition, seriousness, coping strategies or even their attitude towards the recommended 
treatment plan; however, it is important to acknowledge that findings from this study illustrate 
the actual perceptions and emotional concerns of MetS patients in regard to their health 
condition and social context. Notwithstanding, it will still be interesting to see in future research 
how such information, once it is provided through the health care setting, affects illness 
perception and attitude towards treatment of this group of patients in the UAE. 
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With patients' perceptions of their health condition and the clustering of CRFs, the discussion now 
moves to factors influencing patients' attitude towards lifestyle interventions. 
8.2.2 Factors influencing patients' attitude towards lifestyle intervention 
The multifaceted nature of MetS calls for the implementation of both lifestyle and therapeutic 
interventions with a primary focus on controlling diet, reducing fat intake and increasing physical 
activity. However, like Drummond and Mason (1990) who stated that 'health exists in a state of 
competition with other factors deriving from the individual's context' (p, 38), changing behaviour 
in order to adopt a healthier lifestyle is expected to conflict with numerous contextual and 
emotional challenges, which may eventually affect the holistic management of patients with MetS 
(Drummond and Mason 1990; Kappagoda and Amsterdam 2007). Social scientists argue that an 
ideal way to get a sociological understanding of people's food habits is to explore such behaviours 
within the context of the social organisations in which they occur and to elicit the social 
relationships and belief systems that influence such behaviours (Calnan 1990). This study 
examined patients exercise and eating behaviours with relation to their setting and social 
organisations, which identified a number of factors that influenced lifestyle intervention. Such 
factors stemmed from the: (i) contextual features of the UAE (i. e., social norms, urban planning 
and affluence); (ii) environmental (i. e., hot climate, pedestrian-unfriendly urban planning, the 
abundance of fast food chains and lack of healthy alternatives); (iii) health-related factors (i. e., 
physical injuries and other co-existing symptomatic anomalies); (iv) structural factors (i. e., lack of 
social support, family responsibilities and long working hours); and (v) emotional factors (i. e., lack 
of motivation to initiate or maintain a healthy diet and structured exercise programme). 
Available literature provides evidence on the impact of culture on people's health behaviour and 
its role in determining lay perceptions about health and illness and means of obtaining health care 
(Kleinman, Eisenberg et al. 1978; Naeem 2003; Horne, Graupner et al. 2004; Heiman 2007; Willis 
and Elmer 2007; Shuval, Weissblueth et al. 2008; Ludwig, Cox et al. 2011; Nam, Chesla et at. 
2011). Similarly, participants in this study reported a number of socio-cultural norms that 
influenced the implementation of lifestyle interventions. These cultural norms included: (i) 
restrictions to women's outdoor, and to some extent, indoor exercising; (ii) traditional clothes 
that constrained movement; (iii) traditional eating habits, such as eating-centric activities, 
traditional cuisines and sharing one plate of food; (iv) food misconceptions with regards to honey 
and palm dates (see section 5.2.2). 
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Research conducted in the UAE reported similar cultural barriers to lifestyle interventions as 
identified in this study. For example, All et al found that some social-cultural factors restricted 
outdoor exercising for a group of women with diabetes and some reported their need for women- 
only walking tacks and culturally sensitive gyms that do not allow the use of security cameras or 
mobile phones with cameras (Ali, Bernsen et al. 2009; Ali, Baynouna et al. 2010). In a survey that 
explored factors influencing physical activity in patients with diabetes living in the UAE, most of 
the reported culturally-related barriers to exercise were specific to women. Such barriers included 
the limited number of women-only gyms and culturally sensitive health clubs (Al-Kaabi, Al- 
Maskari et al. 2009). Some of the local newspapers and internet sites in the UAE occasionally 
report incidents of pictures being taken and published of women in shopping malls, women-only 
social gatherings and fitting rooms in shops without these women's consent (Al Arabiya News 
Channel 2009). Such news might discourage women from visiting places that have security 
cameras or that allow mobile phones with cameras because of the fear of having their pictures 
taken. Retaining modesty was also paramount for Muslim patients with diabetes living in non- 
Muslim communities, such as the UK and Israel (Khanam and Costarelli 2008; Shuval, Weissblueth 
et at. 2008; Ludwig, Cox et al. 2011). For example, in the UK, walking was perceived by a group of 
patients as an acceptable activity for women rather than other vigorous exercises because it 
reserved modesty (Grace, Begum et at. 2008; Khanam and Costarelli 2008). In another study in the 
UK, the lack of culturally sensitive health clubs was also a concern for female Muslim patients with 
diabetes who were reluctant to join mixed-sex health clubs (Lawton, Ahmad et al. 2006). In a 
conservative society like the UAE, where many women are expected to cover their heads, wear 
ankle-length dresses and sometimes cover their faces, the idea of having their pictures taken, 
when not dressed in this manner, was daunting. Thus, some women in this study resisted the idea 
of joining women-only gyms that have security cameras and requested modifications that 
accommodate for their cultural rules to be applied to gyms in the Emirates. 
Contrary to some HCPs' concerns regarding the negative impact of traditional Emirati clothes on 
exercising, a few female patients suggested that wearing long dresses and covering their faces 
while exercising provided them with a more comfortable setting to exercise outdoors. In their 
opinion, such modesty-reserving and identity-obscuring clothes protected them from being 
scrutinised or identified by the public and, therefore, facilitated their exercising. This view was 
also supported by some interviewed health educators who saw the need to tailor lifestyle 
interventions to fit the socio-cultural demands of the Emirati society. This finding indicates the 
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importance of applying the principles of cultural competence to overcome cultural barriers and 
help patients make the lifestyle changes necessary to lose weight and reduce the risk of MetS. 
Kousar et al were successful in reverting some of the MetS features in a group of Pakistani 
patients living in Australia through the use of a culturally appropriate lifestyle intervention 
(Kousar, Burns et al. 2008), which is an approach that can also be adopted in the UAE. 
The study also identified other social norms that limited patients' control of their diet, such as 
consuming traditional foods that are rich in carbohydrates, sugar content and saturated fats, 
sharing one plate of food, which altered the regulation of portion size, eating-centric activities or 
social foods, feasts and festivals and food misconceptions (see sections 5.3.1 and 5.3.2). These 
findings were also congruent with other studies that explored factors influencing diet control in 
patients with diabetes and other chronic illnesses. For example, Ali et al found that participants 
described traditional Emirati cuisines as unhealthy foods. They also indicated social foods and 
eating-centric activities as a barrier to dietary control and reported the need for education on 
healthy diet (Ali, Baynouna et al. 2010). Family gatherings where food is shared in one large plate 
was a barrier to diet control indicated by HCPs in another recent qualitative study in the UAE (Ali, 
Bernsen et al. 2009). This habit was also common in other Arab countries like Somalia and Oman 
and were also considered to hinder lifestyle intervention (Owens, Piccinin et al. 2009; Al-Sinani, 
Min et al. 2010). 
Honey and palm dates were religiously promoted as therapeutic substances that enhance the 
body's defence mechanisms. Patients, therefore, believed that consuming large quantities of both 
foods were beneficial to the body and have some therapeutic effects, especially with diabetes. 
Dietary misconceptions were assessed in 1,039 patients with diabetes living in Saudi Arabia. The 
results of the survey showed that 34.3% and 17.0% of the participants believed that honey and 
dates were good food items for patients with diabetes, respectively. (Al-Saeedi, Elzubier et al. 
2002). Misconceptions about the value of honey in diabetes were also identified in a survey that 
explored the knowledge, perceptions and barriers to diabetic care of 240 Arab patients with 
diabetes living in Israel (Khatib, Efrat et al. 2007). The study also reported that 56% of the 
participants believed that honey did not affect blood glucose levels. In both studies, patients' 
attitudes towards honey and dates were attributed to inaccurate Islamic and culturally-bound 
beliefs. Heiman (2007) reports that viewing food as medicine or with healing properties is a 
feature of many cultural groups, including the Islamic world, the Indian subcontinent, Latin 
America and China. He also indicates that in many cases such misconceptions about food and 
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drink may have negative effects on patients' health, which is similar to what participants in this 
study have reported. 
Heiman (2007) also presented a number of interrelationships between culture and eating habits 
such as feasts, festival, social eating, and food medicines and how folk models about diet 
influenced health. He states that 'food is more than just a source of nutrition' and 'its role is 
deeply imbedded in the social, religious and economic aspects of everyday life' (p. 52) and, thus, 
carries many symbolic meanings that help in the build-up of relationships between members of 
society. Therefore, dietary beliefs and practices are difficult to change even if such eating habits 
interfere with an individual's health and adequate nutrition (Heiman 2007). Many participants in 
this study (HCPs and patients) suggested that social eating habits and food misconceptions were 
challenging to modify or abolish in the UAE. However, health educators in this study reported that 
they used the principles of cultural competence and health education to modify such eating 
behaviours, which included asking patients to eat seven palm dates every day, rectifying food 
misconceptions, designing diet programmes using traditional foods and educating other members 
of the family about healthy diet. 
A number of patients and a few HCPs, on the other hand, argued that socio-cultural factors were 
no longer profound in the contemporary Emirati society. Old social and gender rules that might 
have influenced exercising and eating habits in the past were waning due to culture integration 
and the modernisation of the UAE society. In their opinion, this societal evolvement facilitated 
behavioural change through, for example, giving women the liberty to publicly engage in different 
types of physical activity and enabling Emirati families to adopt a lifestyle that is more grounded 
on the modern definition of healthy living (i. e., consuming foods of low fat and sugar content and 
increasing daily physical activities). They believed that more attention should be given to other 
structural and personal factors as they have an equal role in patients' adherence to lifestyle 
interventions. 
Although cultural norms provide guidelines for understanding health, illness and health care of 
individuals within their socio-cultural structure, Ahmed (1996) argues that culture should not be 
stripped of its dynamic social, economic, gender and historical context and treated as a rigid 
concept that is not subject to changes across time and open to different interpretations across 
different people. The problem with relying entirely on social norms and cultural rules to 
understand behaviour is that it could obscure other broader factors that may have equal if not 
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stronger impact on patients' health behaviour (Ahmad 1996). Therefore, consideration must be 
taken to the wider context in which patients' behaviours and actions take place and not only their 
underlying belief system or social rules. Anderson et al (1995), in their study of how Canadian 
women with diabetes of Chinese and European descent manage their condition, found that 
strategies used to manage diabetes did not indicate ethnicity roles but were rather influenced by 
the contextual features of women's daily lives coupled with their ability to access resources 
(Anderson, Wiggins et al. 1995). Drummond and Mason (1990) report that patients with diabetes 
face multiple constraints that influence their treatment plan and that include a wider range of 
structural and material factors, such as domestic, home, work, financial and emotional factors 
(Drummond and Mason 1990). Vieira et al published a review on the significance of dietary and 
behavioural changes in patients with cardiometabolic disorders, including MetS, which examined 
15 qualitative studies that explored patient perceptions of lifestyle interventions. They found that 
patients adherence to diet and exercise regimens was a dynamic process that depends on various 
personal and contextual factors and that HCPs need to understand such constraints when 
designing lifestyle interventions or assessing patients adherence (Vieira, Cordeiro et al. 2011). 
Similarly, in this study, a number of patients reported structural, financial, environmental and 
emotional factors that they believed strongly influenced lifestyle intervention and that did not 
necessarily indicate the cultural characteristics of their setting. Such factors included lack of time 
because of competing demands; coexisting health conditions that restricted mobility and physical 
activity; environmental factors; affluence; and lack of desire and motivation to engage in exercise 
or control diet. 
Lack of time because of long working hours and other family and domestic responsibilities 
competed with patients' attempts to engage in regular structural exercising. The responses of 
many patients indicated that they saw physical activity in the broad context that covered a range 
of activities. They, therefore, perceived daily incidental activity as a type of exercise that can 
positively contribute to their health. Such activities included walking to the mosque for prayers, 
sweeping, vacuuming and walking within the office during working hours. Similar constraining 
factors were also reported in the literature. For example, in the UK, one qualitative study 
investigated barriers to physical activity in patients with diabetes attending the Diabetes Clinic in 
Dundee. Findings suggested that lack of time and distraction by other activities were among the 
barriers to physical activity (Thomas, Alder et al. 2004). 
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Coexisting health conditions that limited mobility or regular exercising such as rheumatoid 
arthritis, knee and back pain and injuries from accidents were also identified as barriers to 
physical activity in this study (see section 5.2.3). Such factors were also reported in the literature. 
For example in the UAE, coexisting diseases, such as osteoarthritis, were the most reported 
barrier to physical activity (32.1%) in an Emirati self-reported survey that assessed physical 
activity in 390 patients with diabetes (Al-Kaabi, Al-Maskari et at. 2009). Crosson et al explored 
physicians' perceptions of barriers to control CRFs among patients with diabetes. Their results 
showed that coexisting diseases such as pain and depression were believed to compete with 
patients' efforts to control CRFs. Such competing conditions limited patients' ability to exercise, 
distracted patients and physicians from addressing diabetes management and resulted in 
patients' depression (Crosson, Heisler et al. 2010). Similarly, in this study, a group of patients who 
expressed a sincere desire to engage in regular exercising indicated that other health problems 
that limited mobility also hindered physical activity. Lack of movement due to coexisting health 
conditions in some cases resulted in feelings of hopelessness and sometimes depression. 
The hot climate and pedestrian-unfriendly urban planning were another two factors that 
rendered outdoor exercising a challenge for a number of interviewed patients. The role of 
weather in physical activity was also reported in the literature and extreme weather climate such 
as snow, heat and rain was also identified as a limiting factor to outdoor exercising in a number of 
studies (Eyler, Baker et al. 1998; Wilcox, Tudor-Locke et al. 2002; Belza, Walwick et al. 2004). In 
addition, lack of accessibility to exercise facilities because of location inconveniences was one of 
the most cited barriers to physical activity in many communities around the world (Jones and Nies 
1996; Thomas, Alder et al. 2004; Stamm and Lamprecht 2005). 
Another limiting factor to lifestyle interventions identified in this study was affluence or the 
affordability of a sedentary lifestyle. Affluence was reported by many HCPs in this study, 
especially when talking about the excessive use of cars for transportation and domestic workers 
for household activities, which limited patients' physical activity (see section 5.2.4). Some even 
suggested that such behaviour stemmed from unique and newly constructed social beliefs in the 
Emirates and believed that it was a behavioural feature of Emiratis only. Patients, on the other 
hand, perceived cars and using the aid of domestic workers with house chores as 'help' and 
mechanisms that facilitated a better quality of life. They explained that the hot climate of the UAE 
mandated the use of cars for commuting and many female patients believed that domestic 
workers were there to help and make time for themselves and their families. They also argued 
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that using the help of the domestic workers enabled them to dedicate more time for their regular 
and structured exercising. These views were also identified in Winslow and Honein's (2007) study 
where participants perceived domestic workers as a bridge that helped in various domestic 
responsibilities. 
Lack of self-motivation, drive and desire to initiate or maintain physical activity or diet regimen 
was a commonly reported limiting factor by many patients, including those who indicated other 
structural or environmental factors (see section 5.2.5). Lack of motivation in regard to lifestyle 
intervention was also reported in the literature. For example, in Saudi Arabia, one study explored 
barriers to lifestyle interventions in 450 patients attending a primary health care centre and found 
that lack of willpower was the second most hindering factor to exercise. In addition, 76.8% of 
participants reported lack of social support as another barrier to physical activity and 73.2% felt 
that they lacked the energy to perform exercise. In addition, lack of willpower was the most 
common barrier to diet control (80.3%) (AlQuaiz and Tayel 2009). Lack of self-control was also 
reported as a barrier to diet control by Emirati women at risk of diabetes (Ali, Baynouna et al. 
2010). 
Participants' accounts also indicated that they lacked the motivation to exercise and diet when 
there were other limiting factors (e. g., lack of time, exhaustion because of long working hours, 
lack of family and social support, the absence of a role model, inconvenience of the location of 
the gym and inability to control appetite). Belza et al (2004) explored factors influencing physical 
activity from the prospective of older adults from seven ethnicities that included American 
Indian/Alaska Native, African American, Filipino, Chinese, Latino, Korean and Vietnamese living in 
the USA. They found that lack of motivation was a common theme amongst all seven ethnic 
groups. The responses of participants in their study indicated that even in the presence of 
exercise facilitators, lack of motivation was still a more powerful limiting factor (Belza, Walwick et 
at. 2004). Some HCPs interviewed indicated that they usually seek unconventional strategies that 
were inspired from some Emirati social norms to motivate patients to control their diet and 
exercise more. In their perception, single women were more enthusiastic about losing weight in 
order to look attractive prior to their weddings or other celebratory social occasions. Married 
women, on the other hand, were less motivated but were sometimes stimulated when reminded 
of polygamy or threatened by the idea of her husband getting a second wife. Such an approach 
suggests that the principle of cultural competence should not only be restricted to designing 
273 
Chapter 8 Discussion, implications and reflections 
health interventions but could also be utilised in delivering health messages and motivation 
strategies. 
Lang and Froelicher (2006) indicate that lifestyle intervention is a multifaceted activity that is 
influenced by multiple factors that come into play and influence the degree to which such 
interventions can be adopted and maintained. Similarly, patients and HCPs in this study reported 
a wide range of barriers to diet control and exercise that did not always indicate a cultural role 
but stretched to include structural, material and emotional factors. It is, therefore, important that 
HCPs assess patients' behaviours and actions within the context that these behaviours take place. 
A noteworthy finding in this study was that despite patients' awareness of limitations to diet 
control and exercise, they all admitted that healthy lifestyle was important to improve their 
health condition and control their CRFs. Many patients also expressed their enthusiasm to resolve 
barriers to lifestyle intervention and sometimes expressed hopelessness and depression when 
such barriers were difficult to overcome such as physical injuries and lack of motivation. Davison 
et at (1992) argues that promoting the 'healthy lifestyle' ideology has emphasised people's sense 
of personal responsibility in the maintenance of their own health and ability to avoid the 
development of chronic disease through adopting 'good' health behaviours that involves eating 
healthy food and regular exercising (Davison, Frankel et al. 1992). The focus on health behaviour 
and accepting personal responsibility for health without acknowledging the social process is not 
necessarily empowering and might encourage self-blame and despondency (Backett 1990). Bissell 
et al (2004) explored the views and experiences of a group of British Pakistani patients with 
diabetes of their treatment in the context of the concept of concordance. Results from that study 
showed that while patients expressed anger at their GPs for not being able to understand the 
emotional and material challenges they faced to control their diet, they also expressed self-blame 
and responsibility for failure to change behaviour. Bissell et at argue that these mixed accounts 
from patients illustrated their attempts to accommodate for the demands of everyday life that 
strongly impact their lifestyle interventions and the compliance model that implies their 
responsibility towards their own health (Bissell, May et at. 2004). Similarly in my study, all patients 
accepted responsibility to control their CRFs and prevent future complications; however, they also 
reported contextual, emotional and material challenges that affected their adherence. While it is 
important for patients to be aware of the role of their own behaviour in health, it is essential that 
HCPs do not separate lifestyle from the social condition and circumstances in which it takes place 
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in order to address a broader range of barriers and thus, design interventions that accommodate 
for patients' circumstances. 
With factors influencing the implementation of lifestyle interventions in patients with MetS in the 
UAE, I now move to discuss factors patients' use of their medicine. 
8.2.3 Factors influencing medicines use in patients with MetS 
The primary goal of the clinical management of patients with MetS is to mitigate the modifiable, 
underlying risk factors (obesity, physical inactivity and diet) through lifestyle changes. However, if 
patients are presented with elevated blood lipids, hypertension and/or diabetes, consideration 
should be given to incorporating drug therapy to the regimen in order to target these clustering 
risk factors (Grundy, Cleeman et al. 2005). The treatment plan of all patients in this study included 
advice on lifestyle adjustments and medicines for their presenting CRFs. During interviews, it was 
evident that all patients were able to list their prescribed medicines by name or through the 
physical attributes of these medicines, such as the colour, dose and shape of tablet or capsules. 
They were also able to match the indication of each of these medicines correctly. Patients' 
accounts indicated that they appreciated the importance of taking their medicines as instructed 
by their doctors for the management of their presenting CRFs and the potential risk of not 
adhering to medicines as directed. However, responses of both patients and HCPs revealed a 
number of factors that influenced medicines use, which belong to three main categories: (i) 
patients' beliefs about medicines; (ii) accessibility to medicines; and (iii) knowledge about 
medicines. The following sections discuss these findings in detail. 
8.2.3.1 Beliefs about medicines 
Research on lay beliefs about medicines indicate that people have a range of positive and 
negative views about medicines across different populations, disease groups and countries 
(Horne, Weinman et al. 1999; Britten 2008). Although patients in this study reported that they 
adhered to their prescribed medicines, some expressed negative views about the safety of their 
medicines, which included describing them as 'chemicals' 'harmful', and 'addictive' (see section 
6.2.1). Most of the views expressed by patients, except those indicating brand loyalties, were 
negative perceptions about medicines. Britten (2008) states that people do not report many of 
their positive views about medicines when interviewed because they believe that medicine 
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necessity, effectiveness and safety are obvious attributes of medicines and do not need 
explanation and justification. Similarly, patients in my study might have assumed that the aim of 
my enquiry about their medicines was to elicit the peculiar and not the ordinary since the norm is 
the widely promoted effects of medicines that include their ability to control or revert CRFs and 
improve overall health and wellbeing (Pollock 2005; Britten 2008). However, and as will be 
discussed later in this section, some patients praised some of their prescribed medicines when 
talking about their preferred brands and reasons for their preferences. 
The study also found that patients' feeling about medicine's harmful effects on the body was 
enhanced by increasing the dose or number of their prescribed medicines. These perceptions 
encouraged some to stop taking their medicines for a short period of time (i. e., drug holidays) or 
look for alternative therapies (e. g., herbs, ozone infusion therapy and Islamic medicines) to 
minimise medicines harmful effect on the body. Such views have been reported in literature that 
explored factors influencing patients' attitude towards their medicines. For example, Horne et al 
(1999) reported that patients attending a herbal clinic were significantly more likely to perceive 
medicines as essentially harmful substances that are overused by doctors than a matched sample 
attending a community pharmacy (Horne, Weinman et al. 1999). In the UAE, Albraik et al (2008) 
explored the pattern of herbal medicine use in 330 patients visiting a primary care clinic in Abu 
Dhabi. The survey results showed that 76% of the respondents used herbal medicine in the past, 
while 38% were still using at least one herbal medicine alongside their conventional treatment 
(AlBraik, Rutter et al. 2008). Britten (1994) found that some of her study participants described 
medicines as unnatural chemicals that were harmful to the body and others believed that 
medicines reduced the body's ability to combat infections by damaging the immune system 
(Britten 1994). Patients' fear of addiction to their prescribed medicines was cited as one of the 
contributing factors to patients' nonadherence to medicines (Viasnik, Aliotta et al. 2005). Fear of 
losing independence was also linked to patients reluctance of accepting insulin therapy to be 
added to their treatment plan (Austin 2006), which was also identified in my study. A group of 
Norwegian hypertensive patients expressed fear of getting addicted to medicines including their 
anti hypertensive medicines (Toverud, Roise et al. 2010). 
Fallsberg (1991) identified four main categories of the words people used to describe medicines 
which included: (1) medicines are something positive; (ii) medicines are something negative; (iii) 
medicines are a 'necessary evil'; and (iv) medicines are referred to only with respect to form and 
administration (Fallsberg 1991). She found that patients that described medicines as 'necessary 
276 
Chapter 8 Discussion, implications and reflections 
evil' saw that medicine provided them with the necessary help but caused harm to their bodies at 
the same. This attitude is similar to that identified in my study where, despite patients' claim of 
adhering to their prescribed medicines and acknowledgement of medicines' role in managing 
their CRFs, they also expressed concerns about their potential harm to their body and possibility 
of dependence. Pollock (2005) explains that patients' adherence to their prescribed medicines 
despite their concerns about their safety could be due to their awareness of the 'benefit of 
medicines in the restoration or maintenance of their normal lives and selves'; however, they will 
still 'resent their ongoing need and incapacity to do without' (p. 27). This is again similar to a few 
patients' accounts who express concerns about initiating insulin therapy because of their fear of 
losing their dependence and relying on injections for the rest of their lives. 
Patients' responses also indicated that their negative feelings about medicines (i. e., medicines are 
harmful, addictive and chemicals) intensified as the number of their prescribed medicines 
increased. They explained that taking many medicines increased the chance of experiencing 
adverse effects or organ damage. Some reported that they would prefer to substitute some of 
their conventional medicines with alternative therapies such as herbs and traditional remedies to 
reduce the number of medicines prescribed and to minimise the harm they might be subject to 
because of taking many drugs. 
Another important finding in this study was brand loyalty as reported by some of the study 
participants (see section 6.2.2). Their accounts indicated that both patients and HCPs 
distinguished between different brands of bioequivalent medicines. Some even went to the 
extent of indicating that medicines manufactured in European or North American countries (i. e., 
Western manufactured brands of medicines or WBs) were superior in effectiveness to 
bioequivalent brands of medicines manufactured locally or in other neighbouring Asian and 
Middle Eastern countries (i. e., non-Western brands of medicines or NWBs). Some participants 
referred to NWBs as 'cheap' and 'copies' of the WBs which they also described as 'real' and 
'original'. Such attitudes were believed to affect patients' adherence especially when they refused 
to have their regular brands of medicines substituted with NWBs. A few patients, on the other 
hand, expressed concerns about the safety of WBs because they did not approve of the foreign 
policies of the Western countries that manufactured these medicines. In such cases patients 
believed that locally manufactured medicines were safer and deserved their support. Other 
patients were indifferent to medicines brands and indicated that all medicines, regardless of their 
brand name or country of origin, were harmful chemicals. According to participants' accounts, 
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factors engendering such beliefs included: (i) previous negative experience with NWBs; (ii) the 
influence of HCPs who unintentionally promote WBs; (iii) misconceptions about Western 
manufactured products; and, sometimes, (iv) patients' political views. 
Patients' attitudes towards WBs is not equally reflected in the available literature. Literature on 
patients' brand loyalty mostly examined patients' perceptions of the generic versus the branded 
medicine and not their perceptions of different branded medicines (Ganther and Kreling 2000; 
Hakonsen, Eilertsen et al. 2009; Hassali, Shafie et al. 2009; Shrank, Cox et al. 2009; Hakonsen and 
Toverud 2010; Patel, Gauld et al. 2010; Toverud, Roise et al. 2010). However, one qualitative 
study that explored perceptions of generic medicines in Iraq, reported that participants were not 
familiar with the term 'generic medicines' and referred to branded medicines similar to the 
patent original brand with the term 'tejari', which is Arabic for 'commercial' (Sharrad and Hassali 
2011). Therefore, their accounts might have reflected their opinions of a range of branded 
medicines rather than their perception of generic versus patented medicines, which is similar to 
patients' behaviour in my study. They also found that factors that lead to participants' preference 
for patented brands included: (i) physicians' inclination to prescribe innovative drugs; (ii) patients' 
comfort with innovator brands; and (iii) experiences with counterfeit medicines in the Iraqi drug 
market (Sharrad and Hassali 2011). Another qualitative study in the UK that explored the 
perceptions of British Pakistanis and British Indians of their oral anti-diabetic medicines identified 
similar patients' views towards Western manufactured brands of medicines. They found that 
these patients perceived their oral anti-diabetic agents to be essential, more effective and of 
better quality than those that could be obtained from the Indian subcontinent. Study authors 
concluded that patients' preference of WBs might have been influenced by their experience with 
counterfeit medicine available in patients' countries of origin. This negative experience may have 
damaged their trust in NWBs (Lawton, Ahmad et al. 2005). 
Results from this study illustrated how the attitude of some patients towards different brands was 
sometimes influenced by their preconceived ideas about the countries that manufactured their 
prescribed medicines. For example, perceiving Western countries as scientifically, industrially and 
technologically more advanced than other parts of the world, might have inclined patients to 
perceive medicines produced by these countries to be more potent and effective than those 
produced locally. Conversely, a few patients preferred to use locally manufactured brands of 
medicines and resisted WBs because of their anti-Western political views. Their accounts 
indicated their belief in conspiracy theories or that the West practiced anti-Middle Eastern foreign 
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policies, which repelled them from using WBs. Unfortunately, the associations between political 
views and patients' perceptions of brands of medicines are not adequately reflected in literature. 
However, Pollock (2005) points out that 'medicine-taking behaviour is framed by cultural norms' 
(p. 28). The literature also indicates that people do not use medicines in a vacuum and that social, 
cultural, political and economic realities contribute to how people perceive and use their 
medicines (Blaxter and Britten 1997; Britten 2008). Similarly, patients' attitudes towards the 
brands of their medicines in this study might have been influenced by the collective and shared 
opinions and political views of their societies and communities about Western countries or goods 
produced in Western countries, which either orientated them towards or away from using WBs. 
The literature also reports that patients' perception of their medicines' effectiveness can be 
influenced by the medicines' physical attributes such as colour, shape, branding and price 
(Lonnroth, Tran et al. 2001; Helman 2007; Britten 2008; Patel, Gauld et at. 2010). Patients in this 
study referred to NWBs as cheap alternatives to the more expensive WBs, which might have 
suggested a greater effectiveness of the latter. As such, medicine price became an indication of 
the medicines' quality and effectiveness in combating a health condition. Patel et al explored 
South African consumer perceptions of drug quality and whether these perceptions influenced 
how people procured and used their medicines. Participants' in their study perceived generic 
medicines and medicines supplied without charge through the state to be of poor quality and 
treated them with suspicion (Patel, Gauld et at. 2010). Similarly, in the UAE medicine imported 
from Western countries are usually sold for higher prices than those manufactured locally or 
imported from neighbouring countries. Patients, therefore, might have been under the 
assumption that price difference reflected quality difference, which may have eventually 
reinforced brand loyalty. 
Literature also reports that patients value and appreciate what their physicians prescribe for them 
(Britten 2008). The attributes of prescribers, such as their level of enthusiasm when prescribing 
the medicines or how they praised the treatment, can also affect patients' attitude towards their 
medicines (Helman 2007; Britten 2008). Similarly, in this study, participants' accounts indicated 
that some physicians influenced patients' brand loyalty by refusing to prescribe locally 
manufactured medicines or praising WBs during prescription refills, especially when trying to 
convince patients to accept alternative brands. Such attitudes from HCPs towards WBs influenced 
patients' beliefs about the superiority of WBs in quality and effectiveness to NWBs. Participants in 
the study of Sharrad and Hassali (2011) indicated that they had confidence in what the physicians 
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prescribed for them. They also reported that their physicians `refused to prescribe the commercial 
drug' for them and advised them 'to use the original'. Patients in my study also reported similar 
inclinations from HCPs. Experiencing side effects with certain brands of medicines might have also 
contributed to patients beliefs about these medicines. Pound et al (2005) reported that patients 
sometimes resisted medicines because they experienced side effects such as nausea, vomiting 
and GI distress, which was also the case with some patients in this study. 
Pound et al (2005) produced a model that describes ways in which people take their medicines. In 
that model they suggest four categories of medicine takers that included: (i) passive accepters of 
medicines who take medicines without giving it a lot of thought; (ii) active accepters who have 
thought about taking their medicines, tested them and then took them as prescribed; (iii) 
rejecters who reject taking their prescribed medicines after a period of time and may use 
alternative therapies; and (iv) active modifiers who modify their drug regimen. They also stated 
that these four groups are not static and that patients may use different approaches in taking 
their medicines (Pound, Britten et al. 2005). In comparison with my study results, it was apparent 
that a group of patients had concerns about their medicines, such as medicines' safety, efficacy, 
brand superiority and potential dependence. It was also apparent that some of these concerns 
have influenced patients' ways of taking their medicines and may have inspired some 
modifications that included: (i) taking drug holidays where medicine doses were omitted every 
now and then to prevent dependence and 'regain body's natural defence mechanisms'; (ii) 
resisting brand substitution and displaying brand loyalty; and (iii) seeking alternative therapy (i. e., 
herbal remedies, ozone infusion therapy and Islamic medicine) to prevent the need to increase 
the dose or the number of their prescribed medicines. However, participants' accounts indicated 
that some of these modifications were disclosed with their HCPs who approved and sometimes 
encouraged such practices (e. g., taking herbs or using Islamic medicines) but at the same time 
ensured patients' safety and adherence to prescribed medicines. Literature on medicine use 
indicates that regardless of the efforts to improve patients' adherence to their prescribed 
treatment, patients will continue to test their medicines and modify their treatment regimens and 
reduce their medicines intake (Pound, Britten et al. 2005). However, Pollock and Grime (2000) 
argue that since patients' modifications to their treatment regimens tend to under rather than 
over-medicate, then HCPs should accept that and assist patients in finding their own level of 
treatment (Pollock and Grime 2000). 
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8.2.3.2 Accessibility of medicines 
Discussion, implications and reflections 
Data from this study also showed that the limited or excessive availability to medicines influenced 
patients' medicines use. The new health insurance scheme and medicine shopping behaviour 
where two factors that some participants believed influenced patients' accessibility to medicines 
(see section 6.4). For example, the health insurance policy of some patients did not cover the 
costs of all their medicines, which meant that some of the medicines were sometimes not 
dispensed, which affected patients' adherence and therapy outcomes. A few patients in this study 
talked about the financial burden caused by prescription copayments, particularly with regard to 
the fact that essential MetS treatments such as statins were not covered by their health insurance 
policy. In addition, the pharmacological management of MetS involves the prescribing of multiple 
medicines that target each of the clustering CRFs, including drugs for elevated blood pressure, 
diabetes, high blood lipids and obesity. In most cases of MetS management, patients may need to 
use more than one agent from each these drug groups, which results in increasing the financial 
burden on patients through increasing prescription copayments. Available literature reports that 
patients' use of medicine was affected by financial difficulties that hindered medicine accessibility 
(Blaxter and Britten 1997; Pound, Britten et al. 2005; Britten 2008). For example, health economic 
studies in the USA (Soumerai, Avorn et al. 1987; Stuart and Grana 1998) and the UK (O'Brien 
1989; Hughes and McGuire 1995) show that drug consumption by the patient is reduced with 
increasing prescription copayment. Other studies found that paying for medicine prescriptions 
was an important factor that prevented non-exempt patients from getting their medicines 
dispensed (Beardon, McGilchrist et al. 1993; Jones and Britten 1998). In the UK, Schafheutle et al 
(2002) explored the impact of medicine charges on decisions made by a group of patients with 
chronic diseases on the management of their health. The results found that participants used a 
wide range of cost-saving strategies to reduce the expense of their medication, such as not 
collecting some prescribed items dispensed, reducing doses or buying a cheaper over-the-counter 
product (Schafheutle, Hassell et al. 2002). 
In this study, cost-saving strategies were initiated mostly by some physicians and pharmacists 
during medicine supply and prescription refill, which included dividing prescribed medicine over 
two prescriptions to reduce the copayment charges; offering financial support to such patients 
during prescription refills; or more commonly using free samples of medicines provided by 
medical representatives. Some of these strategies were similar to those reported by Weiss et al 
(2001) who explored strategies used by a group of GPs in the UK to help patients with prescription 
copayments. Results in that study found that GPs' strategies to facilitate medicine accessibility 
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included recommending the purchase of an over-the-counter medicine, re-using returned 
medication, and prescribing more for a family member that was exempt from prescription 
charges. One of the patients who had a basic health insurance policy stated that she relied on the 
generosity of her pharmacists who provided her with insulin pens that were either returned by 
other patients or were samples provided by the medical representative of some drug companies. 
Many HCPs also indicated that their cost-saving strategies were not enough to help this group of 
patients overcome their financial barriers and that such a factor might affect the adherence and 
therapeutic outcomes of patients with MetS. It was evident from participants' accounts that the 
privatisation of the health care services in Abu Dhabi that started in 2006 affected medicine 
accessibility and resulted in inequality of health services amongst the country's residents. Some 
pharmacists suggested that the health insurance policy needed to be reviewed or to create 
payment expiations for patients of low annual incomes. 
In contrast to limited accessibility to medicines reported by study participants, over-accessibility 
to medicines or 'medicine shopping' was another issue that HCPs complained of during interviews 
and felt that it increased patients' risk of adverse effects or toxicity (see section 6.4.3). HCPs 
reported that some patients collected medicine prescriptions for their chronic illnesses from 
different private clinics simultaneously and sometimes travelled to seek treatment abroad. They 
believed that this behaviour resulted in over-prescribing and double dosing, especially if the same 
drugs were being prescribed by many physicians. In the literature, the practice of patients 
requesting care from multiple physicians simultaneously with regard to the same episode of 
illness without referral either because they are reliant on certain prescription drugs or they are 
seeking better services has been referred to as 'doctor shopping behaviour (DSB)' (Kasteler, Kane 
et al. 1976; Olsen, Kane et al. 1976). DSB is similar to what the HCPs in this study believed patients 
were doing in the UAE. However, HCPs referred to it as 'medicine shopping' to emphasise that the 
aim of patients was to obtain more of their prescribed medicines. DSB is a universal phenomenon 
and has been explored in many studies with patients from different countries and cultural 
backgrounds (Olsen, Kane et al. 1976; Lo, Hedley et at. 1994; Abdo-Rabbo, Al-Ansari et al. 2009; 
Abdul Rasool, Fahmy et at. 2010). For example, in Oman, Abdo-Rabbo et al (2009) explored 
medicines use in 6,675 patients visiting different primary care centres and found that 66% of 
respondents visited multiple facilities on the same date for the same complaint. Results also 
showed that 39% of respondents did not accept a non-drug therapy after their clinic visit and 30% 
preferred prescription of three or more medicines per visit (Abdo-Rabbo, Al-Ansari et al. 2009). In 
the UAE, a survey that explored patients' irrational use of medicines found that patients had the 
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habit of visiting multiple clinics simultaneously for the same health problem (Abdul Rasool, Fahmy 
et al. 2010). 
The danger of DSB is that it exposes patients to the potential risk of drug-drug interaction, cross- 
reactions and even fatalities during excess medical treatment (Lo, Hedley et at. 1994). DSB has 
also gained a lot of attention and publicity in the last decade because of its association with the 
deaths of many Hollywood celebrities who obtained narcotic drugs and prescription pain killers 
from multiple physicians simultaneously (Park 2010). HCPs in this study showed similar concerns 
about the outcomes of DSB in patients with MetS or other chronic illnesses and believed that a 
health care system that monitors patients' mobility across different health facilities would 
minimise such behaviour. Aside from addiction or reliance on prescription medicines, available 
literature on DSB reports a number of other factors that may also trigger this behaviour. Such 
factors include: (i) lack of confidence in and dissatisfaction with physicians or the cost of the 
health service; (ii) poor patient-provider relationship; NO conveniences of the location of the 
health service; (iv) patients' high tendency to adopt the sick role and higher deposition towards 
hypochondriasis12; (v) financial difficulties; and (vi) other individual predispositions such as 
demography characteristics, social structure and health beliefs (Aday and Andersen 1974; 
Kasteler, Kane et al. 1976; Olsen, Kane et al. 1976). However, when patients in this study were 
asked about reasons for seeking multiple physicians for their chronic illness, their accounts did 
not indicate that their DSB was triggered by dissatisfaction with the health service they were 
receiving their treatment in, financial difficulties or physician-related factors. Instead they 
explained that their intention for visiting other physicians regarding their CRFs was to 'double 
check' their health condition and to 'get a second opinion'. According to their accounts, double 
dosing due to receiving extra quantities of their regular medicines was avoided by providing the 
new physician with a list of their current medications. By doing so, patients made sure that the 
new physicians would be informed of their existing therapeutic treatment and would, therefore, 
avoid prescribing the same treatment regimen again. 
Kasteler et al (1976) argue that once patients realise that `medicine is provided in a seller's 
market' they start to feel that they can access different health care providers and do not need to 
wait for a referral to actually see another physician. They also report that patients tend to believe 
they have a right to the best health care and would, therefore, want a complete return for the 
12 Hypochondriasis is ometimes referred to as health phobia or health anxiety and refers to excessive preoccupation orworry about having a serious 
illness. An individual suffering from hypochondriasis is known as a hypochondriac. 
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money they spent on their treatment (Kasteler, Kane et at. 1976). Although most of the patients 
interviewed in this study did not pay for their health care and instead relied on their health 
insurance policy for medical expenses, their accounts illustrated their desire to ensure they were 
receiving the best treatment. They also illustrated that they were aware of the risk of receiving 
similar prescriptions from multiple physicians and were, therefore, minimising harm by informing 
every physician they visited of their existing therapeutic regimen. 
As illustrated in this section, participants' accounts indicated that they had thought about their 
medicines and were mainly concerned about their safety, efficacy and potential for dependence. 
The accounts of some patients indicated their attempt to modify their regimen through (i) 
including an alternative therapy to their treatment regimen in order to minimise the risk of 
conventional medicines; (ii) taking drug holidays to retain the body's natural defence 
mechanisms; (iii) resisting the initiation of insulin therapy because of their fear of dependence; 
(iv) DSB to ensure they were receiving the best treatment available for their health condition; and 
(v) showing brand loyalty. However, despite patients concerns about their medicines and 
attempts to modify their treatment regimen, they continued taking their medicines. In a study 
that explored issues of compliance in a group of patients with asthma, Adams et al (1997) found 
that patients' who complied with the treatment had accepted asthma as a condition into both 
their lives and self-image. Therefore, 'accepting treatment was a valuable aid to their self- 
presentation and an expected, normal consequence of having an on-going medical condition or 
chronic illness' (p. 197). Similarly, in my study, because medicines can influence patients' 
experience of identity and sense of wellbeing, accepting medicines regardless of concerns could 
indicate a patient's way of normalisation and maintenance of their life and self (Adams, Pill et al. 
1997; Pollock 2005). This is also relevant to what was discussed previously in section 8.2.1 where 
patients' fear of developing complications of their CRFs such as heart diseases, blindness, kidney 
failure and amputations motivated them to adhere to their prescribed treatment. Taking 
medicine and implementing lifestyle interventions was the patients' method of protecting their 
health from further deterioration. In addition, patients' concerns about their medicine is always 
antagonised by the active marketing of medicines that promote medicines as agents that treat 
diseases and restore wellbeing and the ability to withstand stress (Pollock 2005). This factor could 
have also influenced the attitude of patients in this study towards taking their medicines. Pollock 
(2005) clarifies that patients feel the need to reach a middle ground that would help them 
balance their personal concerns about medicines and their promised benefits, their trust in their 
HCPs and distrust in drugs, resistance to treatment regimens and acceptance of expert authority, 
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their longing for autonomy and doubt about self management of their condition. It is, therefore, 
important for HCPs to be aware of this context in order to understand and respond sensitively to 
patients' attitude towards medicine. They also need to accept that patients will continue to test 
and modify their treatment plan and should, therefore, help them find their own level of 
treatment (Pollock 2005). 
8.2.3.3 Knowledge about medicines 
Another noteworthy finding in this study concerning factors influencing patients' medicine use 
was knowledge about drugs. Most HCPs believed that the attitude of patients towards 
conventional therapy (e. g., negative views, poor adherence, brand loyalty and DSB) could be 
rectified through providing them with comprehensive information about medicines and other 
MetS treatment requirements (see section 6.5). The limited number of health educators, 
underutilisation of pharmacists in the health education process and patient-related factors (e. g., 
educational background, high rates of non-attendance at health education sessions and refusing 
to have their medicines use assessed by pharmacists when offered) were also reported as factors 
affecting patients' knowledge. In addition, all pharmacists interviewed agreed that having a bigger 
role in patients' health education would improve patients' adherence to their prescribed 
treatment. Their accounts indicated that patients' reluctance and sometimes resistance to 
receiving advice on their medicine use was due to multiple factors, such as the lack of a 
consultation rooms and specialised training for pharmacists on medicines use assessments. 
Data from patients' interviews showed that not all patients in this study were able to list their 
prescribed medicine by name. However, they were able to describe these medicines through their 
physical attributes (i. e., colour of tablet, form and dose) and relate these medicines to their 
accurate indication. They were also aware of their recommended doses and some talked about 
mechanisms that they used to help remind them of their doses (see section 6.1). Some patients 
talked about their awareness of the consequences of not taking their medicines as recommended 
by their doctors. During patients' interviews I did not get a sense of their lack of awareness or 
ignorance towards their treatment plan. However, hearing HCPs call for more efforts to be placed 
on patients' drug education was understandable as they might have been influenced by the 
widespread understanding that patients adherence improves with providing comprehensive 
information about medicine use (Blaxter and Britten 1997; Pollock 2005). The interest in patient 
health education began in the 1970's as links between patient ignorance and widespread non- 
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compliance in medicine-taking were discovered and made through a number of health research 
studies (Ley 1979a; Ley 1979b; Ley 1982; Paterson, Russell et al. 2001). Such studies found that 
patients were not able to recall most of what the physician had told them during the consultation, 
which strengthened the assumption that patients' incompetence led to treatment failure. Since 
then, professional perspectives have became more focused on the problem of patients' 
noncompliance and have started to view patients' attitude towards medicine, especially when 
rejecting conventional prescribed treatment, as irrational and an indication of their ignorance and 
incompetence. This has increased professionals' sense of duty towards patients' education and 
their attempt to improve communication and provide patients with factual information about 
their treatment plan, which was also apparent in the accounts of many HCPs in this study. 
Given the complex nature of MetS treatment where multiple drugs are prescribed to help control 
the clustering CRF5, regular follow-up reviews of patients' medicine use could help HCPs identify 
treatment and patient-related issues that might affect clinical outcomes (Kappagoda and 
Amsterdam 2007). One way of assessing medicine use is through the utilisation of pharmacists 
during drug counselling sessions and prescriptions refill. After all, pharmacists' role in improving 
adherence and therapeutic outcomes of patients with CRFs and the effectiveness of their 
collaboration with physicians to improve therapeutic management are well documented in the 
literature (Smith and Salkind 1990; Morrow and Hargie 1992; Carter and Elliott 2000; Chen and 
Britten 2000; Campbell 2002; Cording, Engelbrecht-Zadvorny et al. 2002; Joy, DeHart et al. 2005; 
Morello, Zadvorny et al. 2006). One example is Chen and Britten's study that examined 
pharmacists' counselling of a group of patients in a primary care clinic. Pharmacists were able to 
identify a number of beliefs about medicine that were not previously picked up by physicians 
during clinic visits. They were also able to provide feedback to physicians on how patients used 
their medication and factors affecting adherence (Chen and Britten 2000). In Jordan, pharmacists' 
role in the management of MetS was assessed in six family medicine outpatient clinics using a 
randomised controlled trial (Hammad, Yasein et al. 2011). Pharmacists were involved in providing 
patients with drug counselling, answering patient and physician enquiries and providing advice on 
the importance of adherence and a healthy lifestyle. Although the study did not identify issues 
related to patients' medicine use habits, the results, however, showed that pharmacists' 
intervention was associated with a significant shift of patients from a MetS status to a MetS-free 
status. The results from such a study and many others have reinforced the assumption that 
patients' noncompliance and clinical outcome could be resolved by providing effective 
information, which reflects the enormous efforts placed on interventions to change patients' 
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attitudes towards their prescribed medicines (Blaxter and Britten 1997; Gottleib 2000). The strong 
belief in the impact of information and drug education on patients' medicine use behaviour was 
also evident in the accounts of many HCPs in my study as they talked about utilising pharmacists 
in health education to improve patients' drug knowledge and eventually medicine use. 
HCPs also need to pay attention to the type of information patients want in a consultation or 
medicine use assessment and the way through which this information is communicated. In this 
study, for example, pharmacists reported that patients usually refused to have their medicines 
reviewed because they were regular users of their medicines and claimed expertise and 
competence. This attitude of patients is appreciated considering the characteristics of a chronic 
health condition such as MetS where patients are normally regular users of their medicines. 
Therefore, with time, through repeated clinic visits and communication with HCPs patients start 
to gradually acquire the needed factual knowledge about their medicines. As such, patients 
become real experts with the skills and competence needed for self-management of their 
multifaceted health condition. However, pharmacists and many physicians interviewed in this 
study seemed to be keen on providing information and expressed disappointment of patients' 
resistance to their counselling attempts. Thorne et al in their qualitative study found that HCPs 
still regarded themselves of a superior competence and knowledge when dealing with patients 
with type 1 diabetes who were experienced in the complicated insulin therapy needed to control 
their blood glucose levels (Thorne, Ternulf Nyhlin et al. 2000). Physicians in their study 
disregarded patients' expertise and skills and discredited their contribution to the management of 
their diabetes. Although HCPs in my study did not express these views in their accounts, they still 
perceived themselves as the main source of knowledge and indicated that their contribution to 
patients' education was the missing link to patients' behaviour change with regard to medicine 
use. Available literature also suggests that premature advice that pharmacists provide without 
waiting for patients to initiate the topic or without eliciting the patient's needs is usually 
unappreciated and is often rejected by patients. In some cases, pharmacists continued to give 
advice despite patents' display of knowledge and competence (Pilnick 1999; Salter, Holland et al. 
2007). Results reported from these studies and accounts of pharmacists and other HCPs in my 
study, regarding the need to improve patients' knowledge, illustrate the existing hierarchy of 
knowledge in the health care setting. The literature indicates that physicians believe that patients' 
knowledge obtained from their input is more credible and legitimate than knowledge obtained 
from other sources (Pilnick 1999; Salter, Holland et al. 2007). This seemed to be the assumption of 
many HCPs in my study, who felt solely responsible for providing accurate information about 
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medicines to patients (e. g., pharmacists insisting to provide counselling to patients on chronic 
medications), without acknowledging or accepting patients' own experience and competency to 
taking their drugs. 
While it is important to provide patients with comprehensive information on their medicine to 
help improve patients' adherence, HCPs need to remember that the way in which medicines are 
used is complex and involves many factors. Pollock argues that 'patient rejection or modification 
of medical treatment and intervention is not as professionals commonly assume the product of 
ignorance or incapacity, rather, it results from the application of a different kind of rationality, 
reflecting different priorities and values from those pursued in clinical medicine' (Pollock 2005, p. 
75). Certainly this study illustrated such complexity through eliciting a number of factors that 
affected medicine use within the MetS context. Although patients in this study claimed 
competency and adherence to prescribed treatment (see chapter 6, section 6.1), their accounts 
revealed factors that influenced their medicine use which illustrates that increasing knowledge 
might not always guarantee improved adherence or less therapy modification. 
A noteworthy finding in this study was the accounts of many patients that indicated their 
satisfaction with pharmacists' contribution during prescription refill. Other patients sympathised 
with pharmacists' busy working schedule, which discouraged them from asking questions or 
seeking advice during prescription refills. These views are comparable to those identified in a 
qualitative study in the USA that explored the perception of people with migraines about the role 
pharmacists' may play in helping them manage their condition. Many patients in that study 
viewed pharmacists as unapproachable and expressed reluctance to ask them questions about 
their medicines because they appeared busy. Other patients cited the layout of the pharmacy as 
an additional barrier that prevented communicating with pharmacists (Skomo, Desselle et al. 
2008). Concerns about time pressure and the awareness of feeling hurried in the consultation 
were identified in the literature as factors that prevented patients from playing an active role in 
consultations or seeking advice when needed (Tuckett, Boulton et at. 1985). 
Tuckett et at (1985) recorded the consultations between 16 GPs and 328 patients in 1,302 clinics 
around the UK to help researchers understand the mechanisms underlying good communication 
between patients and physicians and the consequences of failing to understand each other's 
views during the consultation. They identified many factors that included physicians' ineffective 
communication skills, lack of interest in patients' experiences and concerns and unawareness of 
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patients' ideas and views about their illness. They argued that physicians needed to acknowledge 
that patients' knowledge and understanding would continue to grow through the input of 
different sources of information such as family, friends, society and health care. They, therefore, 
encouraged physicians to change how they perceived their role in a consultation and to start 
viewing patients as experts on their health concerns that they could learn from and work with to 
reach a treatment plan that best managed the patients' health problems (Tuckett, Boulton et al. 
1985). Although the study of Tuckett et al was carried out more than 20 years ago, their 
observations are comparable to some of the patients' accounts in my study who expressed their 
disappointment in their physicians' lack of listening and attentiveness to their personal and health 
concerns. Further exploration of aspects of patient-provider encounters that might have 
influenced the communication of information was not carried out in my study as it was beyond its 
aims and objectives. Clinical consultations are social interactions between the life-world and the 
system prospective. Therefore, an exploration of this relationship requires a robust research tool 
that is able to capture the wider socio-cultural constrains that influence the production and 
communication of medical knowledge and the making of treatment decisions. Such tools would 
have included observation or recording of patient-provider encounters, which were not used in 
this study. However, accounts from my study that indicate the presence of patient-provider 
barriers during clinic consultations might inspire future researchers who are interested in 
exploring this dimensions of patient management within the MetS context or other illnesses in 
the UAE. 
The next section will discuss factors limiting the utilisation of the MetS concept within the clinical 
setting and public health in the UAE. 
8.2.4 The utility of the MetS concept in clinic work and public health 
The clinical utility of the MetS concept refers to the applicability of the MetS diagnostic criteria as 
a tool for identifying individuals at high risk of developing type 2 diabetes and cardiovascular 
complications within the primary care setting. It also refers to the use of the MetS concept as a 
clinical guideline for management of this group of patients who would benefit from an early 
therapeutic intervention (Grundy, Cleeman et al. 2005; Alberti, Eckel et al. 2009). Apart from a 
few studies that assessed public and professional awareness of the MetS definition (Suppes, 
McElroy et al. 2007; Becker, Bromme et al. 2008; Lewis, Rodbard et al. 2008), there has been very 
little research directly addressing the utilisation and implication of the MetS concept in primary 
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health care or its impact on public health and/or health promotion activities. In the midst of the 
continuing controversy that surrounds the MetS concept and the voices of experts that still 
dispute on its value in clinical practice, HCPs might find themselves uncertain and sometimes 
disagreement on the legitimacy of MetS as a cardiovascular risk predicting tool or a clinical 
guideline (Simmons, Alberti et al. 2009). Therefore, one of this study's aims was to elicit the views 
of HCPs on the clinical practicality and limitations of the MetS concept based on their own 
experience and to ultimately gain a deeper understanding of the contextual and organisational 
constraints to its use. Exploring HCPs views on the MetS concept identified six main factors that 
limited the utilisation of the MetS concept within a clinical setting. These factors included: 
1. The unequal awareness of the MetS concept amongst different health specialities 
2. Physicians' uncertainty towards the ability of the MetS concept in guiding the clinical 
management of this group of patients, especially in prediabetes 
3. The multiple definitions and names of MetS that confused its application in clinical practice 
4. Physicians' uncertainty about the usefulness of the MetS concept in triggering patients' 
behaviour change 
5. The absence of the MetS from the list of reimbursed medical diagnoses 
6. Physicians' preference of documenting the individual CRFs rather than the MetS diagnosis 
These limiting factors are discussed in the following sections. 
8.2.4.1 HCPs' awareness of the MetS concept 
Upon investigating the perceptions of HCPs about the MetS concept, their accounts showed that 
physicians were better informed about the MetS definition and diagnostic criteria than other 
HCPs of different specialities, such as pharmacists, dieticians and health educators. Some 
pharmacists admitted that their first encounter with the term 'metabolic syndrome' was through 
the study information sheet. This variation in awareness of the concept amongst HCPs could be 
attributed to the level of exposure to and the use of the MetS criteria across different health 
specialties and departments. For example, some physicians explained that they were in constant 
contact with patients who met the diagnostic criteria of MetS through their clinical practice and 
were regularly updated with research on MetS through meetings, training workshops and 
seminars. Other HCPs did not have that level of exposure to the MetS concept and were not 
involved in the process of identifying patients with cardiometabolic diseases through the use of 
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any screening tool, including the MetS diagnostic criteria. HCPs' limited awareness of MetS 
identified in this study is not adequately reflected in the literature. However, in Evans et al's 
(2007) study in the UK, many of the physicians who were involved in the development of the 
WAKEUP toolkit felt that they lacked knowledge about MetS and were keen for written materials, 
including information on the nature of MetS, its causes and risks (see section 2.4.3). Therefore, 
two toolkits were designed that provided information about MetS to patients and physicians 
(Evans, Greaves et al. 2007). 
Another example of the limited knowledge of MetS amongst HCPs was identified through an 
online survey that assessed the awareness of 500 American psychiatrists of MetS in patients with 
bipolar disorder (Suppes, McElroy et al. 2007). Results showed that, although all participants 
reported awareness of MetS, only 28% correctly listed all the CRFs that constituted MetS. The 
study concept was based on the fact that some of the medicines used for the management of 
bipolar disorder could result in weight gain and eventually MetS. Therefore, enhancing 
psychiatrists' awareness of MetS would prompt better monitoring of MetS risk in that group of 
patients (Suppes, McElroy et al. 2007). Similarly, facilitating the prevention and management of 
MetS across different health specialities and departments through the dissemination of the MetS 
concept amongst different HCPs could drive a widespread monitoring of cardiovascular risk 
parameters and initiate early lifestyle and therapeutic interventions. 
Available literature also reports that pharmacists, as members of the health care team, have a 
valuable role in identifying patients with MetS and providing them with education and lifestyle 
modification advice (Irons, Mazzolini et al. 2004; Sanders, Lubsch et al. 2006; Schneiderhan, 
Batscha et al. 2009; Olenak and Calpin 2010; Benavides, Kohler et al. 2011; Hammad, Yasein et al. 
2011). Therefore, pharmacists' involvement in a multidisciplinary approach might enhance the 
prevention of CVDs through the screening of MetS features and early detection of patients in 
need of interventions. 
8.2.4.2 The usefulness of the MetS clinical guideline 
All physicians expressed their support for the MetS concept and the need to use it in their daily 
clinical practices. Some physicians acknowledged that the MetS definition highlighted the need 
for early diagnosis and therapeutic interventions for individuals at higher risk of developing 
diabetes and cardiovascular complications. They also perceived the MetS criteria as a simple and 
291 
Chapter 8 Discussion, implications and reflections 
easy to use tool that was available and accessible to all HCPs, which enabled fast and effective 
identification of patients at risk of CVDs. Despite these positive views, some physicians expressed 
reservations on the exclusiveness of the MetS concept to guide the clinical management of 
patients at risk of developing CVDs or its ability to promote patients' behaviour change. For 
example, some physicians believed that the MetS criteria were outperformed by traditional 
clinical guidelines of individual CRFs, especially in the absence of a clear recommendation for a 
pharmacological intervention in prediabetes, such as the use of metformin in patients whose 
body mass index was more than 30 kg/m2. The lack of a clear recommendation for a medicine 
intervention in patients with prediabetes to prevent the development of diabetes is frequently 
cited by the critiques of the MetS concept (Simmons, Alberti et al. 2009; Hughes 2010; Sadikot 
and Hermans 2010). 
So far, the MetS clinical guidelines restrict the use of glucose lowering agents in prediabetes due 
to the lack of clinical evidence on the cardiovascular protection effect of such an intervention. 
Therefore, patients with MetS but in a prediabetes state are only placed on intensive lifestyle 
intervention (Grundy, Cleeman et al. 2005; Grundy 2006; Alberti, Eckel et al. 2009). A recently 
published review encouraged the use of drugs in prediabetes, such as metformin, in addition to 
lifestyle interventions due to its cardiovascular protective properties (Sullivan and Ratner 2011). 
However, until an evidence-based medicine intervention in prediabetes gains official recognition 
by the MetS advocates, physicians might remain unmotivated to prioritise the MetS criteria over 
traditional clinical guidelines of individual CRFs. Notwithstanding, physicians still believed that 
MetS criteria provided an available, accessible and affordable tool that could enable the early 
diagnosis of individuals with cardiovascular risk and the initiation of a comprehensive treatment 
of the risk for diabetes and CVDs. They, therefore, welcomed the idea of having the MetS criteria 
used by HCPs, such as nurses and pharmacists, during their clinical practices or in outreach 
campaigns to screen for CRFs. 
8.2.4.3 The controversy of the MetS definition and aetiology 
Another group of physicians believed that the clinical utility of the MetS criteria was confused by 
the existence of multiple definitions that resulted in identifying different risk populations. 
Although the components of the two most popular versions of the MetS definition (i. e., the IDF 
and the AHA/NHLBI versions) are the same, physicians stated that the two definitions differ in the 
weighting given to the components that define an abnormality and the manner in which they can 
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be combined to make a positive diagnosis. This variation in cut-points and criteria that determine 
diagnosis might result in confusion and disagreement amongst physicians on which definition to 
chose and why. However, it is important to mention that this research took place before the 
harmonisation between the two commonly used definitions of MetS (Alberti, Eckel et al. 2009), 
which has ironed out the creases between the MetS definitions of the AHA/NHLBI (Grundy, 
Cleeman et al. 2005) and the IDF (Alberti, Zimmet et at. 2006). Therefore, HCPs accounts on the 
confusion resulting from multiple definitions of MetS might have reflected their perceptions 
before the harmonisation report was published. 
Physicians also reported that the different definitions and names of the syndrome (i. e., the insulin 
resistance syndrome, syndrome X, cardiometabolic syndrome and metabolic syndrome) indicated 
the lack of an accepted central underlying mechanism that can explain its aetiology and 
pathological history. Insulin resistance (Reaven 1988) and central obesity (Carr, Utzschneider et al. 
2004) have both been proposed as underlying aetiologies of MetS. However, other central or 
contributory mechanisms have also been considered, such as chronic activation of the immune 
system; some endocrinological and hormone disorders; chronic stress; and the contributions of 
cytokines, hormones and other molecules produced by adipocytes (Eckel, Grundy et at. 2005; Ford 
2005b). In addition, genetic predisposition and lifestyle are also reported to play a role in the 
development of MetS (Fernandez-Twinn, Ekizoglou et al. 2006). Although the absence of a clear 
explanation for the aetiology of MetS can suggest that it is a provisional rather than a definitive 
concept, physicians still asserted that MetS is a real condition. Physicians also stated that the 
medical community should not to be distracted by the controversies surrounding the syndrome, 
as the MetS concept is useful in detecting cardiovascular risk. 
8.2.4.4 Informing patients about the MetS concept and diagnosis 
The accounts of other physicians indicated uncertainty about the therapeutic benefit of 
disseminating the MetS concept amongst patients. Data analysis showed that two main factors 
resulted in physicians' reluctance to inform patients about their MetS diagnosis or concept, which 
were the complexity of the term 'metabolic syndrome' and their doubt in its ability to trigger 
behaviour change. This group of physicians expressed their lack of confidence in patients' ability 
to understand the term 'metabolic syndrome' and believed that simplifying health information 
required the dichotomisation of the MetS features through informing patients of the individual 
CRFs (i. e., blood pressure, diabetes, elevated lipids and obesity) rather than calling them 
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collectively 'metabolic syndrome'. The unavailability of a simple Arabic alternative to the term 
'metabolic syndrome' was another factor that discouraged physicians from informing patients of 
the MetS diagnosis and believed that such a complex term13 would be difficult for patients to 
remember or understand. In addition, physicians felt that they did not see the benefit of 
informing patients about the MetS because they doubted the superiority of such information in 
triggering behaviour change over information on individual CRFs. In that sense, the MetS concept 
did not offer a promise to enhance adherence or guarantee an improvement in therapeutic 
outcomes. Such beliefs are opposing to Grundy's argument that informing patients of the 
significance of the clustering of risk factors on one's health would communicate a sense of 
urgency for intervention than would the presence of a single risk factor (Grundy 2006). The 
literature also reports that patients who received sufficient information about their chronic heart 
diseases showed a significant improvement in their adherence to their treatment plan (AIm- 
Roijer, Stagmo et al. 2004). Hammad et al (2011) also found that pharmacist-led MetS 
management, which included providing patients with information about their diagnosis and the 
MetS concept, helped reverse MetS status in 39.1% of the study participants. Unfortunately, 
studies that explore reasons behind physicians' reluctance to inform patients about their MetS 
diagnosis or the incorporation of the MetS concept into patients' health education were 
unavailable during the write-up of this thesis. However, Evans et at (2007) in the UK developed 
the WAKEUP toolkit to provide patients with sufficient information about the MetS concept 
through the feedback of both patients and physicians who were keen on enhancing patients' 
awareness about the syndrome (see section 2.4.3). The attitude of physicians' in the Evans et at 
study is contrary to the attitude of physicians in my study who did not see a need to inform 
patients about MetS. 
Physicians' views towards the impact of enhancing patients' health knowledge on health 
behaviour were inconsistent in this study. For example, physicians were adamant that enhancing 
patients' health education would improve their medicine use behaviour (see section 8.2.3.3). 
However, physicians seemed less enthusiastic towards informing patients about the MetS concept 
and doubted its significance in triggering behaviour change. This attitude could be attributed to 
the limited amount of research on MetS that is dedicated exploring the clinical utility of the MetS 
concept or its role in health education and improving patients' health behaviour. It could also be 
explained by the lack of an organisational or institutional support of the MetS concept where 
13 Mutanazelat Al-Aidh is the Arabic literal translation of 'metabolic syndrome'. Physicians believed that this Arabic alternative for MetS was complex 
and difficult for patients to remember and understand unlike diabetes (sukkari n Arabic) and hypertension (pressure in Arabic) that are easy to 
memorise and understand. 
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HCPs are provided with the policy and the tools that facilitate its utilisation within the clinical 
setting. 
8.2.4.5 Limitations to the use of the MetS diagnosis 
The lack of support from health organisations and policy makers to enhance the clinical utility of 
the MetS concept became more evident as a number of physicians expressed their 
disappointment towards the absence of the MetS diagnosis from the list of reimbursed health 
conditions. Physicians explained that because MetS was not included in the list of reimbursed 
diseases, patients' health insurance policies did not cover prescribed medicines prescribed based 
on a MetS diagnosis. Therefore, documenting the MetS diagnosis in prescriptions would increase 
prescription copayments and eventually complicate adherence, especially in patients with basic 
health insurance policies. Physicians' reluctance to document MetS as a diagnosis is reported in 
the literature. For example, although the MetS international code for diagnosis (ICD-9-CM code 
277.7) was introduced in 2001, physicians in the USA seldom use this code in diagnosing patients 
with MetS (Reynolds, Muntner et al. 2005; Ford 2005a). This attitude is not surprising considering 
that the website of the Endocrine Society warns its members about the denial of coverage by 
health insurance companies when a MetS diagnosis is used. It also claims that lack of 
reimbursement is mainly due to the inclusion of obesity in the MetS definition (Reynolds, 
Muntner et al. 2005). Such health insurance policies that prevent reimbursement of prescriptions 
based on a MetS diagnosis, and, therefore, increase prescription co-payments, can discourage 
physicians from using the MetS as diagnosis. Physicians' inability to document the MetS diagnosis 
could have also reduced the perceived value of informing patients about MetS concept. Some 
physicians also admitted that they also were accustomed to documenting individual CRFs rather 
than MetS in patients' medical files. They added that dichotomisation of MetS is a common 
feature in the definition and therefore, they did not see the need to document the MetS 
diagnosis. However, they believed that the use of the MetS diagnosis might increase with time as 
the concept starts to disperse throughout the clinical practice and across different disciplines, and 
with the elimination of organisational restrictions to its use. 
8.2.4.6 The role of MetS in public health and health promotion 
Almost all HCPs talked about the importance of including the MetS concept in the public health 
care policy and health promotion campaigns. They believed that the core principle of such 
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approaches should be to reduce the prevalence of underlying causes of MetS and key risk factors 
for CVDs (i. e., low levels of exercise, high fat consumption, elevated blood pressure and diabetes) 
across the entire adult and young populations of the UAE (see chapter 8). They also focused on a 
number of government sectors and stakeholders (i. e., health authorities, schools and higher 
education authorities, the mass media, urban planning and even members of the royal family) 
who they believed could collaborate to help address MetS holistically and not in a merely 
treatment-oriented manner. They felt that intersectoral health alliances would enable the 
targeting of services based on wider consultations, pooling of different knowledge and expertise 
and the use of different tools and strategies that cater for different community needs, which 
would narrow the gaps and result in health equity amongst patients with MetS. HCPs' accounts 
indicated that they were not mainly concerned with enhancing public awareness of the MetS 
concept, but rather with strategies that would target the broader determinants of cardiovascular 
prevention and would, therefore, have a powerful impact on the overall health of the population. 
This could explain why all their accounts about methods to improve the management of MetS 
revolved around health awareness and health education that would improve patients' health 
behaviour. However, HCPs' strong belief in the role of changing health behaviour is 
understandable since the prime emphasis in the management of MetS per se is to alleviate the 
modifiable, underlying risk factors (i. e., obesity, physical inactivity and diet) through lifestyle 
changes (Grundy, Cleeman et al. 2005; Alberti, Zimmet et al. 2006). They also repeatedly stated, 
during interviews, that lifestyle interventions were the most challenging aspect of MetS 
management for patients compared to taking medicines (see 6.1). 
In 2007, MetS was ranked a top health priority in HAAD's list of health priorities for Abu Dhabi's 
public health strategy (HARD 2007). Available data on health promotion strategies in the UAE 
indicate the presence of a number of approaches that targeted MetS features but with greater 
focus on diabetes and obesity (ICLDC 2007; HAAD 2009; Hajat and Harrison 2010; Olenak and 
Calpin 2010; WEQAYA 2010). Many of these approaches were facilitated through the conjoint 
efforts of different concerned sectors in the UAE, including the authorities that represent health, 
schools, tourism, communication and urban planning (see sections 2.4.1 and 2.4.2). Although the 
core principle of most of these campaigns was to prevent diabetes and increase public awareness 
about the importance of early screening and management, they also drew public attention to 
other causes of MetS and CVDs, such as hypertension, obesity, sedentary lifestyle and unhealthy 
diet. The impact of such health prevention and promotion strategies or their effectiveness in 
preventing CVDs or MetS features has not been assessed yet. While there is very little research 
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directly addressing the impact of MetS on public health and/or health promotion activities, the 
introduction of the concept and the consequent surge of interest in the syndrome have 
stimulated valuable thinking and research across different disciplines in different parts of the 
world. For example, MetS interventions led by nurses (Palmer and Luther 2007) and pharmacists 
(Irons, Mazzolini et al. 2004; Sanders, Lubsch et al. 2006; Schneiderhan, Batscha et al. 2009; 
Olenak and Calpin 2010; Benavides, Kohler et al. 2011; Hammad, Yasein et al. 2011) were 
reported to be successful in the screening for MetS, providing education and improving 
therapeutic outcomes. In 2009, the Hungarian National Committee of Pharmaceutical Care 
produced a MetS pharmaceutical care programme, which provides interested pharmacists in 
Hungary with the training required for MetS screening, patient education and management. After 
completing the training programme, pharmacists are then authorised to provide a pharmacy-led 
MetS management programme in their respective places of work (i. e., community pharmacies or 
hospitals) to patients who meet the MetS criteria (Hungarian National Committee of 
Pharmaceutical Care 2009). The Government of Japan has recently introduced a national 
screening programme using the MetS concept as a single point of entry to identify people at high 
risk who might benefit from an intervention to reduce CVD risk (Kohro, Furui et al. 2008). Other 
anecdotal evidence, including HCPs' accounts in this study, suggests that the MetS concept has 
educated HCPs on the importance of risk factor clustering and the need to assess related risk 
factors when one risk factor is detected. It has also encouraged HCPs not to focus simply on 
diabetes or CVD (Grundy 2006; Sadikot and Hermans 2010). However, one could still wonder how 
advocating prevention measures that are exclusive to MetS would differ from the strategies used 
to tackle any of its features such as hypertension, diabetes and obesity. Certainly, more research 
is needed to explore the impact of the MetS concept on health behaviour and the therapeutic 
outcomes of MetS patients in order to formulate a clearer idea on the impact of its utility in public 
health. However, until such tangible evidence becomes available, policy makers might feel 
reluctant to introduce the MetS concept into national or local health campaigns. Health 
authorities in Abu Dhabi have recognised the importance of including the MetS as a prime target 
in Abu Dhabi's public health policy; however, the MetS concept is still absent from health 
promotion messages and campaigns and limitation to its clinical utility still exists. 
As discussed in this section, physicians' accounts indicated their concerns about the multiple 
definitions of MetS, the controversy surrounding its pathophysiology, its limitation to guide the 
clinical management in prediabetes, the uncertainty towards the benefit of including the concept 
in patients' health education and the limitations within health policy to its use as a diagnosis. 
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However, they still insisted that MetS was a 'real condition' that brought the attention of the 
medical community to a complex set of CRFs that increased an individual's potential for 
developing CVDs. Physicians' also seemed to agree on the importance of a collaboration of 
different clinical disciplines to facilitate patients' identification and early interventions using the 
MetS criteria. Despite HCPs' reservations about informing patients of their MetS, they were 
confident that public health policy should adopt the concept in health promotion strategies. This 
could suggest professionals need for an official recognition of the MetS concept to motivate its 
use in the clinical setting. It might also indicate that they perceive MetS as a concept that does not 
have a utility beyond its ability to screen for CRFs and identify patients at risk of CVDs, which is a 
view that is advocated by the critics of the syndrome (Brietzke 2007; Ferrannini 2007; Kahn 2007; 
Gale 2008). 
8.2.4.7 Conclusion on the utility of the MetS concept (the researcher's opinion) 
Overall, it was interesting to listen to physicians express concerns about the MetS controversy 
and limitations to its clinical utilisation, whilst maintaining optimism about its potential role in 
identifying patients at risk of CVDs. This attitude is understandable knowing that for us to reach a 
distinct opinion on the utility of the MetS we need to investigate four main areas, which are the 
pathophysiology of the syndrome, its epidemiology, clinical work and its impact in public health. 
As far as the pathology of the syndrome is concerned, there is still ongoing research that has not 
yet identified an agreeable and clear underlying aetiology of the condition. This lack of clarity in 
the pathophysiology of MetS suggests that the definition of the syndrome is still provisional and 
not definite indicating that our understanding of this concept is still limited and in need of further 
research. However, one can still challenge this assumption by the acknowledgment of other 
chronic conditions that still do not have a defined pathophysiology. For example, research on the 
underlying causes of diabetes and essential hypertension are still generating new data on their 
underlying mechanisms. However, no one questions the authenticity of diabetes and essential 
hypertension as diseases in their own right. One way of defending MetS is to acknowledge the 
fact that it is a complex disorder with multifactorial underlying risk factors. The two main 
underlying causes that have gained worldwide acceptance are insulin resistance and central 
obesity. However, ongoing research on the pathophysiology of the syndrome will continue to 
produce new information similar to that of other chronic diseases. 
298 
Chapter 8 Discussion, implications and reflections 
When it comes to the epidemiology of MetS, estimates suggest that it is present in at least a third 
of the population in most countries (Tonkin 2004). For example, in the UAE the syndrome 
prevalence amongst the population of adults from different ethnicities was found to be 40.5% 
(Malik and Razig 2008). Even in sub-Saharan African countries, where the prevalence of CVD is 
low, MetS is emerging as a public health problem, largely because of the long-term use of 
antiretroviral drugs in HIV-positive individuals (Mutimura, Crowther et al. 2008). Regardless of the 
definition used to identify these estimates, the MetS concept was able to highlight the burden of 
this composite risk profile that appears to be large and increasing worldwide. 
Unfortunately, research on the clinical utility of MetS is extremely limited. This study is likely to be 
the first that has explored physicians' perspective of the MetS definition and factors affecting its 
use within their clinical practices. Accounts from HCPs indicated overwhelming limitations to a 
real clinical utility and public dissemination of the MetS concept. These limitations ranged from a 
health policy that impairs the use of the diagnosis, personal preferences for documenting 
individual CRFs rather than the MetS diagnosis, failure of the concept to deliver novel 
management guidelines, especially for patients with prediabetes, and uncertainty about the 
therapeutic value of introducing the MetS concept to patients. HCPs, however, admitted that the 
MetS criteria provided an easy to use, accessible and affordable tool to screen for CRFs and 
identify patients at risk of CVDs. They were also enthusiastic towards a multidisciplinary approach 
where different heath specialities are involved in the screening process. This, they believed, 
would prompt a better cardiovascular prevention strategy and enable early therapeutic 
intervention. These accounts, however, indicated that the MetS concept is mainly valued as a tool 
for risk screening rather than a concept that guides clinical management. This perspective 
towards the MetS concept is also adapted in research that explores the role of pharmacists in 
MetS management. In these studies, the MetS concept was utilised as a diagnostic tool rather 
than a clinical management guide (Schneiderhan, Batscha et al. 2009; Olenak and Calpin 2010; 
Benavides, Kohler et al. 2011; Hammad, Yasein et al. 2011). Although this confirms the perception 
that the MetS concept fails to attract professionals to use it as a clinical guideline, it also 
counteracts critics' claims that traditional cardiovascular risk prediction algorithms such as 
Framingham (Sytkowski, Kannel et al. 1990), surpasses the MetS concept in its ability to identify 
cardiovascular risk. In addition, the fact that such studies reported the success of pharmacists' 
interventions in identifying patients with MetS and providing them with the necessary health 
assessment, contradicts critics' claims that the MetS concept fails to identify CVD risk and should 
be avoided in screening for cardiovascular risk. 
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Research that can provide information on the impact of the MetS concept on health promotion 
and public health is very limited or non-existent. Although Abu Dhabi's health authority has 
acknowledged the MetS as a health burden that affects almost half of the multiethnic adult 
population of the country, the MetS concept has still not been utilised in the country's health 
promotion campaigns or public health strategies. Therefore, there is little that can be concluded 
on that aspect. 
More research on the four key areas (i. e., pathophysiology, epidemiology, clinical work and public 
health) that assess the utility of the MetS concept is still needed. Until then, the question of 
whether the MetS concept has a useful role in clinical practice remains valid and probably still 
unanswered. 
I now move to present the implications of this study for patients, professionals, society and health 
policy of the UAE. 
8.3 Implications of the study 
The results of this study have provided valuable insights that further our understanding of the 
complexities of MetS management and the utilisation of the syndrome concept in practice. The 
data also provide an insight into factors that impact patients' perceptions of their clustered 
cardiometabolic diseases. The following section draws on the findings of this study and presents 
the implications for patients, society, professionals and policy makers. 
8.3.1 Implications for patients 
The study was able to identify several issues that are of importance to patients with MetS. 
Although this group of patients were aware of the CRFs documented in their medical files, they 
were unfamiliar with the MetS diagnosis. This was due to physicians' reluctance to inform them 
about the MetS concept. Grundy et al (2006) argues that informing patients about the MetS 
diagnosis, which signifies a risk factor clustering, would convey more of a sense of urgency for 
adherence than would the presence of only a single risk factor. Since disease representations are 
in effect cumulative, with information being adopted, discarded or adapted as necessary, this 
suggests that as patients become better informed of the MetS diagnosis and concept, their 
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attitude towards the associated risk and treatment needs may improve accordingly. Patients' 
accounts indicated that, in the absence of information about the MetS concept, other factors 
affected patients' perceptions of their CRFs in this study. For example, the communality of 
developing CRFs in the UAE, physical attributes of these diseases, information about illness and 
the experiences of other patients with MetS features seemed to affect patients' perceptions of 
MetS features. This resulted in a range of attitudes towards the seriousness of CRFs that included 
downplaying risk and grading the risk of individual CRFs. Disseminating the MetS concept amongst 
this group of patients might reinforce and enhance patients' awareness of the cardiovascular risk 
and might therefore result in better perception of the seriousness of having a cluster of CRFs. 
Patients' accounts regarding the management of their clustered CRFs indicated some challenges 
that hindered their adherence to lifestyle interventions. Such factors did not always reflect a 
socio-cultural constraints and sometimes indicated structural, environmental, emotional and 
financial factors. Patients, therefore, should be encouraged to talk about limitations to lifestyle 
interventions during their consultations with their physicians, dieticians and health education 
workers. Such information will help in the tailoring of lifestyle interventions that accommodate 
patients' individual needs and circumstances. 
This study was also able to identify a number of factors that affected patients' use of their 
prescribed medicines. Negative views about medicines, brand loyalty, and accessibility to 
medicine were factors that affected the attitude of patients with MetS in this study. Available 
literature indicates that patients will continue to modify their treatment regimens (Pound, Britten 
et al. 2005). Therefore, patients should be encouraged by HCPs to express their concerns about 
their prescribed medicines and assisted to find their own level of treatment. Patients should also 
be empowered to become more assertive in discussing treatment options with their physicians 
and pharmacists. Patients' empowerment will generate a better sense of responsibility towards 
health and eventually improve adherence (Koelen and Lindstrom 2005). 
8.3.2 Implications for professionals 
There are a number of implications for HCPs based on the findings of this study. One key finding 
from this study is that pharmacists, health educators and dieticians were not well informed of the 
MetS concept and were not involved in the screening of this group of patients. A recognition of 
MetS amongst all HCPs of different specialties could drive a widespread monitoring of 
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cardiovascular risk parameters and initiate early lifestyle and therapeutic interventions in this 
group of patients (Grundy 2006). Therefore, training for different HCPs on the MetS concept and 
management guidelines through continuous professional training programmes, workshops or 
local seminars could facilitate the dissemination of the MetS concept amongst different health 
professions and clinical specialities. This could also be coupled with an organised and well- 
planned multidisciplinary approach that facilitates the identification and referral of patients with 
MetS to the necessary family medicine clinics to initiate an early intervention. Engaging different 
health professionals in the screening of MetS features will lead to better monitoring and 
prevention of cardiovascular risk. A multidisciplinary approach will also help to reinforce health 
information and enhance awareness amongst this group of patients, as they will receive more 
informed health messages and advice on lifestyle from different clinical specialities. 
Another key finding in this study was factors that affected patients' attitudes towards their 
medicines. Many of these issues were elicited during pharmacists' interviews and the focus group; 
however, pharmacists were not actively engaged in assessing the medicine use of patients with 
MetS or issues affecting their adherence to treatment. The literature indicates that pharmacists 
were effective in the screening of MetS features and in providing this group of patients with 
medicine use assessment and health education necessary to improve their therapeutic outcome 
(Hammad, Yasein et al. 2011). Therefore, pharmacists should actively engage in the medicine 
assessment of patients with MetS and organise pharmacy-led services where factors affecting 
medicine use in this study could be addressed during counselling sessions. Many pharmacists in 
this study felt that their attempts to initiate medicine assessment during prescription refills were 
usually rejected by patients. Therefore, training programmes for pharmacists on counselling 
techniques and communication is key to guide medicine assessment and improve their 
communication skills. However, pharmacists should also remember to assess patients' needs 
before initiating advice. They also need to treat patients as experts on their health and medicine. 
Many MetS patients are on chronic medicines and usually visit the pharmacy for repeat 
prescriptions; therefore, pharmacists should expect that such patients acquire knowledge and 
competency with time and eventually become experts in their health and self-management. 
Another key finding in this study was physicians' reluctance to inform patients of the MetS 
diagnosis and concept. The complexity of the term and concept and their uncertainty of the 
therapeutic benefit this information would have on patients' health behaviour were the two main 
factors that prevented physicians from disseminating the MetS diagnosis and concept amongst 
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patients with MetS. This attitude is inconsistent with their statements about the importance of 
providing patients with information about their health and treatment to improve their attitude 
towards medicine-taking. These views also contradict their enthusiasm about engaging 
pharmacists in MetS management through MetS screening and education programmes. 
Therefore, physicians need to be consistent in their attitude towards providing patients with 
information relevant to their diseases and treatment plan. They should also remember that part 
of patients' empowerment is attained through providing patients with comprehensive 
information about their diagnosis and the risks associated with their diseases. This may mean that 
physicians will need to work with health educators, pharmacists and other members of the 
multidisciplinary team to develop simple education materials/programmes about MetS that are 
designed specifically for patients with MetS. 
HCPs need to recognise the sophistication of patients' assessments of the seriousness of their 
conditions and their risk of developing CVDs (see section 8.2.1). They also need to understand 
how such assessment affects the choices patients make to reduce this risk. They also need to be 
aware of the personal and contextual factors that influence patients' adherence to treatment. 
This means moving away from the view that patients should be compliant with lifestyle targets or 
medicines and the moral implications associated with this view. 
HCPs also need to encourage patients to talk about their concerns regarding their diseases and 
prescribed treatment. The role of leading a stressful lifestyle on the management of CRFs, 
misconceptions about the Risk of MetS features and brand loyalty were amongst the health issues 
identified in patients' accounts. HCPs should, therefore, be trained on methods to effectively elicit 
patients' treatment needs and explore their views, beliefs and concerns about treatment. A 
shared decision-making approach would probably be of value to help physicians as well as 
pharmacists to empower patients and encourage them to talk about their treatment needs. 
Available literature reports that patients who were actively involved in making decisions about 
their treatment plan were able to achieve better management of their diseases and reduce 
functional limitations (Pollock 2005). Dowell argues that establishing a consultation environment 
where patients' and physicians' intentions are made clear would prevent the prescribing of 
unnecessary medicine. It would also increase patients' commitment towards the treatment plan 
because their autonomy and self-determination has been respected and acknowledged (Dowell 
2004). Health professionals should also acknowledge and accept that patients will continue to 
modify their treatment or reject some of their prescribed medicine. Therefore, HCPs should 
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understand the contextual factors and patients' beliefs and values that influence their decisions 
and medicine use and work with them to find their preferred treatment options. 
HCPs need to also be equipped with information about social-cultural norms and even religious 
beliefs in order to understand patients' stances concerning their beliefs and cultural norms. As 
such, HCPs can then provide patients with different treatment options that best suit their beliefs. 
They can also rectify some of the patients' treatment misconceptions or health behaviours by 
using culturally appropriate approaches. In relation to information about medicines, patients 
should be provided with accurate and clear information about the potential for medicines to 
cause harm, which health professionals continue to have reservations about (Raynor, Blenkinsopp 
et al. 2007). This might clarify some of the misconceptions that some patients had about the risk 
of medicines, which affected their medicine use. 
8.3.3 Implications for society 
The study was able to highlight some of the contextual factors that affected patients' 
implementation of their treatment plans. These factors sometimes indicated a strong dominance 
of socio-cultural norms and beliefs about patient approaches to the management of MetS, which 
affected their health behaviour. Since society can sometimes play a key role in determinants of 
health and health behaviour (Naidoo and Wills 2009), society should be informed of the MetS 
burden in the UAE and the risk the country faces in terms of the high prevalence of MetS features 
and the potential cardiovascular complications. Members of the UAE society should also 
understand how this health problem, if left unaddressed, would eventually affect them and their 
families. Such awareness might enable society to comprehend and appreciate their role in 
facilitating the prevention and improvement of MetS through providing social support to its 
members and advice to health policy makers. 
According to reported estimates, the population of the UAE has reached eight million. The vast 
majority of the population are foreigners from different parts of the world. The Emirati population 
of one million, on the other hand, represent the minority (UAE Interact 2010). This suggests that 
different communities of different cultural backgrounds and different health beliefs and values 
reside in the UAE and access its health care facilities. Literature on health promotion indicates 
that strengthening community actions results in the empowerment of people to take 
responsibility of their health and gain control over the factors affecting their therapeutic 
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outcomes (Naidoo and Wills 2009). Therefore, different communities living in the UAE should 
realise the importance of working in partnership with health care leaders and policy makers to 
facilitate the tackling of the MetS health problem. Community members, as such, can act as 
advocates for their socio-cultural needs and can provide advice on the best ways to cater for 
those needs. For example, individuals in need of women-only gyms or healthy restaurants in malls 
and shopping centres can communicate these needs to policy makers through their community 
representatives. In addition, the collaborative role of society in the management of MetS would 
extend a sense of responsibility towards promoting health and combating contextual barriers. 
This could reduce the impact of socio-cultural roles that currently hinder MetS management 
because members of the community will feel responsible towards their health and the health of 
people living in their societies. 
8.3.4 Implications for health policy 
The place of MetS within the UAE health policy remains a question that requires thorough 
assessment and exploration. Findings from this study, however, highlighted potential gaps within 
the UAE's public health policy and health promotion programmes that address MetS. Participants' 
responses regarding facilitators to MetS prevention and management in the UAE identify areas in 
need of further improvement. Currently the MetS concept is included in one of the targets of the 
public health targets of Abu Dhabi. An extension of this policy is needed to include health policies 
of other cities in the UAE, which could be facilitated through the authority of the country's 
ministry of health. The collaboration between local health authorities in the UAE could result in 
health equity and would emphasise the need to address MetS as a national burden that affects all 
residents of the UAE. 
Results in this study showed that many patients graded the risk of individual CRFs rather than 
viewing all as driving forces of cardiovascular complications. They also believed diabetes to have 
the highest risk compared to blood pressure and obesity. This could in part be due to health 
promotion campaigns in the UAE that mainly focus on diabetes and encourage early screening. 
Therefore, disseminating information about MetS during health promotion campaigns might 
communicate the augmented risk of the clustering CRFs rather than individual CRFs, such as 
diabetes. This might also encourage patients to address all CRFs rather than focus on one or 
perceive one disease as more serious than the other. 
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The absence of the MetS diagnosis from the list of reimbursed diseases antagonises the efforts of 
Abu Dhabi's health authority in tackling the MetS risk in the UAE. The MetS burden has been 
recognised by the public health policy of Abu Dhabi since 2007 (HAAD 2007) and has been 
incorporated into its health promotions and cardiovascular prevention plan (HAAD 2009). 
Therefore, the MetS diagnosis needs to be included into the list of reimbursed diseases to further 
enhance the clinical utility of the syndrome. 
The study identified many barriers that were influenced by socio-cultural norms. Therefore, public 
health promotion for the prevention of MetS needs to address these barriers and cater for them 
in their strategies. Providing multiple options that meet the needs of different communities of 
different cultural background will be ideal for the management of MetS. Health policy makers 
might benefit from allowing members of different communities to act as advocates of their 
communities' needs. This will ensure that health reforms cater for the multicultural population of 
the UAE. 
The new national health insurance policy imposed limitations on the patients who had the basic 
health insurance scheme. Health authorities need to create exemptions on prescription 
copayments for patients with chronic illnesses, including patients with MetS. This will facilitate 
access to medicines and will minimise the risk of nonadherence. Creating copayment exemptions 
for patients with basic health insurance policies will work alongside the public health policy 
objectives in tackling the MetS health burden in the UAE. 
There is also a need for more national health research that explores health needs for the 
prevention and management of MetS. The health authority of Abu Dhabi (HAAD) reported MetS 
as one of the top health challenges in the UAE (HAAD 2009). HAAD also collaborated with other 
non-health authorities to advocate for healthy lifestyles through the implementation of different 
health promotion (Diabetes UAE 2007) and disease prevention programmes (Hajat and Harrison 
2010; WEQAYA 2010). However, there was no reported information on whether population 
health needs were assessed prior to the implementation of such programmes. There were also no 
reports that indicated whether the health impact or effectiveness of ongoing health promotion 
programmes were assessed and evaluated. Lack of literature that describes health needs or the 
health care system in the UAE was a barrier identified when designing this study (see section 
2.2.1) and was equally reflected in participants' responses (see section 7.2.2). The study also 
identified many of the patients' misconceptions about lifestyle and medicines, their condition and 
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the risk of CRFs. Through national health research, such issues can be further explored on a 
sample that represents the UAE population and findings from such studies can inform future 
health promotion strategies. 
Having discussed the significance of the findings, how these relate to the literature and the 
implications of the findings for patients, professionals, society and policy makers, the discussion 
now turns to consider the limitations and strengths of the study. 
8.4 Study limitations and strengths 
As with any research, there were several limitations that affected the data presented in this 
thesis. The first limitation was the study sample (29 patients, 27 HCPs and 9 pharmacists in the 
focus group). The study was conducted in one hospital in Abu Dhabi. Patients were mostly 
recruited from SKMC outpatient clinics and family medicine clinics while they attended their clinic 
appointments. Therefore, this sample may not be representative of all patients with MetS in the 
UAE. In addition, patients who access medical care may be more concerned about their health or 
face a different set of barriers to MetS management than those who do not access medical care 
or attend their appointments. 
Recruitment of HCPs was a mixture of direct approach and then snowballing. This may suggest 
that only HCPs who were enthusiastic about taking part in the study were included. Snowballing 
meant that initially interviewed HCPs suggested others for the study, which may have resulted in 
bias. As discussed in section 3.7, a sample selection in qualitative research is not usually intended 
to be representative of a large population or to produce generalisable data; rather the study aims 
to provide reliable, detailed information, which accurately reflects the context of the research or 
the individuals that are the topic of the research. Patients' selection was not confined to UAE 
nationals, as SKMC started registering and treating patients of different nationalities since the 
enforcement of the national health insurance scheme in 2007. By including a wider range of 
nationalities we aimed to identify health care issues that can be transferable to other patients 
with varying ethnic background, gender and age. 
As previously presented in section 3.7, the participant sample was guided by emerging data and 
continued until no new themes emerged. No new themes appeared to emerge as the interview 
reached 25 patients and 23 HCP interviews. However, an additional four patients and four HCPs 
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were interviewed to ensure no new themes were missed or ignored. Some of the themes 
identified during the focus group did not emerge in previous interviews. These new themes were 
concerned with the pharmacy profession and pharmaceutical care in the UAE and were not 
specific to MetS management. All participants in the focus group were pharmacists which could 
explain why, at some point during the meeting, discussion diverted to include topics of shared 
interest, such as strategies to improve pharmacy practice in the UAE. Pharmacy profession- 
related themes were not discussed or included in this thesis but highlighted areas for future 
research (section 8.6). 
The researcher's identity as a pharmacist may have influenced participants' responses. For 
example, it is possible that patients tried to give an impression that they adhered to their 
treatment plan during interviews when they were asked about factors affecting their therapeutic 
outcome. They might have been inclined to report external factors, such as work stress, genetic, 
and lack of social support, to justify suboptimal control of their CRFs rather than their medicine 
use and health behaviour. However, they might have also been inclined to provide me with 
detailed information about their health condition and concerns about their therapeutic 
management because they trusted me as a HCP. During interviews, many patients referred to me 
as 'doctor', which is how pharmacists are commonly addressed in the UAE. They sometimes 
shared information about the health of their relatives and asked for professional advice. Other 
patients admitted that their attitude towards diet and exercise were responsible for their 
uncontrolled CRFs and indicated that a change in their health behaviour might improve their 
health condition. Such accounts indicated that patients were able to freely engage in the 
interviews and express their views and opinions regarding factors affecting their health. In 
general, patients were found to be relaxed during interviews and appeared to trust me with 
information about their health and treatment plan, which facilitated the generation of accounts 
that helped answer the research questions. More elaboration on the researcher's impact on the 
interview dynamics and participants' responses is provided in section 8.5.1. 
The researchers' identity might have also influenced the accounts of HCPs. For example, HCPs 
might have tried to convey their competence in managing patients with MetS and to blame 
patients' health behaviour for the inability to attain therapeutic goals. They might have felt the 
need to present themselves knowledgeable about the MetS concept and its management. 
However, many HCPs admitted their lack of knowledge about the MetS concept despite their 
exposure to this group of patients during their daily practice. Some physicians took responsibility 
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for patients' lack of awareness of their MetS diagnosis and admitted their role in the limited 
utilisation of the MetS within clinical practice. Such accounts and others illustrated HCPs 
willingness to express their views on MetS and different factors that affect MetS management in 
the UAE. 
To minimise the impact of the researcher identity on participants' accounts, patients and HCPs 
were informed that the research was independent of SKMC and that taking part in the study 
would not affect their treatment or work respectively. Participants were also assured of the 
confidentiality with which their identities and accounts would be treated and handled. In 
addition, participants were allowed time to ask the researcher about her identity, job, study 
location, and future implication of the research. They were also provided with an information 
sheet prior to participation. In this way, the participants knew more about the study and about 
the researcher. In order to check for researcher bias, coding of data was checked and the findings 
were discussed with the research supervisors who were satisfied that the coding was accurate. 
Table 3.2, presented in chapter 3, illustrates all measures taken to ensure the credibility of this 
study. 
Despite the above-mentioned limitations, a large amount of valuable data were collected and 
analysed during this study. This study was able to draw on views of both patients and HCPs in 
conjunction with the researcher's notes. This facilitated the exploration of MetS management in 
the UAE from the perspectives of multiple participants and through a range of paradigms. As 
outlined in the literature review (section 2.9.2), research that explored patient and professional 
perceptions of MetS and its management within the UAE context are lacking. Therefore, this 
study provides valuable information on MetS management needs in the region and was able to 
highlight areas for future studies. 
8.5 Reflexivity 
Assessing the standard of qualitative studies relies on the transparency with which the research 
process was conducted. Therefore, researchers need to acknowledge their own presuppositions, 
what they bring into the research and how this influences the research process. The researcher's 
epistemology needs to be acknowledged in order to assess the validity of a qualitative study. 
Social scientists have considered how the contextual details, such as the interview setting and the 
interactions between their own and the respondent's personal characteristics, may influence their 
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data. Awareness of these factors is called reflexivity (Charmaz 2006). As researchers, we need to 
sustain an informed reflexive consciousness to contextualise our own subjectivity in data 
interpretation and representation of experiences in the research process. Self-reflexivity allows 
for the understanding of our personal incentives for conducting research and responsibility 
towards the studied population. As such, the real challenge in qualitative research is not to 
eliminate but rather to document the influence of self, others and the research context on what 
we see, how we see and what made us see. As self-reflexive researchers, we need to constantly 
acknowledge our place in the setting being investigated. We need to carefully monitor our 
position in the research process, and the relationship with the study participants, which is 
important in maintaining a focus on the research agenda (Guillemin and Gillam 2004). This section 
presents some thoughts on the research process including the researcher's identity, recruitment 
to the study and influence on interviews. 
8.5.1 The researcher's identity 
The emphasis on the close connection between personal and representational process has 
formed the common ground of qualitative research. Our representations are only partial truth. 
How we represent and account for others' experiences is intimately related to who we are and 
the connections need to be spelled out (Guillemin and Gillam 2004). It is within this common 
ground that I root my self-reflexive account of the study I conducted about patient and 
professional views of MetS in the UAE. Going back to the UAE to conduct the qualitative research 
raised many questions. Trying to separate 'home' from 'work' was challenging. I knew as an 
Emirati and a Muslim the impact of the socio-cultural context of the Emirati society on many 
aspects of life, yet I was embarking on research that required asking about the 'obvious'. 'How 
can I assess neutrally? How can I ask about issues that I might know the answers to? ' I was 
concerned about facing the obviousness of what my informers might be saying. I strove to find a 
position from which I could see the world I knew well with a new mindset and a new pair of eyes. 
While a foreign researcher runs the risk of being culturally blind, an indigenous researcher runs 
the risk of being blinded by the familiar. The literature on indigenous research addressed the 
problem of location by emphasising the difficult task native researchers' face in creating enough 
distance between themselves and their own cultures (Dwyer and Buckle 2009). 
During the fieldwork I introduced myself as a Pharmacist/PhD student who is affiliated with a 
British institution. Being a Muslim, female and an Emirati are also key components of my identity. 
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However, I did not feel the urge to include such identities into my portfolio as I felt that my dress 
code (in the traditional Emirati black attire), my surname and the accent I spoke with would give 
away my nationality, religion and cultural background. As I tried to assign myself in a defined 
social category, it was resisted by my informers' unintentional attempts to stretch my identity so 
that it embraced different attributes including their own. I faced a number of challenges and 
opportunities as a result of my positionality in the research. I have come to recognise how 
significant individual and cultural contexts allow access, rapport and trust to groups of patients 
and HCPs. While doing the field research, my status was simultaneously that of insider and an 
outsider. The insider-outsider position is sometimes seen as an epistemological principle centred 
on the issue of access. From the literature, I have reviewed in my study it seems that the issue of 
access can take two forms. One is a 'monopolistic access' in which researchers have exclusive 
knowledge of the community and its members or have privileged access by having a claim to the 
hidden knowledge of the group that an outsider as a 'professional stranger' who is not a member 
of the community under study would not be able to access. In this framework the insider is an 
individual who has intimate knowledge of the community and its members which offers insights 
that are at times difficult to access by an outsider. The advantage of having shared experience 
with informers is that it provides researchers with greater access, better cultural interpretation, 
and deeper understanding and clarity of thought (Dwyer and Buckle 2009). 
I was a relative insider by virtue of my indigenous cultural status and my nationality. My national 
identity assertion did not mean my Emirati identity so much as being from the UAE and its 
indigenous people. As the research progressed I felt that 'nationalism' might have overarched my 
gender, social, religious and educational positions when it came to how people connected with 
me. I was mostly referred to as the 'Emirati who is doing a PhD'. Nationalism, national identity 
and preserving heritage within the UAE were and still are the focal interest of the country's ruling 
elites. The national identity ideology of the UAE does not reflect a nationalist history associated 
with a struggle for self-determination seen, for example, in other parts of the Middle East, nor 
does it relate to the national prejudice and expansionism associated with some European nations 
in the nineteenth and twentieth centuries. The nationalism of the UAE does not derive from a 
conscious act of liberation but rather nationalistic sentiments are employed as a tool to build and 
develop a relatively young nation-state. As an Emirati brought up in the UAE, nationalism was 
nurtured in schools, universities and in workplaces. Advocating nationalism in such intensity, 
promoted patriotism and loyalty to the UAE. As Emiratis, we perceived ourselves and those who 
followed us as 'builders of the nation'. Helping 'builders build the nation' was perceived as a 
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national duty. Because the UAE joined the global map in the early 1970's, the production of local 
professionals and intellectuals was still in the development phase. Nationalism was not merely 
employed for physical construction but also to pave the way for nationals (individuals) to develop 
intellectually and professionally. 
The nationalism ideology was put into re-play mode as I witnessed the impact of my nationality in 
gaining access and to informers' responses. I was frequently praised about my educational 
background by informers, 'God protect you, you're doing a PhD nowl You make us all proud'. On 
numerous occasions at the end of an interview participants would recite a short supplication 
wishing me success 'maybe one day you'll be the Minister of Health. God willing'. Such statements 
co-occurred with acknowledgements of our national commonality: 'you are our daughter it's our 
pleasure to take part'. Being an Emirati PhD student might have stimulated their nationalistic 
sentiments. In that sense, taking part in the study might have been perceived as a national duty. 
Taking part in the research resembled, in part, helping a member of the national population 
become a better contributor to the society. Helping national individuals better themselves was 
consistent with their nationalistic sense. 
Declaring my profession as a pharmacist added to my ability to establish better rapport with 
informers. Informing participants of my pharmacy profession as part of my research identity 
brought in different dynamics concerning the insider-outsider and the politics of representation 
across other axes of the social differentiation beyond sharing nationality or ethnicity. In the 
Emirati society, like many in the world, HCPs are perceived as having an elite social status. 
Different HCPs (i. e., doctors, pharmacists, dentists and laboratory chemists) are all referred to as 
'doctors' and are believed to have a trusted moral authority over other professions. Patients' 
responses in particular indicated a sense of trust and a desire to share information about their 
health with me once they realised I was a pharmacist. This became salient as a number of patients 
disclosed intimate details about their health condition and sensitive side effects of some of their 
prescribed medicines: 'you are a doctor so it is ok to tell you this'. 
Although I met my informers as a fairly casually dressed woman wearing the traditional Emirati 
attire, the fact that I carried a notebook and a digital recorder placed me in a conflicting position 
of difference. Research is not a commonly seen activity in places of public gathering. People 
usually associate research with 'reading books' or engaging in 'lab-based experiments'. Signing a 
consent form, getting interviewed and having responses audio-recoded were other aspects of the 
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qualitative research that attracted informers attention. A few informers questioned the value of a 
consent form: 'only political prisoners sign consentsl I'm not a criminal'. Others resisted having 
their voices audio-recorded and sometimes pleaded to have it erased or deleted once their 
responses were transcribed. Myths, and sometimes facts, surrounding Middle Eastern states' 
security services discourage people from engaging in conversations that might reflect upon a 
government organisation. The risk of being misinterpreted was not worth taking if the 
consequence was losing your job, or being interrogated. I sympathised with my informers as I 
remembered my father's advice on my first day of work: 'keeping quiet and not criticising or 
questioning authority guarantees ambitious employees promotions and long lasting jobs'. Arabic 
literature is rich with proverbs that cement the idea of being watched or the risk of being 
detained: 'stay silent and you'll confuse your enemy, 'the walls have ears'. This became a vivid 
memory as I heard some informers mention their American and British nationalities indicating 
'immunity' and authority to cross boundaries without risking career loss or getting arrested: '1 
have an American passport so I'll tell you the truth as it is, I'm not afraid'. I became concerned 
that reassuring my informers of the study's confidentiality might not be convincing enough. 
Although my research gave informers the freedom to address any factor they saw as influential in 
MetS management, I did not want them to feel restrained about confronting taboos. 
Even though my research tools might have positioned me as the 'other' in that manner, the fact 
that I lived in the UK and studied in a British institution promoted openness and disclosure of 
perceptions and views by the informers. Many Arab communities believe that Arabs/Muslims who 
live in western countries become appreciative of the value of independence and autonomy: 
'you're open minded and understanding. I think it's because you live in the UK'. It is common in 
Middle Eastern communities to associate democracy with western societies including outsiders 
who live in such societies. Informants frequently linked my pro-democracy (by association) 
identity with my previously established national (builder of the nation) identity and perceived me 
as the reformer and ameliorator: 'soon you'll come back and you'll fix everything'. In general, 
people were by and large incredibly willing to talk. At some point, I realised people love talking 
and they just need some sort of ground to voice their opinions: 'we can talk to you for hours, but 
you probably don't have time. I wish we had similar meetings in our department so we can just 
get everything off of our chests'. The issue of confidentiality needed to be ensured strictly and it 
was critical to achieve mutual trust between the respondents and the interviewer during the 
interview process. 
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It was hard to define the role of my gender (female) in the research and how it lends itself to my 
positionality in isolation from my religion and nationality. Although my research did not explore 
sensitive health issues, the collaborative role of my gender, nationality and religious position 
influenced the technicality within which this research was conducted when approaching male 
participants of the study. As a Muslim female Emirati brought up in an Islamic society, I felt 
responsible towards my religious and traditional heritage. Being a good researcher, in my belief, 
should not compromise being a good Muslim/Emirati. I had to act and behave in a way that 
satisfied the societal rules and expectations. While female patients and female HCPs had the 
privilege of selecting a location for the interview (i. e., clinical setting, work place, homes, public 
places or over the phone) men, on the other hand, were left with two options, which were either 
within a clinical setting or through a telephone conversation. Although gender segregation in 
public places is no longer a social necessity in the UAE, women and men of no marital or 
immediate family relationship are not expected to be seen together in public places nor to be 
together alone behind closed doors. In cases where I needed to meet my informer in his office or 
in one of the health education rooms the door was always kept slightly open. I am not certain 
whether this was a deliberate act or if this setting was spontaneous, but in all similar cases the 
door was never fully closed. I had to question whether this arrangement has violated the 
confidentiality of the interviewee making the conversation liable to eavesdropping by passerby. 
Although this was not, in all cases, an issue for my informers, I did reach a conclusion that I had no 
option but to accept this arrangement. 
My religious identity was a powerful commonality that came into play at specific points during 
interviews conducted with Arabic/Muslim informants. Participants' sense of our religious unity 
was augmented as I asked about the impact of the UAE socio-cultural context on MetS 
management. Informants constantly directed answers towards the British institution I was 
studying in rather than directing them at me: 'When you go there, tell them that [... ]'. Because I 
am a Muslim/Emirati, my informers assumed that I knew the answers to questions regarding the 
impact of the UAE socio-cultural context. The assumption that such questions were engendered 
by my lack of knowledge was unrealistic. The only logical explanation to such enquiry was to 
inform the British institution about the religion. As the topic of religion was raised, participants 
would immediately align me to their side where 'we' (participant and I) became 'one' against the 
other 'you and I know very well that our religion encourages us to medicate'. The study 
informants knew that research data will subsequently be reported to the British institution where 
there will be a number of non-Muslim/non-Arabic (western) panel of co-researchers: 'tell them 
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that [... ]. Explicit responses about the relation between religion and health were narrated with 
intensity and passion to an extent that made me feel they were using it as an opportunity to 
defend Islam: 'it's good you are there [in the UK], when they see a good example of Muslims, 
they'll change their view about Islam'. I felt that informants were using our global identity as 
Muslims regardless of our social, class and educational differences. Globally we have been 
homogenised and our identities were flattened and erased. I became an insider In this sense for 
my research informants because of my outsider status in the eyes and the minds of people who 
view all Muslims through a 'western' paradigm. 
In other instances, some respondents were asking irrelevant questions that were not related to 
the field of interest. Some were more interested in my family background, why I chose the UK to 
study, how I paid for my tuition fees or how they (or their son/daughter) can apply for a PhD in 
the UK. Some asked me for advice on patient-provider relationship issues or who to contact to 
complain about an incident they encountered in the clinic. I had to politely engage with or listen 
to such conversations and steer them back to my research questions. In dealing with such 
dynamics of conversation, I sometimes needed to bargain in negotiating what was in the best 
interest in both getting my research done and not offending the respondent. From my previous 
professional experience, I know that such questions need to be diplomatically handled. In this 
manner, the fieldwork was an intensely personal experience for me. It felt like being part of a 
larger family where people felt free to interfere and be dogmatic. It also raised the questions 
about the ethics and politics of research involving negotiating relationships that simultaneously 
are respectful and allowed the research to proceed (to the extent possible). 
Such positioning meant that research ethics had to be negotiated in practice on a continual basis. 
Such fluidity and openness in the research process is not always easy to endorse or maintain, 
especially when inserted into multiple scales of power relations and institutional affiliations, time 
constraints and distances (physical, emotional, philosophical and political). I know that regardless 
of all attempts to fill in gaps and position myself where my informers wanted me, I will always 
have limited ability to access people's lives and learn about their concerns and views. The 
important thing for me was to be as faithful to the relations in that space and time, and to the 
stories that were shared and the knowledge that was produced through the research, however 
limited or partial. In this respect, while the participants and I did not share some of the identities, 
we were able to share many views on the basis of mutual respect and trust that helped us to have 
some common ground from which to speak (Bolak 1996; Brayboy and Deyhle 2000). 
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It is important for researchers to reflect upon their professional backgrounds and their personal 
characteristics and to address the impact of such attributes on data collection and analysis. it is 
critical to pay attention to reflexivity, the production of knowledge and the power relations that 
are inherent in the research processes in order to undertake ethical research, especially in the 
international field of research contexts. Reflecting upon my professional background and the way 
others constructed my identity helped enable the engagement with the research process and data 
analysis in a more meaningful way (Mays and Pope 1995). 
8.5.2 Translation dilemmas 
Good qualitative cross-cultural research analysis is not an easy task as it requires knowledge and 
understanding of different approaches and techniques of the appropriate language. In my 
research it was fundamental that the process of translation/interpretation is investigated and that 
the epistemological implications of being the researcher and translator/interpreter at the same 
time are examined. Translation and interpretation in research involves the hierarchies of 
language, power and the situated epistemologies of the researcher and issues around naming and 
speaking for people who may be seen as 'other'. In a society, individuals who do not speak the 
dominant language of the international research arena are dependent on others to speak for 
them; speaking for others, in any language, is a political issue which engages the use of language 
to construct the self and others (Temple and Young 2004). 
As a bilingual individual, I have been involved in translation at different stages in my life, at school 
and university projects, for my family members who could not speak English and during my 
professional development. Dealing with translation dilemmas was, to some extent, part of the 
way I learned and communicate with others. The importance of identifying the act of translation 
and interpretation was particularly important in terms of exploring my epistemological position as 
the researcher. As Temple and Young (2004) explain, 'translation itself has power to reinforce or 
to subvert long standing cross-cultural relationships, but that power tends to rest in how 
translation is executed and integrated into the research design and not just in the act of 
translation per se' (P: 167). As such, I found it important that, as a researcher, I acknowledge my 
position within the social world, the relationships within research and explore how my location 
influenced the way I interpreted things. A cross-cultural researcher involved in translation argued 
that there is no single correct translation/interpretation of a text. Translation is not a matter of 
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finding the meaning of a text in a culture by using a dictionary but in understanding that the 
language is attached to local realities, to literacy forms and to changing identities (Regim, Naidoo 
et al. 2010). Through my own experiences in the translation and interpretation of data I realised 
that communication across two languages involved more than a literal relocation of information. 
The translation and interpretation process involves discussing concepts, ideas and positions which 
are all important parts of the negotiation process of 'cultural meaning'. Language and 
interpretation were identified and presented as a theme by some of the study participants when 
defining barriers to patient-provider communication (section 7.4). The role of interpretation in 
conveying cultural concepts was evident as some participants' misinterpreted patients' religious 
phrases (section 7.2.1). 
During the translation and interpretation process, I had to make decisions about the cultural 
meanings that patients' responses (language) indicated. I spent a lot of time trying to evaluate the 
degree to which different worlds inhabit the same meaning. Because I am fluent in Arabic, I had 
an advantage, as far as research methods are concerned, over other researchers in cross-cultural 
research who do not have mastery of the language. My ability to discuss points in the transcribed 
text, reassessing the meaning and how much it reflects the cultural concept conveyed, became 
one way of assessing the validity of interpretation (Young and Ackerman 2001). However, this did 
not necessarily produce texts that were absolute truths, because as a researcher I am always 
situated in complex social locations. Through my dual role as the researcher and 
translator/interpreter, the role seemed to be shifting and this was linked to how I am positioned. 
Researching from inside the language of the informants is a fulfilling and liberating act when the 
researcher-interpreter shares the common culture of those researched. This, however, does not 
necessarily mean that multilingual researchers produce better research than the monolingual 
researcher. In addition, being a multilingual researcher is not the only enquiry to better represent 
informants (Young and Ackerman 2001). Twine (2000) points out that translation/interpretation is 
not merely about 'racial matching' of the researcher with the informants because race and 
ethnicity are not the only, or always the over-riding factor in the translation/interpretation 
process. Twine stresses that having a certain degree of 'insiderness' because of language nativity 
is not a guarantee of an unproblematic position and, at the same time, difference may be a 
stimulator as well as a block to communication (Twine 2000). In any research that involves the use 
of translators/interpreters, it is critical that the translator/interpreter adopt the role of an 
informant or a 'neutral and objective transmitter of messages' (Temple & Young, 2004: 167). 
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Without establishing the views and perceptions of the translator and interpreter about the issues 
being explored, it becomes difficult to allow for differences in understanding of words, concepts 
and worldviews across the languages. Therefore, reporting the translator/interpreter's 
involvement in the research process is important. Acknowledging the translator/interpreter's 
social position contributed to the knowledge being produced, because as individuals we are all 
positioned differently in the social world influencing our understanding of people as social actors 
(Temple and Young 2004). 
As researchers we need to be reflective of the ways in which we, as individuals with social 
identities and particular perspectives, influence the interpersonal relations of the fieldwork. As 
researchers we need to be aware of our own social and political positions, make the 
translation/interpretation process visible and be responsible for the research data and the 
population we study. It is also important that translators/interpreters are included in the reflexive 
act. As a bilingual researcher, I have come to learn that one cannot assume that translating 
concepts across languages is not problematic. During interviews, I realised that a number of the 
Arabic HCPs were concerned about how their responses would be interpreted into English 'when 
you start translating, if there is something that you can't find an English alternative to call me and 
I'll help you'. Because of the culture and religion laden data, informants did not want 
misinterpreted data to be presented to a non-Arabic speaking panel when the data was 
transmitted to the UK: 'Our religion instructs us to medicate [in Arabicl so when you translate this 
use the word medicate [in Englishl'. The fear of having these values misinterpreted was linked 
with their concerns about having Islam and Arabic cultural concepts misinterpreted by a non- 
Arabic speaking panel. Although during the process of interpretation/translation I made sure that 
I conveyed the actual meaning, I have to admit that as a Muslim/Emirati I shared my informants' 
concern. In my study, I felt that I have spent time trying to make my identities as the 
translator/interpreter, researcher and Muslim visible, which have highlighted some of the 
tensions in asking the researcher to represent the 'other'. 
8.6 Recommendations for future research 
This thesis reported a number of important findings that have been highlighted throughout this 
chapter, but it also generated a number of areas for future investigation that included UAE health 
policy, patient-provider communication and pharmaceutical care in the UAE. Details about these 
areas are presented in this section. 
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8.6.1 The UAE health care policy 
Discussion, implications and reflections 
Whether it was a lack of health research or poor publications, there seems to be a need to 
explore patient-provider communication and the impact it has on patient satisfaction and 
therapeutic outcomes within the UAE context. The multicultural nature of the health care system 
in the UAE has widened the language gap and the consequential cultural incompetence between 
patients and HCPs. The strategy of health authorities in the UAE to close communication gaps was 
through providing onsite language interpreters. However, findings from this study suggest that 
the ramifications of cultural incompetence still existed and affected patient-provider 
communication and relationships. 
8.6.2 Patient-provider communication 
This study also identified a lack of concordance, as well as factors that hinder patients' 
empowerment and autonomy as reported by the study participants. Future studies can explore 
factors limiting cultural competence, concordance and patient-centred health care approaches. 
An ethnographic study that includes both observations of counselling sessions and interviews with 
patients and HCPs would provide an in-depth understanding of the dynamics of patient-provider 
relationships. Findings from such studies can then be utilised to design interventions that might 
improve patient-provider relationships and patients' satisfaction in the UAE. 
8.6.3 Adherence to treatment plan 
This study was also able to identify factors that altered patients' adherence to both lifestyle 
interventions and prescribed medicines. Some of these factors were influenced by the UAE socio- 
cultural context, food misconceptions and patients' beliefs about medicines. The prevalence of 
such factors and the extent to which they influence health behaviour and therapeutic outcomes in 
MetS management can be further validated in a population that represents the whole of the UAE 
or in culturally similar populations. Findings from such studies coupled with findings from this 
study can be used to design culturally sensitive interventions that enhance adherence to the 
prescribed MetS management. 
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8.6.4 Pharmaceutical care in the UAE 
Discussion, implications and reflections 
Another interesting finding from this study, which was not presented in detail, was pharmacists' 
limited role in patients' treatment plans. This finding was not merely restricted to pharmaceutical 
care of patients with MetS, but rather included all patient groups. Pharmacists were able to 
report many of the patients' beliefs about medicines that affected adherence; however, they 
were not involved in patients' health education and rarely assessed patients' medicine use. Future 
research can explore the pharmacy profession and pharmaceutical care in the UAE and factors 
influencing its development. Such studies can help identify gaps in the profession and the 
development of interventions that will ameliorate pharmaceutical care in the UAE. 
8.7 Conclusion 
This was a qualitative study that aimed at exploring patient and professional perceptions of MetS 
in the UAE. Through conducting semi-structured interviews and a focus group discussion, this 
study was able to identify a number of factors that influenced the holistic management of MetS. 
Factors such as the complexity of the MetS name and the absence of MetS from the list of 
reimbursed medical conditions discouraged physicians from informing patients of their MetS 
diagnosis and limited the clinical utility of the MetS concept, respectively. Family restrictions of 
outdoor exercising by women, lack of culturally sensitive health clubs, food-centric activities and 
eating habits were among the socio-cultural factors that hindered successful implementation of 
lifestyle interventions. Beliefs about medicines influenced patients' medicine-taking habits and 
altered their adherence to prescribed pharmacotherapy. Study participants reported a number of 
facilitators that they believed would improve MetS prevention and management in the UAE. 
HCPs emphasised the key role of the public health policy to prevent MetS and promote a healthy 
lifestyle. 
This study provides important new information for understanding the dynamics of patients' 
health behaviour and attitude towards MetS treatment in the UAE. It also illustrates how aspects 
of the health policy and professionals' clinical practice limit the clinical utilisation of the MetS 
concept. Efforts to promote healthy behaviour and enhance the prevention and management of 
MetS in the UAE need to be stepped up and be tailored to patients' personal, social and cultural 
needs. HCPs should adopt a more patient-centred approach while acknowledging patients' 
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backgrounds in order to address different factors that impact patients' health behaviour and 
adherence to treatment plans. 
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We wish you all the best. 
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Appendix 2: Health care professionals' information sheet 
The University of 
Nottingham 
Patient and professional perceptions of metabolic syndrome and its 
management in the UAE 
You are being invited to take part in a research study. Before you decide it is important for you to 
understand why the research is being done and what it will involve. Please take time to read the following 
information. 
What is the purpose of the study? 
Metabolic syndrome is defined as the clustering of cardiometabolic risk factors (i. e., hypertension, type 2 
diabetes or impaired fasting glucose, dyslipidaemia and obesity. Metabolic syndrome is believed to be the 
new driving force of type 2 diabetes and cardiovascular diseases. The multifaceted nature of the metabolic 
syndrome mandates the implementation of both lifestyle and pharmacological interventions. However, 
many factors can prevent successful management. In the UAE it is estimated that 40.5% of the country's 
adult population have metabolic syndrome. Literature that describes the needs of patients with metabolic 
syndrome in the UAE is scarce; therefore, the aim of this study is to explore patients' health needs through 
the perceptions of both patients and health care professionals in the UAE. 
Why have I been chosen? 
Health care professionals who are involved in the management of patients with metabolic syndrome are 
an important source of information about patients' health needs and other factors that might hinder or 
facilitate their management. Physicians, pharmacists, dieticians and health educators are part of the 
multidisciplinary team of metabolic syndrome management and are invited to take part in the study. 
Do I have to take part? 
No. It is up to you to decide whether you want to take part. If you do, you will be given this information 
sheet to keep and be asked to sign a consent form. You are still free to withdraw at any time and without 
giving a reason. Any data collected from you will be destroyed if you decide to withdraw from the study. 
What will happen to me if I take part? 
You will be interviewed by the researcher for approximately 30 minutes to 1 hour. This interview will 
gather information about your knowledge and experience in managing patients with metabolic syndrome. 
You will be asked whether you will allow the researcher to audio tape this interview or not. You and the 
researcher will agree on a location and timing for the interview once you agree to take part. 
What do I have to do? 
On(v you agree to take part in this study you will only be required to take part in this interview. 
What are the possible disadvantages and risks of taking part? 
it is not anticipated that there will be any risk associated with the study. The interviews are unlikely to 
cover any sensitive issues, and you will not be forced to answer any questions you feel uncomfortable 
with. 
What happens when the research study stops? 
The Study will not affect your continued treatment in any way. 
What will happen to the research study records? 
Data will be stored securely in a locked cupboard. Any data stored electronically will be fully password 
protected and at the end of the study data will then be destroyed. 
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What will happen to the findings of the research study? 
The findings of the study will be published as a full report, as a research paper in academic and 
professional journals and presented at conferences. This is likely to be in 3-years time when the full study 
is completed. If you would like a copy of the findings, please let the researcher know either through email 
or by phone (see contact details at the end of this sheet). 
No individual patient will be identified in any of the reports, papers or findings 
What if there is an issue that I want to report? 
Any issue related to the interview that you feel needs to be reported can be reported to SKMC assigned 
co-supervisor : Dr. () Contact number( 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be handled in confidence. 
Who is organising the research? 
This study is organised by the Division of Social Research in Medicines and Health at the school of 
pharmacy in the University of Nottingham and the researcher for a PhD degree. 
Contact details for further information: 
If you have any questions or need further information, either now or at any time during the research, 
please contact me at the contact details given below: 
Miss Naseeba Al Ozaibi BSC/MSc 
Division of Social Research in Medicines and Health 
School of Pharmacy 
University of Nottingham 
NG7 2RD 
Email: paxna(@nottinpham. ac. uk 
Tel UK: () 
Tel UAE: () 
Thank you for taking the time to read this information sheet 
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Appendix 3: Patients' information sheet 
The University of 
Nottingham 
Patient and professional perceptions of metabolic syndrome and its 
management in the UAE 
You are being invited to take part in a research study. Before you decide it is important for you to 
understand why the research is being done and what it will involve. Please take time to read the following 
information. 
What is the purpose of the study? 
Metabolic syndrome is defined as the clustering of cardiometabolic risk factors (i. e., high blood pressure, 
type 2 diabetes or high blood glucose levels, elevated lipid profile and obesity). Metabolic syndrome is 
believed to be the new driving force of type 2 diabetes and cardiovascular diseases. The multifaceted 
nature of the metabolic syndrome mandates the implementation of both lifestyle and pharmacological 
interventions. However, many factors can prevent successful management. In the UAE, it is estimated that 
40.5% of the county's adult population have metabolic syndrome. Literature that describes the needs of 
patients with metabolic syndrome in the UAE is scarce; therefore, the aim of this study is to explore 
patients' health needs through the perceptions of both patients and health care professionals in the UAE. 
Why have I been chosen? 
You have been chosen because you have the metabolic syndrome; therefore, you are a suitable candidate 
for this study. Patients with metabolic syndrome are able to talk about their health needs. Therefore, your 
participation in this study will help researchers understand factors that can improve patients' 
management and strategies that can prevent metabolic syndrome in the future. 
Do I have to take part? 
No. It is up to you to decide whether you want to take part. If you do you will be given this information 
sheet to keep and be asked to sign a consent form. You are still free to withdraw at any time and without 
giving a reason. Any data collected from you will be destroyed if you decide to withdraw from the study. 
What will happen to me if I take part? 
You will be interviewed by the researcher for approximately 30 minutes to 1 hour. This interview will 
gather information about your knowledge and experience with metabolic syndrome and its management. 
You will be asked whether you will allow the researcher to audio tape this interview or not. You and the 
researcher will agree on a location and timing for the interview once you agree to take part. 
What do I have to do? 
Once you agree to take part in this study you will only be required to take part in this interview. 
What are the possible disadvantages and risks of taking part? 
It is not anticipated that there will be any risk associated with the study. The interviews are unlikely to 
cover any sensitive issues, and you will not be forced to answer any questions you feel uncomfortable 
with. 
What happens when the research study stops? 
The study will not affect your continued treatment in any way. 
What will happen to the research study records? 
Data will be stored securely in a locked cupboard. Any data stored electronically will be fully password 
protected and at the end of the study data will then be destroyed. 
What will happen to the findings of the research study? 
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The findings of the study will be published as a full report, as a research paper in academic and 
professional journals and presented at conferences. This is likely to be in 3-years time when the full study 
is completed. If you would like a copy of the findings, please let the researcher know either through email 
or by phone (see contact details at the end of this sheet). 
No individual patient will be identified in any of the reports, papers or findings. 
What if there is an issue that I want to report? 
Any issue related to the interview that you feel needs to be reported, can be reported to SKMC assigned 
co-supervisor: Dr. () Contact number( 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be handled in confidence. 
Who is organising the research? 
This study is organised by the Division of Social Research in Medicines and Health at the school of 
pharmacy in the University of Nottingham and the researcher for a PhD degree. 
Contact details for further information: 
If you have any questions or need further information, either now or at any time during the research, 
please contact me at the contact details given below: 
Miss Naseeba Al Ozaibi BSC/MSc 
Division of Social Research in Medicines and Health 
School of Pharmacy 
University of Nottingham 
NG7 2RD 
Email: paxna()nottingham. ac. uk 
Tel UK: () 
Tel UAE: () 
Thank you for taking the time to read this information sheet 
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Appendix 4: Health care professionals' consent form 
Centre number: 
Study number: 
Health care professional identification number: 
PROFESSIONAL CONSENT FORM 
Title of the Study: 
The University of 
' Nottingham 
1 
Patient and professional perceptions of metabolic syndrome and its management in the UAE 
Name of the researcher: Naseeba Al Ozaibi 
Please initial Box 
1. I confirm that I have read and understand the information sheet dates () for the Q 
above study. I have had the opportunity to consider the information, ask questions and have 
had these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, Q 
without giving any reason, without my medical care or legal rights being affected. 
3. I understand that relevant data collected during the study may be looked at by responsible Q 
individuals from the University of Nottingham where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to this data. 
4. I give my consent for the audio-taping of the interview that will take place between me and Q 
the researcher. 
5.1 give my consent for anonymised direct quotes to be used in reports and publications. 
6.1 agree to take part in the above study. 
Name of health professional Date 
Name of person taking consent 
(if different from researcher) 
Date 
RPSPi((her Date 
F71 
Signature 
Signature 
Signature 
When completed, 1 for professional; 1 researcher site file 
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Appendix 5: Patients' consent form 
Centre number: 
% The University of 
Study number: 
' Nottingham Patients' number: t- 
PATIENT CONSENT FORM 
Title of the Study: 
Patient and professional perceptions of metabolic syndrome and its management in the UAE 
Name of the researcher: Naseeba Al Ozaibi 
Please initial Box 
I confirm that I have read and understand the information sheet dates () for the above study. I 
have had the opportunity to consider the information, ask questions and have had these answered 
satisfactorily. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, without giving Q 
any reason, without my medical care or legal rights being affected. 
3. I understand that relevant data collected during the study may be looked at by responsible individuals Q 
from the University of Nottingham where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to this data. 
4. I give my consent for the audio-taping of the interview that will take place between me and the Q 
researcher. 
5 give my consent for anonymised direct quotes to be used in reports and publications. Q 
E, I agI P to take part in the above study. F-I 
Name of patient 
Name of person taking consent 
(if different from researcher) 
Researcher 
Date 
Date 
Date 
Signature 
Signature 
Signature 
When completed, 1 for patient; 1 researcher site file 
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Appendix 6: Patients' interview guide 
Awareness of metabolic syndrome 
1. Can you remember when you where first diagnosed with (MetS features)? 
2. What other health problems do you have if any? 
3. Do you have any symptoms? Can you describe to me what it feels like having these 
health problems? 
4. How serious do you feel your condition is? 
Patient's feelings towards their health condition 
1. Did being a patient with MetS (CRFs) change your life? If so how? 
2. Do you know anyone else who has a similar health condition? How does their condition compare to 
yours? 
Patient's knowledge about their treatment plan 
1. Can you tell me what drugs you are taking now? 
2. How long have you been on these medications? 
3. Can you tell me what each is used for and how you're taking them? 
Patient's feelings towards their treatment plan 
1. How do you feel towards your current treatment plan? 
2. Did your treatment plan go through many changes? 
3. If yes, what were they? How did that make you feel? 
4. Do you agree with everything your prescriber suggests/prescribes? (yes/ no) Why? 
5. Do you think this treatment is working for you? / How successful this treatment plan is? 
6. How do you feel you should be treated? 
Factors affecting management 
1. Can you tell me what you do to look after your health condition? 
2. Do you face similar difficulty with your drug regimen? 
3. How hard is it for you to keep taking your drugs as prescribed? 
4. What do you think will happen if you do not take your medication as prescribed? 
5. Are there other factors that make this worse? 
6. How do you think this should be solved? 
7. Did you talk to your doctor about it? Why? (yes) How did they feel about it? 
8. How hard was it for you to adjust your lifestyle? 
9. Why do you think it is hard? 
10. How do you think this could be made easier? 
11. How important or necessary do you feel it is to improve your lifestyle? 
12. What do you think will happen if you do not change your lifestyle? 
Is there anything else that you want to add about your health condition or medicines? 
Is there anything you expected me to ask you about and I did not? 
Thank you for taking part in this interview. 
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Appendix 7: Health care professionals' interview guide 
Awareness of MetS 
1. What do you think of the MetS? 
2. Do you use MetS to identify patients at risk of diabetes or CVDs? 
3. What definition of MetS do you use in the clinical setting? 
4. Do you think that the MetS concept is useful within the clinical setting? 
5. From your experience, how significant is the MetS in the UAE/ Abu Dhabi 
6. What do you think the reasons are behind the high prevalence of MetS in the UAE? 
7. What do you think patients' with MetS in the UAE need? 
Existing strategies for the management of MetS in the UAE 
1. How are patients usually identified? 
2. Do you inform patients of their MetS diagnosis? 
3. Can you describe for me the steps followed in managing patients with MetS? 
 Health education 
 Referrals 
 Assessing adherence 
 Patients' adherence 
Barriers to MetS management in the UAE 
1. What do you think influences the management of MetS in the UAE 
2. What do you think influences patients' attitudes towards their condition? 
3. What do you think influences patients' attitudes towards their treatment plans? 
4. In your opinion, what are the barriers to MetS management in the UAE? 
 Health care related barriers 
 Health care professionals related barriers 
 Patients related barriers 
 Cultural related barriers 
Facilitators to MetS management in the UAE 
1. In your opinion what will facilitate the management of patients with MetS? 
2. How can patients' therapeutic outcomes be improved? 
3. How can we prevent the metabolic syndrome? 
4. Do you think existing strategies are sufficient to improve MetS management and prevention? 
 Public health policy 
 Prevention strategies 
 Health promotion strategies 
 Special health service for patients with MetS 
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Appendix 8: Pharmacist focus group interview guide 
Awareness of MetS 
1. What is MetS? 
2. Did you hear about it before this focus group? Where? 
3. How do you identify patients with MetS? 
4. Do you have the tools to identify patients with MetS? 
5. How different is a patient with MetS from that of other patients with other conditions? Do they need 
special attention? Do they have special health needs? 
Barriers & facilitators to MetS management 
1. What are the barriers and facilitators the management of patients with MetS? 
 Patient-related barriers 
 Pharmacists-related barriers 
 System-related barriers 
 Culture-related barriers 
2. Are there any specific issues related to medicine-taking? 
 Adherence 
 Refills 
 Side effects 
3. What are the most frequent issues reported by patients regarding their medicine? 
4. How do you usually resolve patients' health issues when reported or identified? 
5. In your opinion what will help improve the management of patients with MetS? 
Pharmacists' role in managing patients with the metabolic syndrome 
1. From your experience what is pharmacists' role in MetS? 
2. What are the things you do with patients other than dispensing their medicines? 
3. Do you assess patients' adherence/ review medicine use? 
4. Do you do any kind of medicine use reviews? Do you investigate ADR? 
5. Do you give advice on lifestyle? Why? 
6. Do doctors welcome your recommendations? 
7. When patients say they don't use certain medicines but they will still collect it, what do you do? 
8. How often do you give advice on medicine or get asked about a drug-related issue? 
9. What are the most common concerns of patients with MetS when they ask for the pharmacists' 
assistance? 
10. Do you want to be involved in MetS management? (if yes) How would you like to be involved? (if No) 
Why? 
11. Who do you think is better suited for the task: clinical or dispensing pharmacists? 
12. What are the limitations in contributing as clinical pharmacists? How do you think they can be 
resolved? 
Future work 
1. Do you think you want to have a role in managing patients with MetS? 
2. How can pharmacists contribution to the managing of patients with MetS be improved? 
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Appendix 9: Information of HCPS taking part in the interviews 
This table also illustrates interview duration, language with which the interview was conducted and 
location of the interview. 
Professional Gender Nationality Language Location Duration 
Doctor-1 Male Palestinian Arabic FMC 00: 37: 49 
Doctor-2 Male Sudanese English SKMC 00: 57: 33 
Doctor-3 Female Emirati English DC 00: 36: 42 
Doctor-4 Female Jordanian English OPC 00: 58: 21 
Doctor-5 Female Jordanian English DC 00: 35: 11 
Doctor-6 Male Egyptian English OPC 00: 32: 06 
Doctor-7 Female Egyptian English OPC 00: 37: 01 
Doctor-8 Male Iraqi English OPC 00: 28: 30 
Doctor-9 Male Palestinian English OPC 00: 28: 30 
Doctor-10 Female British English FMC 00: 26: 35 
Pharmacist 1 Female Canadian English DC 01: 40: 49 
Pharmacist 2 Female Emirati Arabic FMC 00: 32: 16 
Pharmacist 3 Female Sudanese English FMC 00: 47: 56 
Pharmacist 4 Female Lebanese Arabic Coffee Shop 00: 33.31 
Pharmacist 5 Female Jordanian English OPC 00: 32: 26 
Pharmacist 6 Female British English OPC 00: 58: 31 
Pharmacist 7 Female Emirati Arabic OPC 00: 74: 46 
Pharmacist 8 Female Emirati English OPC 00: 48: 18 
Pharmacist 9 Female Singapore English OPC 00: 38: 56 
Pharmacist 10 Female Emirati English FMC 00: 52: 16 
Pharmacist 11 Female Jordanian English OPC 00: 34: 31 
Educator 1 Female Bahraini Arabic DC 00: 51: 30 
Educator 2 Female Jordanian Arabic DC 00: 21: 06 
Dietician 1 Female Jordanian Arabic DC 00: 43: 09 
Dietician 2 Female Emirati Arabic DC 00: 28: 37 
Dietician 3 Female Emirati Arabic FMC 00: 30: 00 
Dietician 4 Female Emirats Arabic OPC 00: 17.14 
Duration units: (hours: minutes: seconds) 
Abbreviations: 
DC: Diabetes Centre 
FMC: Family Medicine Clinic 
OPC: Outpatient clinic 
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Appendix 10: Information of pharmacists taking part in the focus group 
Focus group took place a meeting room at the of SKMC. 
Duration of focus group was Olhr: 30m: 35s 
Professional Gender Nationality Pharmacy 
Pharmacist 12 Male Syrian FMC 
Pharmacist 13 Male American/Palestinian OPC 
Pharmacist 14 Female Egyptian OPC 
Pharmacist 15 Male Jordanian FMC 
Pharmacist 16 Female Egyptian FMC 
Pharmacist 17 Female Egyptian OPC 
Pharmacist 18 Female Egyptian OPC 
Pharmacist 19 Female Jordanian FMC 
Pharmacist 20 Female Egyptian FMC 
All participants in the focus group did not participate in the previous interviews 
Abbreviation: 
FMC: pharmacist working in a pharmacy located in one of the Family Medicine Clinics 
OPC: pharmacist working in the Outpatient Clinic Pharmacy 
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Appendix 11: Information of patients taking part in the interviews 
Gender Age lit ti N Educational BG Location Duration Patient 
Male Female (yrs) 
y ona a 
Patient 1  45 British High-school OPC 42: 21 
Patient 2  33 Emirati University DC 44: 01 
Patient 3  69 Yemeni Read and write Patient home 21: 16 
Patient 4  60 Yemeni University DC 33: 00 
Patient5  50 Indian University Patient work 23: 43 
Patient 6  65 Yemeni University Telephone 19: 56 
Patient 7  70 Emirati Illiterate Patient home 08: 41 
Patient 8  52 Iranian Primary-school Patient home 07: 36 
Patient 9  43 Palestinian High-school FMC 13: 52 
Patient 10  50 Palestinian Primary-school FMC 17: 07 
Patient 11  67 Emirati Illiterate Telephone 07: 10 
Patient 12  43 Palestinian High-school Telephone 26: 54 
Patient 13  49 Bangladeshi University DC 32: 39 
Patient 14  73 Sudanese University DC 24: 21 
Patient 15  55 Yemeni Read and write DC 20: 44 
Patient 16  57 Palestinian High-school FMC 10: 27 
Patient 17  60 Jordanian High-school Telephone 12: 10 
Patient 18  54 Sudanese Primary-school Patient home 13: 44 
Patient 19  67 Emirati University Telephone 28: 37 
Patient 20  37 Emirati High-school Telephone 10: 34 
Patient 21  49 Emirats Illiterate Patient home 16: 50 
Patient 22  52 Yemeni Primary-school OPC 08: 04 
Patient 23  55 Emirati Read and write Patient home 07: 26 
Patient 24  46 Emirati Primary-school FMC 06: 50 
Patient 25  60 Egyptian Primary-school FMC 05: 59 
Patient 26  53 Iranian Illiterate OPC 18: 32 
Patient 27  55 Emirati High-school OPC 11: 06 
Patie! t 28  45 Yemeni University Patient home 16: 28 
Patient 29  34 Emirati University Telephone 33: 21 
Abbreviations: 
BG: Background 
DC: Diabetic Centre 
FMC: Family Medicine Clinic 
OPC: Outpatient Clinic 
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Appendix 12: Publications and presentations from this study 
CONFERENCE PAPERS 
Alozaibi N, Anderson C, Boyd M. How culture and modernity limit successful management of the 
metabolic syndrome in the United Arab Emirates (UAE): a qualitative study with health care professionals 
and patients. East Midlands University Association 2010; available online: 
http: //www. emua. org. uk/article/postgraduate 
ABSTRACTS PUBLISHED 
  
Alozaibi N, Anderson C, Boyd M. Health professionals talking about cultural influences in managing 
patients with the metabolic syndrome: a qualitative study in the United Arab Emirates (UAE). 
International Journal of Pharmacy Practice 2010; 8(Suppl. 1): 83 
  
Alozaibi N, Anderson C, Boyd M. Hospital pharmacists' role in the management of metabolic 
syndrome in the United Arab Emirates (UAE): a qualitative study. International Journal of Pharmacy 
Practice 2010; 8(Suppl. l): 83 
  
Alozaibi N, Anderson C, Boyd A. Why don't patients with metabolic syndrome achieve recommended 
blood pressure targets? A pilot study in the United Arab Emirates. International Journal of Pharmacy 
Practice 2010; 18(Suppl. 1): 32-33 
PRESENTATIONS 
Oral presentations 
  
How culture and modernity limit successful management of the metabolic syndrome in the United 
Arab Emirates (UAE): a qualitative study with health care professionals and patients. East Midlands 
University Association Conference 2010. Nottingham, United Kingdom 
  
Metabolic syndrome in the UAE. What are the health issues? A qualitative research. School of 
Pharmacy Post Graduate Seminar Series. The University of Nottingham July 2010 
 A closer look at metabolic syndrome management in the UAE. Division of Social Research in 
Medicines and Health Research Group Presentation. The University of Nottingham July 2009 
  
identifying factors that influence BP control in patients with the metabolic syndrome. 
A mixed method research in the UAE. Division of Social Research in Medicines and Health Research 
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